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Background 
Physiotherapy  is  a  central  feature  of  organized  stroke  care  but  there  is  little  direct 
evidence  to  support  its  use.  In  particular  we  do  not  know  the  optimum  amount  of 
physiotherapy  for  individual  patients  and  recent  trials  have  been  inconclusive.  We 
conducted  an  individual-p  ati  ent-  data  meta-analysis  of  trials  testing  increased  levels  of 
physiotherapy  input. 
Methods 
We  carried  out  a  literature  search  (up  to  the  end  of  December  2002)  and  included  all 
randomised  controlled  trials  of  intensity  of  physiotherapy.  We  also  contacted  authors  of 
four  trials  that  were  not  fully  published  by  that  date  but  have  subsequently  reported.  A 
Collaborative  group  was  formed  and  trialists  provided  individual  patient  data  for 
analysis.  Using  standard  methods  (Stewart  and  Clarke  1995),  data  were  cleaned  and 
categorized  by  patient  details,  intervention  and  outcomes. 
We  compared  intended  physiotherapy  dose  against  change  in  outcome  for  those  studies 
with  available  data.  We  used  multivariate  logistic  regression  to  examine  the  following 
outcomes  in  relation  to  patient  characteristics  (age,  severity  of  disability  and  arm 
impairment  at  baseline)  and  treatment  characteristics  (target,  total  treatment  contrast, 
time  to  start  treatment,  daily  treatment  contrast  and  duration  of  treatment),  measuring 
differences  between  augmented  and  standard  groups  and  interactions  between  the 
subgroups. 
Primary  outcome:  overall  disability. 
Secondary  outcomes: 
overall  impairment 
survival 
improvement  in  arm  and  leg  impairment 
improvement  in  arm  and  leg  function 
change  in  activities  of  daily  living  (ADL)  measured  by  the  Barthel  Index  (BI). 
length  of  hospital  stay 
treatment  success  -  "Good  recovery"  -  greater  than  median  recovery  (measured  by  BI) 
in  the  control  group. 
treatment  success  -  "Excellent  recovery"  -  greater  than  the  upper  quartile  of  recovery 
(measured  by  BI)  in  the  control  group. Results 
We  incorporated  9  trials  (951  subjects). 
We  found  no  statistically  significant  differences  between  patients  receiving  intensive  or 
standard  amounts  of  physiotherapy,  in  terms  of  overall  disability  or  overall  impairment 
scores,  length  of  hospital  stay  or  survival. 
Secondary  analyses  showed  improvements  in  Motricity  Index  scores  for  the  upper 
limbs  (5.2  units,  95%  CI  1.5  to  8.8,  P=0.0058)  and  lower  limb  1-  s  (6.8  units,  95%  Cl  ')  -2- 
11.4,  P=0.0042).  Improvements  were  also  seen  in  Action  Research  Arm  Test  scores 
(1.8  units,  95%  CI  -1.2  to  4.8, P=0.25)  in  younger  patients  (under  70  years)  and  those 
with  higher  baseline  Barthel  scores,  and  in  recovery  of  walking  speed  (increase  of 
0.056  m/s,  95%  Cl  -0.018  to  0.130,  P=0.14)  (when  the  target  of  treatment  was  lower 
limb  or  gait  focused). 
There  was  no  significant  difference  in  change  in  ADL  (measured  by  BI  (7  trials)) 
between  the  groups  (0.15  units  of  change  in  BI,  95%  Cl  -0.38  to  0.67,  P=0.58).. 
There  were  increased  odds  of  a  "good  recovery"  i.  e.  (improvement  of  6  points  or  up  to 
the  maximum  of  20  /  20  on  BI),  (odds  ratio  1.33;  0.96  -  1.85;  P=0.09)  and  of  "excellent 
recovery"  (>  8  points  or  up  to  the  maximum  on  BI),  (odds  ratio  1.47;  1.03  -  2.05; 
P=0.04)  in  the  augmented  group. 
The  higher  contrast  trials  in  our  study  (typically  15  -  44  hrs  additional  physiotherapy, 
with  earlier  onset  at  7-10  days  after  admission,  higher  daily  contrast  and  longer 
duration)  are  more  likely  to  show  treatment  effects  than  lower  contrast  trials,  with 
respect  to  impairment  measured  by  the  Motricity  index  and  disability  measured  by  the 
BI. Conclusion 
Modest  increases  in  the  intensity  of  physiotherapy  after  stroke  did  not  produce 
substantial  changes  in  the  primary  outcomes.  Targeted  additional  therapy  in  selected 
patients  may  improve  limb  impairment  and  walking  speed. 
Our  results  confirm  what  might  be  expected  and  provide  estimates  of  the  modest 
treatment  effect  likely  in  these  domains. 
Individual  patient  data  meta-analyses  provide  the  opportunity  to  explore  subgroups  in 
order  to  answer  clinically  relevant  questions  and  guide  further  research.  Large  numbers 
of  subjects  are  required  for  randomised  controlled  trials  (RCTs)  of  intensity  of 
physiotherapy.  Considering  the  challenges  involved  in  running  such  trials  we 
recommend  the  use  of  similar  outcome  measures  in  order  to  facilitate  future  meta- 
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CHAPTER] 
INTRODUCTION 
Introduction 
This  thesis  examines  the  subject  of  the  optimum  intensity  of  physiotherapy  input  for 
patients  after  stroke.  In  this  introductory  chapter  I  describe  some  of  the  problems  of 
stroke,  how  these  are  currently  managed,  including  physiotherapy,  before  stating  my 
hypothesis  and  the  questions  about  intensity  of  physiotherapy  that  I  aim  to  address.  I 
also  define  some  of  the  terms  I  will  use,  and  finally,  describe  the  structure  of  the  thesis, 
laying  out  how  I  set  out  to  address  these  questions. 
The  problem  of  stroke 
Information  on  the  importance  of  stroke  and  the  potential  impact  of  developing 
treatments  that  may  reduce  its  effects  is  widely  available  and  well  described  (Bonita 
1992,  Warlow  1998,  Warlow  et  al.  2001).  However,  it  does  bear  repeating  briefly  in  this 
introduction. 
Stroke  is  the  third  greatest  cause  of  death  worldwide  (Warlow  1998)(Wolfe  2000)  and 
one  of  the  biggest  causes of  handicap  in  the  community  (Bonita  &  Beaglehole 
1988)(Khaw  1996)(Warlow  et  al.  2001).  The  incidence  of  first  ever  in  a  lifetime  stroke 
(where  it  has  been  studied,  in  the  predominantly  white  population  of  the  world)  is 
estimated  at  about  two  per  1000  per  year  and  about  four  per  1000  per  year  in  people 
aged  45  -  84  years.  In  the  United  Kingdom  (U.  K.  )  it  is  estimated  to  be  approximately 
145  per  100  000  (Rothwell  et  al.  2004).  There  are  approximately  15,000  new,  first  ever 
strokes  and  70,000  existing  strokes  each  year  in  Scotland.  The  rate  of  stroke  recurrence 
is  about  5%  per  year  (with  a  higher  rate  in  the  initial  weeks  and  months  after  first 
stroke)  (Warlow  1998). 
Some  authors  have  described  a  small  reduction  in  the  incidence  of  stroke  reported 
worldwide  (Bonita  1992)  though  the  exact  explanation  for  this  remains  uncertain 
(Warlow  1998).  This  reduction  may  be  attributable  to  the  development  of  effectiN-e 
primary  (and  secondary)  prevention  strategies  or  to  trends  in  risk  factors  for 
cerebrovascular  disease.  Alternatively,  it  may  reflect  difficulties  in  collecting  accurate 
data  over  time  in  a  number  of  countries. Chapter  I 
Despite  this  apparent  reduction,  the  number  of  patients  presenting  with  stroke  is  still 
likely  to  be  substantial.  With  life  expectancy  increasing,  populations  will  contain  larger 
proportions  of  elderly  people.  Increasing  age  is  a  risk  factor  for  stroke,  therefore  the 
number  of  people  with  stroke  in  absolute  terms  is  likely  to  increase  (Bonita  1992).  The 
problems  associated  with  stroke  seem  set  to  continue  to  present  themselves  to  patients 
and  their  carers,  clinicians,  those  responsible  for  health  service  provision  and  the 
societies  in  which  they  live. 
In  this  thesis  I  use  a  widely  accepted  definition  of  stroke:  "a  clinical  syndrome 
characterized  by  rapidly  developing  clinical  symptoms  and/or  signs  of  focal,  and  at 
times  global  loss  of  cerebral  function,  with  symptoms  lasting  more  than  24  hours  or 
leading  to  death,  with  no  apparent  cause  other  than  that  of  vascular  origin"  (Hatano 
1976).  1  did  however,  exclude  patients  diagnosed  with  sub-arachnoid  haemorrhage. 
In  broad  terms,  patients  with  stroke  can  be  divided  into  three  groups;  those  that  have  a 
minor  stroke  with  symptoms  which  are  mild  and  are  likely  to  make  a  speedy  and 
complete  or  near  complete  recovery  (approximately  30%  of  patients);  a  middle  band  of 
patients  who  have  considerable  deficits  that  require  rehabilitation;  and  those  with  severe 
stroke  that  are  unlikely  to  survive  beyond  the  first  month  after  stroke  onset 
(approximately  20  -  28%  of  cases)(Warlow  1998)  (Wolfe  et  al.  1999). 
Up  to  50%  of  surviving  patients  are  left  with  some  sort  of  residual  neurological  deficit 
(Effective  Health  Care  1992)  such  as  motor  loss  (hemiplegia),  possibly  with  loss  of 
upper  limb  function  and  the  ability  to  walk,  visual  loss,  altered  muscle  tone,  loss  of 
communication,  loss  of  cognitive  function  and  sensory  or  perceptual  problems.  These 
may  result  in  difficulties  in  self-care  and  activities  of  daily  living  (ADL)  (with  about  a 
third  of  all  patients  requiring  some  assistance  with  ADL  up  to  6  months  after  their 
stroke)  (Bonita  &  Beaglehole  1988). 
In  addition  to  the  personal  costs  involved,  these  patients  require  considerable  health 
service  and  community  resources.  Costs  based  on  studies  over  the  past  25  years, 
estimate  that  4-7.6%  of  hospital  expenditure  can  be  attributed  to  stroke  (Hakim  & 
Bakheit  1998)  or  approximately  two  billion  pounds  in  1999  in  the  UK  (Ebrahim  2000). Chapter  I 
Health  service  costs  vary  between  countries  and  estimates  put  costs  at  about  t8,000  per 
patient  in  Sweden  in  1983  and  L6,000  per  patient  in  a  later  study  in  Scotland  in  1988 
(Isard  &  Forbes  1992).  A  more  recent  comparison  of  stroke  care  provision  estimated 
costs  for  conventional  hospital  care  in  Newcastle,  England  to  be  E7480  per  patient 
(McNamee  et  al.  1998).  A  more  comprehensive  estimate  including  communit,  y  and 
social  services,  family  costs  and  loss  of  productivity  may  be  more  like  E70  000  per 
patient  in  an  estimate  in  the  United  States  of  America  in  1990  (Taylor  et  al.  1996). 
The  greatest  proportion  of  acute  hospital  inpatient  expenditure  (more  than  90%)  can  be 
attributed  to  nursing  and  "hotel"  costs  (Warlow  et  al.  2001).  The  length  of  hospital  stay 
varies  greatly  from  patient  to  patient,  and  can  depend  on  a  number  of  factors  including 
clinical  subtype  of  stroke,  the  patients'  age,  sex  and  functional  dependency  and  the 
views  of  the  consultant  caring  for  them  (Hakim  &  Bakheit  1998). 
Tackling  the  problem  of  stroke 
If  some  form  of  effective  treatment  was  available  for  those  patients  requiring  stroke 
rehabilitation  then  considerable  improvements  in  patients'  abilities,  independence  and 
quality  of  life  might  be  made. 
The  group  of  patients  with  a  poor  prognosis  and  high  death  rate  are  often  the  target  of 
studies  of  interventions  aimed  at  saving  life.  However,  some  researchers  have 
reservations  about  developing  interventions  that  may  prevent  deaths  but  result  in  very 
dependent  survivors.  If  there  were  proven  effective  rehabilitation  treatments,  then  this 
might  encourage  further  development  of  promising  acute  treatments,  safe  in  the 
knowledge  that  survival  might  not  necessarily  mean  dependence  and  disability. 
Improved  knowledge  of  effective  treatments  would  also  allow  finite  resources  to  be 
targeted  to  maximum  effect  and  to  reduce  waste.  Any  method  that  reduces  treatment 
times,  in  particular  hospital  inpatient  stay,  may  be  particularly  useful  in  reducing  costs. 
So  far,  the  most  effective  way  of  improving  stroke  patient  outcomes  is  with  stroke  units. 
This  was  recognised  in  an  overview  of  methods  of  managing  patients  with  stroke 
(Stroke  Unit  Trialists  Collaboration.  1997).  This  overview  provided  good  evidence  of 
benefits  to  patients  with  stroke  that  are  managed  in  a  stroke  unit  as  opposed  to  a  general 
medical  ward.  These  benefits  included  improved  survival,  decreased  dependence  in 
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activities  of  daily  living,  decreased  institutionalisation  and  decreased  length  of  hospital 
stay  (by  up  to  8%).  Compared  to  general  medical  management,  for  every  100  patients 
treated  in  a  stroke  unit,  3  deaths  and  2  admissions  to  institutional  care  are  avoided  and 
an  additional  5  patients  are  discharged  home  (Stroke  Unit  Trialists  Collaboration  1997) 
(Stroke  Unit  Trialists  Collaboration  2003).  There  is  some  further  evidence  that  these 
benefits  may  be  sustained  over  a  longer  period  (up  to  10  years  after  stroke)  (Indredavik 
et  al.  1999). 
Stroke  Units  are  difficult  to  define  precisely  and  vary  widely  between  different  health 
care  systems.  They  do  however,  appear  to  have  a  number  of  common  features,  including 
a  co-ordinated,  multi-  di  scip  linary  team  that  is  specialised  in  stroke  care  (Stroke  Unit 
Trialists  Collaboration  1997)  (Langhorne  &  Dennis  1998)  (Langhorne  &  Pollock  et  al. 
2002).  Overall,  this  multi-faceted,  complex  intervention  is,  at  present,  poorly 
understood.  In  1989  the  World  Health  Organisation  (WHO)  Task  Force  on  Stroke 
recognised  this  problem  and  stated  that:  "Controlled  clinical  trials  are  essential  if  the 
role  of  rehabilitation,  its  indications,  and  its  contraindications  are  to  be  adequately 
understood"  (WHO  Task  Force  on  Stroke  1989).  There  have  been  many  more  clarion 
calls  echoing  this  statement  over  the  past  decade,  giving  rise  to  the  term  "unpacking  the 
black  box  of  rehabilitation".  Though  there  are  increasing  numbers  of  trials  and  studies 
of  rehabilitation,  there  remains  a  great  deal  to  discover  about  the  individual  components 
of  stroke  unit  rehabilitation  and  how  they  interact  (Wade  2001)  to  produce  their 
beneficial  effect. 
One  of  the  recognised  core  components  of  rehabilitation  within  a  multi-disciplinary 
stroke  unit  team  is  physiotherapy  (Stroke  Unit  Trialists  Collaboration  1997)  (Langhorne 
&  Dennis  1998).  Whilst  it  seems  reasonable  to  assume  that  physiotherapists  play  a  part 
in  the  restoration  of  patients'  mobility  after  stroke,  there  are  many  aspects  of 
physiotherapy  intervention  that  require  to  be  evaluated  (Legg  et  al.  2000)(Pomeroy  & 
Tallis  2000)(Pomeroy  &  Tallis  2002)(Scottish  Intercollegiate  Guidelines  Network 
(SIGN)  Guidelines  2002).  Amongst  these  is  the  need  to  deten-nine  which  patients 
benefit,  at  which  stage  after  stroke,  from  which  treatments  and  in  which  setting.  I  was 
particularly  interested  in  determining  the  optimum  amount  of  physiotherapy  that  should 
be  provided  for  patients  with  stroke. 
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Defining  physiotherapy 
Before  proceeding,  it  is  worth  defining  physiotherapy  as  it  will  be  used  in  this  thesis, 
looking  at  its  historical  background  and  then  describing  current  physiotherapy  practice 
in  the  treatment  of  stroke. 
Physiotherapy  is  the  process  of  treatment  of  disease  and  injury  by  physical  means  (as 
opposed  for  example  to  pharmaceutical  and  surgical  means).  Commonly,  physiotherapy 
utilises  treatment  methods  such  as  exercises,  movement,  thermal  treatments  e.  g.  heat 
packs  or  ice,  electrotherapy,  massage  and  education.  Treatment  is  often  given  in  order  to 
resolve  or  minimise  a  patient's  impairment,  disability  and  handicap.  Neurological 
physiotherapy  is  a  sub-specialty  focused  on  the  treatment  of  patients  diagnosed  with 
neurological  disease  or  disorders  of  the  nervous  system.  It  is  usually  administered  by 
specialists  but  often  draws  on  other  branches  of  physiotherapy  and  the  application  of 
general  principles.  It  often  takes  place  in  the  context  of  a  multi-disciplinary  team  and 
has  a  role  focused  on  the  restoration  of  movement  or  mobility  and  function. 
Neurological  physiotherapists  work  worldwide  in  a  number  of  settings  including 
hospital  in-patient  and  outpatient  departments,  in  the  community  or  patients'  own 
homes  (SIGN  Guideline  2002). 
Historical  context 
Historically,  patients  with  stroke  were  not  always  treated  with  physiotherapy,  even  in  its 
broadest  sense.  The  diagnosis  and  pathology  of  stroke  were  not  clearly  understood  and 
physical  treatments  were  applied  to  patients  for  a  wide  variety  of  reasons  (Warlow  et  al. 
2001).  These  included  massage,  heat  and  even  electricity  from  natural  or  man-made 
sources.  Some  patients  with  mobility  disability  secondary  to  paralysis  did  receive  some 
form  of  physical  assistance  in  an  attempt  to  compensate  for  their  disability. 
In  the  UK,  physiotherapy  as  we  might  recognise  it,  is  first  mentioned  with  the  upsurge 
in  the  use  of  spa  treatments  and  hydrotherapy  that  became  popular  in  the  late  eighteenth 
century  in  England  in  spa  towns  such  as  Bath  and  Leamington  Spa.  Later,  Scotland  was 
to  have  the  "Hydros"  at  Peebles  and  along  Speyside.  Hydrotherapy  was  a  fashionable 
treatment  for  a  whole  host  of  ailments  but  there  is  little  information  on  stroke  specific 
treatment  from  this  time.  Treatments  may  have  depended  upon  the  patients'  belief  in  its 
benefit  or  their  budget,  rather  than  any  prescribed  regime  that  was  recorded.  Massage 
and  movement  of  the  limbs  were  often  incorporated  into  spa  treatments. 
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Even  with  the  development  of  the  physiotherapy  profession  in  the  UK,  there  is 
remarkably  little  recorded  about  the  treatment  of  patients  with  stroke.  The  Society  of 
Trained  Masseuses  was  established  in  1894  to  promote  "medical  rubbing"  (mostly 
carried  out  by  nurses)  and  to  distinguish  therapeutic  massage  from  the  unsavoury  image 
that  massage  had  at  the  time,  and  to  some  extent  retains  today.  At  the  turn  of  the 
twentieth  century  the  Swedish  Institute  a  school  for  remedial  exercise  introduced 
Swedish  exercise  therapy  to  the  UK  and  within  10  years  the  Incorporated  Society  of 
Trained  Masseuses  was  also  responsible  for  training  and  examining  medical  gymnastics 
and  electrotherapy.  Many  of  the  techniques  taught  in  those  times  persist  to  this  day  in  an 
amended  forin  and  are  still  the  basis  of  today's  physiotherapy  treatments. 
The  numbers  of  trained  masseuses  increased  greatly  during  the  First  World  War.  In 
1943  the  Chartered  Society  of  Physiotherapy  was  formed  and  with  the  development  of 
the  National  Health  Service  in  1947,  it  controlled  standards  and  provided  training  for 
women  and  men  entering  the  profession  (Thornton  1994).  Records  of  the  training  and 
treatment  of  stroke  in  the  early  days  of  the  profession  give  little  reference  to  the  amount 
of  therapy  that  should  be  given  to  patients.  Early  treatments  still  consisted  of 
"therapeutic  massage"  and  passive  movements  to  the  limbs.  Often  patients  were  given 
treatments  allowing  them  to  maximise  the  use  of  their  unaffected  limbs,  e.  g. 
strengthening  exercises  in  order  to  compensate  for  a  limb  weakness  on  the  opposite 
side.  Splinting  materials  were  employed  to  control  abnon-nal  muscle  function  and 
generally  the  use  of  callipers,  splinting  and  wheelchairs  appears  to  have  been  more 
commonplace  than  today.  The  aim  of  treatment  was  often  "the  attainment  of  a  safe,  not 
a  non-nal,  mode  of  travel"  (Perry  1969). 
In  contrast  to  this  compensatory  or  functional  approach,  the  1950s  and  1960s  saw  an 
increase  in  the  popularity  of  methods  broadly  based  on  contemporary  understanding  of 
the  physiology  of  the  nervous  system.  Some  of  these  methods  are  still  practiced  today 
with  some  modification  and  have  some  ardent  followers  despite  there  being  little  sound 
evidence  to  support  their  use. 
The  Bobath  approach  (Bobath  1990)(Davies  1985)  broadly  follows  a  neuro- 
developmental  sequence  similar  to  that  seen  in  a  normal  developing  infant.  A  therapist 
promotes  non-nal  movement  patterns  and  facilitates  movement,  with  "abnon-nal"  reflex 
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reactions  being  discouraged.  Johnstone  (Johnstone  1978)  had  a  similar  approach  but 
focussed  on  stability  of  the  proximal  joints  often  employing  inflatable  plastic  splints  to 
support  the  limbs.  In  contrast  such  "abnormal"  patterns  and  reflex  movements  are 
allowed  and  encouraged  in  another  two  approaches  advocated  by  Temple  Fay  (Kidd  et 
al.  1992)  and  Brunnstrorn  (Brunnstrom  1970),  who  considered  the  mass  movement 
patterns  to  be  a  necessary  stage  in  developing  motor  control. 
The  latter  two  approaches  involved  treating  patients  (both  adult  and  children  with  a 
variety  of  neurological  conditions  including  stroke)  for  "an  hour  or  so  per  day  or  even 
every  other  day"  (Kidd  et  al.  1992).  A  review  by  Bower  describes  the  Bobath  approach 
as  lasting  for  30  -  60  minutes  per  session,  with  I-5  sessions  per  week  (Bower  1993). 
An  alternative  was  a  neuropsychological  approach  termed  "conductive  education" 
developed  by  Peto,  in  Hungary  during  the  Second  World  War.  In  the  Peto  Institute  in 
Budapest  a  continuous,  24  hour  approach  is  taken  to  re-educate  movement  (though  used 
largely  in  the  treatment  of  cerebral  palsy  in  children,  adults  with  neurological  disease 
are  treated)  (Cotton  &  Kinsman  1983).  This  approach  places  the  emphasis  on  the 
patients'  own  efforts,  with  conceptualisation  of  tasks,  verbalisation  and  feedback  from  a 
"conductor"  and  repetition,  often  in  a  group  setting,  along  with  the  use  of  specialised 
equipment  and  furniture. 
In  the  late  1980s  two  Australian  physiotherapists,  Carr  and  Shepherd  described  a  "motor 
relearning  programme"  for  stroke  based  on  an  understanding  of  kinematics  and  kinetics 
of  non-nal  movement,  motor  control  processes  and  motor  learning.  Although  popular  in 
Australia  and  increasingly  employed  and  taught  in  the  UK  it  is  still  less  popular  in  the 
UK  than  the  Bobath  approach.  It  recommends  that  patients  repeatedly  practise 
movement  tasks  focussed  on  function  in  order  to  achieve  recovery  (Carr  &  Shepherd 
1987). 
Although  there  have  been,  and  still  are,  several  other  recognised  physiotherapy 
approaches  to  treating  stroke  e.  g.  Rood,  Knott  and  Voss  they  are  not  widely  practised 
(Bower  1993)(Partridge  1995)(Davidson  &  Waters  2000). 
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There  have  been  many  trends  in  physiotherapy  treatment  for  stroke  over  the  post-war 
period,  with  most,  surprisingly,  not  specifying  their  intensity.  Many  al-C  based  on 
developmental  work  aimed  at  the  treatment  of  children  with  cerebral  palsy.  Whilst  some 
specific  regimes  were  popular  for  children,  ranging  from  some  contact  cý,  ery  few  weeks 
with  a  physiotherapist,  to  5  minutes  treatment,  5  times  a  day,  to  several  hours  per  daý', 
the  same  cannot  be  said  for  adult  treatment.  Many  of  the  paediatric  methods  have  been 
advocated  and  used  in  treatment  of  adult  stroke,  with  claims  that  the  physiological 
principles  of  treatment  are  similar.  However  without  the  emphasis  of  educational  and 
physical  development  (and  the  necessary  resources,  often  based  in  educational 
institutions)  and  practical  difficulties  involved  in  dealing  with  physically  demanding 
disabled  adults  e.  g.  it  is  difficult  to  carry  out  passive  movements  to  the  limbs  of  a  100 
kg  man  for  6  hours  a  day,  these  rigid  regimes  have  never  been  as  popular  in  adult  as 
paediatric  envirom-nents. 
None  of  the  popular  proponents  of  contemporary  physiotherapy,  with  the  exception  of 
Carr  and  Shepherd  (motor  relearning  programme),  clearly  specify  a  dose  of  therapy  or 
the  manner  in  which  it  should  be  applied.  Many  merely  put  forward  a  philosophy  or 
principles  of  treatment  to  be  followed.  Most  suggest  "as  much  as  tolerated"  or  that 
exercises  or  therapy  should  be  carried  out  "daily"  or  "as  often  as  possible".  The 
majority  adhere  to  the  idea  of  individual  assessment  and  avoid  giving  a  formula  or  a 
regime  for  stroke  treatment.  Such  regimes  were  commonplace  in  the  physiotherapy 
treatment  of  other  conditions,  for  example  the  "DeLon-ne  and  Watkins"  and 
"Macqueen"  regimes  to  allow  muscle  strengthening  after  musculo-  skeletal  injury 
(Hollis  198  1). 
What  does  today's  physiotherapy  involve? 
Physiotherapy  treatments  with  patients  with  stroke  remain  diverse  (Pomeroy  &  Tallis 
2002)  (SIGN  Guidelines  2002).  Typically  they  consist  of  exercises  which  may  be 
active;  with  the  patient  participating  and  carrying  out  the  movement  under  their  own 
volition;  or  passive  when  the  patient  receives  full  assistance  to  carry  out  the  movement 
from  the  therapist;  or  active/assisted  which  is  somewhere  between  the  other  two  types, 
usually  the  patient  being  asked  to  join  in  with  the  movement  as  much  as  possible. 
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The  movements  may  be  assisted  or  facilitated  by  the  therapist  or  resisted  by  a  number  of 
means  (e.  g.  manual  resistance,  body  weight  resistance,  weight  resistance).  Generallv, 
the  aims  of  the  treatment  are  discussed  with  the  patient  and  often  goals  are  negotiated. 
These  may  be  based  around  reducing  impain-nent  e.  g.  reducing  abnormal  muscle  tone, 
reducing  disability  e.  g.  practising  the  functional  task  of  standing  up  from  a  chair  or 
reducing  handicap  e.  g.  practising  walking  outdoors  in  order  to  allow  access  to 
community  facilities. 
There  are  differences  of  opinion  as  to  the  best  exercise  treatment  approach 
physiotherapists  should  use  with  patients  with  stroke.  In  the  UK  the  two  most  popular 
approaches  are  Bobath  (also  known  as  "Normal  Movement")  and  the  Motor  Relearning 
Programme  (MRP)  (also  known  as  "Movement  Science").  There  are  some  regional 
differences  in  the  claimed  use  of  these  techniques  (Davidson  &  Waters  2000).  There  is 
also  considerable  debate  as  to  their  efficacy  and  difficulties  in  discriminating  between 
the  approaches  in  order  to  define  the  interventions  (Langhammer  &  Stanghelle 
2000)(van  Vliet  et  al.  2001).  Many  therapists  (up  to  87%  in  a  recent  national  survey  in 
the  UK  (Davidson  &  Waters  2000))  admit  to  using  an  eclectic  approach,  varying  their 
approach  with  and  specifically  around  each  patient's  assessed  needs. 
Other  techniques  may  be  employed  such  as  the  application  of  thermal  treatments  e.  g.  ice 
packs,  the  provision  of  mobility  aids  or  equipment,  splinting,  electrotherapy  treatments, 
or  techniques  aimed  at  relieving  pain  such  as  trans-cutaneous  nerve  stimulation  (TENS) 
or  acupuncture.  Physiotherapists  are  also  involved  in  multidisciplinary  teams,  helping 
patients  to  adjust  to  changes  in  their  abilities  and  providing  information  to  patients  and 
their  relatives. 
Example  of  physiotherapy  treatment 
To  illustrate  how  physiotherapy  services  are  delivered  an  example  of  a  typical 
physiotherapy  treatment  in  a  stroke  unit  is  given  below: 
Patients  who  are  unable  to  stand  due  to  hemiplegia,  reduced  muscle  tone  and  a  loss  of 
standing  balance  reactions  would  be  encouraged  and  physically  assisted  to  stand  up  at 
an  early  stage  after  their  stroke  (as  early  as  the  first  day  after  their  stroke  in  some  units 
(Langhorne  &  Pollock  et  al.  2002)).  This  process  aims  to  assist  regaining  fuiictional 
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muscle  control  in  the  anti-gravity  muscles  in  the  trunk  and  lower  limb  and  to  stimulate 
the  muscles  that  provide  joint  stability  through  weight  bearing.  The  physiotherapist 
encourages  symmetry  of  movement  and  weight  bearing  and  discourages  the  use  of  the 
unaffected  side  merely  to  compensate  for  any  weakness.  The  patient  might  repeatedlý, 
practise  rising  from  a  plinth  (which  may  be  raised  to  make  the  task  easier)  into  a 
standing  posture  with  assistance  of  the  physiotherapist.  If  this  is  particularly  difficult, 
more  than  one  physiotherapist  may  be  required  or  electrical  hoisting  equipment  may  be 
employed.  Massage  techniques  (brushing  or  rubbing  with  the  fingers)  may  be  used 
directly  on  the  weak  muscle  groups  that  would  normally  be  involved  in  the  movement, 
in  order  to  stimulate  contraction.  The  procedure  would  be  explained  to  the  patient  and 
verbal  feedback  and  encouragement  would  be  given  throughout  the  session.  Several 
attempts  to  stand  might  be  made  and  the  patient  allowed  to  take  short  rests  between 
each  attempt.  The  physiotherapist  assesses  the  patient's  posture  and  ability  to  control 
the  movement  and  to  maintain  their  balance.  The  upper  limb  would  be  supported 
throughout  the  treatment  and  time  spent  assisting  the  limb  through  passive  or  active  / 
assisted  movements  in  order  to  maintain  range  of  motion  at  the  joints.  Further 
functional,  goal-based  movements  (e.  g.  stretching  out  to  reach  for  a  cup  then  grasping 
this  and  lifting  it  towards  the  mouth)  to  stimulate  the  normal  movement  patterns  would 
also  be  practised.  The  movement  is  supervised,  assisted  if  necessary  and  corrected  to 
minimise  any  abnormal  movement  patterns  or  associated  abnormal  reactions  or  reflexes. 
A  typical  treatment  session  might  last  30  -  45  minutes  and  would  probably  occur  once 
on  a  weekday.  Time  may  also  be  spent  recording  assessments  and  treatment  notes, 
encouraging  the  patient  to  perform  exercises  or  activities  on  their  own  and  discussing 
treatment  with  relatives  and  other  multidisciplinary  team  members. 
Similar  treatments  are  carried  out  throughout  the  country  most  days  of  the  week. 
However,  despite  some  encouraging  results  in  the  recent  research  (Langhorne  et  al. 
1996)  (Kwakkel  et  al.  1999)  it  is  still  not  known  how  many  times  the  treatment  should 
be  repeated  or  for  how  long  it  should  last. 
From  these  observations  of  current  and  historical  practices,  we  are  given  little  indication 
of  how  today's  physiotherapists  working  in  the  UK  have  arrived  at  their  level  of 
intervention.  Rather  than  being  based  on  scientific  evidence,  current  levels  of  intensity 
are  likely  to  reflect  customary  work  practices,  exercise  tolerance  (for  both  the  patient 
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and  therapist),  the  patients'  ability  to  take  in  new  infon-nation,  demand  for  servIces  and 
available  resources,  clinical  opinion  and  the  time  of  onset  of  symptoms.  GenerallY,  most 
physiotherapy  in  the  UK  is  available  in  the  early  stages  after  stroke. 
If  we  could  determine  the  optimum  physiotherapy  input  for  patients  with  stroke  Ný"e  may 
have  an  impact  on  levels  of  impairment,  disability,  handicap  experienced  by  patients,  as 
well  as  health  costs.  It  might  also  contribute  to  our  understanding  of  the  process  of 
rehabilitation  and  physiotherapy. 
Difficulties  in  investigating  physiotherapy 
Our  uncertainty  about  the  optimum  intensity  of  physiotherapy  may  exist  for  several 
reasons:  it  may  be  in  part  due  to  a  lack  of  research  skills,  experience  and  understanding 
within  the  physiotherapy  profession;  a  lack  of  interest  (some  twenty  or  thirty  years  ago, 
stroke  was  seen  as  a  "Cindarella  service"  -  often  overlooked  and  under-funded);  a  lack 
of  time  dedicated  to  the  question,  or  the  practical  difficulties  in  implementing  clinical 
trials.  These  possible  reasons  reflect  those  perceived  by  stroke  rehabilitation 
professionals  as  barriers  to  implementing  evidence-based  practice  (Pollock  et  al.  2000) 
and  may  indicate  something  of  the  UK's  health  care  culture. 
One  way  of  investigating  the  efficacy  of  physiotherapy  would  be  to  carry  out  a 
randomised  controlled  trial  of  physiotherapy  with  two  groups  of  patients  with  stroke; 
one  receiving  treatment  and  the  other  receiving  none,  then  comparing  their  outcomes. 
However,  physiotherapy  is  now  so  well  established  (at  least  in  the  UK)  as  a  key  element 
to  rehabilitation  that  this  proposal  is  unlikely  to  gain  approval  from  local  ethical 
authorities  (Rice-Oxley  &  Turner-Stokes  1999).  Such  studies,  if  they  gained  approval, 
may  have  difficulty  in  recruiting  patients  who  might  fear  they  were  to  miss  out  on 
treatment  that  patients  and  their  relatives  perceive  to  be  beneficial.  Indeed,  the  amount 
of  physiotherapy  received  by  patients  is  an  area  in  which  patients  and  their  relatives 
have  expressed  satisfaction  and  dissatisfaction  with  their  hospital  care  (Pound  et  al. 
1994(a))(Pound  et  al.  1994(b))(Wellwood  et  al.  1995(a)). 
In  order  to  evaluate  physiotherapy  after  stroke  we  therefore  have  to  take  a  pragmatic 
approach  (Roland  &  Torgerson  1998).  In  this  thesis  I  am  not  concerned  with  any 
particular  physiotherapeutic  intervention,  but  with  examining  the  effect  of  different 
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intensities  of  physiotherapy  as  it  is  currently,  commonly  provided  in  hospitals  in  the  UK 
to  patients  after  stroke.  This  approach  reflects  current  practice  and  in  turn  allows  rcsults 
to  be  readily  interpreted,  widely  generalised  and  implemented. 
Unlike  a  trial  of  a  drug  where  a  clear  prescription  can  be  made,  involving  dose  strength 
(concentration)  and  frequency  of  administration,  there  are  difficulties  when  Nve  try  to 
compare  intensities,  doses  or  input  units  of  physiotherapy. 
We  need  to  define  whether  we  are  discussing  the  duration  of  treatment  or  the  degree  of 
effort  or  exertion  (concentration)  used  during  that  treatment  session.  We  also  need  to 
decide  whether  we  are  examining  the  direct  intervention  of  the  physiotherapist  (face-to- 
face  contact),  or  any  indirect  effects  such  as  what  the  patient  themselves  carry  out  e.  g. 
unsupervised  exercise,  practise  of  techniques  or  strategies  taught  by  a  physiotherapist 
but  perhaps  then  used  with  other  rehabilitation  team  members  or  carers.  Most  studies  in 
the  past  have  settled  to  measure  the  amount  of  face-to-face  contact  time  the 
physiotherapist  spends  with  a  patient.  Throughout  this  thesis  I  will  use  the  term 
intensity  to  refer  to  the  duration  of  physiotherapy  treatment.  This  is  the  amount  of  time 
spent  by  the  physiotherapist  that  can  be  directly  attributed  to  each  patient  i.  e.  face-to- 
face  contact  and  indirect  contact  time  (such  as  record  keeping  or  telephone 
conversations)  in  connection  with  delivering  care  for  that  individual  patient. 
Both  drug  and  physiotherapy  trials  may  suffer  from  problems  with  compliance  if  the 
patients  are  not  directly  supervised,  taking  their  medication  or  their  prescribed  exercise 
regime. 
In  considering  trial  design,  a  placebo  is  often  easy  to  design  and  administer  as  part  of  a 
drug  trial.  This  is  less  easy  to  specify  in  physiotherapy  trials  especially  to  find  "dummy" 
treatments  that  might  be  substituted  in  place  of  rehabilitation  exercises.  Standardisation 
of  treatment  is  also  reasonably  easy  in  drug  trials.  The  human  interaction  involved  in  the 
physiotherapeutic  process,  by  its  nature,  makes  the  standardisation  of  the  intervention 
and  its  delivery  complex,  though  this  is  not  altogether  impossible  for  example  by  the 
use  of  strict  treatment  or  trial  protocols,  following  "care  pathways"  or  standardised 
interventions  such  as  home  exercise  regimes  delivered  in  a  standard  way  such  as  by 
booklet  or  video  recording. 
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Attempts  to  examine  intensity 
Several  observational  studies  (Table  1-1)  have  attempted  to  quantify  the  actual  amount 
of  physiotherapy  (or  "therapy")  that  patients  receive.  These  arose  partly  to  investigate 
rehabilitation  interventions  and  partly  from  concerns  that  patients  apparently  spent  long 
periods  of  the  day  unoccupied.  The  duration  of  inpatient  therapy  ranged  from  an 
average  43  minutes  (Newall  et  al.  1997),  to  21  minutes  on  a  medical  xvard  and  36 
minutes  on  a  stroke  unit  (Lincoln  et  al.  1996),  to  45  minutes  (Wade  et  al.  1984). 
Physiotherapy  ranged  from  30  minutes  (day  hospital)  to  90  minutes  (outpatient 
department)  (Gladman  et  al.  1991)  with  an  average  of  60  minutes  on  a  domiciliary  visit 
(Ballinger  et  al.  1999).  Locally,  an  unpublished  survey  indicated  that  acute  stroke 
patients  in  rehabilitation  units  in  Glasgow  received  an  average  of  45  minutes  of 
physiotherapy  five  days  a  week  (Langhorne  et  al.  -  unpublished  feasibility  study). 
Table  1.1  Duration  of  physiotherapy  treatment 
Study  Setting  Average  treatment 
time  (minutes) 
per  weekday 
Wade  et  al.  1984  Inpatient  45 
Gladman  et  al.  1991  Day  hospital  30 
Gladman  et  al.  1991  Outpatient  90 
Lincoln  et  al.  1996  Stroke  unit  36 
Lincoln  et  al.  1996  Medical  inpatient  21 
Newall  et  al.  1997  Inpatient  43 
Ballinger  et  al.  1999  Domiciliary  60 
Langhorne  et  al. 
(unpublished  data) 
Stroke  unit  45 
There  are  also  considerable  variations  in  physiotherapy  service  provision  between 
countries  (Beech  et  al.  1996)(de  Weerdt  et  al.  2000).  A  direct  comparison  of  clinical 
outcomes  achieved  in  areas  or  countries  where  there  is  a  difference  in  intensity  is  likely 
to  be  complex  due  to  different  service  provision  and  constraints,  case  mix  and 
heterogeneous  interventions. 
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There  may  also  be  practical  problems  with  data  collection  on  the  intensity  of 
physiotherapy.  Whilst  some  physiotherapy  services  routinely  record  the  amount  of  time 
spent  with  patients,  many  do  not,  with  data  being  limited  to  clinical  records  of  treatment 
and  a  record  of  face-to-face  contacts. 
Probably  the  most  accurate  and  helpful  way  of  assessing  intensity  is  to  carry  out  a 
randomised  controlled  trial  (RCT).  Those  intensity  RCTs  that  have  been  published  are 
reviewed  in  the  next  chapter.  They  had  an  average  intervention  of  45  minutes  per  day 
for  the  "control"  groups,  reflecting  general  practice  in  the  UK  as  described  in  the 
observational  studies  above. 
Research  questions  to  be  addressed  in  this  thesis 
In  this  thesis  I  examine  the  uncertainty  of  the  effect  of  intensity  (i.  e.  the  duration)  of 
physiotherapy  treatment  on  patients  with  stroke  during  their  rehabilitation  in  hospital. 
To  do  this  I  will  compare  outcomes  achieved  with  the  provision  of  a  standard  amount  of 
physiotherapy  with  those  achieved  when  additional  physiotherapy  is  provided. 
I  put  forward  the  hypothesis  that  intensive  physiotherapy  after  stroke  will  produce 
benefits  which: 
a)  speed  recovery  in  terms  of  impairment  and  disability. 
b)  are  greater  when  targeted  (e.  g.  on  upper  limb  recovery). 
c)  are  greater  for  patients  with  moderate  impairment  and  little  co-morbidity. 
d)  are  greater  in  the  shorter  (3  months)  than  longer  terin  (6  -  12  months). 
e)  result  in  a  reduced  duration  of  inpatient  rehabilitation. 
I  will  attempt  to  describe  any  benefits  in  mobility,  function  and  cost  in  useful  and  easily 
understood  tenns  e.  g.  by  relating  to  standard  scales  and  giving  cost  savings  per  patient. 
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Structure  of  the  thesis 
In  chapter  2,1  examine  the  published  evidence  about  intensity  of  physiotherapy  after 
stroke.  I  describe  how  I  selected  and  reviewed  the  available  evidence. 
In  chapter  3,1  describe  the  randomised  controlled  trial  that  aimed  to  address  the 
hypothesis. 
In  chapter  4,1  introduce  the  statistical  technique  of  meta-analysis  that  may  be  a  useful 
tool  to  further  test  the  hypothesis.  I  describe  a  combined  analysis  of  several  trials  of 
intensity  (including  data  from  the  study  in  chapter  3). 
In  chapter  5,1  describe  forining  a  collaborative  group  in  order  to  carry  out  a  detailed 
individual-patient-data  meta-analysis. 
In  chapter  6,1  draw  conclusions  from  the  randomised  controlled  trial  and  the  meta- 
analysis.  I  review  to  what  extent  I  managed  to  establish  satisfactory  answers  to  the 
questions  set  out  in  this  chapter.  I  also  discuss  some  limitations  of  the  work  and  indicate 
areas  that  could  be  developed  for  further  research. 
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Summary 
*  Stroke  is  a  major  worldwide  health  problem  that  will  continue  to  effect  IndIvIduals, 
their  carers  and  society  and  poses  a  huge  challenge  to  those  charged  with  providing  I 
effective  clinical  services  in  order  to  reduce  impairment,  disability  and  handicap. 
9  Currently,  the  most  effective  intervention  in  the  treatment  of  patients  with  stroke  is  carc 
carried  out  in  an  organised  stroke  unit. 
e  Most  stroke  units  include  physiotherapy  as  part  of  their  treatment.  We  remain  uncertain 
as  to  which  patients  might  benefit  most  and  in  which  ways  in  response  to  which  type 
and  amount  of  physiotherapy.  We  need  to  determine  how  best  to  deliver  such  services 
for  optimum  effect  and  value. 
9  Physiotherapy  is  a  well-established  part  of  many  health  services  for  people  with  stroke. 
It  seems  to  offer  some  benefits  to  patients,  however  there  is  little  evidence  to  support  its 
routine  use.  There  are  practical  and  ethical  difficulties  in  evaluating  this  rehabilitation 
intervention  in  a  scientific  manner. 
9  We  know  very  little  about  the  optimum  intensity  of  physiotherapy  either  from  historical 
records  or  reviewing  current  practice.  We  have  some  information  from  research  into  the 
area:  observational  studies  about  the  intensity  of  physiotherapy  currently  delivered  and 
interventional  studies.  The  randomised  controlled  trials  of  intensity  are  reviewed  in  the 
next  chapter. 
*  In  order  to  explore  the  issue  of  optimum  intensity  of  physiotherapy,  I  propose  a 
hypothesis  and  set  out  a  number  of  research  questions  that  I  aim  to  address  in  this  thesis. 
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CHAPTER  2 
REVIEW  OF  THE  LITERATURE 
Introduction 
The  questions  posed  in  the  previous  chapter  have  been  of  interest  to  stroke  researchers 
for  many  years  and  there  have  been  several  attempts  to  address  them.  In  this  chapter  I 
describe  some  of  the  studies  from  over  the  past  30  years  that  have  added  to  our 
understanding  of  intensity  of  physiotherapy  after  stroke. 
Aims 
In  this  chapter  I  aim  to: 
1).  Describe  the  important  literature  relevant  to  physiotherapy  intensity. 
2).  Describe  desirable  features  of  rehabilitation  trials. 
3).  Discuss  difficulties  in  researching  complex  healthcare  interventions. 
4).  Discuss  selected  studies  in  relation  to  the  research  questions  outlined  in  Chapter  1. 
The  Literature 
Although  research  into  stroke  has  been  carried  out  for  many  years  there  have  been 
relatively  few  specific  studies  of  physiotherapy  and  rehabilitation  and  even  fewer  of 
intensity  of  physiotherapy.  However,  there  has  been  an  increasing  amount  of  interest  and 
number  of  scientific  trials  carried  out  over  the  past  15  years.  This  increase  in  research 
activity  may  be  attributed  to  the  increasing  challenge  presented  to  service  providers  due 
to  the  increasing  burden  of  stroke.  Enthusiastic,  interested  individuals  have  taken  up  this 
challenge  at  local,  professional  and  political  levels.  They  have  largely  been  responsible 
for  driving  the  research  agenda,  prompting  initiatives  from  scientific,  government  and 
charitable  bodies  such  as  the  Kings  Fund  and  the  Stroke  Association.  Many  of  these 
bodies  made  recommendations  for  action  to  attempt  to  reduce  the  burden  of  stroke,  e.,  -,. 
guidelines  from  international  bodies  such  as  the  European  Stroke  Initiative  (EUSI) 
(EUSI  2003),  from  government  departments;  such  as  the  National  Service  Framework 
(NSF)  for  Elderly  People  from  the  Department  of  Health  in  England  and  Wales 
(Department  of  Health  2001);  and  professional  bodies  such  as  the  Royal  College  of 
Physicians  (RCP)  (Intercollegiate  Working  Party  for  Stroke  2002)  and  the  Scottish 
Intercollegiate  Guidelines  Network  (SIGN)(SIGN  2002). 
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Although  there  are  moves  towards  basing  such  recommendations  on  scientific  evidence 
many  guidelines  do  not  have  a  clear  scientific  foundation.  Recognising  this,  many 
bodies  have  made  recommendations  for  further  investigation  into  areas  including 
I 
therapy  and  rehabilitation.  In  turn,  research  bodies  have,  to  some  extent,  responded  to 
these  recommendations  and  funded  relevant  projects.  However  the  process  from 
proposal  to  publication  can  be  lengthy. 
Searching  the  literature  uncovers  a  variety  of  papers,  many  of  which  appear  relevant  to 
the  questions  I  set  out  in  Chapter  1.  However  to  fully  address  all  my  questions  on 
physiotherapy  intensity  and  in  order  to  influence  clinical  practice  and  health  policy 
decisions,  any  trial  would  have  to  produce  results  that  are  reliable  and  can  be 
generalised.  Unfortunately,  such  a  trial  does  not  appear  to  exist. 
It  is  difficult  to  estimate  just  how  large  such  a  trial  would  have  to  be  in  order  to  change 
clinical  practice  in  physiotherapy.  In  an  often-quoted  example  from  the  field  of 
medicine,  the  use  of  aspirin  after  myocardial  infarction  was  considered  beneficial  in 
early  small  studies  (even  these  are  relatively  large  in  comparison  to  many  rehabilitation 
studies)  yet  it  was  not  until  the  large  ISIS-2  trial  (ISIS-2  Collaborative  Group  1988)  in 
the  late  1980s,  involving  over  17,000  patients  was  conducted  and  reported  that  clinical 
practice  started  to  change.  There  is  little  to  suggest  that  therapists  are  any  more  liable  to 
accept  change  than  the  medical  profession  and,  given  that  treatment  effects  of  physical 
therapy  may  well  be  more  modest  than  in  the  last  example,  it  seems  likely  that  large 
numbers  of  subjects  would  need  to  be  recruited  in  order  to  change  clinical  practice. 
Reviews  of  physiotherapy  intensity 
I  undertook  a  literature  search  using  several  electronic  databases  (Medline  1966  to 
present,  CINAHL  1982  to  present  and  the  PEDRO  and  Cochrane  Stroke  Group 
Specialised  Trials  registers),  by  referring  to  recently  published  reviews  and  by 
discussing  literature  with  other  researchers  and  experts  within  this  area. 
I  found  several  reviews  of  the  available  literature  on  effectiveness  and  intensity  of 
physiotherapy  (up  to  12  reviews  over  the  past  15  years  were  identified  recently  by  van 
der  Lee  et  al.  )  (van  der  Lee  et  al.  2001),  some  narrative  in  style  e.  g.  (Ernst 
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1990)(Ashburn  1997),  some  following  the  more  recent  trend  towards  more  fori-nal 
systematic  reviews  e.  g.  (Langhorne  et  al.  1996)(Kwakkel  et  al.  1997)(van  der  Lee  et  al. 
2001).  Each  considered  slightly  different  aspects  of  intensity,  identified  and  selected 
different  trials  and  used  different  methods  to  appraise  and  in  some  cases  analyse  the 
available  evidence.  The  reviewers  found  the  trials  to  be  mostly  small,  focused  on 
various  aspects  of  stroke  e.  g.  functional  ability  or  arm  impairment,  and  at  times  arrived 
at  different  conclusions.  With  some  exceptions,  the  earlier  studies  before  1990  were 
generally  less  methodologically  rigorous,  reflecting  an  earlier  stage  of  clinical  trials, 
clinical  science  and  review  methodology. 
The  narrative  reviews 
Ernst  noted  that  many  trials  were  not  blinded,  non-randomised  and  had  potential  for  bias 
(Ernst  1990).  He  suggested  that  the  physiotherapy  approach  was  immaterial.  He  also 
noted  that  settings  were  different,  interventions  varied,  outcomes  were  non-standard  and 
that  all  subjects  showed  some  early  recovery.  He  came  to  the  conclusion  that  "if  an 
optimal  treatment  exists,  we  have,  so  far,  failed  to  identify  it.  Until  ftirther  evidence 
emerges,  we  should  therefore  select  therapies  that  are  most  cost-effective  and  that  can  be 
given  to  the  largest  number  of  patients.  Well  planned  clinical  trials  aimed  at  finding  the 
best  approach  and  discriminating  potential  responders  from  non-responders  are  urgently 
needed.  ". 
Pollock  et  al.  (Pollock  et  al.  1993)  and  Ashburn  in  1997  (Ashburn  1997),  highlighted 
some  of  the  shortcomings  of  rehabilitation  studies:  in  general  they  were  of  poor  quality; 
used  insensitive  outcome  measures  e.  g.  activities  of  daily  living  (ADL)  scales  may  not 
be  sensitive  to  change  in  motor  and  sensory  impairment  -  often  the  level  at  which  the 
intervention  is  aimed;  lacked  detail;  used  inconsistent  definitions;  poorly  described 
outlying  subjects,  and  selected  different  end  points  at  which  to  measure  outcomes.  All  of 
these  were  present  on  a  background  of  spontaneous  recovery  after  stroke. 
Ashburn  (Ashburn  1997)  recommended  researchers  include  a  broader  spectrum  of 
patients  and  use  standard  measures  whilst  recognising  the  limitations  of  some  of  the 
widely  used,  popular  measures  such  as  the  Barthel  Index.  Doing  so  would  allow 
comparison  between  studies  and  facilitate  combination  in  meta-analysis. 
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Formal  reviews 
Langhorne  et  al.  used  different  methods  in  a  well-conducted  fon-nal  revie,,  N,  (Langhome 
et  al.  1996),  and  found,  like  Ernst  (Ernst  1990),  the  evidence  for  improved  outcome  ýý'Ith 
increased  intensity  of  physiotherapy  to  be  lacking  and  of  variable  quality.  They  included 
a  number  of  studies  that  would  be  relevant  in  answering  my  questions  but  included 
some  out-patient  based  studies.  They  also  concluded  that  further  study  was  required  in 
order  to  obtain  a  definitive  answer. 
A  year  later,  Kwakkel  et  al.  in  their  study  using  clearly  stated  methods  and  broader 
inclusion  criteria,  concluded  that  a  greater  intensity  of  physiotherapy  would  lead  to 
benefits  (Kwakkel  et  al.  1997).  However,  their  overview  included  some  confounded 
trials.  They  highlighted  that  trials  were  small,  had  problems  with  blinding  and  were 
heterogeneous.  Recognising  that  most  recovery  is  probably  spontaneous  they 
recommended  that  treatment  should  start  as  early  as  possible  and  also  suggested  that  the 
treatment  approach  may  be  immaterial. 
Van  der  Lee  et  al.  's  review  of  upper  limb  physiotherapy  had  a  broad  scope  and  included 
a  wide  variety  of  interventions  many  of  which  could  be  defined  as  physiotherapy  but 
might  not  be  recognised  as  normal  physiotherapy  practice  (at  least  currently  in  the  UK) 
e.  g.  constraint  induced  therapy  and  robot  assisted  movement  practise  (van  der  Lee  et  al. 
2001). 
Individual  studies  and  trials 
Even  within  the  relatively  small  number  of  studies  of  intensity  of  physiotherapy  there  is 
remarkable  diversity,  reflecting  a  variety  of  perspectives  on  the  subject;  from  service 
evaluation  (Smith  et  al.  198  1),  to  consumer  satisfaction  surveys  (Pound  et  al.  1994(a))  to 
investigation  of  novel  treatment  techniques  (Feys  et  al.  1998).  There  are  a  corresponding 
variety  of  study  designs  to  accommodate  these  perspectives  with  an  increasing  number 
of  randomised  control  trials  being  conducted,  in  order  to  gain  scientific  credibility  and 
better  address  clear  scientific  questions.  There  are  also  a  wide  variety  of  subjects  and 
participants,  interventions,  settings,  time  points  and  outcomes: 
20 Chapter  2 
Subjects  andparticipants 
The  subjects  vary  considerably  in  the  studies  from  early  acute  in-patlents  (e.  g.  KN,,  -akkel 
et  al.  1999),  seen  a  few  days  after  onset  of  symptoms,  to  patients  receiving  treatment 
over  a  year  after  stroke  (e.  g.  Wade  et  al.  1992)(Green  et  al.  2002).  Many  studies  recruited 
selected  patients.  In  many  cases  this  is  because  patients  are  required  to  give  infon-ned 
consent  which  may  be  difficult  or  impossible  to  obtain  when  the  stroke  has  resulted  in 
cognitive  or  communication  impairment.  If  the  studies  have  been  limited  by  ethical 
considerations  or  have  not  had  the  option  of  gaining  informed  consent  from  a  relative  or 
carer,  the  sample  group  can  be  skewed  towards  a  less  disabled  group.  Some  revieNý,  crs 
have  commented  (Ashburn  1997)  that  patients  at  the  extremes  of  seventy  are  not  well 
represented  in  trials  as  they  are  either  too  sick  or  too  well  to  detect  change  or  to  be 
maintained  in  a  study. 
On  the  other  hand  where  all  patients  are  included  e.  g.  Partridge  et  al.  2000  included 
severely  disabled  subjects,  this  better  reflects  a  typical  clinical  situation  allowing  results 
to  be  generalised.  The  disadvantage  in  this  is  that  we  would  expect  different  prognoses 
for  different  patients  after  stroke,  dependent  on  for  example  on  their  age  or  the  severity 
of  symptoms.  Any  potential  treatment  effect  being  investigated  is  likely  to  be  diluted 
and  possibly  go  undetected  unless  very  large  numbers  of  subjects  are  recruited.  Only 
where  there  are  large  enough  numbers  can  sub-group  analyses  be  carried  out  and  may 
identify  groups  that  did  respond  or  responded  better  to  the  intervention. 
Slade  et  al.  (Slade  et  al.  2002)  examined  intensity  of  therapy  in  a  mixed  group  where 
patients  with  stroke  and  patients  with  head  injury  were  studied.  Again  this  may  reflect 
clinical  practice  in  some  mixed  neurological  rehabilitation  units  but  needs  careful 
interpretation  in  order  to  isolate  the  results  that  are  relevant  to  patients  with  stroke. 
Some  studies  examined  the  intervention  when  delivered  by  different  therapists.  In  one 
study  (Lincoln  et  al.  1999),  an  experienced  "expert"  therapist  was  contrasted  with 
trained  therapy  assistants  working  under  supervision.  Other  studies  examined 
"conventional"  service  provision  (Partridge  et  al.  2000),  aiming  to  reflect  normal 
clinical  practice. 
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In  several  cases,  intensity  of  "therapy"  was  considered  as  "physical  therapies"(as 
opposed  to  drug  or  psycho-social  interventions)  and  included  occupational  therapy  in 
addition  to  physiotherapy  (Smith  et  al.  1981)(Slade  et  al.  2002).  In  these  cases  "physical 
therapy"  would  include  the  practise  of  physical  tasks,  in  some  cases  undertaken  by  a 
variety  of  healthcare  workers. 
Intervention 
Novel  interventions  have  been  trialed  with  a  view  to  evaluating  their  effectiveness.  e.  g. 
the  use  of  sensori-motor  stimulation  using  a  rocking  chair  and  an-n  splint  (Feys  et 
al.  1998)  or  patients  practising  exercises  using  a  mirror  (Altschuler  et  al.  1999)  or  robot- 
assisted  movement  (Volpe  et  al.  2000).  In  other  studies  current  clinical  practices  were 
evaluated  (Sunderland  et  al.  1992)(Lincoln  et  al.  1999)(Partridge  et  al.  2000).  One  study 
(Pollock  et  al.  2002)  took  an  alternative  approach,  investigating  the  effect  of 
independent  practice  of  an  exercise  without  direct  supervision  of  a  physiotherapist. 
Because  of  the  complex  nature  of  physiotherapy,  involving  interpersonal  and  physical 
components,  many  studies  have  experienced  difficulties  in  describing  what  the 
intervention  involves.  Most  have  related  intensity  of  therapy  to  a  component  of  time. 
None  have  considered  "intensity"  to  include  how  much  effort  the  patient  applies  or  has 
applied  to  them  during  the  therapy  session.  Pragmatically,  this  reflects  how  therapy  is 
delivered  in  a  clinical  setting  and  avoids  the  complex  difficulties  in  attempting  to 
measure  therapeutic  effort  either  on  the  part  of  the  patient  or  therapist.  Most  studies 
have  opted  to  increase  the  amount  of  time  spent  with  the  therapist  by  increasing  the 
duration  or  the  number  of  the  sessions  delivered.  Even  this  latter  approach  has 
difficulties,  as  for  example,  delivering  two  half  hour  sessions  of  treatment  may  be 
different  to  delivering  a  single  one  hour  session  due  to  potential  problems  with  fatigue 
or  training  effects  that  may  develop  during  a  single  longer  session. 
Some  reviewers  (Ernst  1990)  argued  that  the  content  of  the  intervention  itself  was 
unlikely  to  be  of  importance  but  the  duration  of  contact  with  the  therapist  may  be.  Even 
if  this  is  the  case,  in  order  to  be  able  to  generalise  results  it  is  important  to  have  a  clear 
description  of  both  the  subjects  and  the  methods  used  in  the  studies. 
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Setting 
Within  the  hospital  setting  there  may  be  confounding  from  other  services.  The  Stroke 
Unit  Trialists  Collaborative  group  in  1997  (Stroke  Unit  Trialists  Collaboration  1997) 
shed  new  light  on  the  effectiveness  of  stroke  units.  Their  meta-analysis  shoNved 
outcomes,  in  terms  of  survival,  dependence  and  institutionalisation  at  12  months  after 
stroke,  to  be  significantly  better  in  patients  managed  in  a  stroke  unit  compared  to 
"conventional  care",  often  delivered  in  general  medical  wards.  These  results  meall  that 
some  of  the  previous  studies  of  physiotherapy  intensity  were  in  fact  confounded,  as  they 
compared  specialised  stroke  unit  and  general  medical  care  (Peacock  et  al.  1972  -  though 
no  details  of  intensity  of  therapy  are  available  -  quoted  in  (Langhorne  et  al. 
1996))(Sivenuis  et  al.  1985)  where  we  might  expect  a  difference  in  outcome.  Generally, 
better  results  were  found  in  the  stroke  unit  groups  and  this  had  partly  been  attributed  to 
patients  receiving  more  therapy,  however  there  may  be  a  much  more  complex 
interaction  of  interventions  that  provides  the  real  explanation  of  the  "stroke  unit  effect". 
With  a  change  in  focus  from  provision  of  healthcare  in  institutions  towards  provision  in 
the  community,  several  intensity  studies  have  been  carried  out  on  an  out-patient 
(Duncan  et  al.  1998)  (Smith  et  al.  1981)(Werner  &  Kessler  1996)  or  domiciliary  basis 
(Wade  et  al.  1992)  (Green  et  al.  2002). 
As  mentioned  in  Chapter  I  (page  13)  the  amount  of  therapy  that  is  standard  in  one 
setting  may  well  be  different  in  another  e.  g.  there  are  considerable  differences  in  the 
average  amount  of  therapy  delivered  in  the  UK,  other  parts  of  Europe  (de  Weerdt  et  al. 
2000)(McKevitt  et  al.  2000)  and  North  America  (Jette  et  al.  2005).  Comparisons  of 
intensity  across  national  boundaries  are  difficult  to  carry  out  due  to  other  constraints  and 
likely  confounding  factors  between  the  healthcare  systems  and  cultures.  Consequently, 
these  studies  rarely  go  beyond  describing  the  differences. 
Timing 
In  trying  to  determine  the  optimum  time  to  deliver  services  some  researchers  have 
provided  the  intervention  at  a  time  when  recovery  is  considered  to  have  reached  a 
plateau  and  conventional  therapy  has  usually  stopped.  This  may  make  controlling  for 
I 
treatment  effects  easier,  allow  a  different  study  design  (e.  g.  interrupted  time  series 
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designs  such  as  ABA  crossover)  (Wade  et  al.  1992)  to  investigate  optimal  timing  or  It) 
allow  ethical  considerations  to  be  accommodated  (e.  g.  concerns  about  denying  patielits 
potentially  beneficial  interventions).  As  most  patients  are  discharged  from  treatment 
soon  after  leaving  hospital  this  often  involves  contrasting  some  treatment  N"'ith  the 
66non-nal"  amount,  which  is  often  none  (Green  et  al.  2002). 
Outcomes  have  also  been  measured  at  a  variety  of  end  points,  e.  g.  two  weeks  after 
stroke,  on  hospital  discharge,  at  six  months  or  a  year  after  stroke.  The  baseline  for 
several  studies  varies  and  can  be  the  date  of  admission  into  acute  or  rehabilitation 
hospital,  date  of  recruitment  or  date  of  first  intervention.  These  variables  can  make  the 
comparison  of  results  between  studies  complex. 
Outcomes 
To  reflect  the  different  interventions  used  in  the  studies  a  corresponding  array  of 
outcome  measures  were  employed.  Unfortunately,  some  of  these  are  non-standard,  have 
poorly  established  measurement  qualities  and  are  insensitive  to  changes  likely  to  be 
attributed  to  the  intervention.  The  Barthel  index  (BI)  for  example  is  widely  used  as  a 
measure  of  activities  of  daily  living  (ADL)  or  as  a  disability  scale,  but  is  widely 
acknowledged  to  have  limitations.  One  study  estimates  that  the  Barthel  index  may 
underestimate  the  patients'  and  carers'  problems  in  up  to  a  third  of  subjects  (Wellwood 
et  al.  1995(b)).  With  a  marked  ceiling  and  floor  effect,  it  is  clearly  insensitive  to  certain 
disabilities  e.  g.  subjects  that  are  deaf,  blind,  unable  to  speak  and  have  only  one 
functional  arm  are  able  to  score  full  marks  on  the  scale.  Some  therapists  argue  that 
changes  in  ADL  scores  are  not  the  primary  focus  of  physiotherapy  treatments  that  may 
be  targeted  more  at  the  level  of  impairment  (Ashburn  1997)  (Pomeroy  &  Tallis  2000). 
A  number  of  studies  reported  length  of  hospital  stay  as  an  outcome.  With  the  majority  of 
hospital  inpatient  costs  attributed  to  nursing  care  (Warlow  et  al.  2001),  length  of  stay  is 
sometimes  taken  as  a  proxy  measure  of  in-patient  costs.  Service  providers  do  not  want 
patients  to  be  discharged  earlier  only  to  increase  the  burden  on  the  community  services 
or  to  be  re-admitted.  Although  hospital  costs  could  be  reduced  by  reduced  hospital  stay, 
overall  contact  or  treatment  intensity  with  therapy  staff  may  not  be  significantly  affected 
if  treatment  continues  after  discharge  from  hospital.  Where  this  outcome  measure  has 
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been  used  we  require  information  about  the  blinding  of  "decision  makers"  (often 
consultant  physicians  or  the  multi-disciplinary  team)  that  decide  when  the  patient  Nvill 
be  discharged  (e.  g.  Slade  et  al.  2002). 
Rationale 
Comparing  the  justification  for  the  physiotherapy  intervention  or  "schools  of  thought" 
has,  to  date,  not  resulted  in  a  contrast  of  "intensity"  in  terms  of  time  or  duration  of 
contact  with  a  physiotherapist.  For  example,  Langhammer  and  Stanghelle  contrasted 
the  Bobath  approach  with  a  motor  relearning  programme  (Langhammer  &  Stanghelle 
2000).  The  main  reasons  for  this  are  likely  to  be  a  conscious  effort  to  standardise  the 
interventions  in  as  many  respects  as  possible.  Alternatively,  it  may  be  because  the 
different  approaches  are  generally  poor  at  prescribing  a  strict  treatment  regime 
indicating  the  intensity  of  treatment. 
Taken  as  a  whole,  the  literature  is  limited.  It  highlights  many  difficulties  in  this  area  of 
healthcare  research  and  many  authors  recommend  that  more  high  quality  studies  be 
carried  out. 
Difficulties  in  healthcare  research 
The  methodological  difficulties  that  have  been  discussed  mean  that  the  quality  of 
evidence  on  which  clinical  practice  is  based,  may  be  limited  or  questionable. 
Physiotherapy  is  not  unique  in  experiencing  these  methodological  difficulties.  Many 
branches  of  healthcare,  certain  aspects  of  medicine,  surgery,  nursing  and  therapies  have, 
so  far,  been  poorly  researched.  For  example  surgical  procedures  are  half  as  likely  to  be 
based  on  randomised  controlled  trial  (RCT)  evidence  as  internal  medicine  interventions 
(McCulloch  et  al.  2002). 
Along  with  the  methodological  difficulties  mentioned  in  Chapter  I  (page  3)  and  the 
professional  barriers  described  by  Pollock  et  al.  (Pollock  et  al.  2000),  there  are  a  number 
of  problems  common  to  those  wanting  to  study  complex  healthcare  interventions  (see 
table  2.1)(McCulloch  et  al.  2002). 
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Table  2.1  -  Problems  in  researching  complex  healthcare  interventions 
(McCulloch  et  al.  2002). 
Small  trial  size 
Complex  (sometimes  non-standard)  interventions 
Difficulty  in  defining  intervention 
Difficulties  in  monitoring  the  quality  of  intervention 
"Learning  curve"  for  techniques. 
Blinding  is  difficult  and  impossible  in  some  cases 
Testing  established  practice 
Patient  uncertainty  in  consenting  to  clinical  trials 
Interventions  may  develop  gradually  rather  than  being  research  lead. 
Difficulties  accepting  the  requirement  for  RCTs  and  acknowledging  clinical  uncertainty. 
Limited  funding,  education,  infrastructure  and  experience  of  clinical  research 
Small  trial  size 
Many  branches  of  healthcare  research  are  typified  by  small,  single  centre  trials  that 
make  their  results  difficult  to  generalise,  or  compare  to  other  populations,  settings  or 
services.  In  the  case  of  stroke  the  interpretation  of  results  is  made  more  complicated  by 
the  natural  course  of  spontaneous  recovery.  Although  this  is  usually  dealt  with  by 
selecting  a  randomised  controlled  trial  design,  with  random  allocation  of  subjects  to 
groups,  if  the  numbers  of  subjects  is  small  there  may  not  be  an  even  distribution  of 
subjects  that  are  making  spontaneous  improvement. 
Difficulties  standardising  interventions 
It  is  difficult  to  monitor  the  quality  of  interventions  during  trials  of  therapy  (and  other 
interventions  such  as  nursing).  The  processes  are  often  complex,  lengthy  and  subject  to 
variability.  Clear  definitions  of  interventions  and  procedures  and  pre-trial  training  to 
attempt  to  standardise  interventions  or  gather  infon-nation  about  non-standard 
interventions  may  be  helpful  in  tackling  this  problem.  Alternatively,  sampling  using 
direct  observation  or  video  recording  may  help  to  detect  variations  from  the  prescribed 
intervention. 
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Frequently  there  is  poor  contrast  between  treatment  groups  being  in,  "est'gated  and  anN, 
treatment  effect  that  is  dose-dependent  may  go  undetected.  Generally  speaking,  close 
monitoring  of  the  intervention  is  required  and  variation  from  the  treatment  protocol 
should  be  recorded.  Repeated  problems  in  delivering  the  protocol  should  raise  concerns 
with  the  researchers  that  action  needs  to  be  taken  e.  g.  training  or  retraining,  or  in 
extreme  cases  that  the  trial  should  be  discontinued. 
Some  healthcare  professionals  learn  specific  techniques  and  trials  may  need  to 
acknowledge  that  there  is  a  "leaming  curve"  where  new  techniques  are  being  compared 
or  that  there  are  differences  in  levels  of  training  or  experience  between  those 
undertaking  the  intervention.  Such  a  "skill  mix"  usually  needs  to  be  accepted  and  at  a 
minimum  recorded  and  described. 
Blinding 
Often  there  are  not  suitable  placebo  or  "sham"  treatment  techniques  that  can  be  offered 
to  maintain  patient  blinding  or  blinding  of  the  therapist.  In  some  cases  this  is  possible 
e.  g.  where  equipment  is  being  used,  but  generally  with  exercise  or  physical  handling  of 
the  patient  it  is  impossible  to  provide  a  double-blind  intervention,  so  the  single-blind 
design  is  common.  Maintaining  blinding  of  observation  at  follow  up  can  be  difficult  and 
patients  and  therapists  providing  the  intervention  must  take  precautions  to  prevent 
disclosing  the  treatment  allocation. 
Testing  established  practice 
Healthcare  researchers  have  the  problem  of  testing  established  practice  e.  g.  testing 
accepted  techniques  against  a  placebo  or  no  treatment  may  become  ethically  difficult.  In 
the  case  of  stroke,  physiotherapy  is  an  accepted  component  of  stroke  unit  care  (Stroke 
Unit  Trialists  Collaboration  2003)(Langhome  &  Pollock  et  al.  2002)  and  as  such,  it 
would  be  difficult  to  deny  patients  what  may  be  an  important  part  of  their  rehabilitation. 
Some  patients  may  be  reluctant  to  participate  in  trials  of  therapy,  especially  if  they 
perceive  these  to  be  straying  from  established  practice.  Investigations  into  why  patients 
make  decisions  to  accept  treatment,  or  to  participate  in  clinical  trials,  may  help  in  the 
design  of  RCTs,  making  sure  that  eligible  patients  understand  their  options  and  that 
recruitment  is  maximised. 
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Creeping  changes  in  practice 
Healthcare  may  develop  gradually  rather  than  through  a  research  base.  In  this  way  small 
incremental  changes  to  process  may  be  individually  insignificant  and  often  go  un- 
researched.  However  over  a  period  of  time  a  significant  change  may  have  occurred. 
Regular  clinical  audit  as  part  of  routine  service  delivery  may  alert  researchers  to 
creeping  changes  in  practice  or  outcomes  and  may  be  the  basis  for  recognising  the  need 
to  carry  out  RCTs.  The  trials  I  reviewed  span  nearly  thirty  years,  though  most  were 
published  in  the  last  ten  years.  We  need  to  assume  that  "physiotherapy"  as  an  entity  has 
not  altered  considerably  within  this  period.  It  seems  fair  to  make  this  assumption, 
despite  different  treatment  methods  being  in  vogue  or  different  explanations  of  the 
mechanism  of  treatment  being  hypothesised  at  different  times.  The  fundamental 
underlying  physical  nature  of  the  use  of  exercise  and  movement  for  treatment  appears  to 
have  changed  very  little.  However  without  specific,  clear  descriptions  or  records  of  the 
interventions  (especially  in  some  earlier  trials)  for  comparison,  this  has  to  remain  an 
assumption. 
Resistance  to  change 
Just  as  there  have been  champions  of  research  and  scientific  evaluation  in  individual 
professions  there  are  also  a  small  number  of  individuals  with  difficulties  accepting  the 
requirement  for  RCTs,  and  acknowledging  clinical  uncertainty.  This  small  minority  may 
refuse  to  participate  in  clinical  trials  or  be  hesitant  to  change  their  clinical  practice  in  the 
light  of  sound  research  findings. 
Given  that  physiotherapy  as  a  profession  is  still  relatively  young,  small  and  developing, 
its  current  position  in  developing  its  research  foundations  is  perhaps  understandable. 
Along  with  some  other  professional  groups  its  members  might  claim  there  is  a  lack  of 
funding,  education  in  clinical  epidemiology,  research  infrastructure  and  experience  with 
which  to  rapidly  tackle  these  challenges. 
Tackling  some  of  the  problems 
The  problems  of  carrying  out  research  into  complex  healthcare  interventions  that  ha,,  ýe 
been  discussed  are  not  insunriountable.  Campbell  et  al.  (Campbell  et  al.  2000)  haý,  e 
described  sequential  phases  of  developing  RCTs  of  complex  interventions  for  those 
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embarking  on  research  into  complex  interventions  such  as  stroke  rehabilitation.  Thex,, 
comment  that  the  "use  of  iterative,  phased  approach  using  qualitative  and  quantitatiVe 
methods  should  lead  to  improved  study  design,  execution  and  generalisabilitý,  of  results" 
(see  Table  2.2).  They  further  recommend  qualitative  study  of  the  processes  of 
implementation  of  interventions  in  study  arms  as  this  may  further  show  the  validity  of 
the  study  findings. 
Researchers  should  aim  for  adequately  powered  feasible  studies.  Preparatory  work 
should  establish  availability  of  subjects  and  resources  to  deliver  the  intervention.  Where 
this  is  likely  to  be  difficult,  co-operation  between  centres  can  assist  in  recruitment, 
however  this  requires  a  co-ordinated  approach  and  communication  between  the  centres 
and  a  network  of  researchers  willing  to  concentrate  on  the  same  project. 
Piloting  trials  may  help  identify  methodological  difficulties  before  precious  resources 
are  committed  to  a  large-scale  trial.  Where  recruitment  is  likely  to  be  difficult  then  every 
effort  should  be  made  to  include  eligible  participants.  Examining  characteristics  of 
subjects  who  chose  not  to  participate  in  pilot  studies  may  help  identify  reasons  for 
difficulties  in  recruitment  e.  g.  age,  gender  or  method  of  recruitment  approach.  Careful, 
clear  wording  of  recruitment  literature  and  open  discussions  ensuring  true  inforined 
consent  will  often  be  rewarded  with  good  rates  of  recruitment.  Ashburn  recommends 
including  a  broader  spectrum  of  patients  in  terms  of  their  abilities  (Ashburn  1997)  but 
this  could  lead  to  recruitment  problems  (because  of  the  requirement  for  consent  in  even 
severely  disabled  patients)  and  a  dilution  of  any  treatment  effect  because  we  would 
expect  different  clinical  outcomes  from  the  different  groups  e.  g.  differences  in  age  and 
severity  of  stroke. 
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Table  2.2  Phased  development  of  RCTs  of  complex  interventions  (Campbell  et  al. 
2000) 
Stage  Phase  Possible  actions 
Theory  Pre-clinical  examining  previous  studies. 
Modelling  Phase  I  carrying  out  descriptive  studies 
considering  qualitative  work  around  the  topic 
carrying  out  a  survey  to  look  at  possible 
implementation 
producing  a  description  of  services  to  be  investigated. 
Exploratory  trial  Phase  11  .  carrying  out  feasibility  studies 
acknowledging  the  possible  presence  of  a  learning 
curve 
considering  methods  to  ensure  the  intervention  is 
applied  in  a  standard  way. 
arranging  training  if  required  in  order  to  attain 
consistency. 
make  recommendations  for  pilot  work  /  exploratory 
trials. 
defining  the  control  intervention. 
calculation  of  the  sample  sizes 
Definitive  RCT  Phase  HI  carry  out  the  definitive  study 
Long-term  Phase  IV  dissemination  of  results, 
implementation  considering  generalisation  of  results 
planning  leading  to  implementation  of  results 
Campbell  et  al.  go  on  to  recommend  that  the  intervention  should  be  monitored  and 
standardised  by  pre-trial  training.  The  production  of  written  guidelines  or  manuals  and 
handbooks  can  assist  researchers  to  standardise  the  conduct  of  the  trial.  This  can  be 
particularly  important  when  several  centres  are  involved  and  many  staff  or  a  turn-over  of 
staff  (for  long  running  trials)  are  likely  to  be  involved  in  the  trial  on-going  re-training 
may  be  required. 
Efforts  should  be  made  to  establish  and  maintain  blinding  of  the  participants  or 
observers.  This  could  be  simple  measures  such  as  reminding  subjects  or  those  who  are 
aware  of  treatment  allocation  not  to  disclose  this  to  the  blinded  assessor  or  to  avoid 
documentation  being  available  or  out  of  sight  from  the  observer.  Carrying  out  follow  up 
assessments  at  a  different  location  to  that  where  the  intervention  is  provided  may  help  to 
ensure  that  blinding  is  maintained. 
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The  use  of  standard  measures  with  established  measurement  qualities  (Hobart  et  al. 
1996)  allows  comparison  between  studies,  making  interpretation  and  generalisation  of 
results  easier  and  facilitates  combination  in  meta-analysis. 
Desirable  features  of  a  randomised  controlled  trial  are  summarized  in  Table  2.3. 
(Mulrow  &  Oxman  1997,  Langhorne  &  Dennis  1998). 
Table  2.3 
Desirable  features  of  randomised  controlled  trials 
Clearly  stated  aims  and  objectives  (focussed  question) 
Adequate  number  of  subjects  based  on  power  calculation 
Explicit  inclusion  and  exclusion  criteria 
Description  of  groups  at  baseline 
Efforts  to  reduce  selection  bias  e.  g.  concealed  randomisation  of  subjects 
Monitoring  of  clearly  defined  intervention 
Subjects  in  groups  receive  similar  treatment  apart  from  the  intervention 
Double  blind  intervention 
Reporting  of  adverse  events 
Use  of  standardised  outcome  measures  with  known  measurement  qualities  (reliability 
and  validity) 
Blind  assessments 
Complete  follow  up  of  subjects 
Intention  to  treat  analysis 
In  terms  of  reporting,  the  results  from  trials  should  be  disseminated  as  widely  as 
possible.  However  not  all  results  are  likely  to  reach  the  public  domain  due  to  publication 
bias  (discussed  in  Chapter  4).  This  can  perpetuate  difficulties  in  carrying  out  trials  as 
researchers  are  denied  the  opportunity  to  discover  the  difficulties  experienced  by  other 
researchers  and  to  discuss  possible  solutions.  Additionally,  where  small  trials  could  be 
combined  in  a  meta-analysis,  unpublished  trials  are  likely  to  be  missed  or  difficult  to 
obtain  by  those  carrying  out  secondary  research. 
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Where  formal  research  is  difficult  or  impractical  a  culture  of  audit  or  descriptive  studies 
may  still  provide  important  information  and  help  to  establish  the  foundations  or  basis  of 
clinical  trials.  This  may  be  as  simple  as  getting  staff  accustomed  to  data  gathering  and 
handling  and  the  rigour  required  to  successfully  run  a  trial  in  a  clinical  setting. 
Finally,  Wade  warns  of  the  potential  for  Type  III  error  -  an  error  of  interpretation  of 
results  (Wade  2001)  when  considering  trials  of  complex  interventions.  Recommending 
that  as  "there  are  likely  to  be  interdependent  components  of  the  rehabilitation  "black 
box"  and  if  individual  studies  find  negative  results  then  these  should  be  further 
investigated  in  the  context  of  the  other  components". 
Addressing  my  research  questions 
My  questions  in  Chapter  1  are  best  addressed  using  a  randomised  controlled  trial  design. 
When  I  tried  to  relate  the  available  results  of  the  RCTs  in  the  literature  to  my  questions, 
some  trials  were  clearly  more  relevant  than  others. 
A  number  of  trials  focused  only  on  outpatient  interventions  (Smith  et  al.  1981)(Werner 
&  Kessler  1996)  (Duncan  et  al.  1998)  or  were  examining  late  intervention  out-with  the 
hospital  setting  (Wade  et  al.  1992)(Green  et  al.  2002).  Some  studies  featured  unusual 
interventions  that  did  not  reflect  physiotherapy  practice  in  the  UK:  using  a  rocking-chair 
and  a  splint  to  give  sensory-motor  stimulation  (Feys  et  al.  1998);  patients  practising  ann 
movement  on  their  own  with  the  use  of  a  mirror  (Altschuller  et  al.  1999)  and  self- 
practise  of  rising  from  the  chair  (Pollock  et  al.  2002).  Some  other  studies,  although 
contrasting  intensity  of  therapy,  appeared  to  be  more  focused  on  investigating  the 
intervention  rather  than  the  intensity  of  the  intervention  (Carey  1990)  (Walker  et  al. 
2000). 
The  studies  that  seemed  more  relevant  to  establishing  if  intensive  physiotherapy  after 
stroke  would  produce  benefits  are  described  below. 
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Lincoln  et  al.  1999 
In  what  is  clearly  the  largest  physiotherapy  intensity  study  to  date,  with  282  patients, 
Lincoln  et  al.  carried  out  a  high  quality  single-blind  RCT  comparing  the  effect  of 
increased  physiotherapy  on  arm  function  (Lincoln  et  al.  1999)(Parry  et  al.  1999(a)). 
Additionally  they  investigated  the  effects  of  this  treatment  when  administered  by  a 
qualified  physiotherapist  or  by  a  trained  supervised  assistant.  Their  study  followed  a 
typical  approach  found  in  UK  practice,  mostly  based  on  the  Bobath  approach,  though 
was  limited  to  upper  limb  intervention  and  involved  a  highly  experienced  and  motivated 
therapist.  They  aimed  to  give  ten  hours  of  additional  therapy  over  a5  week  period. 
They  recruited  acute  patients  up  to  5  weeks  after  stroke.  Subjects  were  randomly 
allocated  to  control,  additional  therapy  with  a  qualified  physiotherapist  or  additional 
therapy  with  a  therapy  assistant  working  under  supervision.  Outcomes  were  assessed  at 
the  end  of  intervention  (5  weeks),  3  and  6  months  after  stroke  using  arm  function  and 
ADL  measures  (Rivermead  Mobility  Index  (RMI),  Rivermead  Mobility  Assessment 
(RMA)  (Arm  section),  Action  Research  Arm  Test  (ARAT)  and  the  Barthel  Index  (BI). 
They  found  no  differences  between  the  groups  with  no  significant  effect  on  arm 
function.  This  negative  result  may  be  due  to  the  content  of  the  therapy,  patient  selection, 
chance  or  possibly  a  lack  of  intensity,  as  only  half  of  the  patients  allocated  to  the 
additional  therapy  groups  completed  the  programme. 
A  post-hoc  analysis,  examining  sub-groups  suggested  that  less  severely  impaired 
patients  benefited  from  intervention  from  a  supervised  therapy  assistant  rather  than  a 
qualified  physiotherapist.  It  is  possible  that  there  was  more  contrast  in  the  content  of  the 
sessions  delivered  by  the  supervised  assistant.  The  qualified  therapist  may  have  spent 
more  time  discussing  treatment  and  negotiating  with  the  patient  whilst  the  assistants 
may  have  spent  a  greater  proportion  of  the  time  actually  carrying  out  exercises. 
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Kwakkel  et  al.  1999 
In  a  well  conducted  single  blind  RCT  Kwakkel  et  al.  investigated  the  effects  of  different 
intensities  of  arm  and  leg  rehabilitation  on  the  functional  recovery  of  activiti  I  'es  of  dail,  y 
living,  walking  ability  and  dexterity  of  the  paretic  arm  (Kwakkel  et  al.  1999). 
Within  14  days  of  onset  of  primary  middle  cerebral  artery  stroke,  patients,  recruited 
from  seven  hospitals,  were  randomly  assigned  to  one  of  three  groups:  to  receiN,  e  a 
rehabilitation  programme  with  the  emphasis  on  the  arm;  a  programme  with  the  emphasis 
on  the  leg  and  a  control  group  that  immobilised  the  arm  and  leg  using  an  inflatable 
splint.  The  intervention  was  applied  for  30  minutes  per  day  for  5  days  per  week  for  a 
period  of  20  weeks.  This  was  over  and  above  their  normal  rehabilitation  programme. 
The  intervention  was  described  in  treatment  diaries  (in  blocks  of  15  minutes).  It  was  not 
reported  who  provided  the  treatment. 
Their  primary  outcome  measures  were  ability  in  activities  of  daily  living  as  measured  by 
the  Barthel  Index  (BI),  walking  ability  described  by  functional  ambulatory  categories 
and  upper  limb  dexterity  assessed  by  the  Action  Research  Arm  Test  (ARAT)  at  6,12,20 
and  26  weeks  after  stroke. 
They  found  higher  scores  in  the  leg  training  group  for  all  of  the  outcomes  and  a  small 
improvement  in  dexterity  in  the  arm  group.  These  effects  had  disappeared  by  week  20. 
They  concluded  that  increased  intensity  of  physiotherapy  produced  short-term  benefit 
and  that  exercise  therapy  produces  benefit  in  the  area  at  which  it  is  aimed.  They  went  on 
to  follow  up  their  subjects  at  9  and  12  months  (with  un-blinded  assessments)  but  found 
no  significant  differences  between  the  groups. 
It  is  difficult  to  generalise  from  their  results  to  the  general  stroke  population.  They 
recruited  approximately  3%  of  patients  admitted  to  their  hospital,  all  of  whom  had 
marked  disability  (a  BI  score  of  9/20  or  lower)  and  were  non  ambulant.  They  achieved 
positive  results  though,  taken  overall,  the  study  is  probably  not  large  enough  to  actually 
change  clinical  practice.  Some  other  studies  have  had  a  limited  contrast  betXveen 
treatment  groups  and  Kwakkel  et  al.  's  results  may  reflect  their  ability  to  maintain 
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treatment  contrast  by  immobilising  the  control  group  in  inflatable  splints  and  that  their 
intervention  started  early. 
Partridge  et  al.  2000 
Partridge  et  al.  carried  out  a  single-blind,  randomised  controlled  trial  of  physlotherapy 
intensity  reported  in  2000  (Partridge  et  al.  2000).  They  recruited  114  patients  and 
followed  them  up  at  6  weeks  and  6  months  using  a  variety  of  less  frequently  used 
outcome  measures:  timed  walk  (over  5m);  profiles  of  recovery  (POR);  2  arm  function 
tests;  the  step:  time  ratio;  a6  item  ADL  scale;  a5  item  quality  of  life  scale,  the 
functional  reach  test;  timed  sit  to  stand;  the  Hospital  Anxiety  and  Depression  index 
(HAD)  and  a  measure  of  perceived  locus  of  control  over  recovery  (RLOC). 
In  this  pragmatic  study  the  researchers  included  all  patients  referred  to  their  stroke  unit 
and  aimed  to  contrast  30  minutes  treatment  with  60  minutes  treatment.  They  could 
detect  no  significant  difference  between  the  groups  using  their  outcomes.  The 
intervention  probably  reflected  UK  practice,  however  their  sample  included  many 
patients  with  poor  prognosis  (elderly,  incontinent  of  urine,  communication  impaired  and 
with  low  mood).  The  outcomes  they  selected  make  interpretation  of  the  results  difficult 
for  those  unfamiliar  with  the  measures  and  comparison  across  studies  is complex.  Some 
elements  were  not  reported  with  little  detail  of  those  patients  that  failed  to  complete  the 
trial  (21  /  114,  approximately  17%).  It  is  unclear  whether  those  patients  died,  withdrew 
or  were  intolerant  of  the  intervention.  Although  they  had  set  out  to  tackle  relevant  and 
interesting  aspects  of  stroke  physiotherapy  the  researchers  concluded  that  their  study 
lacked  precision. 
Richards  et  al.  1993 
In  1993  Richards  et  al.  reported  a  pilot  RCT  to  investigate  the  effect  of  early,  intensive, 
gait-focused  physical  therapy  on  ambulatory  ability  in  acute  stroke  (Richards  et  al. 
1993). 
Patients  were  randomly  allocated  to  one  of  3  groups:  conventional  physiotherapy;  and 
groups  that  received  intensive  physiotherapy  that  either  started  early  or  at  the  usual 
(conventional)  time.  The  subjects  were  assessed  at  entry,  6  weeks,  3  and  6  months  later, 
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by  a  blinded  independent  evaluator  using  standard  measures:  gait  analysis;  gait  speed;. 
Fugl-Meyer  (leg  and  balance)  and  the  ambulatory  component  of  the  Barthel  Index. 
They  reported  modest  short-terin  benefit  that  disappeared  at  3  and  6  months.  This  was  a 
small  study  that  was  focussed  on  the  lower  limb  and  attempted  to  address  several 
questions  at  once.  Because  of  the  small  numbers  involved  (27  subjects  in  3  groups)  and 
the  subjects  being  described  only  as  "middle  band"  of  severity  it  is  difficult  to  generalise 
from  the  results. 
Slade  et  al.  2002 
In  a  study  with  a  focus  on  reduction  of  length  of  hospital  stay  and  costs,  Slade  et  al. 
carried  out  a  randomised  controlled  single-blind  trial  examining  the  cost  effectiveness  of 
increased  intensity  of  "therapy"  (physiotherapy  and  occupational  therapy)  on  a  mixed 
group  of  patients  in  a  neurological  rehabilitation  unit  (Slade  et  al.  2002). 
Their  experimental  group  were  younger  than  in  many  of  the  other  studies,  reflecting 
inclusion  of  head  injured  patients  and  those  with  multiple  sclerosis  (87  /141  (60%)  were 
stroke  patients).  They  aimed  to  deliver  67%  enhancement  of  therapy,  though  actually 
provided  59%  enhancement,  the  equivalent  of  one  and  a  quarter  hours  of  physiotherapy 
and  occupational  therapy.  They  looked  to  length  of  stay  as  a  measure  of  cost 
effectiveness. 
They  found  an  average  reduction  in  length  of  hospital  stay  of  17  days  with  cost  saving 
calculated  as  f  1737  per  patient.  The  ability  to  generalise  results  to  other  stroke  units  is 
limited  due  to  the  limited  reporting  of  sub-groups  according  to  their  condition. 
Sunderland  et  al.  1992 
Sunderland  et  al.  conducted  one  of  the  earlier  trials,  reported  in  1992,  with  many  good 
features.  It  was  a  single  blind  RCT  to  investigate  the  effect  of  an  enhanced  physical 
therapy  regime  on  upper  limb  recovery  (Sunderland  et  al.  1992). 
It  was  a  relatively  large  trial  with  135  patients  and  featuring  the  use  of  high  quality 
standard  measures  and  blinded  assessments.  They  contrasted  two  groups  that  received 
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therapy  for  the  arm  (32minutes  v  20  minutes).  They  assessed  outcome  by.  using  tllc 
Extended  Motricity  index,  Motor  Club  Assessment,  passive  movement  and  pain, 
Frenchay  Arm  Test  (FAT),  Nine  Hole  Peg  Test  (9HPT)  and  Barthel  index  at  1,3  and  6 
months. 
They  found  a  small  but  statistically  significant  difference  in  recovery  of  strength,  range 
and  speed  of  movement  in  favour  of  the  experimental  group  after  6  months.  The 
treatment  effect  was  more  marked  in  the  mildly  impaired  group  and  was  still  present  at  6 
months  but  was  lost  at  longer-term  follow  up  at  one  year.  Again,  the  two  groups  had  a 
limited  contrast  (mean  of  12  minutes). 
Do  these  studies  answer  my  questions? 
Returning  to  my  original  questions  in  Chapter  1,  it  is  worth  discussing  to  what  extent 
they  are  addressed  by  these  studies. 
"Does  the  provision  of  intensive  physiotherapy  after  stroke  produce  benefits  which:  " 
a)  lead  to  reductions  in  impairment  and  disability. 
The  results  from  several  trials  suggested  small  but  significant  benefit  from  increased 
physiotherapy  intervention,  at  least  in  the  short  ten-n  (Sunderland  et  al.  1992)  (Richards 
et  al.  1993)  (Kwakkel  et  al.  1999),  whilst  others  have  reported  little  or  no  measurable 
benefits  (Lincoln  et  al.  1999)  (Partridge  et  al.  2000). 
Most  studies  do  not  address  the  effect  of  physiotherapy  on  "mobility",  with  many 
reporting  outcomes  in  terms  of  activities  of  daily  living  or  impairment  using  a  variety  of 
measures. 
b)  are  greater  when  targeted  (e.  g.  on  upper  limb  recovery). 
Three  studies  consider  the  arm  in  isolation  (Sunderland  et  al.  1992)(Lincoln  et  al. 
1999)(Miller  et  al.  2000  (abstract))  whilst  one  (Richards  et  al.  1993)  concentrated 
intervention  only  on  the  lower  limb.  Kwakkel  et  al.  randomised  subjects  to  upper  or 
lower  limb  groups. 
37 Chapter  2 
c)  are  greaterfor  patients  with  moderate  impairment  and  little  co-morbidity. 
Sunderland  et  al.  found  most  benefit  for  "mild"  cases. 
d)  are  greater  in  the  shorter  (3  months)  than  longer  term  (6  -  12  months). 
Short  term  benefit  was  noted  in  the  trials  by  Sunderland  et  al.,  Richards  et  al.  and 
Kwakkel  et  al.  The  other  trials  either  did  not  demonstrate  a  difference  or  did  not  have 
comparable  follow  up  points. 
e)  result  in  a  reduced  duration  of  inpatient  rehabilitation. 
Slade  et  al.  was  the  only  trial  to  use  length  of  stay  as  their  primary  outcome  measure. 
Patients  with  greater  intensity  of  therapy  were  discharged  from  hospital  sooner  than  the 
control  group,  however  we  do  not  know  if  this  resulted  in  a  reduction  of  overall 
rehabilitation  time.  Rehabilitation  treatment  may  have  continued  on  an  outpatient  basis. 
The  trials  available  in  the  late  1990s  still  did  not  appear  to  have  adequately  tackled  the 
methodological  problems  or  reached  a  clear  answer  to  these  questions.  Therefore  the 
issue  of  increased  intensity  of  physiotherapy  remains  on  the  research  agenda  (Legg  et  al. 
2000). 
Conclusion 
There  are  several  studies  in  the  literature  that  examine  physiotherapy  intensity  after 
stroke,  however  these  are  mostly  relatively  small,  inconclusive  and  at  times  arrive  at 
contradictory  conclusions.  The  trials  are  varied  and  none  seem  to  adequately  address  the 
questions  set  out  in  the  first  chapter.  Many  demonstrate  the  problems  associated  with 
physiotherapy  trials  and  investigating  complex  healthcare  interventions.  This  lack  of 
evidence  could  be  due  to  differences  in  trial  methodology,  patient  selection,  therapy 
technique,  outcome  measures  or  simply  due  to  chance.  It  seems  that  Ernst's  conclusion 
that  "Well  planned  clinical  trials  aimed  at  finding  the  best  approach  and  discriminating 
potential  responders  from  non-responders  are  urgently  needed.  "  despite  some  high 
quality  trials  in  the  intervening  years  still  held  true  ten  years  later. 
With  this  in  mind  and  acknowledging  the  methodological  challenges,  a  group  in 
Glasgow  set  out  to  complete  a  randomised  controlled  trial  of  intensity  of  physiotherapy 
after  stroke.  This  trial  is  described  in  the  next  chapter. 
38 Chapter  2 
Summary 
*I  discuss  and  review  some  of  the  important  papers  that  have  examined  intensit%, 
of  physiotherapy  after  stroke  in  relation  to  the  research  questions. 
*  Many  trials  have  limitations  and  demonstrate  problems  common  to  research  into 
complex  healthcare  interventions. 
9  Some  solutions  and  desirable  features  in  trial  design  are  proposed. 
01  conclude  that  there  is  still  a  lack  of  evidence  about  the  optimum  intensity  of 
physiotherapy  and  that  further  well-conducted,  randomised  controlled  trials  may 
be  useful.  I  go  on  to  describe  such  a  trial  in  the  next  chapter. 
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CHAPTER  3 
THE  GLASGOW  AUGMENTED  PHYSIOTHERAPY  AFTER  STROKE 
(GAPS)  STUDY 
Introduction 
In  this  chapter  I  describe  a  randomised  controlled  trial  of  augmented  physiotherapy 
that  I  helped  develop  and  co-ordinate,  aiming  to  address  my  questions. 
Background 
The  systematic  reviews  discussed  in  the  last  chapter  (Langhorne  et  al.  1996(a)) 
(Kwakell  et  al.  1997)  (van  der  Lee  et  al.  2001)  suggest  that  augmented 
physiotherapy  may  speed  up  recovery  after  stroke.  The  apparent  effects  were 
modest  but  could  contribute  to  patients  achieving  their  potential  and  returning  home 
at  an  earlier  stage.  However,  because  the  available  studies  were  small  and 
heterogeneous  there  was  a  lack  of  reliable,  practical  information  on  the  relationship 
between  physiotherapy  intensity  and  patient  outcomes. 
Few  of  the  previous  trials  have  specifically  focussed  on  the  recovery  of  mobility,  an 
obvious  choice  since  it  is  a  core  activity  of  physiotherapy  and  a  key  factor  in 
determining  functional  outcomes  after  stroke.  If  the  "natural"  rate  of  recovery  after 
stroke  cannot  be  altered  then  increasing  therapy  input  above  conventional  levels 
would  be  a  waste  of  effort  and  resources.  However  if  the  period  in  which  the  patient 
remains  dependent  (and  in  hospital)  can  be  reduced  then  a  reduction  in  nursing  and 
"hotel"  costs  (currently  over  95%  of  hospital  stroke  costs)  could  be  achieved 
through  an  increase  in  therapy  input  (currently  accounting  for  only  1%  of  costs) 
(Warlow  et  al.  2001). 
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Having  identified  this  issue  (Langhorne  &  Dennis  1996),  in  1998  a  group  led  by 
Professor  Peter  Langhorne,  successfully  appli  e  'ed  for  funding  from  the  Strok 
Association  to  carry  out  a  randomised  controlled  trial.  I  was  employed  by  this  group  to 
develop  the  existing  protocol  and  methods  and  co-ordinate  the  trial,  setting  out  to 
answer  the  basic  question 
"Does  the  provision  of  additional  in-patient  physiotherapy  after  stroke  speed  up  the 
recovery  of  mobility?  ". 
With  mobility  as  our  primary  outcome,  we  wanted  to  use  sound  methods  and 
attempt  to  address  some  of  the  limitations  of  the  previous  studies. 
We  wanted  specifically  to  develop  and  address  five  key  questions: 
a).  Does  augmented  physiotherapy  speed  recovery  in  terms  of  the  achievement  of 
mobility  milestones,  patient  activity  and  quality  of  gait. 
b).  Does  augmented  physiotherapy  allow  patients  to  be  fit  for  and  able  to  return 
home  earlier. 
c).  Does  augmented  physiotherapy  improve  patient  satisfaction  with  care. 
d).  Does  augmented  physiotherapy  result  in  sustained  benefits  (in  terms  of  mobility, 
activities  of  daily  living,  and  quality  of  life) 
e).  Does  augmented  physiotherapy  result  in  cost  recovery  through  improved  patient 
outcomes  or  reduced  length  of  hospital  stay. 
Subjects 
We  included  patients  admitted  to  stroke  rehabilitation  wards  at  Stobhill, 
Drumchapel  and  Lightburn  Hospitals,  in  Glasgow.  I  visited  each  of  the  hospital 
sites  once  or  twice  a  week  to  screen  all  new  admissions.  I  did  this  by  asking  staff  on 
the  wards  and  physiotherapy  department  and  checking  the  admissions  register  and 
the  casefiles  of  all  patients  on  the  rehabilitation  wards.  In  addition,  the 
physiotherapy  staff,  including  the  project's  research  physiotherapists,  were  asked  to 
contact  me  by  telephone  if  any  potential  subjects  were  admitted.  I  was  also  aware  of 
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some  potential  subjects  that  would  be  transferred  from  an  acute  hospital  where  I 
continued  to  have  clinical  duties. 
All  subjects  had  a  clinical  diagnosis  of  stroke  within  the  previous  1-4  weeks  and 
were  able  to  tolerate  and  benefit  from  mobility  rehabilitation  i.  e.  they  had 
independent  functional  sitting  balance,  no  major  co-morbidities,  no  major 
communication  deficit  or  cognitive  impairment,  and  were  previously  independelit 
(pre-stroke  Rankin  score  of  less  than  3)(Wade  1992). 
These  criteria  were  determined  by  casenote  review  and  discussion  with  relevant 
ward  staff  e.  g.  the  treating  speech  and  language  therapist  was  consulted  to  estimate 
the  patient's  ability  to  understand  recruitment  information.  Cognitive  impairment 
was  routinely  recorded  with  the  Abbreviated  Mental  Test  (AMT)  score,  with  a  score 
of  less  than  or  equal  to  8/  10  being  considered  as  impaired  (Hodkinson  1972). 
Functional  sitting  balance,  i.  e.  the  ability  to  sit  unsupported  with  the  feet  on  the 
ground  for  a  period  of  at  least  approximately  one  minute,  was  taken  from  the 
casenote  or  after  discussion  with  the  treating  physiotherapist.  Major  co-morbidities 
were  noted  as  recorded  in  the  casenote  by  medical  staff.  These  were:  dementia; 
arthritis  that  limited  activities  of  daily  living;  unstable  angina  that  limited  exercise; 
chronic  obstructive  pulmonary  disease  (COPD)  that  limited  exercise;  major  surgery 
in  the  past  3  months;  poorly  controlled  diabetes;  myocardial  infarction  in  the  past  3 
months  and  peripheral  vascular  disease  that  limited  exercise. 
We  recorded  the  type  of  stroke  (Bamford  et  al.  1991)  and  in  the  case  of  hemiplegia, 
the  side  affected. 
Methods 
Feasibility 
Several  pilot  investigations  to  support  this  project  had  been  carried  out  before 
funding  was  awarded.  The  systematic  reviews  of  the  randomised  controlled  trials 
(RCTs)  mentioned  previously  (Langhorne  et  al.  1996)  indicated  that  a  doubling  of 
therapy  time  might  produce  measurable  improvements  in  recovery.  Physiotherapy 
input  at  the  three  sites  was  established  as  involving  approximately 
30  -  45  minutes  per  day  (Monday  to  Friday)  direct  therapy  time.  Pilot  observations 
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indicated  that  over  900  patients  would  be  admitted  to  the  study  sites  during  an  Is 
month  recruitment  period  of  whom  25%  (225  patients)  would  meet  the  trial 
inclusion  criteria.  Of  these  the  majority  (>80%)  would  regain  independent  walking 
taking  a  mean  (SD)  of  18  (11)  days  to  recover  walking  over  10  paces,  26  (15)  days 
to  recover  walking  over  10  metres  and  45  (25)  days  to  return  home.  The  peak 
walking  speeds  averaged  0.32  (0.08)  metres/sec. 
Power  calculation 
Based  on  these  figures  and  taking  into  account  possible  attrition,  we  estimated  that 
recruiting  100  patients  would  give  the  study  an  80%  power  (at  5%  level)  to  detect  a 
7-day  reduction  in  the  time  taken  to  recover  independent  walking  and  0.05 
metres/sec  increase  in  walking  speed.  The  trial  was  unlikely  to  have  adequate  power 
to  show  a  significant  improvement  in  activities  of  daily  living  (ADL).  It  was 
designed  to  be  compatible  with  previous  RCTs  of  intensive  physiotherapy  to 
facilitate  a  combined  prospective  meta-analysis. 
Ethical  approval 
We  applied  for  and  obtained  ethical  approval  on  all  three  hospital  sites. 
Randomisation 
After  giving  informed  consent,  patients  were  randomly  assigned  (through  a 
telephone  randomisation  procedure  based  at  the  Roberson  Centre  for  Biostatistics  at 
the  University  of  Glasgow)  to  one  of  two  groups:  a)  conventional  in-patient  stroke 
services  including  conventional  physiotherapy  input  (30  -  40  minutes  per  day,  5 
days  per  week),  or  b)  conventional  stroke  services  plus  additional  physiotherapy 
input  (to  approximately  double  the  total  daily  physiotherapy  time  to  60  -  80  minutes 
per  day,  5  days  per  week). 
Randomisation  was  stratified  by  site,  age  (75  years  or  over),  and  disability  level 
(Barthel  Index  greater  than  or  equal  to  10)  at  recruitment. 
Due  to  limited  resources  to  supply  the  intervention,  patients  were  only  put  forward 
for  randomisation  when  we  could  ensure  that  the  intervention  could  be  delivered. 
Thus  when  several  patients  were  receiving  additional  intervention  we  delayed 
randomisation  for  suitable  subjects.  Once  resources  were  available  patients  were  put 
forward  for  randomisation  as  soon  as  possible. 
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Intervention 
Because  of  the  great  diversity  of  symptoms  that  stroke  patients  experience,  Nve 
considered  it  impossible  to  designate  in  advance  a  standard  treatment  for  all 
patients.  The  three  centres  were  chosen  as  they  have  similar  physiotherapy 
approaches  representative  of  normal  UK  practice  (Sackley  &  Lincoln.  1996) 
(Davidson  &  Waters  2000).  Outline  treatment  schedules  were  developed  based  on 
the  approach  of  Edwards  et  al.  (Edwards  et  al.  1991)  by  the  trial  management  group 
to  ensure  consistency  of  treatment  categories.  Treatment  was  broadly  based  on  the 
"Nom-ial  Movement"  (Bobath)  approach  i.  e.  using  a  knowledge  of  normal 
movement  to  inform  a  problem  solving  approach  to  the  assessment  and  treatment  of 
the  individual  patient.  The  range  of  techniques  included  non-nalising  tone  and 
sensory  input,  re-education  of  balance  reactions  and  facilitating  selective  movement 
to  achieve  functional  independence.  The  overall  goals  were  to  improve,  maintain  or 
prevent  deterioration  of  physical  skills.  Specific  functional  objectives  included  the 
establishment  of  independent  sitting  balance  (already  achieved  in  our  patients), 
standing  balance,  upper  limb  function  and  walking. 
Recording  the  treatment 
A  standard  format  for  recording  the  type  and  amount  of  therapy  was  also  developed 
and  tested  (see  Appendix  1).  These  recorded  patient  identification  details,  the 
treating  therapist,  position  and  activity  of  the  intervention,  the  focus  of  the  treatment 
e.  g.  upper  limb  functional  re-education,  and  the  number  of  minutes  spent  with  the 
therapist  in  the  various  components  of  the  treatment  session.  Time  was  split  into 
"direct"  contact  time  e.  g.  "hands-on"  treatment,  direct  supervision  of  exercises  and 
discussion,  or  "indirect"  contact  time  e.  g.  written  recording,  reporting  at  case 
conferences,  telephone  conversations.  The  number  of  minutes  was  taken  to  the 
nearest  5  minute  "unit".  These  timesheets  were  completed  for  each  contact  with  the 
patient.  I  collected  these  sheets  on  my  visits  to  the  hospitals,  checking  they  were 
completed  correctly.  Therapists  were  encouraged  to  complete  the  forins  as  soon  as 
possible  after  contact  with  the  patient. 
Monitoring  the  treatment 
I  inforinally  monitored  the  amount  of  time  the  therapists  were  spending  with  the 
patients,  depending  on  their  treatment  allocation.  Where  patient  treatment  times 
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were  less  or  more  than  expected  I  would  discuss  the  therapists'  reasons  for  this 
being  the  case.  Without  influencing  the  content  of  the  therapy,  the  treating 
physiotherapists  were  reminded  to  try  to  maintain  a  treatment  contrast  of  twice  as 
much  therapy  for  those  subjects  in  the  treatment  arm  of  the  trial. 
By  this  monitoring  and  having  research  physiotherapists  on  two  of  the  sites  we 
attempted  to  maintain  consistency  of  intervention  and  accuracy  of  records  by 
reducing  any  delay  in  completion  of  data  collection.  Monitoring  the  intervention 
was  complex,  as  staffing  levels  normally  fluctuate  according  to  staff  leave  for 
holidays,  sickness  and  training.  Therefore  at  certain  times  during  the  study  some  of 
the  intervention  group  would  receive  less  therapy  input  than  at  other  times.  We  had 
to  accept  that  this  would  be  the  case  and  concentrated  on  maintaining  a  contrast 
between  the  groups  within  the  available  physiotherapy  service  at  any  one  time.  To 
try  to  minimise  this  problem  the  two  half-time  research  physiotherapists  that  we 
employed  provided  "back  fill"  time  support  for  physiotherapists  delivering  the  extra 
therapy.  This  resource  could  be  drawn  on  to  ensure  the  trial  was  seen  as  a  priority 
by  those  providing  the  clinical  service.  This  "pooling"  of  these  staff  also  allowed  us 
to  examine  treatments  being  provided  by  a  broad  variety  of  physiotherapists  e.  g. 
junior  staff,  senior  staff,  and  therapy  assistants  and  undergraduate  students  working 
under  supervision.  This  reflects  how  services  are  normally  provided  to  patients 
rather  than  an  intervention  that  is  provided  by  a  single  highly  trained  and  skilled, 
enthusiastic  specialist. 
Other  interventions 
Patients  in  both  groups  had  the  nonnal  access  to  occupational  therapy,  speech  and 
language  therapy,  nursing  and  medical  interventions  whilst  inpatients  and  after 
discharge  in  the  community. 
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Outcome  measures 
We  used  the  following  outcome  measures  (see  table  3.1).  Copies  of  the  data 
collection  fonns  are  given  in  Appendix  11  along  with  references,  a  description  and 
rationale  for  the  use  of  these  measures. 
Table  3.1  Outcome  measures  for  each  domain  and  the  timetable  for  follow  up. 
Measure  Baseline  Weekly  while 
inpatient  up  to 
10  weeks 
4 
weeks 
3 
months 
6 
months 
Impairment 
Motricity  Index 
Trunk  control  test 
10  metre  walking  test 
(preferred  gait  speed) 
Functional  reach  test 
9  hole  peg  test 
Rivennead.  Visual  Gait 
Assessment  (RVGA) 
Gait  analysis 
Disability  (activities) 
Barthel  Index  (BI) 
Nottingham  Extended 
Activities  of  Daily  Living 
Index  (NEADLI) 
Mobility  milestones 
Action  Research  Ann  Test 
(ARAT) 
Rivermead  Mobility  Index 
(RMI) 
Portable  electronic  activity 
monitor 
Once 
at  3 
weeks 
Handicap  (participation) 
Rankin  (Oxford  Handicap 
scale) 
Quality  of  Life 
Euroquol 
Patient  satisfaction  scale  4  weeks 
after  dis- 
charge 
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We  selected  these  measures  because  they  are  established,  reflect  the  domains  that 
interested  us,  have  (in  general)  known  measurement  properties  (reliability,  validity, 
sensitivity)  and  are  practical  to  administer  to  patients  in  a  hospital  environment 
(with  the  exception  of  the  patient  satisfaction  scale  which  was  sent  as  a  postal 
questionnaire).  In  addition  to  these  we  assessed  patients'  medical  complications,  use 
of  equipment  and  use  of  community  resources. 
We  used  the  following  methods  related  to  the  key  questions. 
Question  a).  Does  augmented  physiotherapy  speed  recovery  in  terms  of  the 
achievement  of  mobility  milestones,  patient  activity  and  qualiti,  ofgait? 
We  carried  out  the  follow  up  schedule,  gathering  data  on  the  two  groups  as  outlined 
in  Table  3.1. 
We  examined  the  Mobility  Milestones  (Partridge  et  al.  1987,  Smith  and  Baer  1999) 
for  differences  in  terms  of  levels  of  achievement,  time  taken  to  achieve  each 
milestone  and  the  change  in  status  ("how  many  milestones  were  passed  on  the 
journey  to  recovery"  e.  g.  from  having  no  milestones  Oust  able  to  sit)  to  walking  10 
metres  involves  "gaining"  3  milestones,  whereas  being  able  to  take  10  steps  to 
being  able  to  walk  10  metres  involves  gaining  just  the  one  milestone.  ).  We  also 
tested  to  see  if  those  changes  were  sustained. 
Patient  activity  was  measured  using  an  "activity  monitor"  developed  by  the 
Bioengineering  Unit,  University  of  Strathclyde  (Suckalingham  1993).  The  "activity 
monitor"  was  able  to  classify,  on  a  continuous  basis,  the  activity  of  the  patient  into 
the  two  primary  classifiers  -  sitting  and  standing  -  using  the  output  of  a  single 
sensor  attached  to  the  patient.  This  sensor  consisted  of  a  commercial  miniature 
pressure  transducer  connected  to  a  flexible,  fluid-filled  tube.  The  fluid-filled  tube 
and sensor  were  taped  to  the  lateral  side  of  the  patient's  unaffected  leg  (Fig.  3.1). 
The  pressure  measured  depends  on  the  end-to-end  length  of  the  tube,  which  changes 
during  activity.  The  transducer  produces  a  simple  output  that  is  characteristic  of  the 
posture  or  activity  of  the  subject  (Fig.  3.2).  Data  were  recorded  on  a  data  logger 
[Biomedical  Monitoring  Ltd,  UK]  on  a  single  occasion,  3  weeks  after 
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randomisation.  The  patients  wore  the  monitor  from  early  morning  to  just  before 
going  to  bed  at  night  (their  "waking  day").  The  outcome  measures  of  "proportion  of 
time  spent  upright"  and  "number  of  transitions  between  sitting  and  upright  per 
hour"  were  recorded  for  the  patients'  waking  day. 
In  addition  to  this,  we  divided  the  day  into  the  period  before  4:  30pin  (the  time 
during  which  activity  was  considered  to  be  directly  influenced  by  the 
physiotherapists)  and after  4:  30pin  (the  time  during  which  activity  was  dependent 
on  the  patient's  own  ability  and  motivation,  and  nursing  staff  assistance)  to  look  for 
differences  in  activity.  This  allowed  us  to  compare  patient  activity  during  the  period 
therapy  staff  were  on  duty  with  the  period  they  were  not,  in  order  to  establish  if 
there  is  a  difference.  It  also  allowed  us  to  compare  the  activity  before  4-30pm 
between  the  two  groups  of  patients  to  see  if  the  augmented  group  were  indeed  more 
active.  Comparing  the  two  groups  after  4-30pin  would  also  indicate  if  the 
augmented  group  were  less  active  later  in  the  day,  perhaps  due  to  fatigue. 
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Figure  3.1  Activity  monitor  attached  to  patient's  unaffected  leg 
(image  -  T.  Egerton) 
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Figure  3.2  Output  from  the  activity  sensor.  Different  output  levels  are  seen 
for  sitting,  standing  and  walking. 
We  compared  the  patients'  quality  of  gait  using  walking  speed  and  a  "body  worn 
gait  analysis  system".  This  system  (Granat  et  al.  1995)  consisted  of  shoe  insoles  that 
incorporated  four  force-sensitive  resistors  [Interlink  Electronics,  Luxembourg], 
acting  as  switches,  placed  at  the  position  of  the  heel,  head  of  the  first  metatarsal, 
head  of  the  fifth  metatarsal  and  the  big  toe.  They  were  mounted  on  thin  plastic  film 
cut  to  the  shape  of  the  subject's  feet.  The  subjects  walked  along  a  walkway  of  12m 
and  all  data  were  collected  on  a  data-logger  [Biomedical  Monitoring  Ltd,  UK]  wom 
around  their  waist.  This  allowed  us  to  measure  speed  and  symmetry.  Symmetry 
was  calculated  as  the  ratio  of  the  swing  time  of  the  unaffected  leg  to  the  swing  time 
of  the  affected  leg.  Again,  we  examined  for  differences  between  the  two  groups  in 
ternis  of  levels  of  achievement,  speed  to  achieve  these  levels  and  to  see  if  those 
changes  were  sustained. 
Question  b).  Does  augmented  physiotherapy  allow  patients  to  befit  for  and  able  to 
return  home  earlier? 
We  recorded  the  patients'  length  of  stay  in  hospital,  reasons  that  might  have  delayed 
discharge  and  the  frequency  of  complications  and  adverse  events. 
Although  we  did  not  expect  to  see  statistically  significant  changes  in  these  domains 
we  included  two  commonly  used  measures;  the  Barthel  Index  and  the  Rankin 
Handicap  Score. 
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Question  c).  Does  augmented  physiotherapy  improvepatient  satisfaction  with  care? 
We  compared  responses  from  the  two  groups  to  a  patients'  satisfaction 
questionnaire  sent  to  them  four  weeks  after  discharge  from  inpatient  rehabilitation. 
Question  d).  Does  augmented  physiotherapy  result  in  sustained  benefits  On  ternis  of 
mobility,  activities  of  daily  living,  and  quality  of  life)? 
We  examined  all  of  these  variables  for  differences  between  the  two  groups  over 
time.  We  expected  the  amounts  of  data  to  vary  considerably  from  patient  to  patient 
depending  on  their  length  of  stay  in  hospital.  We  therefore  identified  "key"  time 
lines  as  being:  randomisation,  4  weeks,  3  months  and  6  months  after  randomisation 
to  examine  if  change  was  sustained. 
Question  e).  Does  augmented  physiotherapy  result  in  cost  recovery  through 
improvedpatient  outcomes  or  reduced  length  of  hospital  stay? 
We  measured  levels  of  impairment,  disability,  handicap,  dependency  and  quality  of 
life  as  described  above. 
With  the  vast  majority  of  acute  stroke  costs  being  related  to  inpatient  nursing  care 
and  hospital  overheads  we  compared  length  of  hospital  stay  as  our  main  estimate  of 
cost.  Outwith  this,  any  cost  differences  between  the  groups  were  likely  to  be 
attributable  to  the  following  events: 
i).  complications  whilst  the  patients  were  in  hospital, 
ii).  community  support  being  requested  at  discharge, 
iii).  the  provision  of  equipment  and  adaptations, 
iv).  the  rate  of  adverse  events  in  the  months  after  stroke, 
v).  use  of  community  services. 
The  first  two  were  monitored  during  the  patients'  stay  by  notes  review  and  discussion 
with  the  treating  therapists  and  then  from  reviewing  their  notes  on  discharge. 
Complications  were  considered  to  have  been  present  if  noted  in  the  patients'  medical 
records.  We  did  not  attempt  to  define,  quantify  or  verify  any  of  the  complications. 
Adverse  events  were  recorded  at  patient  follow  up  interviews  at  3  and  6  months,  where 
we  asked  directly  "Since  leaving  hospital  have  you  had  any  falls?  "  and  "Haý,  e  you  had 
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any  other  problems  or  illnesses  since  leaving  hospital?  ".  We  relied  on  the  patients'  self- 
report  for  data  on  these  and  the  provision  of  equipment  and  services  as  we  did  not  have 
resources  to  confirm  these  data  e.  g.  by  consultation  with  the  patients'  general 
practitioner  or  social  services. 
We  were  also  interested  in  possible  differences  in  the  patient  groups  that  may  be 
attributable  to  their  treatment  allocation: 
a).  Survival 
b).  Discharge  destination 
c).  Complication  rates,  e.  g.,  falls,  fractures,  depression,  pressure  sores,  painful 
shoulder,  extension  (recurrence)  of  stroke 
d).  Use  of  services,  e.  g.  follow  up  in  the  community  (particularly  physiotherapy), 
day  hospital  referral. 
e).  Use  of  equipment  e.  g.  adaptation  to  home,  wheelchairs. 
We  specifically  monitored  for  adverse  events  and  the  possible complications  of  pain, 
falls  and  fatigue  at  patient  interview  by  the  blinded  assessor  at  weekly,  3  and  6  month 
follow  up.  During  the  weekly  follow-up  interviews  whilst  in  hospital,  patients  were 
asked:  "During  the  past  week  have  you  had  any  pain?,  During  the  past  week  have  you 
had  any  falls?  During  the  past  week  have  you  been  feeling  tired?  ".  We  did  not  attempt  to 
specifically  define  or  quantify  these  areas  but  asked  the  patients  to  report  what  they  had 
experienced. 
The  primary  outcome  measures  used  to  answer  our  questions  were:  the  Mobility 
Milestones,  Rivermead  Mobility  Index,  gait  speed  and  length  of  hospital  stay 
(thereby  costs).  We  used  other  outcome  measures  to  monitor  the  effects  of  treatment 
e.  g.  did  increased  intensity  of  physiotherapy  lead  to  a  decrease  in  the  rate  of 
complications  or  onward  referral  to  community  services  such  as  day  hospital. 
Blinding 
All  assessments  were  carried  out  in  an  area  separate  from  where  treatment  was 
delivered.  Ms  Egerton  was  not  allowed  access  to  patients'  notes,  treatment  timetables  or 
the  ward  areas  where  she  might  have  become  aware  of  the  treatment  allocation. 
Physiotherapy  assistants  brought  the  patients  to  and  from  the  assessment  area.  Patients 
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were  reminded  not  to  disclose  their  treatment  group  allocation  before  each  assessment 
and  staff  members  were  instructed  not  to  discuss  patient  care  when  Ms  Egerton  was 
present. 
Analysis 
Data  were  gathered  on  each  of  the  sites  for  infon-nation  on  input  and  outcomes.  The 
blinded  assessor,  Ms  Thorlene  Egerton,  left  her  assessments  in  a  file  and  these  were 
collected  at  least  weekly.  Once  the  assessments  were  made  she  had  no  access  to 
previous  assessments  for  comparison.  All  other  data  such  as  time  sheets  and 
registration  documents  were  collected  by  me  and  kept  in  a  secure  central  location 
for  safekeeping,  to  be  checked  for  completeness  and  to  avoid  unblinding.  I  had 
regular  meetings  with  Ms  Egerton  to  ensure  that  all  documentation  had  been 
submitted  and  received.  Data  were  then  "masked"  to  remove  any  patient  names, 
photocopied,  batched  and  delivered  to  the  Robertson  Centre  for  Biostatistics  at  the 
University  of  Glasgow  for  management  and  analysis.  The  data  were  "double 
entered"  to  reduce  the  chance  of  errors  and  a  code  used  to  indicate  treatment 
allocation.  We  remained  blinded  to  the  code  of  the  data  until  all  analyses  were 
completed. 
All  analyses  were  according  to  the  intention-to-treat  principle,  using  all  available 
data  for  each  measurement  at  the  appropriate  visit.  No  formal  adjustment  was  made 
for  multiple  comparisons. 
The  Bioengineering  Unit  at  the  University  of  Strathclyde  interpreted,  analysed  and 
reported  on  data  gathered  from  the  activity  monitor  and  gait  analysis  system  using 
custom  written  software.  Ms  Egerton  gathered  all  these  data,  then  delivered  the 
downloaded  data  directly  to  the  University  of  Strathclyde,  remaining  blinded  to 
treatment  allocation. 
We  analysed  the  data  at  the  Imonth,  3  month  and  6  month  outcomes.  Patients  were 
assessed  weekly  (up  to  a  maximum  of  ten  weeks)  during  their  hospital  stay  or  until 
discharge.  For  those  subjects  discharged  within  ten  weeks,  their  best  scores  for  the 
following  outcomes  were  used  in  the  analyses:  fastest  10m  walking  speed; 
maximum  RMI  score,  maximum  Motricity  index  score;  maximum  trunk  control  test 
and  best  functional  reach.  Other  outcomes  were  only  measured  at  1  month,  3  month 
and  6  month  assessments. 
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Results 
Between  22  July  1999  and  12  February  2001,1  screened  708  patients  (Drumchapel 
267,  Lightbum  203  and  Stobhill  238)  from  which  we  recruited  70  (9.9%)  to  our 
study.  Thirty-five  patients  were  randomised  to  each  arm  of  the  study  (figure  3.3). 
Thirteen  eligible  patients  refused  to  enter  the  study. 
Figure  3.3  GAPS  study  recruitment  and  randomisation 
Patients  Admitted  with  stroke  to 
North  Glasgow  Rehabilitation  Units 
imchapel  267 
bhill  238 
. 
htbum  203 
otal  708 
Eligible  83 
13 
RandoMised  70 
Standard 
35 
Followed  up 
At  4  weeks 
At  3  months 
Excluded  625 
(see  Table  3.2) 
Augmented 
Dhvsiothera-Dv  35 
Followed  up 
35  At  4  weeks  34 
34  At  3  months  32 
At  6  months  34 
(34  complete,  I  refused) 
Died 
At  6  months  31 
(29  complete  data, 
2  partially  complete  data, 
1  refused,  I  unwell) 
Died  2 
The  reasons  patients  were  excluded  from  the  study  are  given  in  Table  3.2 
(categories  are  not  mutually  exclusive).  Some  patients  could  not  be  randomised 
because  we  had  limited  resources  e.  g.  when  the  sites  had  several  subjects  on 
augmented  treatment  they  sometimes  felt  that  if  another  patient  was  randomised  to 
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augmented  therapy  by  the  randomisation  centre  they  would  not  have  sufficient 
resources  to  maintain  the  target  treatment  times.  However,  when  resources  became 
available  or  subjects  were  discharged  we  immediately  reconsidered  these  subjects. 
Although  we  did  not  formally  record  the  number  of  subjects  excluded  in  this 
manner  they  were  considered  to  be  small  in  number. 
Seven  patients  were  lost  to  follow  up.  Two  (3%)  patients  died  during  the  study,  one 
of  these  during  the  intervention  stage  (soon  after  randomisation,  but  considered  not 
to  be  related  to  physiotherapy  treatment).  Two  patients  (3%)  were  too  unwell  to  be 
followed  up,  due  to  stroke-related  illness.  Three  (4.5%)  patients  refused  to  complete 
the  follow  up  schedule.  No  patients  were  withdrawn  from  the  intervention.  Blinding 
of  the  assessor  was  maintained  in  556  /  579  (96%)  of  the  follow  up  assessments. 
Table  3.2  Reasons  for  exclusion  from  study 
Exclusion  (categories  not  mutually 
exclusive) 
Number  of 
patients 
Communication  impairment  237 
Previous  history  of  stroke  171 
Cognitive  impairment  (AMT<=8)  169 
No  sitting  balance  101 
Pre-stroke  Rankin  >2  39 
Dementia  26 
Unconfirmed  stroke  24 
Carcinoma  24 
Arthritis  limiting  ADL  23 
Unstable  angina  (limits  exercise)  21 
COPD  limiting  exercise  16 
Major  surgery  (3  months)  14 
Poorly  controlled  diabetes  13 
Recent  MI  (3  months)  10 
PVD  limiting  exercise  6 
AMT  =  Abbreviated  Mental  Test  score,  ADL  =  Activities  of  daily  living 
COPD  =  Chronic  Obstructive  Pulmonary  Disease,  MI  =  Myocardial  infarction 
PVD  =  Peripheral  vascular  disease 
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The  randomisation  was  stratified  by  centre  (Drumchapel,  Lightbum,  Stobhill)  and 
disability  level  (dichotomised  as  Barthel  <  10,  or  ý!  10)  and  age  (<75  years,  ý!  75 
years),  and  the  number  of  subjects  within  each  of  these  stratum  are  reported  in 
Table  3.3. 
Table  3.3  Number  of  subjects per  group  stratified  by  study  centre,  disability 
level  and  age 
Standard 
(n=  35)(%) 
Augmented 
(n  =  35)(%) 
Study  centre 
Drumchapel  14(40.0)  15(42.9) 
Lightburn  5(14.3)  6  (17.1) 
Stobhill  16(45.7)  14(40.0) 
Disability  level 
Baseline  Barthel  <  10  12(34.3)  11(31.4) 
Baseline  Barthel  >=10  23(65.7)  24(68.6) 
Age 
Age  <  75  27(77.1)  28(80.0) 
Age  >=75  8(22.9)  7(20.0) 
The  baseline  characteristics  of  the  subjects  are  surnmarised,  split  by  randomised 
treatment  group  in  Table  3.4.  Continuous  covariates,  such  as  age,  were  reported  as 
means  (with  standard  deviation)  whilst  categorical  covariates,  such  as  gender,  were 
reported  as  numbers  (with  percentage)  of  subjects.  No  formal  comparison  of  baseline 
equality  between  the  randomised  groups  was  perfonned. 
Note:  All  baseline  values  are  expressed  as  percentages  unless  otherwise  stated. 
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Table  3.4  Baseline  characteristics  of  subjects  in  GAPS  study* 
Standard 
(n=  35) 
Augmented 
(n  =  35) 
Age  (mean,  SD)  66.9(10.4)  67.8(10.6) 
Sex  -  Female  51.4  31.4 
Days  after  acute  admission  (mean,  SD)  25.4(17.9)  21.9(14.1) 
Days  after  admission  to  rehabilitation  unit  (mean,  SD)  15.26  (14.0)  13.1(10.9) 
Stroke  classification 
R  side  of  brain  42.9  45.7 
TACI  20.6  17.1 
PACI  50.0  42.9 
LACI  23.5  28.6 
POCI  2.9  5.7 
Other  2.9  5.8 
Barthel  Index  score  (mean,  SD)  10.3(3.1)  11.8(3.3) 
Trunk  Control  Test  (mean,  SD)  68.4(24.1)  71.9(23.0) 
Motricity  Index  (mean,  SD)  100.4  (43.4)  110.4  (43.2) 
Pre-stroke  Rankin  =0  48.6  51.4 
Pre-stroke  Rankin  =1  40.0  28.6 
Pre-stroke  Rankin  =2  11.4  20.0 
*Values  include  all  patients  with  available  data;  n  is  the  maximum  number  in  each  group. 
SD  =  Standard  deviation 
Intensity  of  treatment 
The  intensity  of  physiotherapy  input  between  the  randomised  groups  is  summansed  in 
terms  of  the  total  number  of  hours  and  the  average  number  of  hours  per  study  day 
(defined  as  the  ratio  of  total  hours  of  physiotherapy  by  total  days  in  study)  in  Table 
3.5(a).  The  columns  show  the  overall  (total)  number  of  treatment  hours  per  patient  and 
within  this  figure  the  number  of  hours  the  treating  physiotherapists  considered  they 
were  specifically  treating  the  upper  or  lower  limbs  or  other  areas. 
Table  3.5  (a):  Intensity  of  physiotherapy  input  in  GAPS  study:  hours 
Total  Upper  Limb  Lower  Limb  Other 
Stand  Aug  Stand  Aug  Stand  Aug  Stand  Aug 
(n=3  5)  (n=35)  (n=35)  (n=35)  (n=35)  (n=35)  (n=35)  (n=35) 
Number  of  21(16)  33  5  10  5  9  11  15 
hours  mean  (21)  (5)  (7)  (4)  (7)  (10)  (11) 
(SD)  I 
Number  of  0.41  0.73  0.12  0.18  0.11  0.21  0.19  0.34 
hours  /  study 
days 
Stand  =  Standard,  Aug  =  Augmented,  SI)  =  manclar(l  (leviation 
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The  mean  (95%  confidence  interval)  number  of  physiotherapy  sessions  per  patient 
was  greater  in  the  augmented  therapy  (43;  35-51)  than  the  standard  therapy  group 
(32;  24-40)  (Table  3.5(b)).  This  equated  to  an  average  number  of  physiotherapy 
treatment  hours  in  the  augmented  therapy  group  (34  hours  total;  10  hours  on  upper 
limb  work;  9  hours  on  lower  limb;  15  hours  other  work)  which  was  greater  than  that 
of  the  standard  therapy  group  (21  hours  total;  5  hours  on  upper  limb;  5  hours  on 
lower  limb;  11  hours  other  work).  The  average  number  of  treatment  hours  per 
weekday  differed  by  0.45  hours  (i.  e.  62  vs  35  minutes  -  27  minutes).  No  formal 
comparison was  made  of  these  rates  since  the  augmented  group  was  intended  to 
receive  about  double  the  physiotherapy  of  the  standard  group. 
Table  3.5(b).  Intensity  of  physiotherapy  input  in  GAPS  study:  sessions 
Standard 
(n=:  35) 
Augmented 
(n=35) 
Number  of  sessions  mean  (SD)  32(24)  43(26) 
Number  of  sessions  /study  days  0.61  1.00 
SD  =  Standard  deviation 
Activity  levels 
Activity  monitoring  data  were  available  for  41  (58%)  patients  (19  standard,  22 
augmented).  These  were  analysed  in  terms  of  the  patient's  average  number  of 
transitions  to  the  upright  position  per  hour.  Upright  events  are  changes  from  a  non- 
upright  position  (sitting  or  lying)  to  upright  (standing  or  walking).  The  mean  for  the 
standard  group  was  1.7  (SD  1.26)  upright  events  per  hour  ranging  form  0.25  to  5.62 
per  hour.  The  mean  for  the  augmented  group  was  2.6  (SD  1.21)  per  hour  ranging 
from  0.73  to  5.76.  There  was  a  significant  difference  between  the  two  groups 
(Mann-Whitney  U,  p=0.007)  where  the  augmented  group  appeared  to  be  more 
active  in  terms  of  how  frequently  they  stood  up. 
We  also  examined  the  mean  proportion  of  time  spent  standing  or  walking.  The 
average  proportions  for  the  standard  and  augmented  group  respectively  were  4.8% 
(SD  7.8,  minimum  0.4%,  maximum  34.6%)  and  8.0%  (SD  5.7%,  minimum  0.7%, 
maximum  18.9%).  There  was  a  significant  difference  between  the  two  groups 
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(Mann-Whitney  U,  p=0.002)  where  the  augmented  group  appeared  to  be  more 
active  in  terms  of  how  much  of  the  time  they  were  standing  or  Nvalking. 
When  we  analysed  the  activity  over  different  periods  of  the  day  we  found  the 
augmented  group  were  more  active  (more  transitions  and  a  greater  average 
proportion  of  their  time  spent  standing  or  walking)  during  the  day  (from  8-30am 
until  4-30pm).  There  was  no  significant  difference  in  activity  between  the  groups  in 
the  period  after  4-30pm.  indicating  that  the  increased  patient  activity  occurred 
during  the  period  therapy  staff  members  were  at  work. 
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Primary  Outcomes  -  Mobility 
Mobility  disability  -  "Mobility  Milestones" 
Disability  as  assessed  by  Mobility  milestones  (visit  at  which  subject  achieved 
standing,  walking  10  paces,  and  walking  10  metres)  was  visualised  (Figures  3.4  - 
3.6)  by  plotting  the  proportion  of  patients  having  achieved  the  milestone  at  each 
visit  (baseline,  4  weeks,  3  months,  6  months). 
The  time  to  achieving  each  milestone  was  fonnally  compared  using  a  log-rank 
statistic  (Table  3.6)  by  ascertaining  the  visit  (baseline,  weeks  1-10,3  month  or  6 
month)  at  which  the  milestone  was  achieved,  and  assuming  the  milestone  was 
achieved  on  the  day  of  that  visit.  Subjects  who  did  not  achieve  the  milestone  were 
censored  at  either  their  death,  end  of  study,  or  withdrawal. 
Table  3.6  GAPS  study.  Comparison  of  achievement  of  "Mobility  Milestones" 
Milestone  Standard 
(n=3  5)(%) 
Augmented 
(n=35)(%) 
P-value 
(log-rank) 
Hazard  ratio 
(95%  Cl) 
Standing  35(100.0)  34(97.1)  0.25  1.34  (0.81,2.23) 
10  paces  31(88.9)  32(91.4)  0.20  1.39  (0.84,2.30) 
10  metres  32(91.4)  33(94.3)  0.12  1.48  (0.90,2.43) 
Cl  =  Confidence  interval 
The  hazard  ratios  give  the  overall  relative  chance  of  an  event  on  treatment  as 
compared  to  control  and  account  for  both  censoring  and  time-to-event.  The  results 
show  an  increased  chance  of  patients  receiving  augmented  physiotherapy  achieving 
each  "milestone".  However  the  confidence  interval  is  wide  and  the  estimated 
differences  do  not  reach  statistical  significance. 
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Figure  3.4 
Proportion  of  patients  achieving  standing  at  each  visit  in  standard  treatment 
and  augmented  physiotherapy  groups 
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Figure  3.5 
Proportion  of  patients  achieving  10  steps  at  each  visit  in  standard  treatment  and 
augmented  physiotherapy  groups 
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Figure  3.6 
Proportion  of  patients  achieving  10-metre  walk  at  each  visit  in  standard 
treatment  and  augmented  physiotherapy  groups 
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Mobility  disability  -  Rivermead  Mobility  Index  (RMI) 
The  Rivermead  Mobility  Index  scores  were  compared  between  the  two  randomised 
treatment  groups  using  two-sample  t-  tests  (Table  3.7).  We  were  unable  to  compare 
change  over  baseline  as  this  was  not  recorded  at  randomisation.  Howe\-er,  a 
comparison  was  made  with  the  scores  from  the  Week  I  follow  up  assessment. 
Table  3.7  GAPS  study.  Rivermead  Mobility  Index  (RMI)  scores 
Standard  Augmented  Mean  Difference  P-valuc 
Mean  (SD)  Mean  (SD)  (95%  Cl) 
Week  1  4.56(2.64)  5.18(2.43)  0.62  (-0.61,1.85)  0.32 
n=34  n=34 
Maximum  achieved  at  8.26(2.81)  8.79(3-03)  0.54  (-2.50,1.94)  0.45 
weeks  1-10  n=35  n=34 
4  weeks  6.97(3.49)  7.39(3.30)  0.42  (-1.23,2.08)  0.61 
n=34  n=33 
3  months  8.06(3.65)  9.66(3.33)  1.60  (412,3.32)  0.07 
n=34  n=32 
6  months  9.06(4.03)  10.20  (3.08)  1.14  (467,2.95)  0.21 
n=34  n--30 
Change  from  week  1  to  3.54(2.80)  4.69(2.75)  1.14  (423,2.52)  0.10 
3  months  n=33  n=32 
Change  from  week  1  to  4.45(3.15)  5.07(2.74)  0.61  (-0.88,2.10)  0.41 
6  months  n=33  n=30 
SD  =  Standard  deviation,  CI  =  Confidence  interval 
The  mean  differences  between  the  groups  shows  a  small  improvement  in  RMI  score  for 
those  patients  receiving  augmented  physiotherapy.  These  differences  do  not  reach 
statistical  significance  at  any  timepoint,  though  the  3-month  follow  up  approaches 
statistical  significance. 
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Mobility  impairment  -  Walking  speed 
Impairment  as  measured  by  the  median  10  metre  walking  speed  was  compared 
between  the  two  randomised  groups  at  4  weeks,  3  month  and  6  month  visits  by 
Wilcoxon  rank  sum  tests  and  approximate  95%  confidence  interval  for  the 
difference  in  medians  calculated.  A  further  variable  was  derived  by  taking  the 
fastest  speed  (m/s)  to  complete  the  10m  walking  test  in  any  of  the  first  10  weeks, 
and  then  comparing  between  the  groups  as  above  (Table  3.8). 
Table  3.8  GAPS  study.  10  metre  walking  speed  (m/s) 
Standard 
Median 
Augmented 
Median 
Median  Difference 
(95%  Cl) 
Wilcoxon 
P-value 
Fastest  speed  achieved 
weeks  1-10 
0.53  (n==28)  0.63  (n=31)  0.04  (-0.16,0.23)  0.70 
4  weeks  0.56  (n--21)  0.60  (n=24)  0.00  (-0.19,0.23)  0.97 
3  months  0.53  (n=27)  0.54  (n=30)  -0.03  (-0.19,0.15)  0.77 
6  months  0.45  (n=29)  0.65  (n=26)  0.09  (-0.11,0.28)  0.42 
CI  =  Confidence  interval 
The  differences  between  the  groups  were  small  at  all  timepoints  and  did  not  reach 
statistical  significance. 
Length  of  stay 
To  assess  the  impact  of  augmented  treatment  on  resource  utilisation,  length  of 
hospital  stay  was  compared  between  the  two  randomised  groups  using  both  two 
sample  t-tests  and  Wilcoxon  rank  sum  tests.  Approximate  parametric  95% 
confidence  intervals  for  the  difference  in  mean  stay  were  calculated. 
As  randomisation  took  place  on  average  two  weeks  after  transfer  to  rehabilitation, 
and  rehabilitation  was  on  average  about  ten  days  after  admission  for  stroke,  the  total 
length  of  stay  contains  a  considerable  period  prior  to  randomisation.  We  therefore 
compared  the  time  from  admission  for  stroke  to  discharge  for  rehabilitation,  and 
then  admission  to  rehabilitation  to  randomisation,  and  then  randomisation  to 
hospital  discharge,  using  the  same  method  as  for  total  length  of  stay  (Table  3.9). 
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The  results  show  a  reduction  in  the  mean  length  of  stay  (total  length  of  stay,  from 
rehabilitation  admission  and  from  randomisation)  for  patients  in  the  augmented 
group,  however  there  was  a  wide  distribution  of  length  of  stay  and  the  differences 
did  not  reach  statistical  significance. 
Twelve  (17.1%)  patients  were  considered  to  have  had  their  discharge  delayed  for 
some  external  reason  (e.  g.  awaiting  social  work  intervention). 
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Secondary  outcomes 
Impairment 
Results  from  the  Motricity  Index,  Trunk  Control  Test,  Functional  Reach  Test,  or  the 
9  Hole  Peg  Test  are  given  in  Tables  3.10  to  3.13  respectively. 
Table  3.10  GAPS  study.  Motricity  Index  scores 
Standard  Augmented  Mean  Difference  P-value 
Mean  (SD)  Mean  (SD)  (95%  CI) 
Baseline  100.4  (43.4)  110.4  (43.2) 
n=3  5  n=3  5 
4  weeks  111.2  (45.4)  119.1  (46.5)  7.9  (-14.6,30.3)  0.49 
n=34  n=33 
Maximum  weeks  1-  10  124.8  (44.8)  130.1  (45.7)  5.3  (-16.4,27.1)  0.63 
n=35  n=34 
3  months  120.4  (42.2)  130.1  (44.1)  9.7  (-11.7,31.1)  0.37 
n=3  3  n=32 
6  months  121.5  (51.3)  124.2  (41.6)  2.7  (-20.9,26.2)  0.82 
n=34  n=30 
Change  at  6  months  22.6(27.3)  20.0(20.4)  -2.6  (-14.8,9.6)  0.67 
from  baseline  n=34  n=30 
Cl  =  Confidence  interval,  SD  =  Standard  deviation 
Table  3.10  shows  no  statistically  significant  differences  in  mean  Motri  city  Index  scores 
between  the  groups  at  any  time-point  or  in  change  from  baseline  measurement  at  6 
month  follow  up. 
Table  3.11  GAPS  study.  Trunk  Control  Test  scores 
Standard  Augmented  Mean  Difference  P-value 
Mean  (SD)  Mean  (SD)  (95%  CI) 
Baseline  68.4(24.1)  71.9(23.0) 
n=35  n=3  5 
4  weeks  84.2(21.9)  85.2(17.5)  0.9  (-8.8,10.6)  0.85 
n=34  n=3  3 
Maximum  weeks  1  -10  90.5(17.1)  93.6(9.6)  3.0  (-11.9,9.7)  0.37 
n=35  n--34 
Change  at  week  4  16.0(23.9)  14.5(23.1)  -1.5  (-20.1,10.0)  0.80 
from  baseline 
Cl  =  Confidence  interval,  SD  =  Standard  deviation 
Table  3.11  shows  no  statistically  significant  differences  in  mean  Trunk  Control  Test 
scores  between  the  groups  at  any  time-point  or  in  change  from  baseline  measurement  at 
4  week  follow  up. 
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Table  3.12  GAPS  study.  Length  of  functional  reach  (cms) 
Standard  Augmented  Mean  Difference  P-value 
Mean  (SD)  Mean  (SD)  (95%  Cl) 
Baseline  17.0(7.7)  19.7(5.9) 
n=19  n=22 
Maximum  reach  weeks  24.0(7.0)  25.1(6.5)  1.2  (-2.1,4.4)  0.49 
1-10  n--34  n=3  3 
4  weeks  20.6(7.3)  20.9(7.5)  0.3  (-3.4,4.1)  0.87 
n=32  n=30 
3  months  21.5(6.1)  21.2(7.4)  -0.3  (-3.7,3.2)  0.87 
n=31  n=31 
6  months  22.8(7.6)  21.5(5.4)  -1.3  (-4.7,2.2)  0.46 
n=31  n=29 
Change  at  6  months  8.3(9.4)  3.1(6.6)  -5.1  (-10.3,0.1)  0.05 
from  baseline  n=18  n=21 
Cl  =  Confidence  interval,  SD  =  Standard  deviation 
Table  3.12  shows  no  statistically  significant  differences  in  mean  length  of  functional 
reach  between  the  groups  at  any  time-point.  There  was  however,  a  statistically 
significant  difference  in  change  from  baseline  measurement  at  the  6  month  follow  up. 
Table  3.13 
GAPS  study.  Nine  Hole  Peg  Test  affected  side  -  time  to  achieve  one  peg  (seconds) 
Standard 
Median 
Augmented 
Median 
Median  Difference 
(95%  Cl) 
Wilcoxon 
P-value 
4  weeks  3.4  (n=  12)  2.8  (n=  10)  -0.3  (-1.7,1.0)  0.38 
3  months  3.1  (n=14)  2.8  (n=  13)  0.0  (49,3.1)  0.96 
6  months  3.2  (n=  15)  1  3.2  (n--  13)  0.1  (-1.2,1,8)  0.89 
CI  =  Confidence  interval 
Table  3.13  shows  no  statistically  significant  differences  between  the  groups  for  median 
times  for  Nine  Hole  Peg  test  at  any  time-point. 
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Disability 
Further  measures  of  disability  were  compared  between  the  two  randomised 
treatment  groups  using  two-sample  t-  tests  for  the  Barthel  Index,  (Table  3.14) 
(including  change  over  baseline  at  6  months)  and  the  Nottingham  Extended 
Activities  of  Daily  Living  Index  (Table  3.15). 
Table  3.14  GAPS  study.  Barthel  Index  scores 
Standard  Augmented  Mean  Difference  P-value 
Mean  (SD)  Mean  (SD)  (95%  CI) 
Baseline  10.3(3.1)  11.8(3.3) 
n=35  n=35 
4  weeks  14.1(3.7)  14.6(3.4)  0.5  (-1.2,2.2)  0.55 
n=34  n=3  3 
3  months  16.1(3.3)  16.6(2.8)  0.7  (-0.9,2.2)  0.39 
n=33  n=32 
6  months  16.2(4.2)  16.9(2.7)  0.7  (-1.1,2.3)  0.45 
n=34  n=31 
Change  at  6  months  5.9(4.1)  5.1(3.7)  -0.9  (-2.8,1.1)  0.37 
from  baseline  n=34  n=31 
Cl  =  Confidence  interval,  SD  =  Standard  deviation 
Table  3.14  shows  no  statistically  significant  differences  in  mean  Barthel  index  scores 
between  the  groups  at  any  time-point  or  in  change  from  baseline  measurement  at  6 
month  follow  up. 
Table  3.15 
GAPS  study.  Nottingham  Extended  Activities  of  Daily  Living  (NEADL)  Index 
Standard  Augmented  Mean  Difference  (95%  Cl)  P-value 
Mean  (SD)  Mean  (SD) 
3  months  22.2(11.0)  27.6(12.8)  4.0  (-2.0,9.9)  0.19 
n=34  n=32 
6  months  26.2(13.1)  29.1(11.5)  1.5  (-4.6,7.7)  0.54 
n=34  n=30 
Cl  =  Confidence  interval,  SD  =  Standard  deviation 
Table  3.15  shows  no  statistically  significant  differences  in  mean  Nottingham  Extended 
Activities  of  Daily  Living  Index  scores  between  the  groups  at  either  time-point. 
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Action  Research  Arm  Test  scores  for  the  affected  arms  for  the  two  groups  of 
patients  are  compared  and  presented  in  Table  3.16. 
Table  3.16  GAPS  study.  Action  Research  Arm  Test  scores  -  Affected  Arm 
Standard 
Median 
Augmented 
Median 
Median  Difference 
(95%  Cl) 
Wilcoxon 
P-value 
4  weeks  23  (n=:  35)  22  (n=34)  1(-4,14)  0.52 
3  months  30  (n=33)  29  (n=32)  0(-6,14)  0.78 
6  months  30  (n=33)  29  (n=28)  1(-6,12)  0.67 
ý,,  l  -  k.,  UllilUCIIL;  C  IIILCTVUI 
The  median  differences  in  Action  Research  Am  Test  scores  did  not  reach  statistical 
significance  at  any  time-point. 
Handicap 
Handicap  (as  measured  by  the  Rankin  score)  was  dichotomised  as  0-2  or  3-5  and 
compared  between  the  two  randomised  groups  using  a  Chi-square  test  (Tables  3.17 
& 
Table  3.17(a).  GAPS  study.  Rankin  Handicap  Score  3  months 
Rankin  Handicap  Score  Standard  Augmented  Chi-squared  test 
(n=34)(%)  (n=29)(%)  P-value 
0-2  8(23.5)  7(24.1)  0.95 
3-5  26(76.5)  22(75.9) 
Table  3.17(b).  GAPS  study.  Rankin  Handicap  Score  6  months 
Rankin  Handicap  Score  Standard  Augmented  Chi-squared  test 
(n=34)(%)  (n=3  1)(%)  P-value 
0-2  13(38.2)  11(35.3)  0.82 
3-5  21(61.8)  20(64.5) 
The  number  of  subjects  that  required  some  fon-n  of  assistance  (scores  3-  5)  reduced 
over  time  as  patients  regained  independence,  however  the  differences  between  the 
groups  did  not  reach  statistical  significance  at  either  time-point. 
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Quality  of  life 
Quality  of  Life  was  analysed  by  two  sample  t-tests  on  the  visual  analogue  score  on 
EuroQoL  at  6  months  (Table  3.18).  Change  over  baseline  at  6  months  was  also 
compared. 
Table  3.18  GAPS  study.  Quality  of  life  (visual  analogue  scale  from  Euroqol) 
Standard  Augmented  Mean  Difference  P-value 
Mean  (SD)  Mean  (SD)  (95%  CI) 
Baseline  52.4(18.9)  53.7(18.2) 
n=29  n=32 
6  months  51.8(23.5)  62.3(24.6)  10.5  (-1.8,22.8)  0.09 
n=32  n=29 
Change  -2.0(20.8)  9.78(30.8)  11.7  (-2.8,26.3)  0.11 
n=26  n=27 
CI  =  Confidence  interval,  SD  =  Standard  deviation 
Table  3.18  shows  no  statistically  significant  differences  in  mean  EuroQual  scores 
between  the  groups  at  any  time-point  or  in  change  from  baseline  measurement  at  6 
month  follow  up. 
We  sent  out  64  patient  satisfaction  questionnaires  at  4  weeks  after  the  patients' 
discharge  from  inpatient  rehabilitation.  Six  patients  were  not  followed  up  with  a 
questionnaire  (one  patient  died  in  hospital,  five  patients  remained  in  care  facilities 
beyond  their  hospital  stay).  Forty-seven  (67%)  patients  responded,  seventeen  failed 
to  respond.  We  grouped  the  responses  (strongly  agree/agree  and  strongly 
disagree/disagree)  for  the  analysis  and  used  Fisher  Exact  Tests  to  compare  the 
groups  (Table  3.19). 
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Table  3.19 
GAPS  study.  Patient  satisfaction  questionnaire  at  4  weeks  post  discharge 
Question  Standard  Augmented  Fisher's 
Exact 
Test 
P-N-alue 
SA/A  SD/D  SA/A  SD/D 
n(%)  n(%)  n(%)  n(%) 
Happy  with  amount  of  20(95.2)  1(4.8)  19(76.0)  6(24.0)  0.11 
recovery 
Satisfied  with  type  of  therapy  20(95.2)  1(4.8)  24(96.0)  1(4.0)  1.00 
I  have  had  enough  therapy  7(35.0)  13(65.0)  12(50.0)  12  (50.0)  0.37 
SA/A  =  "Strongly  agree"  /  "Agree"  SD/D  =  "Strongly  disagree"  /  "Disagree" 
Table  3.19  shows  no  statistically  significant  differences  in  responses  to  the  questions 
between  the  two  groups. 
Complications 
Data  on  complications  were  listed  (Table  3.20).  We  further  analysed  those  we 
considered  to  be  particularly  relevant  to  rehabilitation  physiotherapy  (falls,  shoulder 
pain,  other  pain  and  fatigue).  These  were  compared  between  the  randomised  groups 
using  tabulated  Fisher  Exact  Tests  at  4  weeks,  3  months,  6  months  and  at  any  time 
during  the  study  (Table  3.21). 
There  were  no  serious  adverse  events  (i.  e.  serious  injury  or  deaths  directly 
attributable  to  the  intervention)  during  the  trial. 
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Table  3.20  GAPS  studv.  ComDlications  whilst  natients.  wp.  rt,.  in  hn,.  nitni 
Reported  Illness  Standard  (n=34*)  Augmented  (n=35) 
Patients  reporting  any  illness  25(78.1)  29(82.9) 
Events 
Deep  venous  thrombosis  0(0)  1  (2.9) 
Pulmonary  embolus  0(0)  0(0) 
Urinary  tract  infection  1  (2.9)  2(5.7) 
Chest  infection  2(5.9)  0(0) 
Other  infection  0(0)  1  (2.9) 
Fracture  0(0)  0(0) 
Depression  5(14.7)  2(5.7) 
Anxiety  4(11.7)  2(5.7) 
Confusion  0(0)  0(0) 
Pressure  sore  1  (2.9)  2(5.7) 
Painful  shoulder  3  (8.8)  5(14.3) 
Other  pain  13(38.2)  18(51.4) 
Recurrence/extension  of  stroke  0(0)  2(5.7) 
Cardiac  condition  5(14.7)  1  (2.9) 
Seizure  0(0)  0(0) 
Fall  10(29.4)  10(28.6) 
Other  17(50.0)  19(54.3) 
*  One  patient  still  in  hospital  after  6  months  -  no  discharge  forms  completed. 
Table  3.21  Number  of  patients  (%)  experiencing  "Complications"  /  adverse 
reactions  possibly  related  to  physiotherapy  input  at  any  time  during  the  GAPS 
study 
Standard 
(n=35) 
Augmented 
(n=34) 
Fisher  Exact 
Test  P-value 
Falls  20(57.1)  20(58.8)  1.00 
Shoulder  pain  27(77.1)  26(76.5)  1.00 
Other  pain  30(85.7)  31(91.2)  0.71 
Fatigue  - 
ý32 
(91.4)  32(91.2)  1.00 
Across  all  the  follow  up  time-points  there  were  no  statistically  significant 
differences  in  the  number  of  complications  reported  by  the  two  groups. 
Resource  use 
Further  data  on  resource  utilisation  (community  support  requested  at  discharge 
(Table  3.22),  provision  of  equipment  and  adaptations  at  discharge  (Table  3.23),  and 
use  of  community  services  at  6  months  post  stroke  (Table  3.24))  were  compared 
between  the  two  randomised  groups  using  Fisher  Exact  Tests.  We  found  no 
statistically  significant  differences  between  the  groups  in  these  areas. 
74 Chapter  3 
Table  3.22  GAPS  study.  Community  support  being  requested  at  discharge 
Service  Standard 
(n=32) 
Augmented 
(n=34*) 
Fisher's  Exact 
Test  P-value 
Homehelp  11(34.4)  11(32.4)  1.00 
District  nursing  6(18.8)  2(6.1)  0.15 
Day  hospital  28(87.5)  28(82.4)  0.73 
Outpatient  physiotherapy  1  (3.1)  2(5.9)  1.00 
Physiotherapy  home  visit  6(18.8)  5(14.7)  0.75 
Day  centre  0(0)  .  0(0)  N/A 
Meals  on  wheels  2(6.3)  o(o) 
_0.23  *data  available  on  33  subjects  for  district  nursing.  N/A  =  Not  applicable 
Table  3.23  GAPS  study.  The  provision  of  equipment  and  adaptations  at  discharge 
Standard 
(n=32) 
Augmented 
(n=34) 
Fisher's  Exact 
Test  P-value 
Aids  or  appliances  22(68.8)  17(50.0)  0.14 
Adaptive  equipment  or 
alterations  to  property  I 
25(78.1)  22(64.7) 
I 
0.28 
Wheelchair  1  19(59.4)  21  (38.2)  1  1.00 
Table  3.24  GAPS  study.  Use  of  community  services  at  6  months  after  stroke 
Service  Standard 
(n=34) 
Augmented 
(n=3  1) 
Fisher's  Exact 
Test  P-value 
Home  help  7(20.6)  8(25.8)  0.77 
District  nursing  5(14.7)  1  (3.2)  0.20 
Day  hospital  16(47.1)  13(41.9)  0.80 
Outpatient  physiotherapy  4(11.8)  2(6.4)  0.67 
Physiotherapy  home  visit  5(14.7)  1(3.2)  0.20 
Day  centre  1(2.9)  0(0)  1.00 
Meals  on  wheels  1(2.9)  0(0)  1.00 
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Discussion 
We  were  unable  to  demonstrate  any  significant  differences  between  the  two  groups 
of  patients  in  any  of  the  main  outcome  domains  we  studied.  Notably  there  was  a 
lack  of  difference  in  mobility  outcomes,  where  we  might  reasonably  have  expected 
differences  and  where  our  efforts  were  concentrated. 
It  could  be  that  increasing  the  intensity  of  physiotherapy  with  the  type  of  patients 
we  recruited  has  no  effect  on  the  outcomes  we  measured.  Alternatively,  there  may 
be  a  difference  which  we  have  failed  to  demonstrate,  i.  e.  type  11  error.  There  are 
several  possible  reasons  that  our  study  might  have  this  type  of  error: 
]).  Number  of  subjects  (Lack  ofstatistical  power) 
In  our  feasibility  study  we  overestimated  the  numbers  of  patients  that  would  be 
admitted  with  stroke;  we  admitted  just  over  700  patients  in  19  months  (we  estimated 
900  in  18  months).  We  relaxed  our  entry  criteria  several  months  into  the  study  to  try 
to  improve  our  randomisation  rate.  We  accepted  patients  who  were  admitted  more 
than  4  weeks  prior  to  screening  (one  of  our  initial  criteria),  allowing  "slow  starters" 
to  be  included.  However,  most  of  our  patients  were  randomised  within  the  original 
time  "window".  We  also  accepted  patients  with  "mild"  communication  and 
cognitive  impairment.  Unfortunately,  these  changes  had  little  effect  on  our 
randomisation  rate.  Finally,  we  extended  the  randomisation  period  as  much  as 
possible  within  the  available  funding,  in  order  to  recruit  more  patients. 
We  were  also  constrained  by  limited  resources  to  provide  augmented  treatment. 
Eligible  patients  arrived  in  batches  and  some  were  excluded  or  started  late  because 
we  were  unable  to  guarantee  that  if  they  were  randomised  to  the  augmented  arm  of 
the  trial,  we  could  provide  the  intervention.  In  our  feasibility  study  we 
overestimated  the  number  of  eligible  patients.  Our  patients  were  more  disabled, 
took  longer  to  walk  and  return  home  than  we  planned  for  and  therefore  our  power 
calculation  was  imprecise. 
Although  our  number  of  subjects  was  small  our  drop-out  rate  was  lovk,  in 
comparison  to  some  other  studies  e.  g.  Lincoln  et  al.  1999,  Partridge  et  al.  2000.  We 
were  selective  in  our  inclusion  criteria.  This  gives  the  problem  of  being  able  to 
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generalise  any  findings  but  we  felt  that  if  even  the  "fittest"  10%  of  stroke  patients 
can  be  identified  as  potentially  benefiting  from  a  more  intense  treatment  then  this 
should  be  pursued. 
If  the  fittest  group  could  be  shown  to  benefit  from  increased  physiotherapy  then  this 
may  be  of  clinical  significance  and  provide  persuasive  evidence  for  an  ethics 
committee  to  allow  more  disabled  patients,  particularly  those  with  more  significam 
communication  and  cognitive  deficits  to  participate  in  similar  trials,  based  on 
informed  consent  from  relatives.  These  patients  are  often  excluded  from  clinical 
trials.  There  is  little  evidence  so  far  that  increased  physiotherapy  with  this  subgroup 
of  stroke  patients  is  effective.  Several  techniques  used  by  physiotherapists  require 
the  patient  to  be  aware  of  instructions  or  to  understand  a  treatment  technique. 
Physiotherapy  intervention  with  this  group  requires  investigation  in  the  future. 
Relatively  few  patients  eligible  for  the  study  refused  to  take  part.  This  indicates  that 
patients  can  be  persuaded  to  participate  in  trials  with  random  allocation  of 
rehabilitation  treatments  and  that  they  are  willing  to  accept  uncertainty  of  efficacy 
of  treatment.  Although  some  patients  expressed  a  preference  to  be  in  one  group  over 
another,  no  patients  withdrew  during  the  treatment  phase  of  the  study. 
2).  Inadequate  differences  in  physiotherapy  intensity 
Despite  our  attempts  to  standardise  our  interventions  it  proved  difficult  to  maintain 
a  treatment  ratio  of  2:  1  (augmented  to  standard)  treatments.  We  managed  to  provide 
a  ratio  of  about  1.6:  1  overall.  This  may  well  have  diluted  any  expected  treatment 
effect. 
The  potential  for  variation  in  a  complex  human  interaction  makes  monitoring  and 
regulating  behaviour  in  a  rehabilitation  environment  difficult.  For  example  at  times 
treatment  was  interrupted  because  the  patient  felt  unwell  or  treatment  was  extended 
because  they  were  performing  well  or  have  made  progress  within  the  session.  On 
one  of  the  hospital  sites  (Lightbum)  there  were  no  specific  resources  available  to 
provide  additional  treatment. 
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We  speculate  that  many  therapists,  used  to  a  high  degree  of  professional  autonomy, 
do  not  find  it  easy  to  follow  a  tightly  structured  treatment  regime.  It  was  therefore 
difficult  to  guarantee  the  delivery  of  different  intensities  of  treatment,  especiafly 
over  several  hospital  sites  with  many  changes  of  members  of  staff  over  a  prolonged 
period. 
Our  intervention  seems  likely  to  reflect  normal  UK  practice,  involving  a  broad 
spectrum  of  individual  interventions,  delivered  by  different  clinicians.  In  our  study 
we  avoided  the  subjects  being  treated  exclusively  by  an  "elite",  specialised,  highly- 
trained  and  motivated  research  clinician.  Our  patients  were  treated  mostly  by  senior 
and  junior  qualified  physiotherapists,  occasionally  by  physiotherapy  undergraduate 
students  and  assistants  -  both  under  supervision,  in  addition  to  the  senior 
physiotherapists  specifically  employed  by  the  study.  There  is  no  suggestion  that  one 
staff  group  provided  a  different  intensity  whilst  working  with  the  patient. 
3).  Outcome  measures  lacked  sensitivity 
In  our  follow  up  assessments  we  were  looking  for  differences  in  the  levels  of 
achievement  of  mobility  milestones  (overall  and  in  relation  to  the  baseline 
measures),  speed  of  these  achievements  and  whether  they  were  sustained.  Most  of 
the  weekly  follow  up  visits  were  conducted  seven  days  apart.  They  therefore  may 
have  been  sensitive  to  changes  in  performance  on  a  weekly  rather  than  a  daily  level. 
We  administered  a  large  battery  of  follow  up  tests.  Patients  may  have  experienced 
either  fatigue  or  a  learning  effect  when  carrying  out  the  tests,  but  these  phenomena 
should  be  evenly  distributed  between  the  groups  at  randomisation.  Despite  the 
length  of  the  follow  up  tests  (the  longest  administered  at  6  months  took  about  an 
hour  to  complete),  very  few  patients  dropped  out  of  our  study  during  the  follow  up 
phase. 
The  definitions  used  by  Smith  and  Baer  in  their  Milestones  paper  (Smith  and  Baer 
1999)  were  amended  during  the  study.  We  kept  our  working  definition  the  same 
throughout  the  study  for  consistency.  The  Mobility  Milestones  appears  to  be  a 
useful  measure  but  may  have  a  ceiling  effect  with  our  patients  (over  90%  achieved 
10  in  walking)  and  is  not  sensitive  to  change  in  higher-level  mobility. 
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We  did  not  expect  to  see  significant  differences  between  the  groups  based  on  their 
survival  or  ADL  scores  in  any  sample  this  small,  and  this  turned  out  to  be  the  case. 
Another  of  our  secondary  outcome  measures,  complication  rates,  showed  slightly  fewer 
falls  and  more  shoulder  pain  than  reported  in  some  other  studies  (Davenport  et  al. 
1996)(Langhome  et  al.  2000)  but  with  little  difference  between  the  groups.  The 
complications  of  pain,  falls  and  fatigue  were  all  assessed  by  simple  interview  question 
e.  g.  "In  the  last  week  have  you  had  any  falls?  Yes  /  No".  We  depended  on  the  patients' 
responses  and  only  attempted  to  quantify  falls  by  their  seriousness  in  the  "key"  time 
lines  of  4  weeks,  3  and  6  months.  Our  measures  of  complications  may  be  insensitive  to 
the  actual  levels  of  adverse  events  due  to  our  use  of  non-standardised  measures,  our 
dependence  on  patients'  recall  and  that  we  did  not  include  alternative  methods  of 
confirming  clearly  defined  complications  due  to  limited  resources. 
4).  Error  or  bias 
We  aimed  to  minimise  bias  by  using  remote  telephone  randomisation. 
By  chance,  despite  the  randomisation  process,  there  were  differences  between  the 
groups  in  baseline  levels  of  disability  (about  1.5  points  on  the  Barthel  index)  and 
impairment  (about  10  points  on  the  Motricity  index)  (Table  3.4,  page  57).  These 
differences  may  have  produced  a  baseline  bias  that  influenced  our  results.  We  did  not 
adjust  our  analysis  in  order  to  correct  for  these  baseline  differences.  The  factors  we 
considered  to  be  predictive  of  outcomes  were  identified  a  priori  in  the  statistical  plan 
and  were  stratified  at  randomisation  (centre,  age,  Barthel  index  score).  In  a  larger 
sample  these  should  be  more  evenly  distributed.  We  did  not  pursue  what  would  be  a 
more  complex  secondary  analysis  of  the  variables  that  appeared  to  differ  at  baseline. 
Our  analyses  did  include  change  over  baseline  scores  and  this  may  have  helped  interpret 
our  results.  However,  the  best  method  of  reducing  the  potential  for  baseline  bias  is  to 
randomise  a  large  sample. 
We  tried  to  maintain  blinding  of  our  assessor  by  following  a  strict  protocol  avoiding 
contact  with  treating  therapists  and  carrying  out  assessments  away  from  treatment 
areas.  Despite  this  we  were  still  unblinded  in  a  small  number  of  cases.  Where 
possible  if  one  assessor  had  been  unblinded  another  assessor  who  remained  blinded 
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was  brought  in  to  regain  blinded  status  for  the  remainder  of  the  patient's  follow  up 
assessments. 
We  attempted  to  reduce  measurement  error  by  selecting  standard  measures  and 
applying  them  in  a  standard  manner,  using  a  training  programme  and  manual 
designed  by  the  prmcipal  assessor,  Thorlene  Egerton.  The  majority  of  assessments 
were  undertaken  by  the  one  assessor  in  an  attempt  to  reduce  inter-rater  error. 
Although  our  independent  assessor  was  blinded  the  treating  physiotherapists  Nvere 
not.  They  were  encouraged  not  to  disclose  or  discuss  the  patients'  allocation  Nvith 
other  members  of  the  multi-disciplinary  rehabilitation  team  but  at  times  the  patients' 
allocation  would  have  been  obvious.  This  could  have  influenced  decisions  to 
discharge  the  patient  at  an  earlier  or  later  stage  thus  biasing  our  length  of  stay 
results. 
Patients'  reports  of  uptake  of  services,  recall  of  complications  and  healthcare  events 
can  be  inaccurate.  We  did  not  have  resources  to  confirm  these  reports  with  their 
general  practitioner  or  with  a  carer  or  through  hospital  admissions  register  but  any 
inaccuracy  should  be  evenly  distributed  between  the  groups  by  the  randomisation 
process. 
5).  Technical  problems 
We  experienced  considerable  technical  problems  with  two  of  our  secondary 
outcome  measures  the  activity  monitor  and  gait  analysis  system.  These  problems 
may  lead  to  incomplete  or  "missing"  data  sets  in  the  majority  of  patients. 
The  two  groups  in  the  study  were  compared,  looking  for  differences  in  activity 
levels,  with  more  time  spent  upright  being  assumed  to  be  more  active.  We  were  able 
to  establish  whether  our  patients  were  sitting  or  upright.  The  monitor  is  able  to 
differentiate  activities  (e.  g.  walking,  sitting  standing)  more  accurately  in  other 
patient  groups  e.  g.  orthopaedic  patients  after  total  hip  replacement.  However,  the 
complex  data  received  by  the  monitor  when  a  stroke  patient  is  walking  is  difficult  to 
typify  and  differentiate  a  gait  pattern  from  a  standing  pattern. 
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One  useful  function  of  the  monitor  is  its  ability  to  examine  selected  patients' 
activity  during  different  parts  of  the  day.  Generally,  the  activity  monitor  was  well 
tolerated  by  the  patients  and  they  were  able  to  wear  it  for  several  hours  at  a  time. 
However,  as  we  only  have  a  single  "snapshot"  of  our  patients'  activity,  we  are 
unable  to  examine  change  over  time  or  speed  of  any  change.  Patients  were  assessed 
around  3  weeks  after  randomisation,  but  varied  in  the  length  of  time  since  their 
stroke  event.  A  number  of  patients  were  discharged  before  their  assessment  at  3 
weeks.  This  may  bias  our  available  results  towards  a  more  disabled  (and  possibly 
less  active)  group. 
We  also  had  technical  problems  with  our  gait  analysis  equipment.  The  readings 
were  not  available  for  some  of  our  patients  due  to  breakdown  of  equipment  and  the 
severity  of  gait  abnormalities  in  some  others  made  them  difficult  to  analyse.  The 
analysis  was  unable  to  pick  up  on  some  key  points  of  gait  quality  such  as  scuffing 
of  the  foot  on  swing-through  phase,  and  foot  symmetry  during  stance  phase  of  the 
gait  cycle.  The  equipment  would  seem  better  suited  to  small  scale  studies  where 
there  is  easy  access  to  technical  support  and  study  designs  that  allow  re-testing  of 
patients  should  there  be  any  difficulties.  Our  study  required  robust  equipment  that 
would  be  used  on  several  clinical  sites  with  patients  that  were  attending  on  a  single 
occasion  as  an  outpatient. 
This  was  the  first  use  of  this  equipment  in  a  clinical  trial  with  stroke  patients  and 
has  contributed  to  the  further  development  of  the  system. 
The  results  obtained  by  Ms  Egerton  and  the  group  at  Strathclyde  University, 
although  limited  to  a  "snap  shot"  sample  in  a  limited  number  of  patients,  help  to 
confirm  that  the  augmented  group  were  more  active.  We  can  assume  that  this  was, 
at  least  in  part,  due  to  the  increased  time  spent  with  the  physiotherapist. 
Other  measures  and  methodological  issues 
Length  ofstay 
We  did  not  see  any  statistically  significant  reduction  in  the  length  of  hospital  stay, 
therefore  the  vast  majority  of  costs  will  be  similar  for  the  two  groups.  Actual 
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hospital  costs  could  be  calculated  on  a  simple  cost  per  bed  per  day  in  a 
rehabilitation  unit  basis,  but  these  were  assumed  to  be  similar  across  the  three 
hospitals. 
There  were  no  significant  differences  in  additional  marginal  costs  between  tile  two 
groups.  The  frequency  of  provision  of  equipment,  referral  for  health  and  social 
services  in  the  community  and  the  occurrence  of  major  complications  (e.  g.  hip 
fracture)  was  similar  between  the  groups  or  so  infrequent  as  to  be  attributable  to 
chance. 
The  Euroquol  is  a  widely  used  quality  of  life  scale,  but  it  was  generally  not  Nxell 
completed  by  our  patients.  In  particular  many  patients  struggled  to  complete  the 
visual  analogue  scale,  confirming  Price's  findings  (Price  et  al.  1999)  that  this  type 
of  scale  can  be  difficult  for  patients  after  stroke.  Unfortunately  there  are  few 
alternatives  that  we  could  have  used  that  are  as  straight-  forward  and  quick  to 
administer. 
The  postal  satisfaction  questionnaire  was  reasonably  well  received  by  patients  with 
47  of  the  64  (73.4%)  we  sent  being  returned.  We  waited  four  weeks  after  discharge 
from  inpatient  rehabilitation  before  contacting  the  patients.  We  believed  this  would 
be  a  reasonable  length  of  time  for  them  to  be  settled,  yet  not  too  long  for  them  to 
have  forgotten  their  hospital  experience.  As  with  all  questionnaires  it  is  possible  that 
the  responses  reflect  the  views  of  the  person  that  completes  them  (in  some  cases  this 
may  not  have  been  the  patient  due  to  their  disability). 
Our  comparison  was  based  on  the  total  amount  of  time  spent  by  the  physiotherapist 
on  the  patients'  care.  In  addition  to  this  we  monitored  and  described  our 
intervention  in  some  detail.  To  do  this  we  developed  a  simple  tool  to  record 
physiotherapy  intervention  beyond  simple  timing  of  contact  with  our  patients. 
Although  there  were  no  apparent  differences  in  intervention  between  the  two  groups 
this  has  not  been  formally  compared.  Our  recording  tool  would  need  to  be 
investigated  with  regard  to  its  measurement  properties  before  further  data  could  be 
analysed  with  any  degree  of  confidence. 
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One  of  the  reasons  for  monitoring  the  intervention  was  to  see  if  the  therapists  "N-ere 
focussing  their  treatments  in  such  a  way  that  might  influence  our  outcomes.  For 
example  were  all  efforts  being  made  to  discharge  patients  in  the  augmented  group 
earlier  perhaps  by  issuing  them  with  wheelchairs  and  encouraging  early  home 
discharge  or  focussing  purely  on  gait  re-education  (largely  speaking  ambulant 
patients  with  an  upper  limb  weakness  can  be  discharged  and  followed  up  as  an 
outpatient  for  their  continuing  therapy  needs).  There  is  no  indication  that  this  was 
the  case. 
There  may  be  a  difference  in  the  delivery  of  the  intervention.  There  is  little  known 
about  the  effect  of  delivering  the  augmented  dose  over  different  sessions  e.  g.  are 
two  half  hour  sessions  the  same  as  one  full  hour  session?  The  augmented  dose  was 
delivered  over  more  than  one  session  in  a  number  of  subjects.  There  may  be  a 
threshold  of  benefit  in  any  one  dose  of  physiotherapy  and  this  would  be  worth 
exploring  as  fatigue  or  training  effects  may  influence  the  efficacy  of  treatment. 
In  comparison  to  some  earlier  studies  we  recruited  relatively  late  after  onset  of 
stroke.  This  represents  the  normal  time  spent  by  patients  in  the  acute  setting  prior  to 
transfer  to  a  rehabilitation  facility  and  is  probably  fairly  typical  of  LJK  service 
provision.  This  may  have  reduced  our  ability  to  detect  early  change  (though  this  is 
likely  to  be  largely  spontaneous  recovery)  or  to  target  a  time  "window"  when 
therapy  may  be  more  beneficial.  As  mentioned  this  was  partly  due  to  our 
requirement  to  recruit  more  patients. 
Although  we  targeted  the  fittest  subjects  we  reasoned  that  they  were  most  likely  to 
tolerate  treatment  and  demonstrate  any  treatment  effect.  We  would  then  have  been 
in  a  position  to  consider  the  effect  on  less  able  patients  in  further  trials. 
Some  patients  had  discharge  delayed  because  of  difficulties  in  service  provision  or 
environmental  adaptation  e.  g.  delays  in  social  services.  These  should  have been 
evenly  distributed  across  the  groups  but  we  do  not  know  this. 
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Conclusion 
Increasing  the  intensity  of  physiotherapy  in  hospital  with  the  selected  patients  in  our 
study  did  not  produce  statistically  significant  benefits  in  terms  of  their  mobility, 
length  of  hospital  stay  or  patient  satisfaction.  No  significant  effect  on  patients' 
mobility  was  noted  during  their  hospital  stay  or  up  to  follow  up  at  6  months  after 
randomisation.  Length  of  hospital  stay  with  these  patients  is  not  significantlý' 
reduced  when  physiotherapy  intensity  was  increased  by  about  60%  over  standard 
levels.  We  were  unable  to  recommend  any  change  in  current  clinical  practice  based 
on  our  results. 
We  had  difficulties  with  patient  recruitment  and  in  maintaining  a  sufficient 
difference  in  intensity  between  the  two  intervention  groups.  Our  assessors 
succeeded  in  following  up  our  patients,  gathering  large  amounts  of  data  and 
remaining  "blinded"  in  most  cases.  The  trial  was  sustained  over  an  extended  period 
with  limited  resources.  In  this  time  we  gained  considerable  co-operation  from 
patients  and  clinical  staff  on  all  the  sites.  The  technology  we  used  to  assist  in  the 
measurement  of  patients'  performance  had  some  technical  limitations.  However,  it 
has  a  role  to  play  and  should  be  developed  further  and  tested  for  use  in  clinical  trials 
in  the  future. 
Some  of  our  difficulties,  and  perhaps  our  results,  highlight  that  physiotherapy  after 
stroke  is  a  complex  and  challenging  intervention  to  investigate.  Our  study  did  not 
set  out  to  achieve  the  definitive  answer  to  the  intensity  question.  Any  one  small  trial 
is  unlikely  to  change  clinical  practice.  However,  we  specifically  tried  in  our  study 
design  (by  selecting  common  outcome  measures,  administered  at  common  end- 
points)  to  allow  the  results  to  be  pooled  in  any  future  meta-analysis  of  intensity  of 
physiotherapy.  This  is  what  I  go  on  to  describe  in  the  following  chapter. 
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Summary 
In  1999  the  GAPS  Collaborative  group  set  out  to  ansN,,,  er  the  basic  question 
"Does  the  provision  of  additional  in-patient  pki'siotherapy  after  stroke 
speed  up  the  recovery  of  mobility?  ". 
We  carried  out  a  randomised  controlled  trial  across  three  centres  in 
Glasgow,  using  sound  methods  and  attempting  to  address  some  of  the 
limitations  of  the  previous  studies.  We  aimed  to  provide  twice  the  standard 
amount  of  physiotherapy  input  to  those  patients  in  the  intervention  group. 
Our  primary  outcomes  were  mobility  disability  (achievement  of  mobility 
"milestones",  Rivennead  Mobility  Index),  mobility  impairment  (as 
measured  by  10  metre  walking  speed)  and  length  of  hospital  stay.  Our 
secondary  outcomes  included  measures  of  impairment,  disability  and 
handicap. 
Over  an  18  month  period  I  screened  over  700  patients  of  whom  70  were 
recruited  and  randomised  (35  to  each  group)  to  the  trial.  A  blinded  assessor 
regularly  followed  these  subjects  up  to  6  months  after  randomisation, 
administering  a  battery  of  standard  outcome  measures. 
Our  analyses  showed  that  increasing  the  intensity  of  physiotherapy  in 
hospital  with  the  selected  patients  in  our  study  did  not  produce  significant 
benefits  in  terms  of  their  mobility,  length  of  hospital  stay  or  patient 
satisfaction.  No  significant  effect  on  patients'  mobility  was  noted  during 
their  hospital  stay  or  up  to  follow  up  at  6  months  after  randomisation. 
Length  of  hospital  stay  with  these  patients  is  not  significantly  reduced  when 
physiotherapy  intensity  was  increased  by  about  60%  over  standard  levels. 
Although  we  were  unable  to  recommend  any  change  in  current  clinical 
practice  based  on  our  results,  they  contribute  to  the  pool  of  data  and 
knowledge  in  this  area. 
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CHAPTER  4 
SYSTEMATIC  REVIEW  OF  PUBLISHED  LITERATURE  ON 
INTENSITY  OF  PHYSIOTHERAPY  AFTER  ACUTE  STROKE 
Introduction 
From  the  previous  chapters  it  can  be  seen  that  there  are  many  difficulties  and  challenges 
in  carrying  out  research  into  physiotherapy  and  rehabilitation  after  stroke.  None  of  the 
previous  studies  have  been  definitive  and  our  own  study,  whilst  successfully  addressing 
some  of  the  previous  problems,  highlighted  the  fact  that  all  of  the  trials  are  relatively 
small  and  lack  statistical  power.  Research  has,  so  far,  failed  to  give  clear  guidance  to 
service  providers  and  clinicians. 
In  this  chapter  I  describe  the  process  of  systematic  reviews  of  trials  and  the  statistical 
approach  of  meta-analysis.  This  is  a  more  rigorous  method  of  evaluating  the  trials  that 
were  described  in  Chapter  2.1  now  describe  a  systematic  review  and  meta-analysis  of 
the  available  trials  of  intensity  of  physiotherapy. 
Aims 
In  this  chapter  I  aim  to: 
1).  Describe  the  process  of  systematic  review  and  meta-analysis. 
2).  Carry  out  a  systematic  review  of  the  published  literature  on  intensity  of 
physiotherapy  after  stroke  in  which  1: 
a).  Define  my  criteria  for  inclusion  in  the  review. 
b).  Find  all  relevant  trials  of  intensity  of  physiotherapy. 
c).  Carry  out  the  review  of  the  published  data  in  a  systematic  fashion. 
d).  Describe  the  trials. 
e).  Analyse  the  results  of  the  published  trials  and  draw  conclusions. 
3).  Discuss  the  findings. 
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Description  of  systematic  reviews 
A  systematic  review  can  be  defined  as  "an  overview  of  primary  studies  that  contains  an 
explicit  statement  of  objectives,  materials,  and  methods  and  has  been  conducted 
according  to  explicit  and  reproducible  methodology.  "  (Greenhalgh  1997). 
Systematic  reviews  have  several  advantages  over  conventional  narrative  reviews  like  the 
one  carried  out  in  Chapter  2  (Mulrow  1994).  By  explicitly  stating  their  methods,  bias  in 
identifying  and  rejecting  studies  is  limited.  Additionally,  conclusions  can  be  more 
reliable  and  accurate  because  of  the  methods  used.  They  may  lead  to  quantitative 
systematic  reviews  (meta-analyses)  that  increase  the  precision  of  the  overall  result. 
Results  of  different  studies  can  be  formally  compared  to  establish  generalisability  of 
findings  and  consistency  (lack  of  heterogeneity)  of  results.  Reasons  for  heterogeneity 
(inconsistency  in  results  across  studies)  can  be  identified  and  hypotheses  generated 
about  subgroups.  Systematic  reviews  can  also  improve  access  to  information  for 
healthcare  providers,  researchers  and  policymakers,  thereby  possibly  reducing  delays 
between  research  discoveries  and  implementation  of  effective  diagnostic  and  therapeutic 
strategies.  Figure  4.1  outlines  the  process  of  systematic  review  of  randomised  controlled 
trials. 
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Figure  4.1  Methodology  for  a  systematic  review  of  randomised  controlled  trials 
(Greenhalgh  1997) 
State  objectives  of  the  review  of  RCTs  and  outline  eligibility  ýcriteria  -1 
earch  for  trials  that  seem  to  meet  eligibility  criteria 
Tabulate  characteristics  of  each  trial  identified  and 
assess  its  methodological  quality 
ply  eligibility  criteria  and  justify  any  exclusions 
semble  the  most  complete  dataset  feasible, 
th  assistance  from  investigators  if  possible 
alyse  results  of  eligible  RCTs,  using  statistical  synthesis 
data  (meta-analysis)  if  appropriate  and  possible 
ompare  alternative  analyses  if  appropriate  and  possible 
Prepare  a  critical  summary  of  the  review,  stating 
aims,  describing  materials  and  methods 
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Assessing  validity 
Systematic  reviews  should  include  an  assessment  of  both  the  internal  and  external 
validity  of  the  included  trials  (Juni  et  al.  2001). 
1).  Internal  validity  in  studies. 
Internal  validity  reflects  the  degree  to  which  a  trial  has  avoided  error  and  bias,  Thus  the 
way  that  the  trial  has  considered  bias,  and  incorporated  methods  to  reduce  or  minimise  it 
within  the  trial,  can  be  evaluated.  This  is  usually  done  by  careful  and  explicit  trial 
design,  conduct  and  analysis.  The  Cochrane  Collaboration  handbook  sets  out  simple 
criteria  against  which  trials  can  be  judged  as  having  low,  moderate  or  high  risk  of  bias 
(Mulrow  &  Oxman  1997).  An  alternative  is  to  use  a  quality  scale  related  to  a  checklist 
of  criteria  that  the  reviewers  consider  important.  Such  checklists  can  be  used,  sometimes 
producing  a  summary  score,  with  or  without  weights  e.  g.  the  Jadad  and  Chalmers 
quality  assessment  scales  (in  Juni  et  al.  2001).  In  practice  there  are  over  thirty  such 
scales  but  no  accepted  "gold  standard"  quality  assessment  score  and  most  of  the  rating 
schemes  that  are  employed  are  arbitrary.  Until  a  "gold  standard"  is  developed  the 
Cochrane  Collaboration  handbook  recommends  that  reviewers  should  use  simple 
methods. 
Reviewers  require  to  understand  the  validity  of  the  trials,  and  what  steps,  if  any,  the 
researchers  took  in  order  to  reduce  bias.  Four  different  types  of  bias  in  trials  are 
described  (Mulrow  &  Oxman  1997): 
Selection  bias:  This  describes  systematic  differences  in  the  groups  being  compared,  e.  g. 
there  is  a  problem  at  randomisation  leading  to  the  non-random  allocation  of  subjects  to 
one  group  rather  than  another. 
High  quality  randomisation  procedures  reduce  the  possibility  of  selection  bias  at  the 
stage  of  assignment  of  treatment.  Ideally,  someone  that  is  remote  from  the  trial  should 
carry  out  the  randomisation,  reducing  the  possibility  of  influencing  the  randomisation. 
This  might  be  the  case  for  example  when  open  random  number  lists  or  other  methods 
are  used,  that  potentially  allow  the  randomising  researcher  to  anticipate  treatment 
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allocation  and  make  a  conscious  or  subconscious  decision  that  could  influence  the  group 
allocation. 
Performance  bias.  -  This  describes  systematic  differences  in  the  care  provided,  other  than 
from  the  intervention  being  evaluated.  Performance  bias  may  Include:  contamination, 
where  the  intervention  being  investigated  is  provided  to  both  groups,  and  /  or  co- 
intervention,  i.  e.  the  provision  of  an  unintended  intervention  to  either  group. 
Attrition  bias.  -  This  describes  systematic  differences  in  how  withdrawals  from  the  trial 
are  handled,  e.  g.  there  is  an  inconsistent  or  incomplete  approach  to  pursuing  subjects 
being  followed  up. 
Detection  bias:  This  describes  systematic  differences  in  outcome  assessment.  The 
process  of  blinding  of  subjects  and  researchers  may  reduce  perfon-nance  and  detection 
biases  where  both  the  subject  and  the  investigator  are  unaware  of  the  allocation  of 
treatment  or  intervention  being  provided.  Any  placebo  effect  from  the  intervention 
should  be  evenly  distributed  between  groups  if  the  trial  design  is  double  blind.  These 
effects  are  often  complex  and  subtle.  Double  blind  trials  may  be  more  complex  to 
organise  and  in  some  situations  may  not  be  feasible,  e.  g.  due  to  the  nature  of  the 
intervention  or  for  ethical  reasons.  None  of  the  intensity  of  physiotherapy  trials 
discussed  in  Chapter  2  were  double  blinded.  Whilst  double  blinding  is  possible  in  some 
physiotherapy  trials,  most  only  achieve  single  blinding  (blinding  of  outcome 
assessments). 
Although  there  is  an  emphasis  on  the  methodological  quality  of  trials,  only  concealment 
of  randomisation  and  blinding  of  assessments  have  been  empirically  demonstrated  to 
affect  outcomes  (Schulz  et  al.  1995).  There  remains  a  considerable  amount  of  research 
to  be  carried  out  into  the  various  methods  that  can  be  utilised  in  the  systematic  review 
process. 
2).  External  validity  (generalisability)  in  studies. 
The  external  validity  of  a  tnal  i.  e.  the  extent  to  which  results  of  a  trial  provide  a  correct 
basis  for  applicability  to  other  circumstances,  can  be  more  difficult  to  establisli  and  is  a 
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matter  of  judgement.  This  should  include  a  consideration  of  the  subjects,  the 
intervention,  the  setting  and  the  outcomes  that  were  selected  by  the  researchers  (Jum  et 
al.  2001).  This  in  turn  will  be  dependent  on  the  availability  of  this  information  to  the 
researchers  carrying  out  the  meta-analysis.  Guidelines  on  the  content  of  reports  of  trials 
and  recommendations  on  minimum  reporting  standards  (e.  g.  Begg  et  al.  1996)  may  be 
helpful  in  standardising  the  availability  of  such  information,  allowing  judgements  to  be 
made  (Altman  &  Bland  1998). 
Sources  of  data  to  be  used  in  meta-analyses 
When  performing  a  meta-analysis,  there  are  several  different  sources  from  which  the 
data  can  be  based: 
1).  Published  data 
II).  Published  data  and  supplementary  additional  information  or  data  provided  by  the 
authors  that  were  not  included  in  the  publication. 
III).  Individual  patient  data  (IPD)  supplied  by  the  trialists. 
I).  Meta-analyses  based  on  published  data 
These  have  the  advantage  of  being  relatively  quick  to  carry  out  but  may  be  limited  by 
the  quality  of  the  data  available  for  the  synthesis  (Egger  et  al.  2001). 
However,  important  trials  may  be  as  yet  unreported  or  awaiting  publication  and  small  or 
pilot  studies  may  not  be  fully  reported  e.  g.  published  only  in  abstract  form.  Authors  are 
often  limited  by  journals  as  to  what  they  can  report.  Most  trials  have  considerably  more 
information  that  cannot  be  presented  within  a  limited  space  or  format.  Just  because  an 
aspect  of  a  study  was  not  reported,  does  not  necessarily  mean  it  was  not  carried  out. 
Added  to  this,  many  trials  without  a  "positive"  result  may  not  get  into  print.  So-called 
publication  bias  is  common,  with  positive  results  increasing  the  likelihood  of 
presentation  and  publication,  especially  in  high  profile  journals  (Egger  &  Davey  Smith 
1998). 
91 Chapter  4 
This  latter  point  is  debated  and  a  larger  study  of  publication  bias  in  trials  in  the  USA 
(Dickersin  et  al.  1992)  did  not  find  sample  size  or  type  of  study  design  to  be  important 
factors.  Instead  they  found  that  trials  with  external  funding  (especially  those  funded  bv 
government  agencies  rather  than  commercial  interests  such  as  phan-naceutical 
companies),  multiple  data  collection  sites  and  significant  results  ývere  positi\-clý, 
associated  with  publication.  They  also  proposed  that  many  studies,  rather  than  being 
rejected  by  journal  editors,  were  in  fact,  never  submitted  by  their  authors  for  publication. 
One  solution  to  avoid  publication  bias  is  to  require  all  research  to  be  registered  before 
starting  allowing  reviewers  to  search  for  topics  and  studies  that  have  been  carried  out 
but  not  widely  reported.  This  may  be  tied  in  with  ethical  or  funding  approval  but  may 
also  be  down  to  the  diligence  of  the  researchers  recognising  the  importance  or  potential 
importance  of  combination  of  trial  results  in  meta-analyses.  There  is  general  acceptance 
that  there  is  now  improved  access  to  information  on  trials  with  data  held  on  electronic 
registers  such  as  the  Cochrane  Trials  Register  and  "Register  of  Registers"  being  readily 
searched. 
If  publication  bias  (or  other  biases  such  as  English  language  bias,  multiple  publication 
bias  and  inclusion  bias)  is  a  concern  there  are  methods  by  which  it  can  be  estimated, 
e.  g.  plotting  of  results  in  a  funnel  plot,  and  in  some  cases  a  statistical  adjustment  made 
to  allow  for  non-included  studies  (Egger  &  Davey  Smith  1998)  (Sterne  et  al.  2001). 
11).  Meta-analyses  based  on  published  data  and  supplementary  additional  information 
Alternatively,  researchers  may  contact  the  authors  and  ask  for  further  information  or 
clarification  on  points  that  are  unclear.  Further  unreported  information  may  be  available 
by  using  this  approach  and  results  can  be  updated  and  potentially  more  data  can  be 
included  in  the  dataset. 
In  a  study  of  attitudes  towards  meta-analysis  (Cook  et  al.  1993)  there  Nvas  acceptance 
amongst  the  meta-analysts  surveyed  that  where  available,  unpublished  results  should  not 
be  systematically  excluded  from  meta-analyses.  In  this  case  the  trial's  results  should  be 
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handled  in  the  same  manner  but  the  results  of  the  meta-analysis  should  be  presented  as 
including  and  excluding  the  unpublished  results 
Some  authors  may  be  reluctant  to  release  results  for  inclusion  in  meta-analyses  because 
they  fear  it  may  jeopardise  publication  of  their  results  in  their  own  right.  This  fear  may 
be  justified;  in  Cook  et  al.  's  survey,  nearly  half  of  the  journal  editors  surveyed,  stated  if 
they  were  considering  a  study  for  potential  publication,  prior  publication  in  a  meta- 
analysis  would  have  a  bearing  on  their  decision  (Cook  et  al.  1993). 
111).  Meta-analyses  based  on  individual  patient  data  (IPD) 
Probably  the  most  infon-nation  can  be  gathered  by  asking  the  authors  to  submit  their 
original  "raw"  data  for  meta-analysis.  Often  considered  the  "gold  standard"  method,  its 
real  strength  is  that  it  provides  the  opportunity  to  review  all  the  available  data,  for  each 
study  to  be  re-analysed,  then  compared  to  the  other  trials  in  the  dataset.  It  allows 
subgroup  analyses  and  time-to-  event  analyses  that  may  not  be  available  when  dealing 
with  summarised  or  compound  data  based  solely  on  published  results.  However  IPD 
meta-analysis  is  considerably  more  time  consuming  and  requires  more  resources. 
EPD  meta-analyses  are  better  if  there  is  a  consensus  between  the  trialists  and  they  all 
agree  to  submit  their  data.  If  there  is  a  lack  of  co-operation,  or  for  some  reason  the 
trialists  are  unable,  or  do  not  wish  to  collaborate,  then  the  analysis  can  continue  but  the 
situation  should  be  made  explicit. 
Every  effort  should  be  made  to  include  all  the  relevant  trials  as  the  advantages  of  this 
method  are  lost  if  trials  are  excluded  from  the  meta-analysis.  Detailed  searching  should 
uncover  published  results,  but  is  dependent  on  the  search  skills  of  the  researcher 
(Dickersin  et  al.  1994),  their  access  to  librarian  assistance  and  methods  of  indexing  and 
searching  the  various  databases.  Hand  searching  and  checking  registers  of  trials, 
personal  correspondence  and  discussion  amongst  researchers,  many  of  whom  are 
involved  in  reviewing  grant  applications  or  journal  articles  as  well  as  undertaking 
primary  research,  can  also  assist  in  uncovering  trials  that  have  been  carried  out,  or  are 
ongoing,  but  have  not  been  published. 
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The  advantages  and  disadvantages  of  aggregate  data  and  EPD  meta-analyses  are  outlined 
in  Table  4.1  (Stewart  &  Clarke  1995). 
Table  4.1 
Possible  benefits  and  disadvantages  of  reviews  of  aggregate  data  and  individual 
patient  data  (IPD) 
(Stewart  &  Clarke  1995) 
Possible  benefits  of  collecting  aggregate  datafrom  trialists 
Include  unpublished  trials 
Include  all  randomised  and  non-randomised  patients 
Analyse  on  the  basis  of  allocated  treatment 
Analyse  common  outcomes 
Analyse  common  patient  subgroups 
Improve  the  overall  follow-up 
Ensure  equal  follow  -up  for  the  randomised  groups 
Possible  additional  benefits  of  involving  the  relevant  trialists  in  the  conduct  of  the 
review 
Better  identification  of  trials 
"  Better  understanding  of  the  trial  intervention 
"  More  balanced  interpretation  and  understanding  of  the  results  of  the  review 
"  Wider  endorsement 
Increased  possibilities  for  dissemination  of  the  results  of  the  review 
Better  clarification  of  the  implications  for  future  research 
9  Possibilities  for  collaboration  in  future  research 
Possible  additional  benefits  of  using  IPD 
"  Analyse  by  time  to  event 
"  Increase  statistical  power 
"  More  flexible  analysis  of  patient  subgroups 
0  More  flexible  analysis  of  outcomes 
Might  be  easier  for  trialists  to  supply  IPD  than  to  prepare  tables 
Easier  for  trialists  to  supply  small  amounts  of  additional  or  new  data 
Data  can  be  checked  and  corrected 
Possible  disadvantages  ofIPD  reviews 
May  take  longer  and  cost  more 
Reviewers  need  a  wider  range  of  skills 
Inability  to  include  EPD  from  all  relevant  trials 
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The  process  of  meta-analysis 
Meta  analysis  is  a  process  that  occurs  in  two  stages: 
Firstly,  a  summary  statistic  is  calculated  for  each  of  the  trials  to  be  entered  into  the 
meta-analysis.  Then  these  summary  statistics  are  combined  to  form  a  weighted  average. 
Most  meta-analyses  are  carried  out  by  computer  programme  that  will  calculate  an 
estimate  of  precision  (a  confidence  interval)  and  a  measure  of  statistical  significance  (a 
P  value).  A  test  statistic  (z)  is  given  for  the  overall  effect  and  P  value  for  statistical 
significance. 
Different  types  of  data  can  be  summarised  (Deeks  et  al.  2001): 
9  binary  data  -  where  a  2x2  table  can  be  constructed  and  odds  ratios,  risk  ratios 
and  risk  differences  calculated  for  the  strength  of  association  between  for 
example  exposure  to  an  intervention  or  risk  factor  and  presence  of  a  clinical 
outcome  or  diagnosis. 
9  continuous  data,  either  calculated  as  differences  in  means  or,  where  different 
measurement  scales  have  been  used  as  standardised  difference  in  the  means.  In 
the  later  case,  the  standardised  mean  difference  (SMD),  the  size  of  the  treatment 
effect  in  each  trial  is  expressed  relative  to  the  variability  observed  in  that  trial. 
9  time-to-event  analyses  where  hazard  ratios  (again  an  estimate  of  the  degree  of 
association)  are  surnmarised. 
These  data  summaries  are  then  analysed  using  either  a  fixed  effects  model  or  a  random 
effects  model.  The  choice  of  model  is  given  as  an  option  on  most  meta-analysis 
statistical  software  packages.  The  decision  is  largely  dependent  on:  the  type  of  data 
being  analysed;  the  choice  of  summary  statistics;  the  amount  of  heterogeneity  that  is 
observed  between  the  trials  and  any  limitations  of  the  computational  methods. 
Fixed  effect  model  -  this  approach  assumes  a  single  "common"  effect  and  can  use  a 
range  of  possible  methods:  Inverse  Variance  method;  Mantel-Haenszel  method  and  the 
Peto  (also  known  as  Peto  and  Yusuo  method.  Fixed  effect  models  can  be  used  to 
calculate  study  weights  dependent  on  the  contribution  made  by  each  of  the  trials  to  the 
meta-analysis. 
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Random  effects  model  -  this  includes  an  estimate  of  between-study-variation 
(heterogeneity),  sometimes  considered  as  the  "combinability"  of  the  trials,  and  usuall%- 
uses  the  DerSimonian  and  Laird  method. 
Deeks  et  al.  describe  the  models  in  detail  and  considered  that  "There  is  no  consensus 
regarding  the  choice  of  fixed  or  random  effects  models,  although  they  differ  only  in  flic 
presence  of  heterogeneity,  where  the  random  effects  model  will  usually  be  more 
conservative.  "  Peeks  et  al.  2001). 
The  same  authors  consider  errors  can  anse  for  the  fixed  effect  models  in  the  following 
instances:  - 
e  Inverse  variance  method  -  this  is  considered  less  robust  and  reliable  when  trials 
are  small  (and  is  rarely  preferable  to  the  Mantel-Haenszel  method). 
*  Both  the  inverse  variance  and  Mantel-Haenszel  methods  are  considered  less 
robust  and  reliable  when  the  rate  of  events  is  very  low. 
*  Peto's  method  is  considered  less  robust  and  reliable  when  treatment  effects  are 
large  and  when  there  are  severely  unequal  numbers  of  subjects  in  treatment  and 
control  groups  in  some  or  all  of  the  trials.  This  last  situation  would  be  unusual 
when  dealing  with  randomised  trials. 
None  of  the  methods  compensate  for  publication  bias  or  deal  with  bias  introduced 
through  poor  study  design  or  execution.  A  table  of  considerations  in  choosing  a  method 
of  meta-analysis  is  given  in  Appendix  IV. 
In  the  second  stage  of  the  meta-analysis  process,  the  weights  of  each  study  are 
calculated  as  the  contribution  they  make  to  the  combined  result.  The  weights  used  are 
often  the  inverse  of  the  variance  of  the  treatment  effect  i.  e.  the  square  of  the  standard 
error.  This  usually  relates  closely  to  sample  size,  with  larger  samples  being  allocated 
greater  weight. 
Considering  heterogeneity 
When  selecting  trials  to  enter  into  the  meta-analysis,  we  should  consider  how  consistent 
are  treatment  effects  across  the  primary  studies. 
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Trials  may  be  fundamentally  different  in  their  alms,  patient  group,  setting,  other 
(concomitant)  care  or  how  the  intervention  was  delivered.  This  "clinical"  heterogeneity 
may  lead  to  variability  of  results.  A  decision  to  include  trials  often  depends  on  clinical 
experience  and  background  knowledge  of  the  patient  groups,  the  interventions  and  the 
disease.  If  trial  results  are  consistent  this  tends  to  corroborate  generalisation  of  any 
treatment  effect.  However,  Type  11  error  (false  negative)  may  anse  where  there  is  a  small 
number  of  studies  which  may  not  detect  excess  variation  (Mulrow  &  Oxman  1997). 
Heterogeneity  may  arise  within  a  group  of  trials  that  appear  to  be  clinically  similar. 
Statistical  testing  for  heterogeneity  is  available  in  the  form  of  the  12  statistic.  This  is  the 
percentage  of  variability  in  point  estimates  that  is  due  to  heterogeneity  rather  than 
sampling  error  (Higgins  et  al.  2003). 
There  are  limitations  of  the  X'  test  of  heterogeneity  as  it  is  sensitive  to  the  number  of 
studies  in  the  meta-analysis.  Where  there  are  few  studies,  as  is  the  case  with  most  meta- 
analyses,  it  is  underpowered  to  detect  differences  between  the  studies,  yet  when  there 
are  many  studies  it  may  overestimate  differences  and  detect  differences  that  are 
unimportant. 
If  significant  or  substantial  heterogeneity  is  identified  by  reviewing  the  trials  or  in 
performing  statistical  tests  of  heterogeneity  we  should  attempt  to  find  a  reason  for  it  or 
abandon  pooling  the  estimate  and  use  another  method.  As  an  alternative  we  can  consider 
a  stratified  meta-analysis  or  "meta-regression"  in  order  to  test  potential  associations 
between  study  factors  and  the  estimated  treatment  effect.  The  important  point  is  that  we 
are  able  to  estimate  the  amount  of  heterogeneity  and  consider  how  it  might  impact  on 
the  findings  of  the  meta-analysis  (see  Table  4.2). 
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Table  4.2  Consideration  of  heterogeneity  can  affect: 
(Deeks  et  al.  2001) 
"  whether  a  meta-analysis  should  be  considered,  depending  on  the  similarity  of  tile 
trial  characteristics. 
"  whether  an  overall  summary  can  have  a  sensible  meaning,  depending  on  the 
degree  of  disagreement  observed  between  the  trial  results. 
"  whether  a  random  effects  method  is  used  to  account  for  extra  betýveen-trial 
variation  and  to  modify  the  significance  and  precision  of  the  estimate  of  overall 
effect. 
whether  the  impact  of  other  factors  on  the  treatment  effect  can  be  investigated 
using  stratified  analyses  and  methods  of  meta-regression. 
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The  systematic  review  of  published  data  on  the  intensity  of  physiotherapy  after 
stroke. 
Objective 
Using  some  of  the  methods  I  have  been  discussing,  I  set  out  to  review  the  published  data 
on  intensity  of  physiotherapy  after  stroke  (most  of  which  were  described  in  Chapter  2). 
In  my  review  I  describe  in  a  systematic  manner,  how  I  selected  and  critically  appraised 
the  available  evidence  using  methods  employed  in  a  Scottish  Intercollegiate  Guidelines 
Network  (SIGN)  guideline  review  of  the  management  of  patients  with  stroke  (SIGN 
2002).  The  SIGN  methods  (SIGN  2004)  largely  reflect  those  laid  out  in  the  Cochrane 
Collaboration  Handbook  (Mulrow  &  Oxman  1997). 
Parts  of  this  work  contributed  to  the  publication  of  the  national  clinical  guideline  (SIGN 
2002). 
Trial  selection  -  Inclusion  I  Exclusion  Criteria 
In  order  to  limit  the  area  of  study  and  focus  on  the  questions  of  interest,  I  wanted  to 
develop  a  specific  literature  search  strategy  yet  avoid  missing  any  potentially  relevant 
papers.  I  limited  variations  due  to  methodology,  by  only  including  randomised 
controlled  trials  in  the  review.  All  trials  needed  to  satisfy  the  following  criteria.  They 
should: 
1).  be  randomised  controlled  trials. 
2).  compare  different  intensities  of  "physiotherapy"  or  "physical  therapy". 
3).  contain  interventions  that  reflect  current  physiotherapy  practice  in  the  UK. 
4).  include  patients  in  the  acute  and  rehabilitation  stages  of  treatment  after  stroke. 
5).  be  mostly  in-patient  based. 
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Finding  the  relevant  trials  of  intensity  ofphysiotherapy 
The  search  for  relevant  trials  was  based  on  the  Cochrane  Stroke  Group  Trials  Register 
with  assistance  from  the  Stroke  Therapy  Evaluation  Programme'  (STEP)  based  at  the 
University  of  Glasgow.  The  Stroke  Group  Trials  Register  is  compiled  from  highlý 
sensitive  searches  of  databases  including  Medline,  EMBASE,  BIOSIS,  Derwent  Dru,,, 
File,  Scisearch,  AMED,  CINAHL,  Cochrane  Controlled  Trials  Register,  Dissertation 
Abstracts,  Healthstar,  National  Research  Register,  Psych  INFO,  SIGLE.  This  is 
supplemented  with  hand-searching  of  over  40  journals,  over  100  textbooks  and  several 
hundred  conference  proceedings.  It  includes  articles  in  all  languages.  The  main  search 
strategy  is  given  in  Appendix  V. 
I  initially  excluded  obviously  irrelevant  studies  before  two  reviewers  independently 
screened  relevant  publications  for  inclusion  (see  review  profile  -  Figure  4.2).  We 
identified  34  potentially  relevant  trials  (See  Appendix  V,  Table  A5.1).  We  repeated  our 
search  during  the  period  of  study  (up  to  end  of  December  2002)  in  order  to  identify  any 
new  trials.  Trials  that  were  excluded  and  the  reasons  for  exclusion  are  described  in 
Appendix  V  (summarised  in  Table  A5.2,  Appendix  V).  We  also  contacted  existing 
trialists  for  additional  information  and  approached  specialist  groups  such  as  The  British 
Stroke  Search  Group,  Society  for  Research  and  Rehabilitation,  and  the  Chartered 
Society  of  Physiotherapy. 
STEP  is  a  project  based  in  Glasgow  Royal  Infinnary,  funded  by  the  charity  Chest,  Heart  and  Stroke 
(Scotland). 
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Figure  4.2  Review  profile 
Titles  reviewed 
n=  4772 
v,  cluded 
=  4537 
Abstracts  reviewed 
n=  235 
Excluded 
On 
=  201 
Papers  retrieved  for  detailed 
evaluation  (n  =  34) 
tudies  included  in  the 
.v ,  iew  (n  =  9) 
Studies  excluded  from  review  n=  25 
Secondary  publications 
ate  intervention  2 
Intervention  rather 
than  intensity  was 
focus  of  trial  5 
Novel  intervention  I 
Non  or  Quasi-randomised  3 
Confoundedinterventions  3 
Community  /  outpatient  - 
based  3 
Ongoing  pilot  study  I 
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There  were  three  existing  systematic  reviews  identified  by  the  search  (Langhorne  et  al. 
1996,  Kwakkel  et  al.  1997,  van  der  Lee  et  al.  2001)  all  used  slightly  different  methods  to 
review  their  selected  papers  and  have  already  been  described  briefly  in  Chapter 
22. 
We  selected  nine  trials,  in  five  cases  a  trial  had  more  than  one  publication  (Table  4.3). 
Table  4.3  Trials  considered  to  fit  the  inclusion  criteria 
Trials  are  grouped  to  indicate  the  main  study  (underlined)  and  secondary  papers. 
GAPS  (unpublished) 
Kwakkel  et  al.  1999 
Kwakkel  and  Wagenaar  2002 
Lincoln  et  al.  1999. 
Lincoln  et  al.  1999. 
Parry  et  al.  1999(a) 
Parry  et  al.  1999(b) 
Miller  et  al.  2000  (abstract  only) 
Partridge  et  al.  2000 
Rodgers  et  al.  (paper  was  being  prepared  and  was  published  in  2003) 
Richards  et  al.  1993 
Malouin  et  al.  1993 
Slade  et  al.  1999  (abstract) 
Slade  et  al.  2002 
Sunderland  et  al.  1992 
Sunderland  et  al.  1994 
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This  group  includes  the  results  from  the  GAPS  study  from  the  previous  chapter 
(subsequently  published  in  2004)  and  results  from  the  trial  by  Rodgers  et  a].  that  had  not 
been  published  at  the  time  of  the  literature  review.  We  were  aware  of  this  trial  and 
considered  it  suitable  to  be  included  at  this  stage  to  allow  comparison  of  data. 
The  trials  have  been  described  in  Chapter  2  and  are  characterised  in  Table  4.4. 
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Systematic  review 
I  used  existing  review  criteria  -  the  Scottish  Intercollegiate  Guidelines  NetN,  ý,  ork  (SIGN) 
criteria  and  rating  system  (see  Appendix  VI). 
The  review  was  considered  in  three  sections: 
I  Description  of  the  study  (where  the  study  intervention,  outcome  measures, 
number  of  subjects  and  scale  and  direction  of  the  measured  effect  are  described). 
2.  Internal  Validity;  (where  the  clarity  of  the  study,  its  attempts  to  minimise  bias 
and  rigour  of  its  analysis  are  assessed). 
I  Overall  assessment  of  the  study  (where  the  study  quality  is  rated). 
Each  section  is  shown  in  tables  4.4  -  4.6. 
I  reviewed  the  nine  selected  trials  along  with  an  experienced,  expert,  independent 
reviewer,  Lynn  Legg,  from  the  related  field  of  occupational  therapy  in  stroke 
rehabilitation,  based  at  the  Stroke  Therapy  Evaluation  Project  (STEP)  at  the  University 
of  Glasgow.  This  had  the  advantage  of  reducing  potential  bias  that  may  anse  when 
reviewers  of  a  similar  professional  background  examine  a  trial.  Neither  of  us  was 
blinded  to  the  authors  of  the  papers.  This  would  have  further  reduced  potential  bias  in 
our  review  but  was  impractical  due  to  the  small  number  of  papers  and  the  fact  that  we 
were  both  familiar  with  a  number  of  the  studies  due  to  previous  work  in  this  field.  An 
adjudicator,  Professor  Peter  Langhorne,  was  appointed,  but  in  practice  was  not  needed 
as  any  differences  in  opinion  on  the  criteria  were  easily  resolved  by  discussion. 
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Trials  excluded  from  the  review 
The  trials  excluded  from  the  review  are  given  in  Appendix  V  along  with  the  reasons  for 
their  exclusion. 
"Combin  ability"  (clinical  heterogeneity)  of  trials 
Considering  how  suitable  the  selected  trials  are  for  combination  in  the  meta-analysis 
raises  a  couple  of  issues.  Firstly,  whilst  most  of  the  trials  were  published  within  the  last 
ten  years,  we  need  to  assume  that  "physiotherapy"  as  an  entity  has  not  altered 
considerably  within  this  period.  Secondly,  one  of  the  trials  (Kwakkel  et  al.  1999) 
suggested  significant  benefit  from  increased  physiotherapy  intervention  while  others 
have  reported  little  (Sunderland  et  al.  1992)  or  no  measurable  benefits  (Partridge  et  al. 
2000,  Lincoln  et  al.  1999,  Rodgers  et  al.  2003).  This  discrepancy  could  be  due  to 
differences  in  trial  methodology,  patient  selection,  therapy  technique,  outcome  measures 
or  simply  due  to  chance  as  all  these  trials  are  relatively  small. 
Outcomes 
Returning  to  my  original  research  questions  (Chapter  I  page  14)  1  analysed  the  data  for 
differences  in  groups  in  terms  of  reduction  in  upper  and  lower  limb  impairment  (in  the 
short  and  longer  term),  reduction  in  disability  (in  the  short  and  longer  terin),  survival 
and  reduction  in  hospital  length  of  stay. 
Changes  in  levels  of  impairment  and  disability  and  timing  of  effect-  there  are  mixed 
results  from  the  studies.  Different  measures  were  used,  particularly  to  measure 
impairment,  there  are  trends  towards  reductions  in  both  impairment  and  disability,  bUt 
these  are  seldom  statistically  significant.  Kwakkel  et  al.  suggested  benefit  in  the  short 
terin  (Kwakkel  et  al.  1999),  but  benefits  may  be  short  lived  and  more  readily  detected  in 
the  acute  phase  of  treatment,  with  other  studies  showing  no  significant  differences. 
Targeting  of  treatment  The  majority  of  the  studies  (5/9)  focussed  on  treating  the  upper 
limb,  whilst  two  focussed  on  treating  the  lower  limb.  The  others  were  looking  for 
general  effects.  Only  Kwakkel  et  al.  specifically  split  their  subjects  allocating  additional 
treatment  for  the  upper  or  lower  limb. 
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Are  any  treatment  effects  greater  for  patients  with  moderate  impairment  and  little  co- 
morbidity. 
This  is  inadequately  addressed  with  a  wide  variety  of  patients  being  Included  and 
Sunderland  et  al.  being  the  only  group  to  report  results  of  analyses  of  their  "mild"  and 
44severe"  groups.  There  are  difficulties  in  defining  co-morbidity  and  a  lack  of 
standardised  measures  used  and  reported  in  the  other  trials. 
Survival  -  analyses  of  rates  of  death  are  normally  calculated,  and  although  we  do  not 
expect  significant  differences  it  is  important  to  identify  potentially  harmful 
interventions. 
Reduction  in  hospital  length  of  stay  -  Slade  et  al.  reported  a  reduction  in  the  length  of 
hospital  stay  but  their  results  may  be  biased  as  their  sample  included  other 
neurologically  impaired  patients.  The  available  data  from  their  paper  does  not  allow 
figures  to  be  entered  into  the  meta-analysis.  Different  studies  use  different  points  in  time 
and  interventions  commenced  at  various  times.  Generally  there  was  a  lack  of 
information  about  blinding  of  "decision  makers"  regarding  decisions  of  when  patients 
should  be  discharged  home. 
Assumptions 
In  order  to  carry  out  the  analysis  a  number  of  assumptions  were  made.  I  needed  to 
consider  the  balance  between  on  one  hand,  including  a  small  number  of  studies  with  a 
complete  data  set  and  on  the  other  hand  including  a  large  number  of  studies  but  making 
assumptions  where  data  were  not  available  or  explicitly  reported.  I  decided  to  adopt  an 
inclusive  approach  that  would  reduce  bias  associated  with  excluding  trials.  In  taking  this 
approach,  it  is  important  to  make  the  assumptions  explicit  (Greener  &  Langhorne  2002). 
However,  this  inclusive  approach  means  that  the  data  should  be  used  with  caution  as 
their  quality  may  be  called  into  question. 
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By  detailing  my  assumptions  and  making  conservative  estimates,  the  limitations  of  the 
data  have  been  made  explicit  (see  Table  4-7).  Table  4.8  describes  the  data  selected  for 
analyses  of  impainuent,  disability,  death  and  length  of  hospital  stay. 
Table  4.7  Assumptions  made  of  the  published  data  for  all  analyses 
We  have  assumed  a  Normal  distribution  of  outcomes  selected. 
Where  interventions  have  been  split  into  subgroups  e.  g.  upper  and  lower  limb 
treatment  we  have  divided  the  control  group  evenly. 
For  secondary  outcome  measures 
Where  only  the  median  is  reported  we  have  taken  this  value  as  an  estimate  of  the 
mean. 
Where  the  standard  deviation  (SD)  was  not  reported,  we  have  estimated  this  by  3 
methods  (Langhorne  et  al.  2005): 
Where  only  inter  quartile  range  (IQR)is  given  - 
SD  =  (IQR  -  0.7)  divided  by  2 
Where  only  range  is given  - 
SD  =  Range  x  0.25 
Where  only  SEM  is  given 
SD  =  SEM  x  ýn  (standard  error  of  mean  times  square  root  of  no  of  observations) 
Where  means  and  SD  have  been  calculated  from  available  data  rather  than  the 
original  number  of  subjects  in  groups  i.  e.  not  an  intention  to  treat  analysis,  figures 
based  on  available  data  have  been  used. 
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Table  4.8  Data  selected  and  assumptions  for  analyses  of  death,  impairment, 
disability  and  length  of  hospital  stay. 
Unless  specified  data,  mean  and  standard  deviation  were  routinely  available  from  the 
text. 
_Trial 
Impairment  Disability  Death  Length  of  stay 
GAPS  Motricity  index  Barthel  index  Calculated  from  date  of 
randornisation  to  discharge 
Kwakkel  Upper  limb  used  Barthel  index  One  death  reported  Not  available 
ARAT  (mean  &  but  group  not 
IQR)  specified  -  allocated 
Lower  limb  used  to  lower  limb 
maximum  gait  treatment 
speed 
Lincoln  RMA  (median  Barthel  index  Not  available 
&IQR) 
Miller  No  available  data  None  reported  None  reported  -  Not  available 
assumed  to  be  none 
Partridge  6  week  follow  up  Profile  of  Reported  21  subjects  Not  available 
used  as  3  month.  recovery  (POR)  as  dead  or  lost  to 
Used  gait  speed  follow  up  at  6  months 
no  further  data. 
Assumed  no  deaths. 
Richards  6  week  data  used  Barthel  index  None  reported  -  Not  available 
as  3  month.  Used  assumed  to  be  none. 
gait  speed  Included  all  baseline 
6  month  data  not  patients 
repo  ed 
Rodgers  Barthel  index  Not  available 
Slade  No  data  available  Barthel  index  No  deaths  reported  -  Not  available 
assumed  none 
Sunderland  100  day  follow  up  Barthel  index  Compared  at  6  Reported  as  weeks  of 
(estimated  from  months  inpatient  therapy. 
figure  in  paper)  Reported  2  deaths  in 
experimental  group,  8  Reported  figures  are  not 
109  patients  deaths  in  control  split  by  mild  /  severe 
assumed  to  be  group  but  no  detail  of  categories. 
evenly  distributed  subgroup  -  assumed  Labelled  "severe"  for  the 
to  be  evenly  analysis. 
experimental  54  distributed 
control  55 
ARAT  =  Action  Research  Arm  Test,  IQR  =  Inter-quartile  range,  KMA  =  Rivermeact  Mobility  Assessment, 
*  Richards  et  al.  's  study  was  not  analysed  on  an  intention  to  treat  basis,  therefore  means  and  SD  were 
based  on  available  data. 
Egger  and  Davey  Smith  recommend  routinely  testing  for  bias  using  funnel  plots  aild 
sensitivity  analyses  (Egger  &  Davey  Smith  1998).  Due  to  the  small  number  of  trials  in 
the  meta-analyses  we  did  not  formally  test  for  publication  bias. 
I  went  on  to  analyse  the  aggregate  (published  and  unpublished)  data  from  the  above 
trials  using  RevMan  software  (Version  4.2)  (Review  Manager  2004). 
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Figures  4.3  -  4.8  show  the  summary  statistics,  meta-analyses  and  forest  plots  for  each  of 
the  six  outcomes.  These  are  summarised  in  Table  4.9  below  along  with  heterogeneity 
statistics  and  interpreted  in  the  following  section. 
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Table  4.9  Summary  of  effects 
Outcome  n  Method  Effect  size  P  value  Hetero- 
(95%  CT)  geneity 
12 
Disability  3  805  SMD  0.15  0.09  21.5 
months  (random)  (-0.02  to 
0.31) 
Disability  end  780  SMD  0.10  0.19  0 
of  study  (random)  (405  to 
0.24) 
Impairment  3  703  SMD  0.07  0.48  23.4 
months  (random)  (-0.11  to 
0.25) 
Impairment  674  SMD  0.05  0.70  67.6 
end  of  study  (random)  (-0.22  to 
0.33) 
Death  1016  OR  0.91  0.76  9.9 
(random)  0.50  to  1.67 
Length  of  202  Not 
hospital  stay  estimable 
SMD  =  Standardised  Mean  Difference,  Random  =  Random  effects  model 
OR  =  Odds  ratio,  Cl  =  Confidence  interval 
Interpretation  of  results 
We  can  see  from  Table  4.9  that  there  is  variable  heterogeneity  between  the  studies 
entered  into  the  analyses.  Interpretation  of  results  of  the  I'statistics  is  a  matter  of  debate. 
Higgins  and  Thompson  suggest  that  as  a  general  rule  I'values  of  30%  and  50%  can  be 
used  as  guidelines.  Mild  heterogeneity  might  account  for  less  than  30%  of  the  variability 
of  point  estimates  and  notable  heterogeneity  substantially  more  than  50%.  Using  this  as 
a  guide  it  was  reasonable  to  combine  the  trials  in  most  of  our  selected  analyses, 
impairment  at  6  months  being  the  only  comparison  with  substantial  heterogeneity. 
Impairment 
The  analyses  indicate  a  trend  towards  a  positive  effect  on  impairment  with  most 
summary  data  being  on  the  right  hand  side  of  the  line  of  no  effect  though  the  confidence 
intervals  tend  to  be  wide. 
120 Chapter  4 
The  combined  figure  (diamond  plot)  though  mostly  favouring  treatment,  is  small  and 
crosses  the  line  of  no  effect.  This  may  reflect  small  numbers  and  the  difficulties  in 
obtaining  full  data  collection  when  measuring  this  outcome  using  a  variety  impairment 
measures.  These  are  possible  reasons  for  the  statistical  tests  for  heterogeneity  in  the  end- 
of-follow-up  analysis  identifying  "notable"  heterogeneity. 
Disability 
There  is  a  trend  towards  positive  results  but  not  large  enough  to  be  statistically 
significant.  This  analysis  had  the  best  availability  of  a  common  outcome  measure,  the 
Barthel  index,  but  the  numbers  are  still  limited.  The  outlying  data  from  Kwakkel  et  al. 
may  have  arisen  due  to  their  ability  to  have  early  intervention  and  maintain  treatment 
contrast  by  immobilising  the  limbs  of  the  patients  in  the  control  group. 
Survival 
As  expected,  survival  appears  unaffected  by  the  intensity  of  physiotherapy.  This  analysis 
acts  as  a  check  that  the  intervention  does  not  appear  to  be  producing  an  excess  of  deaths, 
for  example  by  exercise  induced  death  due  to  repeated  physiological  stress  on  patients. 
The  assumptions  I  made  may  underestimate  the  number  of  deaths  (by  assuming  no 
deaths  where  deaths  were  not  reported  and  that  "lost  to  follow  up"  did  not  necessarily 
mean  "dead"),  but  without  specific  data  we  cannot  be  certain.  The  group  lost  to  follow 
up  in  the  trial  of  Partridge  et  al.  are  likely  to  include  a  few  deaths  and  it  might  be  more 
likely  that  the  deaths  that  Sunderland  et  al.  reported  were  largely  in  the  "severe" 
subgroup. 
Length  of  hospital  stay 
These  data  have  problems  of  definition  of  terms  and  only  two  studies  were  able  to 
contribute  length  of  stay  data.  Interestingly,  data  from  Slade  et  al.  -  the  only  study  to 
have  this  as  its  primary  outcome  measure,  could  not  be  included  as  they  did  not  include 
original  data  in  their  report.  The  meta-analysis  could  not  be  undertaken.  Out  of  all  the 
studies,  only  Slade  et  al.  report  a  reduction  in  mean  length  of  stay  that  reaches  statistical 
significance. 
121 Chapter  4 
Conclusion 
Using  our  inclusion  criteria  and  a  considerable  number  of  assumptions  of  the  data,  I 
could  not  detect  differences  between  the  groups  in  our  overview  based  on  combined 
analyses  of  impainnent,  disability,  death  and  length  of  stay.  Although  there  XN'as  a  trend 
towards  short-term  advantage  with  increased  intensity  of  physiotherapy  the  confidence 
intervals  were  wide. 
With  other  methods  of  meta-analysis  offering  potential  benefits  (Table  4.1),  we  set 
about  fonning  a  collaborative  group  to  carry  out  an  IPD  meta-analysis.  We  aimed  to 
repeat  the  review  using  all  available  data  and  using  EPD  methods.  This  would  give  us 
the  opportunity  to  carry  out  subgroup  analyses  that  might  address  our  questions.  The 
IPD  meta-analysis  is described  in  the  next  chapter. 
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Summary 
*  In  this  chapter  I  outlined  the  process  of  systematic  review  then  go  on  to  carry  out 
such  a  review  based  on  aggregate  data  (published  and  unpublished)  relating  to 
intensity  of  physiotherapy  after  stroke. 
*I  determined  the  criteria  used  to  select  trials  from  the  body  of  available  evidence. 
eI  carried  out  a  literature  search  with  assistance  from  the  STEP  team  and  the 
Cochrane  Stroke  Group  and  identified  9  key  studies  from  the  34  papers  that  were 
identified  that  fitted  the  criteria  for  inclusion. 
Using  recognised  review  criteria  (the  SIGN  review  criteria)  I  reviewed  the 
papers  along  with  an  independent  assessor.  Our  appraisal  of  the  main  studies  is 
tabulated  and  described. 
*I  discuss  the  review  of  the  papers  and  the  other  available  reviews  in  relation  to 
the  research  questions. 
9  We  made  explicit  assumptions  about  data  that  were  not  directly  available.  The 
aggregate  data  were  then  entered  into  the  meta-analysis  and  forest  plots 
generated. 
*  From  the  available  results  I  conclude  that  there  is  still  a  lack  of  evidence  of 
benefit,  in  terms  of  death,  reductions  in  impainnent,  disability  and  length  of 
hospital  stay,  with  an  increased  intensity  of  physiotherapy  after  stroke.  With  this 
uncertainty  in  mind  and  potentially  more  useful  methods  of  meta-analysis 
available,  we  set  out  to  form  a  collaborative  group  to  carry  out  an  individual 
patient  data  meta-analysis. 
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CHAPTER  5 
THE  "PINTAS"  INDIVIDUAL  PATIENT  DATA  META-ANALYSIS 
Introduction 
The  results  from  the  previous  chapter's  aggregate  data  meta-analysis  indicated  a  lack  of 
evidence  of  benefit,  in  tenns  of  death,  or  reductions  in  impairment,  disability  and  length 
of  hospital  stay,  with  an  increased  intensity  of  physiotherapy  after  stroke.  Despite  some 
limitations,  meta-analysis  appears  to  offer  a  unique  and  efficient  use  of  the  available 
information  gathered  from  physiotherapy  trials  at  a  fraction  of  the  cost  of  an  adequately 
powered  new  trial.  Whilst  a  large  prospective  RCT  would  be  ideal,  it  seems  unlikely  to 
happen  in  the  foreseeable  future  due  to  financial  and  practical  constraints.  We  therefore 
wanted  to  explore  meta-analysis  further  and  examine  some  of  the  subgroups  of  patients. 
Given  the  available  data  and  our  aims,  it  seemed  reasonable  for  us  to  select  the 
individual  patient  data  (IPD)  method  (see  Table  5.1).  We  set  out  to  form  a  collaborative 
group,  the  Physiotherapy  Intensity  After  Stroke  (PINTAS)  group,  to  carry  out  an 
individual  patient  data  meta-analysis. 
Table  5.1  Factors  that  may  influence  the  systematic  review  approach 
(Stewart  &  Tiemey  2002) 
When  IPD  may  be  beneficial  When  IPD  may  not  be  beneficial 
Poor  reporting  of  trials:  information  Detailed  and  clear  reporting  of  trials 
inadequate,  selective  or  ambiguous  (CONSORT  quality  (Moher  et  al.  2001)) 
Long  term  outcomes  Short  term  outcomes 
Time  to  event  outcome  measures  Binary  outcome  measures 
Multivariate  or  other  complex  analyses  Univariate  or  simple  analyses 
Differently  defined  outcome  measures  Outcome  measures  defined  uniformly 
across  trials 
Subgroup  analyses  of  patient-level  Patient  subgroups  not  important 
characteristics  important 
Individual  patient  data  available  for  high  Individual  patient  data  available  for  only 
proportion  of  trials  /  individuals  a  limited  number  of  trials 
IPD  =  individual  patient  data 
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Collaborative  EPD  meta-analysis,  by  involving  the  primary  trialists  in  a  more  thorough 
analysis,  can  greatly  improve  the  quality  of  the  information  gathered  and  of  the 
interpretation  of  results  (Stewart  et  al.  1995).  We  successfully  applied  for  funding  from 
the  charity  Chest  Heart  and  Stroke  Scotland  to  carry  out  the  meta-analysis  still  aiming 
to  address  the  hypothesis  set  out  in  Chapter  1. 
Aims 
We  aimed  to  carry  out  a  collaborative  IPD  meta-analysis  of  randomised  trials  that 
compared  standard  physiotherapy  with  an  increased  amount  of  the  same  approach 
(intensive  physiotherapy). 
Design 
We  used  standard  methods  (Stewart  et  al.  1995)  to  define  the  analysis  and  formed  a 
collaborative  group  (comprising  the  contact  authors  of  the  primary  trials)  to  pen-nit 
comprehensive  data  collection,  analysis  and  interpretation. 
The  project  had  three  phases: 
Preparation  -  complete  trial  searching;  liaison  with  collaborators;  refining  the  meta- 
analysis  questions. 
Database  management  -  request  for  and  transmission  of  individual  datasets;  creation 
of  combined  study  analysis  database;  grooming  and  cleaning  of  data;  categonsing  data 
sets;  forinal  meeting  with  collaborators  to  finalize  questions  and  meta-analysis  strategy. 
Analysis  -  statistical  analysis  and  writing  up;  presentation  of  results. 
1.  Preparation 
Literature  search  strategy 
We  used  the  same  search  strategy  as  in  the  previous  chapter  in  order  to  identify  all 
relevant  trials,  including  studies  identified  up  until  the  end  of  December  2002. 
Trial  selection  -  Inclusion  lExclusion  Criteria 
We  used  the  same  criteria  as  in  Chapter  4,  applying  the  same  inclusion  criteria  to 
unpublished  studies  to  determine  whether  they  should  be  included  in  our  analysis  (Cook 
et  al.  1993). 
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Forming  the  collaborative  group 
During  the  pilot  phase  of  the  study  we  made  informal  contact  with  potential 
collaborators.  All  the  potential  collaborators  (primary  authors  of  the  trials)  were  willing  ltý 
to  participate  in  the  study  (see  Appendix  VII). 
Refining  the  meta-analysis  questions 
In  this  type  of  analysis  it  is  important  to  pre-set  the  questions  to  be  addressed  and  make 
judgments  about  categorising  the  data.  This  was  done  after  categorising  the  data  (but 
prior  to  any  analysis)  and  further  discussion  at  a  meeting  of  the  collaborators. 
The  formal  meeting  of  the  collaborating  trialists  was  held  at  the  headquarters  of  the 
Chartered  Society  of  Physiotherapy  in  London  on  the  29th  November  2002.  The  aim  of 
the  meeting  was  to  confirm  the  questions  and  assumptions  to  be  made  in  the  meta- 
analysis,  and  to  decide  about  the  dissemination  of  the  results. 
At  the  meeting  we  discussed  the  potential  analyses,  considering  availability  of  data  and 
our  original  research  questions.  We  selected  activities  of  daily  living  (ADL)  disability 
and  impairment  as  our  primary  outcomes  and  wanted  to  explore  subgroups  in  secondary 
analyses. 
The  ma  .  or  advantage  of  this  study  has  over  a  meta-analysis  based  on  published  data  is  J 
the  availability  of  patient  level  data.  This  allows  the  potential  for  adjusting  treatment 
effects  for  covariates  of  interest,  and  for  examining  treatment  effects  within  subgroups. 
Additionally,  fewer  assumptions  need  to  be  made  of  the  data.  However,  forcing  data 
from  many  studies  carried  out  in  different  places  at  different  times  using  a  variety  of 
patients,  with  various  outcomes  and  differing  sets  of  explanatory  covariates  creates  a 
challenge.  Clearly  such  data  are  not  identical  to  a  very  large  unified  study  conducted  at 
one  place  at  one  time  using  consistent  methods. 
This  challenge  has  two  complementary  parts:  -  to  create  a  unified  database  of  the 
individual  studies  data,  and  to  conduct  a  statistical  analysis  that  in  some  sense  best 
addresses  the  questions  in  the  hypotheses,  whilst  accommodating  the  limitations  of  the 
data. 
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2.  Database  Management 
Grooming  and  cleaning  data 
We  developed  an  outline  database  (see  Table  5.2)  to  provide  a  structure  for  the  many 
variables  in  each  of  the  studies. 
To  reduce  the  barriers  to  participation  in  the  pooling  of  the  data,  we  sought  to  minimise 
the  effort  required  by  the  individual  principal  investigators  and  their  research  teams.  We 
therefore  allowed  data  to  be  sent  in  any  fonnat  on  any  media,  with  the  only  stipulation 
being  that  the  data  were  first  anonymised  before  transmission.  The  Robertson  Centre  for 
Biostatistics  at  the  University  of  Glasgow  has  the  facility  to  convert  data  from  virtually 
any  format  into  a  standard  fon-nat  allowing  the  meta-analysis  to  go  ahead.  This  helped 
to  minimize,  the  workload  of  the  collaborating  trialists. 
Table  5.2  Outline  database  used  in  PINTAS  meta-analysis 
Component  Variable  Example 
Patient  Demographic  Age,  sex, 
Frailty  Pre-stroke  dependency,  co-morbidities 
Baseline  severity  -  general  Barthel  index  at  randonusation 
-  upper  limb  Motricity  index,  Action  Research  Arm  Test  (ARAT) 
-  lower  limb  Motricity  index,  Rivermead  mobility  index 
Intervention(s)  Physiotherapy  type  Philosophy  /  approach  (qualitative  description) 
aims  Target  (eg.  balance,  upper  limb  dexterity) 
amount  Minutes  per  day  (average) 
Outcomes  Upper  limb  impairment  Motricity  index,  ARAT,  peg  test 
Lower  limb  impairment  Motricity  index 
Mobility  Functional  ambulation  category,  Rivermead 
Gait  Gait  analysis 
Activities  of  daily  living  Barthel  index 
Quality  of  life  E  oquol 
Resources  Inpatient  stay,  number  of  contacts,  treatment  time 
Our  simple  draft  version  of  this  database  was,  however,  different  in  most  cases  to  the 
fonnat  in  which  the  trialists'  data  were  stored.  The  heterogeneous  data  therefore  needed 
to  be  categorized  to  produce  a  meaningful  and  manageable  database. 
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Categorizing  data  sets 
We  used  standard  methods  (Stewart  &  Clarke  1995,  Mulrow  &  Oxman  1997)  to  define 
subgroups  that  would  be  clinically  relevant  and  identify  common  outcome  measures. 
We  requested  assistance  from  the  collaborators  to  help  with  the  interpretation  of  their 
data. 
The  data  set  needed  to  be  simplified  in  order  to  find  common  denominators.  These 
needed  to  reflect  physiotherapists'  interventions  with  patients  with  stroke  in  order  to 
help  clinicians  and  service  managers  alike,  understand  the  implications  of  increasing  the 
intensity  of  therapy.  Inevitably  we  had  to  find  a  compromise  between  the  high  quality 
detail  of  the  specific  studies  and  the  general  inforination  available  to  all  the  studies 
when  they  are  combined. 
For  each  eligible  trial  the  principal  investigator  was  asked  to  provide  the  following  basic 
information  for  all  patients  randomised  (see  Table  5.3). 
Table  5.3  Core  data  requested  for  all  trials  in  PINTAS  meta-analysis 
Patient  data 
Date  of  birth  or  age  at  randomisation 
Sex 
Baseline  levels  of  disability  and  impairment 
Intervention  data 
Date  of  randomisation 
Treatment  allocation 
Quantity  (intensity)  of  intervention  -  intended 
-  received  (dates,  durations,  intensities) 
Outcome(s)  data 
Survival  status 
Date  of  death  (if  dead) 
Date  of  last  follow  up  (if  alive) 
Performance  status  (outcomes) 
-  at  end  of  intervention 
-  at  medium  term  (e.  g.  3  months) 
-  at  long  term  follow  up  (e.  g.  6  months,  one  year) 
Exclusionsfrom  trial  analysis 
Reason  for  exclusion  (if  applicable) 
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Data  checking  procedures 
The  data  centre  for  the  project  was  the  Robertson  Centre  for  Biostatistics  at  the 
University  of  Glasgow.  The  collaborators'  data  were  loaded  into  a  new,  unified  analysis 
database.  All  published  results  for  all  trials  on  all  relevant  data  were  reproduced  in  so 
far  as  possible,  and  any  anomalies  or  inconsistencies  queried  to  the  individual  study 
investigators. 
Further  infonnation  is  presented  in  the  Statistical  Appendix  (Appendix  VIII). 
3.  Analysis 
Statistical  Methods 
All  statistical  analyses  were  approved  by  the  Study  Steering  Committee  and  performed 
using  SAS  8.2  for  Windows  on  the  central  study  analysis  database  and  Review  Manager 
(RevMan  4.2)  (Review  Manager  2004)  for  additional  analyses. 
Statistical  analysis  began  with  a  general  description  and  summary  of  key  data.  As 
indicated  these  were  then  checked  against  published  data  to  ensure  comparability  and 
any  queries  directed  back  to  the  primary  trialists.  The  primary  analyses  (the  effect  of 
intensive  physiotherapy  on  disability  and  impairment  scores)  used  all  available  data. 
The  secondary  analyses  were  restricted  to  individual  patient  data  for  which  the  relevant 
outcome  information  were  available  i.  e.  included  only  subjects  with  complete  data  on 
the  selected  groups  of  covariates.  These  analyses  were  adjusted  for  explanatory 
covariates.  With  the  exception  of  length  of  hospital  stay  data,  we  did  not  use  any 
missing  data  techniques  to  explore  the  robustness  of  the  findings  to  missing  data  or  to 
impute  data  for  those  subjects  missing  observations. 
After  discussion  with  the  Collaborative  group  we  decided  on  the  following  analyses 
(Table  5.4): 
Primary  outcome  analyses:  The  primary  outcomes  were  overall  disability  (recorded  at 
3  months),  measured  using  the  Barthel  index  (Mahoney  &  Barthel  1965,  Wade  19921) 
where  this  was  available  or  a  comparable  disability  measure,  and  overall  impain-nent 
(recorded  at  3  months)  measured  using  the  Motricity  index  (Demeurisse  et  al.  1980) 
where  this  was  available  or  a  comparable  impainnent  measure. 
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Secondary  outcome  analyses:  Secondary  outcomes  were:  death  from  all  causes; 
improvement  in  arm  impairment;  improvement  in  leg  impainnent  (both  measured  by 
change  in  the  relevant  sections  of  the  Motricity  index;  improvement  in  upper  limb 
function  measured  by  change  in  the  Action  Research  Ann  Test  (ARAT)  (Lyle  1981); 
lower  limb  function  by  walking  speed  (Wade  1992);  improvement  in  disability  \N'as 
measured  by  change  in  Barthel  index  score.  We  also  examined  length  of  hospital  stay 
and  treatment  success. 
We  first  explored  the  influence  of  each  covariate  in  a  univariate  logistic  regression 
model.  Next  we  examined  the  influence  of  covariates  on  modifying  the  treatment  effect 
by  fitting  each  covariate  in  the  presence  of  treatment.  Finally  we  examined  the  joint 
influence  of  any  covariates  on  the  treatment  effect  found  to  be  significant  at  P<0.05. 
The  battery  of  covariates  felt  to  be  influential  and  of  interest  was  identified  prior  to 
beginning  the  modelling  process  and  was  written  down  in  an  agreed  statistical  analysis 
plan. 
If  data  were  approximately  normally  distributed,  parametric  Wests  were  used  to 
compare  the  two  treatment  groups  with  normal  linear  models  used  to  adjust  the 
treatment  differences  for  covariates.  If  data  were  non-normally  distributed,  then  non- 
parametric  rank  tests  (such  as  Wilcoxon  rank  sum  test)  were  used. 
We  modelled  mean  change  over  baseline  score  using  a  Normal  linear  model.  After 
fitting  a  model  just  with  treatment  (in  the  presence  of  study),  we  then  looked  at  a  study 
by  treatment  interaction.  Then,  age  and  gender  were  added,  and  all  the  interactions 
between  treatment,  age,  gender  and  study  were  explored. 
Treatment  success:  The  final  analysis  defined  a  treatment  success  as  a  subject  who  has 
a  change  over  baseline  Barthel  index  greater  than  or  equal  to  the  stated  threshold  change 
over  baseline  (or  a  subject  who  has  achieved  the  maximum  score  on  the  measure).  We 
defined  "good  recovery"  as  an  improvement  in  activities  of  daily  living  (ADL)  score 
greater  than  the  median  recovery  in  the  control  group  (increase  from  baseline  of  6  or 
more  Barthel  units).  Similarly,  "excellent  recovery"  was  defined  as  an  improvement  in 
ADL  score  greater  than  the  upper  quartile  of  the  control  group  (increase  from  baseline 
of  9  or  more  Barthel  units). 
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Treatment  success  was  then  modelled  as  a  binary  outcome  in  a  logistic  regression  using 
study,  age,  gender,  and  treatment  group  as  covariates.  These  logistic  regressions  xvere 
fitted  separately  for  the  3  months  data  (patterns  were  similar  at  I  and  6  months). 
Subgroup  Analyses:  Several  pre-defined  subgroups  were  identified  (Table  5.4)  and 
analysis  carried  out  as  outlined  above.  The  one  exception  was  the  subgroup  analysis, 
analysed  at  the  level  of  the  trial  (total  treatment  contrast).  This  was  analysed  using 
RevMan  4.2  software  to  calculate  subgroup  effects  and  between-subgroup 
heterogeneity. 
We  were  aware  of  the  potential  of  finding  spuriously  significant  relationships  due  to 
carrying  out  multiple  subgroup  analyses  (Counsell  et  al.  1994,  Mulrow  &  Oxman  1997). 
We  therefore  kept  the  number  of  subgroups  small  and  clearly  recorded  them  in  the 
analysis  plan.  Any  other  analyses  would  be  considered  exploratory,  and  any  significant 
results  treated  with  caution. 
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Table  5.4  PINTAS  meta-analysis  -  Outline  of  analysis  plan. 
Outcome  Measure  Timine  Sub2roups 
Primary  analyses  _ 
Disability  Activities  of  daily  3  months  Target  of  therapy 
living  score  (Barthel 
index  or  comparable 
score) 
Impain-nent  Impairment  score  3  months  Target  of  therapy 
(Morticity  index  or 
comparable  score) 
_Secondary 
analyses 
_Death 
All  cause  death  End  of  follow  up  Target  of  therapy 
Improvement  in  Change  in  an-n  From  Target  of  therapy,  age, 
arm  impairment  Motricity  index  randomisation  to  initial  stroke  severity, 
point  of  follow  up  initial  arm 
impairment,  total 
treatment  contrast 
Improvement  in  leg  Changeinleg  From  As  above 
impain-nent  Motricity  index  randomisation  to 
point  of  follow  up 
Improvement  in  Change  in  Action  From  As  above 
arm  function  Research  Arm  Test  randomisation  to 
point  of  follow  up 
Improvement  in  leg  Walking  speed  From  As  above 
function  (gait)  randomisation  to 
point  of  follow  up 
Improvement  in  Change  in  Barthel  From  As  above 
disability  index  randomisation  to 
point  of  follow  up 
Good  recovery  Change  in  Barthel  From  None 
index  greater  than  the  randomisation  to 
trial  median  point  of  follow  up 
Excellent  recovery  Change  in  Barthel  From  None 
index  greater  than  randomisation  to 
trial  upper  quartile  point  of  follow  up 
Length  of  stay  Length  of  stay  Duration  after  Target  of  therapy 
randomisation 
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Definitions  of  the  subgroups  are  given  in  Table  5.5. 
Table  5.5  Subgroup  definitions  used  in  PINTAS  meta-analysis 
Domain  Subgroup  Definition  -StFat-us 
Patient  characteristics 
Patient  age  Younger  Age  <70  years  Pre- 
Older  Age  >70  years  specified 
Stroke  severity  Moderate  Baseline  Barthel  >10  Pre- 
Severe  Baseline  Barthel  <10  specified 
Ann  impainnent  Moderate  MI  arm  score  >  15  or 
ARAT  score  >0 
Pre- 
specified 
Severe  Severe  =  MI  arm  <  15  or 
ARAT  =0 
Co-morbidity  Minor  Proved  difficult  to  define  Dropped 
Major  ftom 
analysis 
Treatment  characteris  tics 
Physiotherapy  target  Upper  limb  Upper  limb  Pre- 
Mixed  Lower  limb  +  upper  limb  specified 
Total  treatment 
contrast 
Lower  Lower  contrast  trials: 
10  (7-12)  hours 
Pre-planned 
but  not  pre- 
Higher  Higher  contrast  trials: 
32  (15-44)  hours 
specified 
MI  =  Motricity  index,  ARAT  =  Action  Research  Arm  Test 
Treatment  contrast:  The  treatment  contrast  subgroup  was  defined  according  to 
whether  the  mean  difference  in  physiotherapy  contact  time  between  intervention  and 
control  patients  was  above  or  below  the  median  for  all  included  trials.  Lower  treatment 
contrast  trials  had  a  physiotherapy  treatment  contrast  ranging  from  7-12  hours  per  trial; 
higher  contrast  trials  ranged  from  15-44  hours  per  trial.  These  two  subgroups  of  trial 
tended  to  cluster  by  other  characteristics.  The  lower  treatment  contrast  subgroup  also 
tended  to  contain  the  trials  with  a  later  treatment  onset  (12-47  days  post-stroke),  lower 
daily  treatment  contrasts  (30-45  minutes  per  patient,  and  shorter  treatment  duration  (5-6 
weeks).  The  higher  contrast  subgroup  tended  to  cluster  as  earlier  onset  trials  (7-10  days 
post-stroke),  with  higher  daily  treatment  contrasts  (53  -  70  minutes)  and  longer 
treatment  duration  (10  -  20  weeks). 
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"Clinically"  significant  improvement 
In  order  to  aid  interpretation  of  the  results,  before  undertaking  the  analyses,  NN,  e  sent  out 
a  questionnaire  to  the  Collaborators.  We  asked  for  their  opinions  on  what  might  be 
regarded  as  a  "clinically"  significant  change  in  Barthel  index  score  for  patients  Ný'Ith 
stroke  (see  Appendix  VIII).  The  Collaborative  group's  responses  varied  widely  and 
were  difficult  to  interpret.  We  therefore  did  not  pursue  this  category. 
Testing  for  heterogeneity:  As  before,  we  tested  the  data  set  for  heterogeneity,  testing 
the  level  of  inconsistency  in  the  results  from  the  studies  to  detennine  whether  it  ývas 
reasonable  to  combine  the  trials.  The  12  statistics  were  calculated  for  overall  disability, 
overall  impairment,  survival  and  length  of  hospital  stay  outcomes. 
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Results 
Trial  selection 
Essentially  we  had  the  same  set  of  trials  as  in  Chapter  4  but  with  much  more  detailed 
data. 
Study  characteristics 
Table  5.6  shows  the  key  characteristics  of  the  included  studies  which  are  described 
further  in  Table  5.7.  These  included  9  randomised  trials  with  951  participants  (Figure 
5.1).  The  average  participant  age  was  69  years  and  there  was  a  relatively  equal  split  of 
males  and  females  (ranging  from  43%  to  62%  men).  Three  studies  contained  more  than 
one  treatment  group,  which  resulted  in  slightly  more  subjects  receiving  augmented 
physiotherapy  than  standard  physiotherapy.  The  upper  limb  was  targeted  for  62%  of 
participants  with  a  lower  limb  target  in  6%  and  a  mixed  target  for  33%. 
All  the  studies  demonstrated  a  recovery  curve  in  relation  to  mean  levels  of  disability 
(measured  by  Barthel  index).  The  change  in  mean  Barthel  index  score  over  time  is 
shown  in  Figure  5.2. 
The  treatment  approach  in  the  trials  was  broadly  similar,  with  physiotherapists  aiming 
to  restore  normal  movement  and  function  through  regular  exercise,  with  or  without 
physical  assistance  or  adaptive  equipment. 
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Figure  5.1  Number  of  patients  in  trials  in  PINTAS  meta-analysis 
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Figure  5.2  Change  in  mean  Barthel  index  score  over  time  in  trials  in  PINTAS 
meta-analysis 
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Primary  Analyses 
Disability:  The  primary  analyses  included  all  identifiable  data  addressing  disability 
within  the  first  3  months  after  stroke  (median  3  months,  range  6  weeks  -3  months). 
Seven  of  the  nine  trials  used  an  ADL  score  providing  the  largest  group  of  pooled  data 
(805  patients  at  3  months). 
Overall  there  was  no  significant  difference  in  ADL  score  at  3  months  (Standard1sed 
Mean  Difference  (SMD)  0.15;  95%  Confidence  Interval  (CI)  -0.02  to  0.31;  P=0.09)  or 
at  end  of  follow  up  (SMD  0.10;  95%  CI-0.05,0.24;  P=0.19).  These  conclusions  v"ere 
confirmed  if  the  analysis  was  restricted  to  the  Barthel  index  only  or  used  the  change  in 
Barthel  index  between  baseline  and  follow  up. 
RevMan  analyses  (Review  Manager  2004),  carried  out  at  the  level  of  the  trial  and 
stratified  by  the  target  of  the  physiotherapy  are  shown  in  Figures  5.3  and  5.4. 
Impairment  :  Four  of  the  nine  trials  used  the  Arm  Motricity  Index  (maximum  393 
subjects  at  3  months,  373  subjects  at  end  of  follow  up),  and  two  of  these  in  addition 
measured  Leg  Motricity  Index  (maximum  153  subjects  at  3  months,  151  subjects  at  end 
of  follow  up).  Four  studies  used  the  Action  Research  Arm  Test  (ARAT).  (maximum  of 
447  patients  available  at  3  months,  437  at  end  of  follow  up).  Five  studies  used  gait 
speed  (maximum  398  subjects  at  3  months,  354  subjects  at  end  of  follow  up). 
Forest  plots  show  summary  data  from  each  group  at  3  months  and end  of  follow  up. 
This  shows  a  statistically  significant  difference  (6.6;  95%  Cl  0.71  to  12.5;  P  =  0.03)  in 
the  upper  limb  subgroup  as  measured  by  Motricity  index  (arm  section)(see  Figure  5.5) 
and  in  the  lower  limb  subgroup  (11.7;  95%C1  3.79  to  19.54;  P  =  0.004)  as  measured  by 
the  Motricity  index  (leg  section)  at  3  month  follow  up  (see  Figure  5.6),  with  benefit 
with  additional  physiotherapy  intervention. 
At  the  end  of  follow  up  analysis  for  Motricity  index  (Arm)  and  Motricity  index  (Leg), 
though  still  in  favour  of  the  intervention,  the  effect  size  has  decreased  (Ml  Ann  3.03; 
95%Cl  -3.31  to  9.36;  P=0.3.  MI  Leg 5.86;  95%  Cl  -1.96  to  13.67;  P=0.14),  and  the 
pooled  result  crosses  the  line  of  no  effect  (see  Figures  5.7  and  Figure  5.8  respectively). 
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The  ARAT  analysis,  though  with  greater  numbers  of  subjects  does  not  denionstrate 
statistically  significant  differences  between  the  groups  at  either  time  point  (Figures  5.9 
and  5.10)  ARAT  3  months  3.4  1;  95%  CI  -0.8  5  to  7.6  7;  P=0.12.  ARAT  end  of  stud 
1.66;  95%  Cl  -2.73  to  6.04;  P=0.5. 
Similarly,  the  gait  speed  analysis  does  not  demonstrate  statistically  significant 
differences  between  the  groups  at  either  time  point  (Figures  5.11  and  5.12)  Gait  speed  3 
months  0.02;  95%  Cl  -0.04  to  0.07;  P=0.6.  Gait  speed  end  of  study  0.02;  95%  Cl 
-0.04  to  0.08;  P=0.5. 
We  can  consider  impairment  "overall"  i.  e.  when  measured  using  data  from  all  available 
outcome  measures  including  the  upper  and  lower  limb.  RevMan  analysis,  carried  out  at 
the  level  of  the  trial  for  overall  impairment  at  3  months  and  stratified  by  the  target  of  the 
physiotherapy  is  shown  in  Figure  5.13.  Overall  impairment  (SMD  0.07;  95%  Cl  -0.11 
to  0.25;  P  =  0.48). 
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Secondary  analyses 
We  carried  out  analyses  for  measures  of  death,  change  in  impairment  and  disability 
scores  (across  the  Period  of  the  study),  treatment  success  and  heterogeneity. 
Death 
Case  fatality:  There  were  32  deaths  in  418  subjects  who  received  standard 
physiotherapy  (crude  death  proportion  7.7%)  compared  with  44  deaths  in  533  subjects 
who  were  randomised  to  augmented  physiotherapy  (8.3%)  giving  an  odds  ratio  for 
death  of  0.92  (95%  CI  0.55  to  1.52;  P=0.81).  (See  Table  5.8). 
Table  5.8  PINTAS  IPD  meta-analysis  -  Case  Fatality 
Study  n  Standard  n  Augmented 
GAPS  0/35  2/35 
Kwakkel  1/37  0/64 
Lincoln  12/95  29/187 
Miller  0/9  0/12 
Partridge  4/60  2/54 
Richards  0/13  0/9 
Rodgers  7/61  6/62 
Slade  0/40  0/43 
Sunderland  8/68  5/67 
TOTAL  32/418  44/533 
Note  that  we  have  not  conducted  a  time-to-event  analysis  (it  proved  too  difficult  to 
establish  with  certainty  at  what  point  every  subject  in  every  study  died  in  ternis  of  days 
post  randomisation),  and  note  further  that  41  of  the  76  deaths  (over  50%)  occurred  in 
one  study,  and  that  there  were  no  deaths  reported  in  three  of  the  (smaller,  shorter 
duration)  studies. 
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Secondary  analyses  -  Change  in  impairment 
Improvement  in  arm  impairment  (Motricity  Index  Arm):  Table  5.9  summarises  the 
main  arin  impairment  data.  The  main  effects  model  estimated  the  difference  in  an-n 
Motricity  index  due  to  augmented  physiotherapy  as  5.2  (95%  confidence  interval  1.5  to 
8.8,  P=0.0058)  with  an  identical  estimate  returned  after  adjusting  for  age  and  gender. 
There  was  no  evidence  of  a  significant  change  in  the  treatment  effect  of  augmented  over 
standard  physiotherapy  over  time  (P=0.27). 
Subgroup  analysis:  Subgroup  analyses  (Table  5.10)  indicated  that  improvement  in  an-n 
Motricity  Index  score  was  significantly  greater  (P=0.02)  in  higher  treatment  contrast 
trials  9.6  (95%  Cl  3.7  to  15.5;  P=0.001)  than  in  lower  contrast  trials  -0.2  (95%  Cl  -5.4 
to  5.0;  P=0.90). 
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Table  5.10  PINTAS  IPD  meta-analysis  - 
Change  in  arm  impairment  (Motricity  Index  arm)  -  subgroup  analysis 
Subgroup  Level  Augmented-  Standard 
(95%  Cl) 
P-value  Subgroup 
interaction 
Total  All  groups  5.2  (1.5,8.8)  0.006 
Treatment  target  Arm  Only  3.4  (-1.7,8.6)  0.67  P=0.54 
Leg  or  Mixed  4.7  (-0.7,10.1)  0.090 
Age  <70  6.6  (1.6,11.6)  0.0097  P=0.44 
>70  4.8  (-0.5,10.0)  0.075 
Baseline  Barthel  >10  -0.4  (-5.3,4.6)  0.89  P=0.21 
dependency 
Barthel:!  ý10  6.8  (2.2,11.4)  0.004 
Baseline  arm  Moderate  3.2  (41,6.5)  0.056  P=0.40 
impairment  Severe  6.9  (-0.3,14.0)  0.061 
Total  treatment  Lower  -0.2  (-5.4,5.0)  0.90  P=0.02 
contrast  Higher  9.6  (3.7,15.5)  0.001 
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Improvement  in  leg  impairment  (Motricity  Index  Leg):  The  overall  advantage  of 
augmented  compared  with  standard  physiotherapy  was  estimated  as  6.8  units  of  lc, 
-, 
Motricity  Index  (95%  CI  2.2-  11.4,  P=0.0042)  from  a  repeated  measures  model  that 
adjusted  for  age,  sex,  and  baseline  leg  Motricity  Index  score  (Table  5.11).  There  was  no 
statistically  significant  evidence  of  an  interaction  between  treatment  and  time 
(P=0.087). 
Subgroup  analysis:  For  the  pre-specified  subgroups  of  age  and  disability  severity  fliere 
was  no  evidence  of  any  treatment  by  time  interactions,  nor  of  any  formally  significant 
differences  in  treatment  effect  between  the  levels  of  the  subgroups.  The  higher 
treatment  contrast  trials  tended  to  observe  greater  improvements  (higher  contrast  12.1; 
4.8-19.4;  P=0.004  compared  with  lower  treatment  contrast  3.3;  -3.4-10.0;  P=0.33)  but 
subgroup  interaction  was  not  quite  statistically  significant  (P=0.08)  (Table  5.12). 
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Table  5.12  PINTAS  IPD  meta-analysis  - 
Change  in  leg  impairment  (Motricity  Index)  from  baseline  -  subgroup  analysis 
Subgroup  Level  Augmented- 
Standard  (95%  CI) 
P-value  Subgroup 
interaction 
Total  All  groups  6.8  (2.2,11.4)  0.004 
Treatment  target  Ann  Only  Insiifficient  data  ----  --- 
Leg  or  Mixed 
Age  <70  7.2  (1.2  to  13.1)  0.018  P>O.  1 
>70  6.7  (-I.  l  to  14.5)  0.091 
Baseline  Barthel  >10  -0.7  (-9.2  to  7.7)  0.86  P>O.  I 
dependency 
Barthel:!  ý10  7.3  (1.8  to  12.8)  0.010 
Baseline  arm  Moderate  13.5  (1.7,25.3)  0.024  P=0.87 
impairment  Severe  7.2  (-1.4,15.6)  0.097 
Total  treatment  Lower  3.3  (-3.4,10.0)  0.33  P=0.08 
contrast  Higher  12.1  (4.8,19.4)  0.004 
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Change  in  arm  function  (Action  Research  Arm  Test  (ARAT)  scores):  Four  studies 
reported  ARAT  scores  (Table  5.13)(Full  summary  in  Appendix  VIII).  The  estimated 
effect  of  augmented  physiotherapy  compared  with  standard  physiotherapy  in  change 
over  baseline  ARAT  score  was  1.8  (95%  confidence  interval  -1.2  to  4.8,  P=-0.25)  There 
was  no  evidence  that  the  effect  of  augmented  physiotherapy  in  companson  with 
standard  physiotherapy  changed  over  time  (P=0.87).  On  subgoup  analysis  (Table  5.14) 
significant  interactions  were  seen  with  age  and  baseline  severity.  Improvements  in 
ARAT  scores  were  significantly  (P=0.02  for  subgroup  interaction)  greater  in  younger 
patients  (8.9;  95%  CI  3.3-14.5;  P=0.002)  compared  with  older  patients  (1.5;  95%CI 
-2.7-  5.7;  P=0.49).  Improvements  were  also  greater  (P=0.04)  in  patients  with  a  baseline 
Barthel  index  >10  (5.5;  95%  CI  -1.5  -  12.4;  P=0.12)  compared  with  those  with  baseline 
Barthel  index  of  <1  1  (0.6;  95%  CI  -2.8  -  3.9;  P=0.74). 
Table  5.13  PINTAS  IPD  meta-analysis  -  Mean  (SD)  ARAT  scores 
For  4  Time  Standard  Augmented  Total 
Studies  N  Mean(SD)  N  Mean(SD)  N  Mean(SD) 
0  193  9.6(17.2)  313  8.2(15.4)  506  8.7(16.1) 
1  159  16.9(20.7)  259  18.0(21.0)  418  17.6(20.9) 
3  119  26.2(25.4)  139  29.5(23.7)  258  28.0(24.5) 
6  179  26.1(24.7)  263  26.2(23.8)  442  26.2(24.1) 
12  34  12.2(20.7)  57  20.6(23.3)  91  17.5(22.6) 
(SD  =  standard  deviation) 
Table  5.14  PINTAS  IPD  meta-analysis  -  Change  in  arm  function  (ARAT  score): 
subgroup  analysis 
Subgroup  Level  Augmented-  Standard 
(95%  Cl) 
P-value  Subgroup 
interaction 
Total  All  groups  1.78  (-1.25,4.81)  0.25 
Treatment  target  Ann  Only  0.93  (-2.58,4.45)  0.52  P=0.30 
Leg  or  Mixed  1.85  (4.51,8.21)  0.58 
Age  <70  8.91  (3.32,14.5)  0.002  P=0.02 
>70  1.49  (-2.71,5.70)  0.49 
Baseline  Barthel  >I  0  5.45  (-1.52,12.4)  0.12  P=0.04 
dependency  Barthel:!  ý10  0.57  (-2.81,3.94)  0.74 
Baseline  arm  Moderate  -1.23  (-6.26,3.81)  0.63  P=0.22 
impairment  Severe  3.44  (0.29,6.59)  0.032 
Total  treatment  Lower  0.5  (-5.0,6.1)  0.90  P=0.26 
contrast  Higher  7.6  (0.9,14.2)  0.03 
(Cl  =  confidence  interval) 
161 Chapter  5 
Lower  limb  function  (walking  speed): 
Five  of  the  nine  trials  had  used  walking  speed.  Available  data  were  converted  to  metres 
per  second  for  a  10in  walk.  Some  trials  used  ten  metre,  six  metre  or  five  metre  walking 
times.  We  excluded  any  measurements  that  were  not  a  simple  walk  in  a  straight  line  - 
for  example,  a  3m  "there  and  back"  walk  which  involved  a  turn  (See  Table  5.15)(Full 
summary  in  Appendix  VIII). 
There  was  no  evidence  that  any  difference  in  walking  speeds  attributable  to  the  intensity 
of  physiotherapy  changed  over  time  (P=0.51).  The  estimated  magnitude  of  augmented 
compared  with  standard  physiotherapy  in  walking  speed  was  an  increase  of  0.056  m/s 
(95%  confidence  interval  -0.018  to  0.130,  P=0.14)  in  a  repeated  measures  model  that 
adjusted  for  age  and  gender.  The  estimated  effect  of  augmented  compared  with  standard 
physiotherapy  on  walking  speed  excluding  subjects  who  never  walked  during  the  study 
was  0.07  ms-  1  (95%  confidence  interval  -0.02  to  0.16,  P=O.  12). 
Table  5.15  PINTAS  IPD  meta-analysis  -  Mean  walking  speed 
Study  Time  Standard  Augmented  Difference  (Aug.  -  Std) 
(month)  n  Mean(SD)  n  Mean(SD)  Mean(95%  Cl)  P-value 
TOTAL  0  97  0.02(0.14)  118  0.02(0.11)  -  - 
1  188  0.27(0.38)  215  0.33(0.44)  0.05  (-0.03,0.13)  0.23 
3  133  0.42(0.43)  157  0.50(0.56)  0.07  (-0.04,0.17)  0.23 
6  124  0.48(0.47)  143  0.59(0.54)  0.09  (-0.03,0.21)  0.13 
12  72  0.56(0.51)  89  0.69(0.62)  0.09  (-0.09,0.26)  0.32 
SD  =  Standard  deviation,  CI  =  Confidence  interval 
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Subgroup  analysis:  For  the  pre-specified  subgroups  of  age,  disability  severity,  target  of 
treatment,  and  baseline  severity  of  arm  impairment  there  was  no  evidence  of  anY 
treatment  by  time  interactions,  nor  of  any  formally  significant  differences  in  treatment 
effect  between  the  levels  of  the  subgroups  (see  Table  5.16).  The  most  marked  degree  of 
subgroup  interaction  (P=0.21)  was  with  the  target  of  therapy  where  the  improvement  in 
walking  speed  for  leg/mixed  target  trials  was  0.09  m/sec  (0-00  to  0.18;  P=0.047) 
compared  with  -0.02  (416  to  0.13;  P=O.  8  3)  for  upper  limb  trials. 
Table  5.16  PINTAS  IPD  meta-analysis  -  Change  in  lower  limb  function  (walking 
speed) 
Subgroup  Level  Augmented-  Standard 
(95%  CI) 
P-value  Subgroup 
interaction 
Total  All  groups  0.07  (402,0.16)  0.12 
Treatment  target  Ann  Only  -0.02  (-0.16  to  0.13)  0.83  P=0.21 
Leg  or  Mixed  0.09  (0.00  to  0.18)  0.047 
Age  <70  0.07  (405  to  0.19)  0.25  P=0.75 
>70  0.05  (-0.04  to  0.13)  0.28 
Baseline  Barthel  >10  0.0  1  (-0.14  to  0.16)  0.93  P=0.62 
dependency  Barthel:!  ý10  0.09  (-0.03  to  0.20)  0.14 
Baseline  arm  Moderate  0.06  (-0.07  to  0.19)  0.37  P=0.80 
impairment  Severe  0.11  (402  to  0.25)  0.10 
Total  treatment  Lower  0.01  -0.06ý  0.08  0.80  P>0.50 
contrast  Higher  0.06  (-0.07,0.18)  0.41 
Cl  =  Confidence  interval 
It  should  be  noted  that  in  the  comparison  of  leg  function  subgroups  for  target  (mixed  / 
lower  v  ann)  the  only  trial  with  upper  limb  focus  that  provided  data  for  comparison  was 
Sunderland  (unpublished  data).  Most  data  were  available  for  early  outcomes,  i.  e. 
month  and  3  months  outcome  data,  for  comparison. 
Further  information  on  walking  speed  is  provided  in  the  Statistical  Appendix  (Appendix 
Vill). 
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Secondary  analysis  -  Change  in  disability 
Change  in  disability  measured  by  Barthel  index:  Table  5.17  shows  the  mean  change  I 
in  Barthel  index  score  by  treatment  group  and  compares  the  differences  in  the  groups 
(Full  summary  in  Appendix  VIII).  The  estimated  constant  across  time  effect  of 
augmented  in  comparison  to  standard  physiotherapy  was  0.15  units  of  change  in  Barthel 
index  score  (95%  confidence  interval  of  -0.38  to  0.67,  P=0.58). 
Table  5.17  PINTAS  IPD  meta-analysis  -  Change  over  baseline  in  Barthel  index 
score:  By  randomised  treatment  group,  and  difference  in  change  over  baseline 
between  randomised  treatment  groups. 
For  8  Time  Standa  rd  Augmented  Augmented  -  Standard* 
studies*  (month)  n  Mean(SD)  n  Mean(SD)  Difference  P-value 
1  270  4.1(3.9)  381  4.6(4.0)  0.2(-0.4,0.8)  0.55 
3  305  5.6(4.4)  411  6.1(4.6)  0.3(-0.3,0.9)  0.40 
6  266  6.6(4.7)  355  7.2(4.8)  0.3(-0.4,1.0)  0.47 
12 
tTý 
7.9(4.1)  89  9.6(4.6)_  1.0(-0.3,2.2)  0.12 
SD  =  Standard  deviation 
*  From  a  separate  linear  model  for  each  time  point  that  adjusts  for  study.  Otherwise,  for  each  individual 
study,  from  a  separate  linear  model  for  each  time  point. 
Subgroup  analyses:  These  are  shown  in  Table  5.18.  Significant  subgroup  interactions 
were  seen  for  treatment  contrast  (P=0.04). 
Table  5.18  PINTAS  IPD  meta-analysis  -  Improvement  in  disability  (Barthel 
index):  subgroup  analysis 
Subgroup  Level  Augmented-Standard 
(95%  CI) 
P-value  Subgroup 
interaction 
Total  All  groups  0.15  (-0.38,0.67)  0.58 
Treatment  Ann  Only  0.10  (460,0.81)  0.77  P>O.  I 
target  Leg  or  Mixed  0.67  (410,1.43)  0.086 
Age  <70  -0.16  (-0.82,0.50)  0.83  P=0.26 
>70  0.62  (-0.22,1.46)  0.15 
Baseline  Barthel  >I  0  -0.11  (484,0.62)  0.77  P>O.  1 
dependency  _  Barthel:!  ý10  0.25  (440,0.91)  0.44 
Baseline  arm  Moderate  0.08  (-0.78,0.93)  0.86  P=0.91 
impairment  Severe  0.18  (-0.61,0.97)  0.66 
Total  treatment  Lower  0.00  (-0.70,0.70)  0.99  P=0.04 
contrast  _  Higher  1.37  (0.30,2.45)  0.01 
CI  =  Confidence  interval 
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Secondary  analysis  -  Length  of  hospital  stay 
We  compared  the  two  randomised  groups  (augmented  and  standard)  for  the  length  of 
hospital  stay  from  five  trials  (522  patients).  Of  these,  data  on  the  length  of  sta-Y  post 
randomisation  were  available  in  391  (75%)  patients.  In  the  131  (25%)  cases  ýý'here  this 
was  not  available,  we  used  the  total  length  of  hospital  stay,  which  would  include  a 
period  from  admission  for  acute  stroke  to  the  beginning  of  physiotherapy  (or 
randomisation,  which  may  be  strictly  speaking  slightly  before  initiation  of  therapy). 
For  the  effect  of  treatment  alone  (in  a  normal  linear  model  with  study  fitted  as  a  fixed 
effect)  we  found  that  augmented  physiotherapy  resulted  in  a  non-significant  increase  of 
1.4  days  (95%  CI  -5.6  to  8.3,  P=0.70).  This  result  did  not  alter  substantially  in 
multivariate  models  that  adjusted  for  study,  gender,  age,  baseline  stroke  seventy  and 
treatment  target.  There  were  no  significant  subgroup  interactions. 
RevMan  analysis,  carried  out  at  the  level  of  the  trial  and  stratified  by  the  target  of 
physiotherapy  is  shown  in  Figure  5.14. 
165 Chapter  5 
r-  OD 
(i)  wM  di  (11  at 
-4  -4  -4  --1  --1  M0w  In 
X 
Cý 
r- 
I 
Cj  43  4.  )  4.  )  CC) 
HI  L-0  CD  Ir 
rý  43  4.  )  4.  ) 
aj  0)  oD  -  4 
Tu 
4)  (1)  Lý 
A  LA  0  aý 
W  4)  W  -4  N  CJ 
1 
43 
00000 
;  Z;  ;ý0C,  ;4  ;4  ;4  -4 
000 
S  C3  999 
Vý  Iý  OD  v0  Cl)  a 
LI)  kD  U)  0 
1ý  v  I  17ý  LD  `J)  oD  o 
cm  e 
r-  ej  C)  C3  ctý  C; 
cli  V.  -4  1) 
Lf) 
C) 
.0  0 
C3  o 
000 
c  ý 
Cý  Cý  99  C3  0  CD  0  CD 
LO  W 
0  C,  11 
e)  OD  (1) 
Cý  C;  Cý  (ý 
-  - 
4-4  63 
CD  CD  0oo  C)  C) 
C!  99999 
0  C  :)00  C, 
9  1ý  999 
C)  a0  CD  (1)  00  CD  000  co  N  LO 
Cl)  LO  w  r.  LO 
Q  " 
64 
-1  ty)  -4  -1  -4  -4  -4  -4  -q  0  CD  LO  CD 
I  1 
m 
k  w  cl)  Dv(  )  V)  D 
W2  *.  I 
cooo0  oo  In  c! 
CIS 
aomwDDo  ca  oo  cD  ovN  to  m 
W 
(I)  C 
E0 
oooooc: 
)C)  (:,  9  Cý  9  C,  a  CD  0000 
S  cl 
6 
-23  (1) 
ME  6o(,  j  co 
CD,  Cý  Cý  C;  C;  6  Cý  ký 
Lý  iz-. C)  a 
It-  u)  CY) 
i 
kD  OD  lw 
ci 
W 
c 
11 
0-4 
PLý  CL 
II 
;,.,  o-S  .4  -I  -1  -4  v  Cq  Ln  Ln  c"'  a  U)  "'*  iý 
_4  -.  1  C'i  cn  -4  -  C)  it  ýS:  Lo  q.  mm  it  *:  %D  11  ctl 
rA 
--1  -4  CD 
It 
Cj  ý3  C) 
If 
c"I  e: 
M 
-  r-_  E, 
LP 
cn 
ocz 
co  C3  cm) 
.  r-  It  It 
1-4 
(D  a) 
4-o  >  (D 
> 
(u 
0  (U  0x 
L  E  0. 
y 
L  tu 
'r  0)  u>  V> 
2f2  t 
-  -  ,  -6  0  3:  Q)  ao  '  m  CL  C)  in  0  5  .2  ý2  U  ý5 
43  c:  C: 
15  --  03  p  -5  CL  o  -r-  = 
-  -- 
"  9:  .00  t;  0  =3  :33:  g  r2 
I 
3:  -  V  T; 
-J  .9 
'4ý 
.U  .9  ca  12 
0  V  V; 
(1)  w 
' 
X  (1)  U)  :3  (1)  Cu  C,  4  ýc  ct  W  cl.  W  :3  (1)  (D 
P-  (f)  4) 
.  I-  Z 
.4 
V  )0  CD  V)  I.  -  I-  I-  C3 
l) 
E 
V 
0 
> 
U- 
0 
t-e 
C) 
:3 
1  166 Chapter  5 
Secondary  outcome  -  Treatment  success: 
The  final  analysis  defined  a  treatment  success  as  a  subject  who  has  a  change  over 
baseline  Barthel  index  greater  than  or  equal  to  the  stated  threshold  change  over  baseline 
(or  a  subject  who  has  achieved  the  maximum  score  on  the  measure).  Treatment  success 
was  then  modelled  as  a  binary  outcome  in  a  logistic  regression  using  study,  age,  gender, 
and  treatment  group  as  covariates.  These  logistic  regressions  were  fitted  separately  for 
the  3  months  data  (patterns  were  similar  at  I  and  6  months). 
We  first  focussed  on  treatment  effects  greater  than  the  median  recovery  in  the  control 
group  (increase  from  baseline  of  6  or  more  Barthel  units).  There  was  an  increased  odds 
of  an  improved  recovery  in  the  augmented  therapy  group  which  did  not  reach  statistical 
significance  (odds  ratio  1.33;  95%  CI  0.96  -  1.85;  P=0.09). 
The  second  analysis  focussed  on  treatment  effects  greater  than  the  upper  inter-quartile 
level  of  the  control  group  (increase  from  baseline  of  9  or  more  Barthel  units).  There  was 
a  statistically  significant  increased  odds  of  an  improved  recovery  in  the  augmented 
therapy  group  (odds  ratio  1.47;  95%  CI  1.03  -  2.05;  P=0.04). 
Heterogeneity  of  studies 
With  the  same  trials  included  in  the  meta-analysis,  we  expect  the  I'results  to  be  the 
same  or  very  similar  to  those  obtained  in  Chapter  4.  Results  are  given  in  Table  5.19. 
The  exception  is  length  of  stay  which  was  impossible  to  analyse  in  the  aggregate  data 
meta-analysis.  This  showed  12  to  be  39.1%. 
Comparing  published  data  to  IPD  meta-analyses 
To  examine  the  differences  in  the  methods  depending  on  whether  data  are  gathered 
from  published  evidence,  aggregate  data  or  from  individual  patient  data  we  carried  out  a 
published  data  meta-analysis  with  just  the  data  that  were  available  in  print  up  to  the  end 
of  as  at  December  2002  (see  Table  5.19). 
Although  this  is  an  academic  exercise  (as  clearly  we  knew  about  our  own  and  Rodgers 
et  al.  's  unpublished  trials)  it  was  designed  to  reflect  "real  life"  meta-analysis.  The 
results  are  bound  to  be  different  as  there  will  be  fewer  data  in  the  published  data 
analysis.  However  a  comparison  should  demonstrate  the  difference  between  the 
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methods  if  not  actually  demonstrate  the  amount  of  effort  involved  in  undertaking  the 
IPD  meta-analysis  (Stewart  &  Pan-nar  1993)(Stewart  &  Teirney  2002). 
In  carrying  out  this  comparison  I  did  not  use  independent  data  extraction  by  two  authors 
but  simply  looked  at  the  effect  of  removing  those  trials  that  were  unpublished. 
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Table  5.19  Comparing  results  from  meta-analyses  based  on  published  data  to  those 
based  on  individual  patient  data  (IPD) 
Outcome  Published  data 
only 
individual 
patient  data 
Overall 
Disability 
No.  of  trials 
(n  patients) 
6 
n  637 
8 
n=  805 
(at  3  months)  SMD  0.17  0.15 
95%  Cl  -0.04  to  0.38  -0.02  to  0.31 
P  0.11  0.09 
Heterogeneity 
12  (%) 
33.4  21.5 
Overall 
Impairment 
No.  of  trials 
(n  patients) 
6 
n=535 
8 
n=  703 
(at  3  months)  SMD  0.03  0.07 
95%  Cl  -0.19  to  0.25  -0.11  to  0.25 
P  0.78  0.48 
Heterogeneity 
12  (%) 
30.9  23.4 
Death  No.  of  trials 
(n  patients) 
7 
n=  823 
9 
n=951 
OR  0.85  0.92 
95%  CI  0.37  to  1.95  0.55  to  1.52 
P  0.69  0.81 
Heterogeneity 
12  (%) 
23.9  0 
Length  of  stay  No.  of  trials 
(n  patients) 
2 
n=  202 
5 
n=  518 
SMD  Not  estimable  -0.14 
95%  CI  -6.55  to  6.27 
P  I 
Heterogeneity 
12  (%) 
39.1 
SMD  =  Standardised  men  difference,  OR  =  odds  ratio,  Cl  =  Confidence  interval 
169 Chapter  5 
Interpretation  of  results 
We  found  no  statistically  significant  differences  in  the  patient  groups  receiving  standard 
or  augmented  intensity  of  physiotherapy,  in  terms  of  our  primary  outcomes:  overall 
disability  or  impairment  or  of  our  secondary  outcomes;  length  of  hospital  stay  and  case 
fatality. 
There  is  a  statistically  significant  difference  between  the  groups  in  impairment  outcome 
(as  measured  by  the  Motricity  Index  Arm  and  Leg  sections)  in  the  short  terni 
months). 
It  is  perhaps  not  surprising  that  the  improvements  seen  in  the  Barthel  index  are  modest, 
as  the  scale  has  recognised  limitations  in  its  measurement  properties.  However,  we  were 
attracted  by  the  ready  availability  of  data  when  testing  for  a  treatment  effect.  Most 
physiotherapy  intervention  trials  have  impainnent  as  their  primary  outcome  but 
standardised  outcome  measures  have  not  been  universally  adopted. 
While  being  wary  of  the  problems  of  multiple  subgroup  comparisons  (Counsell  et  al. 
1994,  Mulrow  &  Oxman  1997)  the  real  benefit  of  IPD  meta-analysis  is  the  ability  to 
carry  out  subgroup  and  exploratory  analyses.  We  have  highlighted  subgroups  of  patients 
with  stroke  that  may  benefit  ftom  increased  intensity  of  treatment: 
a).  Patients  who  might  show  a  major  decrease  in  disability  (measured  by  BI). 
Those  making  large  gains  in  Barthel  index  score  over  the  short  terin  (3  months)  i.  e. 
making  a  rapid  functional  recovery  ("good"  and  "excellent"  recovery)  may  benefit  from 
more  intensive  physiotherapy  treatment.  This  may  be  due  to  additional  physiotherapy 
treatment  enhancing  natural  recovery  in  the  short  term. 
b).  Patients  who  might  show  a  decrease  in  impairment. 
Benefit  in  terms  of  upper  and  lower  limb  impairment  (measured  by  the  Motricity  Index 
Arm  and  Leg  sections)  can  be  seen  in  those  patients  receiving  more  intensive  therapy  in 
the  high  contrast  trials.  There  are  also  benefits  in  terrns  of  impairment  assessed  by 
change  in  ARAT  score  for  younger  (<  70  years)  patients  and  those  with  less  initial 
disability  (a  baseline  Barthel  index  score  >  10). 
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However  the  evidence  from  the  subgroup  analyses  is  not  consistent,  nor  is  there  a 
consistent  effect  with  targeting  of  therapy  although  for  some  outcomes  e.  g.  walking 
speed  there  was  a  non  statistically-  significant  trend  indicating  a  targeting  effect. 
What  was  more  convincing  was  the  pattern  of  higher  treatment  contrast  trials  observing 
greater  effects  of  augmented  physiotherapy. 
There  were  little  demonstrable  differences  in  length  of  hospital  stay  and  therefore 
inpatient  costs  are  unlikely  to  be  significantly  reduced. 
Our  survival  analysis  did  not  show  significant  differences  but  at  least  demonstrated 
additional  physiotherapy  (as  delivered  in  our  selected  trials)  to  be  a  reasonably  safe 
intervention  when  used  to  improve  patients'  mobility. 
In  some  of  the  plots,  outlying  data  from  Kwakkel  et  al.  may  be  explained  by  their  ability 
to  provide  early  intervention  and  maintain  treatment  contrast  by  immobilising  the  limbs 
of  the  patients  in  the  control  group. 
When  considering  our  results  we  need  to  be  able  to  make  judgements  as  to  whether 
benefits  have  clinical  significance  not  just  statistical  significance.  We  investigated  this 
by  exploring  the  use  of  abridged  versions  of  the  Barthel  index. Changes  in  scores  at  the 
level  most  collaborators  might  consider  to  be  "clinically  significant"  did  not  appear  to 
reach  statistically  significance.  This  analysis  is  made  more  complex  by  variable  baseline 
scores  and  a  measure  with  an  acknowledged  "ceiling"  effect  that  may  not  be  sensitive  to 
the  intervention. 
We  can  see  from  Table  5.20  that  there  is  variable  heterogeneity  between  the  studies 
entered  into  the  analyses.  (Higgins  et  al.  2003).  Using  this  as  a  guide  most  of  our 
selected  analyses  would  be  considered  to  have  "mild"  or  "moderate"  heterogeneity. 
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Discussion 
By  carrying  out  this  IPD  meta-analysis,  using  clearly  defined  methods,  we  haN'e  been 
able  to  thoroughly  explore  the  available  data  from  the  trials  of  intensity  of 
physiotherapy.  To  do  so  required  a  considerable  amount  of  data  handling  and 
interpretation  in  order  to  guide  the  analyses.  Despite  our  inclusive  methods  the  available 
data  were  still  limited.  One  major  limitation  is  that  key  variables  may  cluster  at  the  level 
of  the  trial  resulting  in  co-variance  of  results. 
We  are  also  limited  by  not  having  recognized  measures  of  co-morbidity  and  at  present 
we  would  not  look  to  convert  available  data  into  a  recognized  co-morbidity  score.  Age 
could  be  used  as  a  proxy  measure  along  with  any  available  data  on  pre-stroke  disability 
or  handicap  e.  g.  Pre-stroke  Rankin  score  -  though  few  trials  had  these  data  or  excluded 
patients  with  previous  disability. 
By  perforining  published  and  individual  patient  data  meta-analyses  we  were  able  to 
compare  the  results  obtained  by  both  methods.  At  this  point  there  was  little  difference  in 
any  conclusion  one  might  draw  from  the  results  from  the  main  outcome  measures.  The 
accuracy  of  the  estimate  has  improved  with  smaller  P  values  and  narrower  confidence 
intervals  but  this  may  partly  reflect  the  additional  number  of  studies  available  for  the 
fPD  meta-analysis.  However,  the  main  benefit  of  the  rPD  method  in  our  case  is  that  it 
allows  the  exploration  of  the  subgroups.  Without  this  we  would  not  have  the  results  that 
indicate  there  may  be  particular  benefit  to  certain  groups  of  patients  with  stroke.  We 
should  however  remain  cautious  of  generalizing  from  results  based  on  exploratory 
analyses  of  secondary  outcomes  (Counsell  et  al.  1994). 
Trials  in  the  future  in  this  area  should  carefully  select  their  outcome  measures  especially 
those  sensitive  to  impairment.  This  may  help  to  accurately  target  those  groups  we 
identified  as  benefiting  from  increased  treatment,  and  allow  further  pooling  of  data  in 
meta-analysis. 
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Conclusions 
Bearing  in  mind  our  initial  hypotheses,  a  number  of  conclusions  can  be  drawn: 
1)  We  found  no  statistically  significant  impact  of  augmented  physiotherapy  on  our 
primary  outcome  of  disability. 
2)  We  did  not  identify  any  consistent  effect  with  targeting  of  therapy  although  for 
some  outcomes  (e.  g.  walking  speed)  there  was  a  trend  indicating  a  targeWig 
effect. 
3)  There  was  no  consistent  evidence  that  any  subgroup  of  patients  would  gain  a 
greater  or  lesser  benefit  from  augmented  physiotherapy. 
4)  There  were  no  significant  differences  in  length  of  stay  or  case  fatality. 
Additionally, 
5)  For  those  trials  that  recorded  the  Motricity  Index,  there  was  a  statistically 
significant  improvement  in  impain-nent  (both  in  the  Arm  and  Leg  scores). 
6)  There  was  a  consistent  pattern  of  higher  treatment  contrast  trials  observing 
greater  effects  of  augmented  physiotherapy. 
7)  Our  IPD  estimate  improved  on  information  that  was  available  had  we  only  relied 
on  published  data  up  to  the  end  of  2002. 
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Summary 
*  We  set  out  to  carry  out  an  EPD  meta-analys's  and  set  up  a  collaborative  group  of 
primary  authors. 
*  We  searched  the  literature  as  before,  obtaining  data  from  the  authors.  These 
were  entered  into  a  combined  database  and  the  analysis  strategy  and  questions 
were  discussed  and  agreed  at  the  Collaborators  meeting. 
With  availability  of  data  in  mind,  we  selected  overall  disability  as  our  primary 
outcome  and  overall  impairment,  death  and  length  of  stay  as  secondary 
outcomes.  We  had  the  opportunity  to  explore  the  subgroups  of  patients  derived 
from  our  original  questions. 
*  No  statistically  significant  difference  was  seen  between  the  augmented  and 
standard  groups,  in  overall  disability  as  measured  by  ADL  scale,  length  of  stay 
or  case  fatality. 
*  There  was  a  lack  of  consistency  between  the  results  obtained  from  different 
outcome  measures  used  in  the  subgroup  analyses. 
0  Generally,  effects  were  most  notable  in  those  trials  that  started  early  and 
featured  a  high  contrast  between  the  groups.  Effects  were  more  marked  in  the 
short-ten-n  than  the  long-tenn. 
9  There  was  only  mild  heterogeneity  between  the  included  trials  for  most  of  the 
analyses. 
0  Comparing  the  type  of  meta-analysis  highlighted  some  benefits  of  undertaking 
the  lPD  meta-analysis. 
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CHAPTER  6 
CONCLUSION 
Introduction 
In  this  chapter  I  look  back  on  the  components  of  the  thesis  and  return  to  my  original 
hypothesis.  I  have  attempted  to  address  this  using  a  van  nncy  the  iety  of  methods,  explo  *0 
benefits  and  limitations  of  each,  before  progressing  to  the  next  method.  The  results  at 
each  stage  have  helped  to  build  up  infon-nation  on  the  intensity  of  physiotherapy  after 
stroke. 
Aims 
In  this  chapter  I  aim  to: 
1).  Reflect  on  the  available  results  in  relation  to  my  original  research  questions. 
2).  Consider  the  lessons  learned  from  carrying  out  the  work. 
3).  Identify  areas  for  development  in  the  future. 
4).  Make  recommendations. 
1)  The  results 
I  put  forward  the  hypothesis  that  intensive  physiotherapy  after  stroke  will  produce 
benefits  that  would: 
a).  speed  recovery  in  terms  of  impairment  and  disability. 
Neither  the  GAPS  study  randomised  controlled  trial  nor  the  PINTAS  IPD  meta-analysis 
identified  statistically  significant  benefits  in  terins  of  overall  disability  (see  Figure  5.3, 
page  143),  overall  impairment  (see  Figure  5.13,  page  153),  death  (see  Table  5.8,  page 
154)  or  length  of  hospital  stay  (see  Figure  5.14,  page  166)  with  increased  intensity  of 
physiotherapy.  Perhaps  the  disability  and  death  results  are  to  be  expected,  given  that 
physiotherapy  may  not  always  be  directed  at  reducing  disability  or  preventing  death. 
The  Barthel  index  was  widely  used,  but  may  not  be  sensitive  to  physiotherapy 
intervention.  Even  if  the  intervention  was  shown  to  be  effective,  the  scale  of  the 
improvement  looks  likely  to  be,  at  best,  modest.  Although  this  may  be  of  some 
significance  to  individual  patients,  the  "clinically  relevance"  remains  unclear. 
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Impairment  on  the  other  hand,  is  often  the  focus  of  physiotherapy  treatment,  ýýet  takell 
overall,  we  could  not  show  clear  benefit  with  increased  intensity.  This  may  reflect  the 
ability  of  the  available  outcome  measures  to  detect  modest  treatment  effects. 
When  we  studied  subgroups  in  our  meta-analysis,  patients  receiving  more  intensiVc 
treatment  in  the  high  contrast  trials  showed  greater  improvements  in  upper  and  lower 
limb  impairment  when  it  was  measured  by  the  Motricity  index.  Younger  patients  NN"llo 
were  less  disabled  at  baseline  also  demonstrated  greater  improvements  in  upper  limb 
impairment  when  measured  on  the  ARAT.  Increased  intensity  may  also  assist  rapid 
recovery  in  the  subgroup  of  patients  making  large  improvements  in  their  ADL  scores 
(>9  points  on  the  BI).  There  was  however,  a  lack  of  consistent  benefit  across  the 
subgroup  analyses. 
b).  are  greater  when  targeted  (e.  g.  on  upper  limb  recovery). 
Similarly,  there  was  a  lack  of  consistency  in  the  effects  of  targeting  augmented 
physiotherapy.  The  trend  is  positive  (but  not  statistically  significant)  for  some  areas 
such  as  walking,  but  is  not  clear  for  the  others. 
c).  are  greaterfor  patients  with  moderate  impairment  and  little  co-morbidity. 
In  our  subgroup  analyses  there  were  no  statistically  significant  subgroup  interactions  for 
those  patients  considered  to  have  moderate  baseline  arm  impairment  (categorized  by 
Motricity  index  (Ann)  or  ARAT). 
There  is  a  lack  of  accepted  measures  of  co-morbidity  that  are  routinely  collected  and 
obtaining  accurate  data  about  pre-morbid  states  can  be  difficult.  Consequently,  we  were 
unable  to  carry out  analyses  based  on  co-morbidity. 
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d).  are  greater  in  the  shorter  (3  months)  than  longer  term  (6  -  12  months). 
In  our  selected  trials,  long-terrn  follow  up  is  the  exception,  with  Just  two  of  our  studies 
following  patients  to  12  months.  Available  data  for  these  analyses  Nk'ere  therefore 
limited.  Differences  in  impairment  between  groups,  though  still  in  favour  of  the 
augmented  group,  appeared  to  diminish  over  time  and  lost  any  statistical  significance. 
Although  some  acute  intervention  studies  of  stroke  have  followed-up  subjects  for  up  to 
ten  years  after  intervention  (Indredavik  et  al.  1999),  they  require  sizable  treatment 
effects  for  them  to  be  worthwhile.  The  longer-term  effects  (>  12  months)  of  acute 
physiotherapy  interventions  remain  unclear. 
e).  result  in  a  reduced  duration  of  inpatient  rehabilitation. 
Although  the  GAPS  study  showed  a  non-significant  reduction  In  length  of  hospital  stay, 
and  Slade  et  al.  (Slade  et  al.  2002)  found  a  reduction  in  hospital  stay,  overall  there  was 
little  sign  of  benefit.  Consequently,  there  was  no  consistent  evidence  of  economic 
benefits  arising  from  shorter  admissions. 
The  overall  direction  of  benefit  with  increased  intensity  fits  with  the  picture  developing 
from  other  studies:  the  late  intervention  studies  (e.  g.  Duncan  et  al.  2003,  Green  et  al. 
2004);  suggestions  of  benefit  from  repeated  practice  of  functional  tasks  in  the  motor 
relearning  programme  (Langhammer  &  Stanghelle  2000)  and  possible  benefits  with 
constraint-induced  therapy  (forced  use)  (Taub  et  al.  2002).  Benefit  was  also  seen  in  a 
recent  published-data  meta-analysis  of  "exercise  therapy"  i.  e.  physiotherapy  and 
occupational  therapy  (Kwakkel  et  al.  2004).  This  meta-analysis,  with  broad  inclusion 
criteria  (including  most  of  the  trials  in  our  meta-analysis),  demonstrated  benefit  overall 
and  suggested  greater  benefit  in  trials  with  at  least  16  hours  of  contrast  between  groups. 
Whilst  our  results  show  promise  for  selected  subgroups  of  patients  with  stroke,  the 
results  cannot  yet  be  generalized. 
There  may  be  a  critical  threshold  above  which  we  start  to  see  benefit  -  this  is  suggested 
by  the  subgroups  with  greater  contrast  showing  greater  benefit.  This  may  be  relevant  to 
any  "some  versus  none"  trials.  Although  the  contrast  may  be  high,  the  trial  may  not  be 
able  to  demonstrate  benefit  as  the  intervention  group  may  not  reach  a  threshold  of 
treatment  effect. 
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heterogeneity  of  our  studies 
Some  authors  recommend  routinely  carrying  out  sensitivity  analysis  and  creating  a  I  funnel  plot  when  undertaking  meta-analyses  (Egger  &  Davey  Smith  1998).  We  dId  not 
do  this  as  the  number  of  trials  was  small  and  we  found  only  mild  and  moderate 
heterogeneity  when  considering  most  of  our  outcomes. 
2)  Lessons  from  our  randomised  controlled  trial 
To  sustain  a  robust  and  complex  trial  with  sound  methodology  over  three  sites  f-61-  a 
period  of  18  months,  with  limited  resources,  required  considerable  effort  aiid 
enthusiasm  from  the  research  group  and  the  staff  members  involved. 
Despite  having  carried  out  feasibility  studies,  our  recruitment  rate  was  lower  than 
anticipated.  To  try  to  address  this  we  extended  the  period  of  the  trial  as  much  as  funding 
allowed.  Though  we  would  have  liked  to  extend  the  recruitment  further  it  seemed 
unlikely  that  this  would  alter  our  sample  size  significantly.  Although  attempting  to  run 
the  trial  over  a  larger  number  of  centres  with  more  staff  members  might  have  allowed 
more  rapid  recruitment,  this  would  have  been  costly  and  more  complex  to  organize  and 
sustain.  The  lesson  is  that  recruitment  rates  do  not  always  reach  the  levels  expected  or 
required,  despite  best  efforts. 
Recognising  that  our  one  trial  would  be  unlikely  to  influence  clinical  decision-making 
or  to  be  generalized  to  the  majority  of  patients,  we  gathered  a  broad  range  of  data  from 
our  subjects.  Planning  in  this  way  allowed  us  the  opportunity  to  examine  a  large  number 
of  outcomes  in  the  meta-analysis. 
Lessons  from  Meta-analysis 
Size 
Our  meta-analyses  had  limitations  in  terms  of  the  numbers  of  subjects,  number  of  trials 
and  the  size  of  the  subgroups,  along  with  heterogeneous  Outcome  measures  and 
interventions.  Clearly  we  would  have  preferred  to  have  a  larger  number  of  subjects  from 
more  homogeneous  trials. 
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The  needfor  collaboration 
With  the  EPD  meta-analysis  we  were  fortunate  to  secure  the  co-operation  of  all  of  the 
trialists.  This  strengthened  the  data  set  and  allowed  the  group  to  be  involved  in  the 
interpretation,  dissemination  and  publication  of  results  and  planning  of  further  studies. 
Our  collaborative  group's  formal  meeting  helped  to  focus  our  analysis  and  agree  the 
limitations  of  the  data.  Unfortunately,  we  did  not  budget  for  holding  a  second  meeting. 
This  might  have  been  a  useful  forum  in  which  to  discuss  the  interpretation  and 
dissemination  of  the  results,  the  future  of  the  group  and  further  work.  It  may  have  also 
been  useful  in  helping  to  keep  the  project  running  to  timetable. 
Managing  the  data  was  a  challenge,  requiring  considerable  communication  and 
interpretation  of  the  data,  as  IPD  was  a  new  venture  for  most  of  the  collaborative  group 
members.  As  noted  by  Stewart  and  Clarke  (Stewart  &  Clarke  1995),  it  is  important  not 
to  underestimate  the  length  of  time  required  for  EPD  meta-analysis.  Our  project  was 
time-consuming  and  may  have  benefited  from  the  availability  of  full-time  dedicated 
staff  members  for  data  management  in  order  to  maintain  consistency  and  momentum. 
Such  resources  are,  of  course,  expensive. 
Treatment  contrast 
We  want  to  direct  future  research  to  target  specific  groups,  with  as  much  treatment 
contrast  as  possible.  Yet,  there  are  definite  challenges  in  delivering  and  maintaining  a 
strict  treatment  protocol  in  a  clinical  setting.  In  the  trial  by  Rodgers  et  al.  "competitive 
therapy"  bias  was  encountered  (Rodgers  et  al.  2003).  Therapists  involved  in  delivering 
treatment  to  their  control  group  provided  additional  therapy  as  "compensation"  to  those 
patients  allocated  to  receive  standard  amounts  of  treatment.  Unfortunately  this  resulted 
in  a  significantly  reduced  treatment  contrast  ratio.  The  ability  to  maintain  this  contrast 
may  be  the  reason  we  saw  such  an  outstanding  treatment  effect  in  the  trial  of  Kwakkel 
et  al.  that  featured  both  early  intervention  and  the  maintenance  of  a  high  treatment 
contrast  with  the  use  of  splints  to  immobilize  the  control  group  (Kwakkel  et  al.  1999). 
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Importance  ofpre-determined  analysis  plan 
It  was  important  to  have  a  clearly  deten-nined  and  recorded  analysis  plan  at  the  start  of 
each  phase  and  prior  to  the  analysis.  This  reduces  the  risk  of  significant  results  beirig 
discovered  by  chance  and  helps  to  keep  the  focus  of  the  question  during,  often  complex, 
analyses.  While  it  is  tempting  to  perform  further  analyses  in  the  light  of  available 
results,  these  should  be  regarded  as  exploratory  and  treated  with  caution. 
Limitations  of  available  data 
One  advantage  of  IPD  meta-analysis  is  the  potential  to  perform  "time  to  event" 
analyses.  The  difficulty  we  encountered  was  the  lack  of  consistent  outcome  gathering 
across  the  trials  e.  g.  we  could  have  selected  the  Mobility  Milestones,  discharge  from 
hospital,  first  recorded  ability  to  perform  10-metre  walk.  This  made  selecting  outcomes 
difficult  and  the  number  of  missing  data  considerable. 
Similarly,  we  would  have  liked  to  carry  out  a  "dose  response"  analysis,  however  the 
data  were  so  limited  that  this  proved  impossible.  This  highlighted  the  lack  of  standard 
methods  of  describing  and  recording  physiotherapy  interventions  in  trials.  This  sort  of 
level  of  detail,  if  available,  is  not  often  published  and  trialists  need  to  be  contacted  to 
obtain  information. 
Ultimately,  the  quality  of  the  data  will  be  reflected  in  the  analysis,  results  and 
conclusions. 
The  real  benefit  of  IPD  meta-analysis 
Having  carried  out  an  IIPD  meta-analysis,  we  wanted  to  assess  whether  it  was  worth  the 
considerable  additional  resources  (Stewart  &  Parmar  1993).  We  compared  results  from 
the  different  methods  on  our  selected  outcomes.  Whilst  this  showed  some  benefit  in 
terms  of  the  accuracy  of  the  estimates,  the  obvious  point  is  that  without  carrying  out  the 
IPD  meta-analysis,  none  of  the  subgroup  analyses  would  be  possible  with  just  published 
data.  Our  conclusions  are  likely  to  have  been  the  same  or  similar,  but  the  real  benefit 
was  the  ability  to  explore  and  examine  these  subgroups. 
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3)  Identifying  areas  for  development  in  the  future 
Maintaining  the  database 
Although  a  definitive  large-scale  multi-centre  RCT  of  intensity  might  be  possible,  It 
seems  unlikely  to  happen  in  the  near  future.  We  will  therefore  consider  maintaining  the 
database  and  updating  it  on  a  regular  basis.  This  may  be  useful,  but  it  is  important  not  to 
underestimate  the  complexity  of  the  data  management  and  analysis 
Stewart  and  Tierney  describe  EPD  as  having  a  number  of  benefits  but  also  raise  the  issue 
of  "price  tags"  on  data  sets  and  possible  difficulties  of  sharing  data  due  to  data 
protection  legislation  (Stewart  &  Tierney  2002).  These  were  not  a  problem  for  our 
group  but  could  alter  the  direction  and  possibilities  offered  by  this  method. 
Recent  publications 
We  repeated  our  literature  search  up  to  the  start  of  May  2005  but  failed  to  find  trials  that 
fit  our  inclusion  criteria  or  look  to  significantly  alter  our  results.  We  are  not  aware  of 
any  current  large-scale  randomized  trials  of  physiotherapy  intensity  after  stroke. 
Of  the  trials  that  have  been  published,  one  small  study  (n  =  30),  using  additional 
physiotherapy  sessions  delivered  to  inpatients  in  a  circuit  class  fonnat,  showed  variable 
results  dependent  on  the  focus  of  the  intervention  (Blennerhassett  &  Dite  2004).  While 
preliminary  results  from  another  small  study  (n  =  22)  in  acute  stroke  patients  (Kreisel  et 
al.  2005)  suggest  similar  results  to  our  meta-analysis  with  modest  non-statistically 
significant  improvements  in  motor  scores  when  measured  by  the  Motricity  index. 
In  a  larger,  Chinese  trial  with  156  participants,  Fang  et  al.  set  out  to  carry  out  a  RCT  but 
their  comparison  has  a  number  of  difficulties  (Fang  et  al.  2003).  Their  control  group 
appears  to  receive  no  therapy,  which  though  it  increases  their  treatment  contrast,  may  be 
unusual  for  many  acute  stroke  patients  in  Western  countries.  In  addition,  their 
intervention  group  lost  large  numbers  of  subjects  to  follow  up.  This  reflects  that  these 
trials  are  not  easy  to  deliver,  though  with  a  highly-selected  group  and  high  loss  to 
follow  up  (36%  of  intervention  group  lost  at  3  months  and  85%  lost  at  6  months)  their 
results  are  difficult  to  analyse  and  generalize. 
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Other  trials  may  not  necessarily  have  been  focused  on  intensity  of  physiotherapy  e.  g. 
Martinsson  et  al.  (Martinsson  et  al.  2003),  investigating  the  combination  of  intensive 
physiotherapy  and  amphetamine  in  severely  disabled  patients. 
Further  data  extraction 
Until  further  relevant  trials  are  available  we  could  attempt  to  maximise  the  use  of 
existing  data  by  using  missing  data  techniques  (such  as  multiple  imputation  or  last 
observation  carry  forward)  to  explore  the  robustness  of  the  findings  to  missing  data.  We 
could  also  consider  converting  data  from  the  trials  by  Partridge  et  al.  and  Miller  et  al.  to 
obtain  estimated  Barthel  index  scores. 
Developing  standard  methods  of  describing  and  defining  physiotherapy  interventions  in 
trials 
We  could  investigate  the  properties  of  the  record  of  physiotherapy  input  (Appendix  1) 
used  in  the  GAPS  study.  At  the  start  of  the  study  there  did  not  appear  to  be  recognised 
measures  of  physiotherapy  input  available.  Though  we  gathered  considerable  detail  of 
treatment,  we  utilised  only  a  small  component  of  this  (the  amount  of  time  spent  by  the 
therapist).  It  would  be  useful  to  establish  the  reliability  and  validity  of  this  method  of 
data  collection.  If  it  proved  to  be  a  valid  measure  it  might  be  useful  in  studies  examining 
content  of  treatment  as  well  as  dosage. 
Tyson  and  Selley  have  recently  developed  an  intervention  recording  tool  for  use  with 
stroke  (Tyson  &  Selley  2004)  and  further  work  is  expected  from  an  international 
comparison  of  physiotherapy  practice  in  stroke  rehabilitation  (CERISE  2005). 
Meanwhile  a  study  in  Sweden  has  looked  at  the  characteristics  of  physiotherapy 
intervention  from  both  therapists'  and  patients'  perspectives  (Wottnch  et  al.  2004). 
Exploring  predictors  of  recovery 
We  could  further  explore  the  data  by  examining  predictors  of  recovery  and  exploring 
the  features  of  patients  who  make  a  very  good  or  very  poor  recovery.  Having  the  IPD 
database  puts  us  in  a  good  position  to  carry  out  what  can  be  a  complex  analysis 
(Thompson  &  Higgins  2005).  However,  we  must  be  cautious  of  carrying  out  multiple 
subgroup  analyses  (Counsell  et  al.  1994)  and  recognise  that  numbers  of  available  data 
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are  likely  to  be  small.  These  exploratory  analyses,  though  likely  to  have  limited 
conclusions,  might  be  useful  in  generating  new  hypotheses. 
Disseminating  our  recommendations 
Our  results  have  been  made  available  to  a  wide  audience  (see  Appendix  IX)  and  furtlier 
dissemination  is  planned  through  presentations  and  publication  in  a  variety  of  media. 
The  PINTAS  Collaborative  group  could  consider  registering  the  meta-analysis  as  a 
Cochrane  Review  in  order  to  help  disseminate  our  findings  and  stimulate  continued 
interest  in  this  area  of  stroke  rehabilitation. 
Future  research 
In  the  larger  research  context,  in  order  to  obtain  a  better  understanding  of  the  "black 
box"  of  rehabilitation,  we  may  have  to  adopt  several  different  strategies  in  order  to 
describe  and  test  what  is  happening  e.  g.  Campbell  et  al.  's  framework  for  complex 
interventions  (Campbell  et  al.  2000). 
Optimum  delivery  of  treatment 
While  none  of  the  trials  in  our  analyses  reported  serious  adverse  events  attributable  to 
the  intervention  or  raised  concerns  about  safety,  one  of  the  reasons  treatment  contrast 
cannot  be  maintained  is  poor  tolerance  of  the  intervention.  We  should  consider  methods 
of  optimal  delivery  of  interventions. 
We  have  just  looked  at  intensity,  but  other  treatment  factors  should  be  considered  such 
as:  the  method  in  which  the  additional  therapy  is  delivered  e.  g.  by  one  longer  treatment 
session  or  a  number  of  shorter  sessions;  the  timing  of  the  intervention  e.  g.  the  early 
intervention  trials  appear  to  demonstrate  benefits  but  timing  could  be  further  explored, 
along  with  the  content  of  intervention  (Page  2003)(Van  Peppen  et  al.  2004). 
Such  studies  might  be  aided  by  the  development  of  technical  equipment.  For  example 
the  activity  monitor  used  in  the  GAPS  study  continues  to  be  developed  and  may  help  to 
provide  objective  outcome  data. 
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General  v  specific  questions 
We  need  to  maintain  a  balance  between  questions  addressing  "tbe  big  picture"  of 
rehabilitation  and  small  specific  questions. 
Although  a  recent,  published-data  meta-analys's  (Kwakkel  et  al.  2004)  reported  a 
positive  treatment  effect  with  increased  "exercise  therapy"  we  believe  our  trial  selection 
was  more  specific  and  representative  of  "physiotherapy"  intervention.  Although  our 
meta-analysis  is  smaller  it  allows  us  to  be  more  specific  when  defining  the  intervention 
and  generalising  our  results.  Other  rehabilitation  interventions,  e.  g.  occupational 
therapy,  face  similar  difficulties,  with  a  diverse  gToup  of  patients  and  heterogeneous 
interventions  that  are  poorly  defined  and  understood.  However,  pooling  studies  across 
the  interventions  may  limit  the  extent  to  which  specific  questions  can  be  addressed. 
There  may  be  less  incentive  to  examine  physiotherapy  intensity  in  terms  of  length  of 
hospital  stay  with  co-ordinated  early  supported  discharge  (ESD)  services  proven  to  be 
an  effective  intervention  (Langhorne  et  al.  2005).  However,  all  of  the  trials  included  in 
this  EPD  meta-analysis  of  ESD,  featured  physiotherapy,  and  it  is  still  worth  investigating 
the  effective  components  of  ESD. 
In  other  chronic  diseases  e.  g.  head  injury,  researchers  are  attempting  to  tackle  the 
intensity  question  and  are  likely  to  come  across  similar  difficulties  and  challenges  to 
those  mentioned  in  Chapter  2  (Shell  et  al.  2001).  Slade  et  al.  had  carried  out  a  trial  with 
a  mixed  patient  group,  though  we  only  included  data  from  stroke  patients.  Although  this 
method  may  reflect  service  delivery  in  some  rehabilitation  settings  it  is  obviously  less 
specific  and  results  may  be  difficult  to  generalize. 
Despite  our  focus  being  intervention  delivered  by  a  physiotherapist,  it  may  be  activity 
(regardless  of  how  it  is  delivered),  that  is  the  beneficial  factor  that  should  be 
investigated.  Current  and  future  levels  of  patient  contact  with  physiotherapists  are  likely 
to  be  limited.  Therefore,  there  has  been  recent  interest  in  early  mobilization  trials  that 
involve  interventions  with  a  rehabilitation  approach  that  encourages  activity  and 
repeated  practise  of  mobility,  whether  delivered  by  physiotherapists  or  others  (Berhardt 
et  al.,  Kwakkel  et  al.  -  personal  communication).  Such  broad  treatment  approaches  rnaý' 
be  complex  to  investigate  as  increasing  the  number  of  components  of  the  intervention 
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may  lead  to  contamination.  Consequently,  strict  monitoring  and  large  numbers  of 
subjects  are  likely  to  be  required. 
4)  Recommendations 
Finally,  I  want  to  make  some  recommendations  based  on  the  work  in  the  thesis: 
The  results  of  our  investigations  should  not  lead  to  a  change  in  clinical  practice  or 
service  delivery,  though  our  findings  support  a  general  pattern  in  results  towards  benefit 
to  patients  with  stroke  with  increased  physiotherapy  input. 
The  main  impact  of  the  work  is  likely  to  be  in  infon-ning  future  research  in  this  area. 
Recommendations  could  be  made  to  encourage  researchers  to  use  a  core  standard  of 
methods  and  outcomes  that  would  facilitate  further  meta-analyses. 
Although  we  must  be  cautious  when  interpreting  results  based  on  subgroup  analyses  of 
secondary  outcomes,  there  are  several  recommendations  that  can  be  made: 
a)  Future  trials  should  carefully  select  their  outcome  measures  to  reflect  the  alms  of 
physiotherapy. 
b)  The  greatest  impact  is  likely  to  be  at  the  level  of  impainnent. 
c)  The  greatest  impact  is  likely  to  be  seen  at  higher  treatment  contrasts  (more  than 
15  hours  difference  between  groups). 
d)  There  may  be  value  in  targeting  some  aspects  of  therapy  (e.  g.  lower  limb  focus 
to  improve  walking  speed)  but  our  data  are  inconclusive. 
We  would  encourage  registration  of  new  trials  in  trials  registers  to  allow  access  to  data 
and  inclusion  in  collaborative  efforts  (Egger  &  Davey  Smith  1998). 
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Conclusion 
In  conclusion,  I  consider  I  have  addressed  my  research  questions  as  completely  as 
possible.  Using  sound  methods,  the  analyses  have  provided  some  answers  and  raised  a 
number  of  issues  around  the  methods  and  available  data. 
The  GAPS  study,  though  inconclusive,  had  many  methodological  strengths.  It  was  a 
logical  progression  to  pool  the  data  we  obtained  with  the  other  studies  in  order  to  pursue 
our  questions.  This  also  provided  the  opportunity  to  examine  the  benefits  of  the 
different  methods  of  meta-analysis. 
There  appears  to  be  justification  in  considering  IPD  meta-analysis  as  the  "gold 
standard"  as  it  maximizes  the  use  of  available  data.  However,  although  WD  meta- 
analysis  is  a  strong  method,  it  will  not  compensate  for  poor  quality  data  or  lack  of  data. 
We  have  produced  useful  results  and  recommendations  that  will  contribute  to  the  design 
of  physiotherapy  research  in  the  future  and  been  able  to  direct  further  work  based  on  the 
project.  Considered  in  these  terms,  the  project  has  been  a  success,  tackling  a  complex 
issue  and  providing  information  to  further  this  area  of  rehabilitation  research. 
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Summary 
I  return  to  the  questions  in  my  hypothesis  to  consider  to  what  extent  they  have 
been  addressed  by  the  results  from  the  RCT  and  FPD  meta-analysis. 
Our  results  should  not  lead  to  changes  in  clinical  practice  or  service  deliverY. 
However,  they  provide  estimates  of  the  modest  treatment  effect  likely  in  t1le 
domains  we  examined.  Modest  increases  in  the  intensity  of  physiotlicrapy  after 
stroke  did  not  produce  substantial  changes  in  any  of  the  primary  outcomes  in  my 
hypothesis. 
*  Targeted  additional  therapy  in  selected  patients  may  lead  to  some  improvement 
in  limb  impairment  and  walking  speed.  Treatment  effects  were  greater  in  those 
trials  with  higher  treatment  contrast  (>  15  hours)  that  started  intervention  at  an 
earlier  stage  after  stroke. 
91  discuss  issues  arising  from  the  randomised  controlled  trial  and  the  meta- 
analyses 
9  Individual  patient  data  meta-analyses,  maximize  the  use  of  available  data  and 
provide  the  opportunity  to  explore  subgroups  in  order  to  address  clinically 
relevant  questions  and  guide  further  research. 
9  Large  numbers  of  subjects  are  required  for  randomised  controlled  trials  (RCTs) 
of  intensity  of  physiotherapy.  I  make  recommendations  to  those  designing  such 
trials  to  use  higher  treatment  contrasts  in  order  to  detect  modest  treatment  effects 
and  similar  outcome  measures  in  order  to  facilitate  future  meta-analysis. 
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APPENDIX  I 
GAPS  studyg  Physiotherapy  input  data  collection  form 
GAPS  Study 
Description  of  Physiotherapy 
Version  1.0 
Random  No  Initials  Date  of  Session 
ET=  [I]/[:  = 
D0MMyY. 
NB  RETURN  ONE  FORM  FOR  EACH  INTERVENTION 
A-  PATIENrS  NAME 
B.  WHICH  PHYSIOTHERAPY  SESSION  OF  THE  DAY?  (I=lst,  2=2nd,  etc.  ) 
[J 
C.  TREATMENT  ALLOCATION  Standard  nl  Augmented  f  2] 
D.  AMOUNT  OF  PHYSIOTHERAPY  TIME  THIS  SESSION  (minutes) 
Tj-ý 
mins  1.  Total  indirect  contact  time 
r- 
2.  Total  direct  contact  time  mins 
3.  Combined  physiotherapy  time  mins 
E.  TOTAL  TIME  SPENT  ON  (minutes) 
1.  Gait  re-education 
2.  Upper  limb  re-education 
3.  Discussion  /  Explanation  /  Reassurance 
4.  Postural  set  (minutes) 
5.  Focus  of  Treatment  (Yes/No) 
Circle  as  appropriate 
Initial  assessment 
Tone 
Posture 
Balance 
UIL  function 
LIL  function 
Transfers 
Other 
F.  TREATMENTS  USED 
1.  Which  of  the  follovving  were  used? 
(a)  Trunk  mobilisations  * 
(b)  Wheelchair  education/use 
(c)  Splints  for  the  upper  limb 
(d)  Splints  for  the  lower  limb 
(e)  Education  (pabent,  relatives,  staff) 
mins 
mins 
mins 
Lying  Side  Lying  Sifting  Standing  Other 
Yes 
E] 
13 
No 
F?  ] 
Yes 
E] 
1. 
No 
[j] 
Yes 
5] 
No 
[j] 
Yes 
[j] 
No 
[j] 
Yes 
[j] 
No 
[2] 
El  El  El  F91  El  EO  El  El  El  E0 
El  El  El  El  El  Eil  F-1  El 
'  El  Eil 
El  1ý  E  F21 
E]  E]  ]  E2  E  [A 
Ell  El  El  El  El  El  El  El  El  1ý 
rjý  E]  Ej  E]  El  ] 
F21  El  51 
51  Q  [E  Q  Eil  [A  FT,  [A 
' 
E  Q 
'  El  1ý  El  [ý  E  Eý  El  El  El  EO 
Yes  F-11  No  F21 
Yes  f  1ý  No  r12 
Yes  F-11  NoF21 
Yes  FI]  NoF2j 
YesFl-]  No  [jý 
201 Appendix  I 
GAPS  Study 
Description  of  Physiotherapy  continued... 
Version  1.0 
Random  No  Initials  Date  of  Session 
1  EIIý  =-I:  Y= 
G.  PHYSIOTHERAPIST  DETAILS 
1.  Who  completed  this  form? 
2.  Lead  Physiotherapist 
3.  Number  of  physiotherapists  involved 
H.  TYPE  OF  PHYSIOTHERAPISTS  INVOLVED 
1.  Lead  therapist 
2.  Seniortherapist 
3.  Junior  grade  therapist 
4.  Assistant  therapist 
5.  Student  therapist 
ri 
Yes  1-11  NoF21 
y 
Yes  F-11  NoF-21 
Yes  1-11  No  [21 
YesFl]  NoF2] 
1. 
Yes  F-l1No  [21 
1.  COMMENTS 
1.  Any  comments/problems/complir-atons? 
For  Office  Use  Only 
Signature: 
Date: 
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APPENDIX  11 
GAPS  study,  Outcome  assessment  forms  (example  of  3  month  form) 
GAPS  Study 
Resource  Use  Since  Hospital  Discharge 
Draft  01 
3  Month  Assessment,  Page 
Random  No  Initials  Assessor  Code  Date  of  Visit 
A.  PLACE  OF  RESIDENCE 
Private  address  alone  rq 
Private  address  not  alone 
Sheltered  housing 
Residential  care  41  F 
Nursing  home 
Other 
If  Other,  specify 
B.  AIDS  AND  APPLIANCES 
1.  Are  any  aids  or  appliances 
required?  YesFIj  No  F9--I 
Lýj 
If  Yes,  specify  which 
(a)  Standing/walking  support 
Zimmer  frame  Yes  F11  No  M 
Rollator  YesF1]  NoF21 
Tripod/quad  stick  Yes  ni  No  M 
Delta  frame  Yes  P1  No  M 
Two  sticks  Yes  0  No 
Crutches  Yes  n1  No  ff] 
One  stick  Yes  n1  No 
Other  Yes  F1]  No  F21 
If  Other,  specify 
(b)  Splints/Slings 
AFO  Yes  E  No 
Knee  splint  Yes  n1  No  [21 
I 
Hand  splint  Yes  n1  NoF21 
Shoulder  Sling  YesF-11  No  F4 
Other  Yes  n1  NoF21 
If  Other,  specifY  .7 
(c)  Adaptive  equipment  and  alterations 
to  property?  YesF11  No 
If  Yes,  specify  which 
Bathing  aids  Yes  1-11  No  Ifl 
Kitchen  aids  YesF']  No 
Grab  rails  YesF1]  No 
Kitchen  trolley  Yes  No 
Stair  rail  Yes  No 
Stair  lift  YesF1]  No 
Other  Yes  n1  No  [fl 
ff  Other,  specify 
(d)  Wheelchair,  or waifing  for  a 
wheelchair'?  YesF11  No  M 
(i)  ff  Yes,  specify 
For  outdoor  use  only  F1  I 
Sometimes  use  indoors  Ifl 
Always  use/unable  to  walk 
Ifl 
(ii)  Type  of  wheelchair 
Electric 
Aftendant  propelled 
Self-propelled 
C.  CARER  INFORMATION 
1.  Has  anyone  had  to  stop  work  to  look 
after  the  patient?  YesFqNo 
If  Yes,  what  job  did  they  do? 
Signature: 
Date: 
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GAPS  Study 
Resource  Use  Since  Hospital  Discharge 
Draft  01 
3  Month  Assessment,  Page  2 
Random  No  Initials  Assessor  Code  Date  of  Visit 
FT-1 
A.  SERVICES 
Once  2  times  >2  times 
No  or  twice  Weekly  per  week  per  wee$ 
(a)  Home  help  M  F4]  Fq 
(b)  District  nursing  F3]  M  Fq 
(c)  Day  hospital  n4  [q 
(d)  Outpatient 
physiotherapy  F31  n4  rq 
(e)  Outpatient 
occupational 
therapy  M  Efl  F41  [9 
(0  Outpatient  S&LT[fl  n4 
(g)  Physiotherapy 
home  visit  [fl  M  F31  F41  Fq 
(h)  Occupational 
therapy  home 
visit 
F4]  RI 
(i)  Social  work  F31  M  Fq 
0)  Health  visitor  F2]  (N  [ý]  Fq 
(k)  GP  F4]  [fl 
(1)  Stroke  Clinic  El  M  [N  M  M 
(m)  Day  Centre  EI  M  M  M  rq 
(n)  Meals  on  wheels 
n4  rq 
(o)  Living  with  a 
stroke/Disability 
resource  centre 
(p)  Other  Fq  [1]  f-41  M 
specify 
Signature: 
Date. 
204 Appendix  11 
GAPS  Study 
Adverse  outcomes 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
EFT71  11111  M 
MwDDMMyY. 
A.  FALLS 
1.  Since  discharge  from  hospital,  has 
the  patient  suffered  any  falls?  Yes  0  No 
If  Yes,  give  details 
Fall Severity  Code  Date  of  Fall 
(a)  1-1 
D0MMyY. 
(b)  11  ME=  DDMMyY. 
(c)  F-I  EL]4--IEVEI[--]  DDMM.  y-Y, 
(d)  1:  1== 
DDMMyY, 
(e)  C=Y 
Y.  DDMM 
Fall  Severity  Code  Box 
No  injury  Ffl 
Minor  injury  Pi 
Major  injury  Ifl- 
Signature: 
3  Month  Assessment,  Page  3 
B.  OTHER  PROBLEMS/ILLNESSES 
Any  other  problems  or  illnesses 
since  hospital  discharge?  Yes  n1  No 
If  Yes,  give  details 
Event 
Description  Code  Date  of  Event 
205 
DDmmyY. 
mmyY. 
DDmmyY. 
EI:  Xl=  DDmmyY. 
DD  AA  MyY. 
ED  Er-14--EVI= 
0DmmyY.  m  E:  ix= 
DDmmyY. 
M  EEM:  =  DDmmyY. 
DVT  1 
PTE 
UTI 
Chest  infection 
Other  infecton 
Fracture 
Depression 
Anxiety 
Confusion 
Pressure  sore 
Painful  shoulder 
Other  pain  [q2 
Recurrence/extension 
of  stroke 
Other  pain 
Date: Appendix  11 
UAPS  Study  3  Month  Assessment,  Page  4 
Current  Disability:  Rankin  Scale,  Mobility  and  Barthel  Index 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
[T= 
A.  CURRENT  RANKIN  OXFORD  HANDICAP  SCALE 
1.  'Rankin'Oxford  Handicap  Scale 
Well,  no  symptoms 
Minor  symptoms  affecting  lifestyle 
Minor  handicap  but  independent  in  self  care 
Moderate  handicap,  needing  a  little  help  with  ADL 
Needing  a  lot  of  help  with  ADL  El 
Needing  constant  attention  day  and  night 
B.  POST-STROKE  MOBILITY 
Able  to  walk  200m  outside  m 
Able  to  walk  indoors 
Unable  to  without  help 
C.  BARTHEL  INDEX 
1.  Bowels 
Incontinent  or  needs  to  be  given  enema 
Occasional  accident  (once  a  week) 
Continent 
2.  Bladder 
Incontinent  or  catheterised  and  unable  to 
manage  alone 
Occasional  accident  (maximum  once  per  week)  F1  I 
Continent 
6.  Transfer  (bed  to  chair  and  back) 
Unable,  no  sitting  balance  1fl 
Major  help  (one  or  two  people,  physical),  can  sit  m 
Minor  help  (verbal  or  physical)  Efl 
Independent  FI-2-1 
Lfi 
7.  Mobility 
Immobile  Iq 
Wheelchair  independent  including  comers  FI 
Walks  with  help  of  one  person  (verbal  or  physical)  M 
Independent  (but  may  use  any  aid,  eg.  stick) 
8.  Dressing 
Dependent  Fq 
Needs  help  but  can  do  about  half  unaided 
Independent  (including  buttons,  zips,  laces,  etc) 
9.  Stairs 
Unable 
Needs  help  (verbal,  physical,  carrying  aid) 
Independent 
10.  Bathing 
Dependent 
Independent  (or  in  shower) 
3.  Grooming 
Needs  help  with  personal  care 
Indepenclant  face/hairtteeth/shaving  (implements 
provided) 
4.  Toilet  use 
Dependent  Ffl 
Needs  some  help,  but  can  do  something  alone 
Independent  (on  and  off,  dressing  and  wiping) 
TOTAL  SCORE 
S.  Feeding 
Unable 
Fq 
Needs  help  cuffing,  spreading  butter,  etc. 
m 
Independent 
f-21 
Signature: 
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GAPS  Study  3  Month  Assessment,  Page  5 
Current  Disability:  Rivermead  Mobility  Index 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
FQ  1134  =  ;:  Q 
-  . 
A.  RIVERMEAD  MOBILITY  INDEX  9.  Walking  outside  (even  ground) 
Instructions 
Do  you  walk  around  outside,  on 
The  patient  is  asked  the  following  15  questions,  and  pavements  without  help?  Yes  P1  No 
observed  (for  item  5).  A  score  of  I  is  given  for  each 
)(es'answer.  10.  Walking  inside,  with  no  aid 
Do  you  walk  10  metres  inside  with 
1.  Turning  over  in  bed 
no  caliper,  splint,  or  aid,  and  no 
Do  you  turn  over  from  your  back  to  standby  help?  Yes  19  No 
your  side  without  help?  Yes  M  No  ff] 
11.  Picking  off  floor 
2.  Lying  to  sifting  If  you  drop  something  on  the  floor, 
From  lying  in  bed,  do  you  get  up  to 
sit  on  the  edge  of  bed  on  your  own?  YesFq  No  ffl 
do  you  manage  to  walk  5  metres, 
pick  it  up  and  then  walk  back?  Yes  1fl  No 
3.  Sitting  balance  12.  Walking  outside  (uneven  ground) 
Do  you  sit  on  the  edge  of  the  bed  Do  you  walk  over  uneven  ground 
without  holding  on  for  10  seconds?  Yes  M  No  [fl  (grass,  gravel,  dirt,  snow,  ice,  etc.  ) 
without  help?  Yes  P1  No 
4.  Sitting  to  standing 
Do  you  stand  up  (from  any  chair)  in 
13.  Bathing 
less  than  15  seconds,  and  stand  Do  you  get  in/out  of  bath  or  shower 
there  for  15  seconds  (using  hands,  unsupervised  and  wash  self?  Yes  E]  No  M 
and  with  an  aid  if  necessary)?  Yes  [i]  No  Ffl 
14.  Up  and  down  four  steps 
5.  Standing  unsupported 
Do  you  manage  to  go  up  and  down 
Observe  standing  for  10  seconds 
without  any  aid.  Yes  M  No 
four  steps  with  no  rail,  but  using  an 
aid  if  necessary?  Yes  El  NoF01 
6.  Transfer  15.  Running 
Do  you  manage  to  move  from  bed 
to  chair  and  back  without  any  help?  Yes  No 
Do  you  run  10  metres;  without 
f  t  lk  as  wa  limping  in  four  seconds  ( 
7.  Walking  inside,  with  an  aid  if  needed 
is  acceptable)?  YesrqNo 
Do  you  walk  10  metres,  with  an  aid 
if  necessary,  but  with  no  standby 
help?  Yes  No 
8.  Stairs 
Do  you  manage  a  flight  of  stairs 
?  Yes  ith  t  hel  No  w  ou  p 
Signature: 
Date: 
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GAPS  Study 
Current  Disability  Motricity  Index 
3  Month  Assessment,  Page  6 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
ITTTI 
A.  MOTRICITY  INDEX 
(i)  Tests 
ARM 
1.  Pinch  grip;  2.5crn  cube  between  thumb 
and  forefinger 
No  movement 
Beginnings  of  prehension  (any  movement  of 
finger  or  thumb) 
Grips  cube,  but  unable  to  hold  against  gravity 
Grips  cube,  held  against  gravity,  but  not  against 
weak  pull 
Grips  cube  against  pull,  but  weaker  than  other 
side 
Normal  pinch  grip 
Fol 
fli 
F  q- 
P21 
P-61 
m 
2.  Elbow  flexion;  from  90  degrees,  voluntary 
contraction/movement 
No  movement  161 
Palpable  contraction  in  muscle,  but  no  movement 
Movement  seen,  but  not  full  range/not  against 
gravity  fq4 
Movement;  full  range  against  gravity,  not  against 
resistance  IN 
Movement  against  resistance,  but  weaker  than 
other  side  2q P 
Normal  power 
fl3 
3.  Shoulder  abduction;  from  against  chest 
No  movement 
10-1 
Palpable  contraction  in  muscle,  but  no  movement  ffl 
Movement  seen,  but  not  full  range/not  against 
gravity  fl-41 
Movement  full  range  against  gravity,  not  against 
resistance 
nig 
Movement  against  resistance,  but  weaker  than 
other  side 
ff5] 
Normalpower  [ýJ] 
LEG 
4.  Ankle  dorsiflexion;  from  plantar  flexed  position 
No  movement  M 
Palpable  contraction  in  muscle,  but  no  movement  f  9-1 
Movement  seen,  but  not  full  range/not  against 
gravity 
Movement;  full  range  against  gravity,  not  against 
resistance 
Movement  against  resistance,  but  weaker  than 
other  side 
Normal  power  F',  -13  1 
11"I 
S.  Knee  extension;  from  90  degrees,  voluntary 
contraction/movement 
No  movement  FbI 
Palpable  contraction  in  muscle,  but  no  movement  LII 
Movement  seen,  but  not  full  range/not  against 
gravity  r4 
Movement;  full  range  against  gravity,  not  against 
resistance  M19 
Movement  against  resistance,  but  weaker  than 
other  side  P5 
Normal  power  M33 
6.  Hip  flexion;  usually  from  90  degrees 
No  movement 
MO 
Palpable  contraction  in  muscle,  but  no  movement  Fo-I 
I,, 
Movement  seen.  but  not  full  range/not  against 
gravity  F4] 
Movement  full  range  against  gravity,  not  against 
resistance 
ri  -al 
1  -1 
Movement  against  resistance,  but  weaker  than 
other  side 
F251 
Normalpower  [R3] 
Signature: 
Date: 
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Trunk  Control  Test,  Walking  Test,  Mobility  Milestones  &  Functional  Reach 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
ETTT-1 
DDMMyY. 
A.  TRUNK  CONTROL  TEST  B.  MOBILITY  MILESTONES 
(i)  Tests 
1.  Independent  standing  balance  Yes  No 
1.  Rolling  to  weak  side 
Unable  to  do  on  own  [01 
L__j 
2.  Able  to  walk  10  paces  Yes  No 
Able  to  do,  but  only  with  non-muscular  help-for  3.  Able  to  walk  10  metres  Yes  No 
example,  pulling  on  bed  clothes,  using  arms  to 
steady  self  when  sifting,  pulling  up  on  rope  or 
monkey  pole,  etc.  F2]  C.  FUNCTIONAL  REACH 
Able  to  complete  normally 
1.  Able  to  perform  functional  reach?  Yes  No 
2.  Rolling  to  strong  side  If  Yes,  specify  0  cm  Unable  to  do  on  own 
Able  to  do,  but  only  with  non-muscular  help-for 
example,  pulling  on  bed  clothes,  using  arms  to 
D.  RMI-confirmation  of  question  5. 
steady  self  when  sitting,  pulling  up  on  rope  or  Standinq  unsupported 
monkey  pole,  etc.  1.  Can  the  patient  stand  unsupported 
Able  to  complete  normally  1ý51  for  10  seconds  without  any  aid? 
(Observe)  YesP]  No  1fl 
3.  Sitting  up  from  lying  down 
Unable  to  do  on  own  E.  TIMED  10  METRE  WALKING  TEST 
Able  to  do,  but  only  with  non-muscular  help-for  1.  Was  the  patient  able  to  perform  the 
example,  pulling  on  bed  clothes,  using  arms  to  test?  Yes  No  rfl 
steady  self  when  siding,  pulling  up  on  rope  or 
monkey  pole,  etc.  If  Yes,  specify  the  time  in  seconds  secs 
Able  to  complete  normally  P51 
2.  Aid  used 
4.  Balance  in  sitting  position  (on  side  of  bed) 
None 
Unable  to  do  on  own  One  stick 
Able  to  do,  but  only  with  non-muscular  help-for  Two  sticks 
example,  pulling  on  bed  clothes,  using  arms  to 
Quad  or  tripod  stick 
F-21 
LLJ 
steady  self  when  sitting,  pulling  up  on  rope  or 
Zimmer  frame  El 
monkey  pole,  etc. 
F21 
Able  to  complete  normally 
Rollator 
Other 
if  Other,  specify 
Signature: 
Date: 
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Current  Disability:  Nottingham  Extended  Activities  of  Daily  Living  Index 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
EQ 
DO  YOU...  Not  With  Alone  with  Alone 
A.  MOBILITY  at  all  help  difficulty  easily 
-  walk  around  outside?  M  [fl  Fq  M 
-  climb  stairs? 
-  get  in  and  out  of  the  car?  Ffl 
-  walk  over  uneven  ground?  Ffl 
-  cross  roads? 
-  travel  on  public  transport? 
B.  IN  THE  KITCHEN 
-  manage  to  feed  yourself? 
-  make  yourself  a  hot  drink?  [2]  [3] 
-  take  hot  drinks  from  one  room  to  another?  M  1ý 
-  do  the  washing  up?  Efl  [1]  M 
-  make  yourself  a  hot  snack?  [2] 
C.  DOMESTIC  TASKS 
-  manage  your  own  money  when  out? 
-  wash  small  items  of  clothing?  [fl  Fq  F1  1ý 
-  do  your  own  shopping? 
rfl  1ý 
-  do  a  full  clothes  wash? 
[2] 
D.  MOBILITY 
-  read  newspaper  and  books?  1ý 
-  use  the  telephone? 
-  write  letters? 
-  go  out  socially? 
-  manage  your  own  garden? 
-  drive  a  car? 
Signature: 
DaW 
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Current  Disability.  Rivermead  Visual  Gait  Assessment 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
FTTýQ  EQ 
DDMMyY. 
Scoring:  0  =normal  Deviations:  I=  mild  2=  moderate  3=  severe  (please  cide) 
Upper  Limb  Position 
1.  Shoulder  Depressed/Retracted/Elevated 
2.  Elbow  flexed  :5  450  (=O)  450  to  900  (=1)  >900  (=2) 
Stance  Phase  For  trunk  deviations,  0=  midline 
3.  Trunk  flexedlextended  M  RI  [i]  M  PI  M  RI 
Inclinded.  backward  forward 
4.  Trunk  side  flexed 
S.  Trunk  and  pelvis:  lateral  displacement 
6.  Contralateral  drop  pelvis 
7.  Hip  extension  decreased 
8. 
9A.  Knee  flexion  excessive: 
IOA. 
OR 
9B.  Knee  extension  excessive: 
IOB. 
I  IA.  Ankle  in  excess  plantar  flexion 
OR 
IIB.  Ankle  in  excess  dors!  flexion 
12.  Inversion  excessive 
13.  Plantar  flexion  decreased  at  toe-off 
[N  M  [11  M  Eq  M  [n 
. 
Direction:  left  right 
In  M  PI  M  M  M  M 
Amount:  excessive  reduced 
PI  Ffl  M  M 
M  [!  ]  M  [  -3] 
with  backward  rotation  P]  M  PI  M 
at  initial  contact 
throughout  range 
at  initial  contact 
throughout  range 
M  Fq  MM 
M  FqF21  M 
[fl  F2]  M 
Fq  MM 
M  [1]  F21  M 
M  [fl  M 
IE!  lEfl 
Signature: 
Date: 
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Current  Disability:  Rivermead  Visual  Gait  Assessment  continued... 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
EFT11  E  1;  K.  =. 
Swing  Phase 
14.  Trunk  flexed 
Direction: 
15.  Trunk  side  flexed 
Direction: 
16.  Hike  pelvis  (elevation) 
17.  Backward  rotation  pelvis. 
18.  Decreased  hip  flexion 
19.  Decreased  knee  flexion 
20.  Ankle  In  excess  plantar  flexion 
Any  other  deviations  noted 
21.  Support  required 
AFO 
Knee  splint 
For  trunk  deviations,  0=  midline 
MM  Fq  M  P]  [72]  M 
backward  forward 
mM  m  m 
left  -  right 
m  PI  m  In 
M  DI 
21  F 
M 
m  PI  m  m 
m  PI  m  m 
M  M  m  m 
m  PI  m  m 
M  Eq  MM 
Yes  rqNo  [-2] 
Yes  Fl]  No  M 
Signature: 
Date: 
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Current  Disability:  Body  Worn  Gait  Analysis  and  Nine  Hole  Peg  Test 
Draft  01 
I-  Random  No 
FI-1-1-1 
Initials 
E= 
A.  SIDE  AFFECTED  Left  ni  Right 
B.  ABILITY  TO  UNDERGO  GAIT  ANALYSIS 
1.  Was  the  patient  able  to  undergo 
gait  analysis?  Yes  r1]  No  m 
If  No,  specify  reason 
Patent  unfit  to  undergo  gait  analysis 
Patent  refused  to  undergo  gait  analysis 
Unable  to  walk  10  rnetres 
Equipment  failure 
Other 
If  Other,  specify 
rq 
Fq 
M 
Ifl 
1ý 
Assessor  Code  Date  of  Visit 
EQ 
I 
=..  =., 
" 
S.  Symmetry 
(Ratio  of  swing  phase) 
6.  Speed 
D.  AID  USED 
None 
One  stick 
Two  sticks 
Quad  or  tripod  stick 
Zimmer  frame 
Rollator 
Other 
EM% 
O.  EL] 
nVsec 
Fq 
rq 
1ý 
tf  Other,  specify 
w 
C.  RESULTS  OF  TEST 
1.  Number  of  scuffs 
(fast  contact  during  swing) 
(a)  Affected  side 
(b)  Unaffected  side 
2.  Heel  Strike 
(%  of  total  foot  contact  time) 
(a)  Affected  side 
(b)  Unaffected  side 
EFT-1 
1  1-1. 
12 
3.  Inversion 
(%  of  metatarsal  head  contact  time  with 
only  Sth  head  in  contact) 
(a)  Affected  side  % 
(b)  Unaffected  side  % 
4.  Average  Stride  Length 
(Average  speed  x  Average  time 
for  stride)  crn 
E.  NINE  HOLE  PEG  TEST 
1.  Time  of  test 
24  hour) 
clock 
2.  Results  for  unaffected  side 
Able  to  attempt  test?  YesF11  No  M 
If  Yes,  either 
rime  to  place  all  pegs  Msecs 
or 
If  >  So  seconds,  number 
of  pegs  placed  in  50  seconds  Elpegs 
3.  Results  for  affected  side 
Able  to  attempt  test?  Yes  n'  No 
If  Yes,  either 
Time  to  place  all  pegs  ELI  secs 
or 
If  >  50  seconds,  number 
of  pegs  placed  in  50  seconds  pegs 
Signature: 
Date: 
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Current  Disability:  Action  Research  Arm  Test  (Unaffected  Side) 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit  - 
FIX- 
DDMMYY. 
A.  RESULTS  FOR  UNAFFECTED  SIDE 
Grasp 
1.  Pick  up  10cm  cube,  block  of  wood 
(if  score  =  3,  total  =  18  and  go  to  GRIP) 
2.  Pick  up  2.5cm  cube,  block  of  wo(W 
(if  score  =  0,  total  =0  and  go  to  GRIP)  D 
3.  Pick  up  Scm  cube,  block  of  wood  Fý 
4.  Pick  up  7.5cm  cube,  block  of  wood 
0 
5.  Pick  up  cricket  ball,  7.5cm  diameter  El 
6.  Pick  up  sharpening  stone  10  x  2.5  xI  cm 
TOTAL  SCORE 
Grip 
1.  Pour  water  from  glass  to  glass 
(plastic  tumbler  half  full  (100  m1s;  of  water)) 
(if  score  =  3,  total  =  12  and  go  to  PINCH) 
2.  Lift  tube  2.25cm  from  one  peg  to  another  peg 
on  shelf  (if  score  =  0,  total  =0  and  go  to  PINCH)Fj 
3.  Lift  tube  I  cm  from  one  peg  to  another  peg 
on  shelf  F] 
4.  Lift  washer  3.5cm  in  diameter  from  table  and 
place  over  bolt  on  table 
TOTAL  SCORE 
Pinch 
1.  Pick  up  6mm  ball  bearing  between  3rd  finger 
and  thumb  from  10cm  dish  on  table  to  10cm 
dish  on  shelf  (if  score  =  3,  total  =  18  and  go 
to  GROSSMT) 
2.  Pick  up  I.  Scm  marble  between  first  finger  and 
thunib  from  dish  to  dish 
(if  score  =  0,  total  =0  and  go  to  GROSSMT) 
3.  Pick  up  ball  bearing  between  2nd  finger 
and  thumb 
4.  Pick  up  ball  bearing  between  Ist  finger 
and  thumb 
5.  Pick  up  marble  between  3rd  finger  and 
thumb 
6.  Pick  up  marble  between  2nd  finger  and 
thumb 
Gross  Movement 
SCORING  CODE  BOX 
Performs  test  normally 
Completes  test,  but  long  time  or  great  difficulty  2  R 
Performs  test  partially  , 
Can  perform  no  part  of  test  Mo 
Signature: 
Dateý 
TOTAL  SCORE 
1.  Place  hand  behind  head 
(if  score  =  3,  total  =9  and  finish) 
(if  score  =  0,  total  =0  and  finish) 
2.  Place  hand  on  top  of  head 
3.  Lift  hand  to  mouth 
TOTAL  SCORE 
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Current  Disability:  Action  Research  Arm  Test  (Affected  Side) 
Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
B.  RESULTS  FOR  AFFECTED  SIDE 
Grasp 
1.  Pick  up  10cm  cube,  block  of  wood 
(if  score  =  3,  total  =  18  and  go  to  GRIP) 
2.  Pick  up  2.5cm  cube,  block  of  wood 
(if  score  =  0,  total  =0  and  go  to  GRIP) 
3.  Pick  up  Scm  cube,  block  of  wood  F1 
4.  Pick  up  7.5cm  cube,  block  of  wood  F1 
5.  Pick  up  cricket  ball,  7.5cm  diame.  ter  F-1 
6.  Pick  up  sharpening  stone  10  x  2.5  x  1cm  F] 
TOTAL  SCORE 
Grip 
1.  Pour  water  from  glass  to  glass 
(plastic  tumbler  half  full  (100  mls  of  water)) 
(if  score  =  3,  total  =  12  and  go  to  PINCH)  F] 
2.  Lift  tube  2.25cm  from  one  peg  to  another  peg 
on  shelf  (if  score  =  0,  total  =0  and  go  to  PINCH) 
3.  Lift  tube  I  cm  from  one  peg  to  another  peg 
on  shelf 
4.  Lift  washer  3.5cm  in  diameter  from  table  and 
place  over  bolt  on  table 
TOTAL  SCORE 
Pinch 
I.  Pick  up  6mm  ball  bearing  between  3rd  finger 
and  thumb  from  10cm  dish  on  table  to  10cm 
dish  on  shelf  (if  score  =  3,  total  =  18  and  go 
to  GROSSMT) 
2.  Pick  up  I.  Scm  marble  between  first  finger  and 
thurrýb  from  dish  to  dish 
(if  score  =  0,  total  =0  and  go  to  GROSSMT)  F1 
3.  Pick  up  ball  bearing  between  2nd  finger 
and  thumb  F! 
4.  Pick  up  ball  bearing  between  1st  finger 
and  thumb 
5.  Pick  up  marble  between  3rd  finger  and 
thumb 
6.  Pick  up  marble  between  2nd  finger  and 
thumb 
TOTAL  SCORE  FU 
Gross  Movement 
1.  Place  hand  behind  head 
(if  score  =  3,  total  =9  and  finish) 
(if  score  =  0,  total  =0  and  finish) 
2.  Place  hand  on  top  of  head 
3.  Lift  hand  to  mouth 
TOTAL  SCORE 
SCORING  CODE  BOX 
Performs  test  normally 
Completes  test  but  long  time  or  great  difficulty  2  M 
Performs  test  partially  1 
Can  perform  no  part  of  test  RI 
Signature: 
Date: 
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Draft  01 
Random  No  Initials  Assessor  Code  Date  of  Visit 
ET-M 
Codinq  Difficulties 
1.  Have  there  been  any  problems 
coding  the  data  for  this  visit?  Yes  [ý]  No  M 
If  Yes,  specify 
Patient  no  longer  at  the  rehabilitation  centre  Fq 
Patient  unable  to  attend  assessment  Ill 
Patient  refused  for  part  of  the  assessment  RI 
Patient  refused  for  all  of  the  assessment  31  F 
Assessor  unavailable  [4-1 
Assessor  unblinded  [q 
Equipment  problem  rq 
Other 
specify 
Signature: 
Date'. 
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Rationale  for  selection  Of  Outcome  measures  used  in  the  GAPS  study  (listed 
alphabetically) 
Action  Research  Arm  Test  (ARAT)  (Lyle  1981) 
This  is  a  measure  of  upper  limb  disability  with  4  sections  (grasp,  grip,  pinch  aiid 
gross  movement),  scored  0-  57  (0  =  no  arm  function,  57  ==  normal  arm  ftinction). 
It  is  a  detailed  and  sensitive  measure  of  a  variety  of  upper  limb  functions  over  a 
broad  spectrum  of  functional  levels.  Although  it  is  relatively  complex  and  requires 
special  equipment,  we  included  it  because  it  provides  more  information  than  the  9 
Hole  Peg  Test  and  has  been  used  in  other  intensity  trials. 
Activity  Monitoring  (Suckalingham  1993) 
We  measured  patient  activity  using  a  "high-tech"  monitor  (Figure  3.1,  page  49)  that 
attached  a  sensor  to  the  patient's  unaffected  leg  and  recorded  the  frequency  of 
changes  in  posture.  We  had  hoped  that  the  equipment  would  measure  the 
proportion  of  time  spent  lying,  sitting,  standing  and  walking.  It  records  the  amount 
of  time  spent  in  an  upright  position  and  the  number  of  changes  of  the  patient's 
position  from  sitting  to  standing.  The  monitor  was  worn  on  a  single  occasion  (for  a 
day,  3  weeks  after  randomisation).  Data  were  downloaded  from  the  data  logger 
onto  a  portable  computer  for  analysis. 
It  was  able  to  provided  limited  information  in  terms  of  the  percentage  of  the 
patients'  "waking  day"  that  is  spent  in  an  "upright  position"  e.  g.  standing  or 
walking.  More  time  spent  upright  was  assumed  to  be  more  active.  The  monitor 
allowed  us  to  analyse  levels  of  activity  at  specific  periods  during  the  day  e.  g.  to 
examine  how  active  are  patients  in  the  evening  when  there  are  no  therapists  on 
duty? 
Adverse  Effects 
The  patients  were  monitored  for  falls,  fatigue,  shoulder  pain  and  other  pain  oil  a  Nveeklý' 
basis  until  discharge  (maximum  of  10  weeks)  by  interview.  The  patient  Nvas  also 
interviewed  at  the  3  and  6  month  assessments  regarding  hospital  adnilssions,  falls  and 
other  illnesses  or  problems.  Similar  information  was  gathered  at  the  casenote  review 
when  the  patient  was  discharge  fi7om  inpatient  rehabilitation.  We  could  not  confirni  this 
inforination  with  the  patients'  General  Practitioners  due  to  limited  resources. 
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Barthel  Index  (Mahoney  &  Barthel  1965) 
This  is  a  20-point  scale  over  10  items  (bowel,  bladder,  grooming,  toilet  use, 
feeding,  transfers,  mobility,  dressing,  stairs  and  bathing)  (0  =  dependent,  20  = 
independent)  measuring  dependency  in  activities  of  daily  living  (ADL).  It  is 
probably  the  most  commonly  used  measure  of  "disability"  or  "dependency-  M  both 
clinical  practice  and  research. 
Originally  designed  to  measure  "dependency"  this  frequently  used  questionnaire  is  used 
as  an  indication  of  activity  limitation  in  activities  if  daily  living.  It  has  been  adapted, 
but  we  used  its  original  version.  It  has  well  recognised  limitations  in  its  floor  and 
ceiling  effects  and  that  it  does  not  address  the  domains  of  communication  or  cognitivc 
ftniction.  It  is  simple,  quick  and,  if  necessary,  could  be  adi-ninistered  over  the  telephone 
for  limited  follow  up  with  non-compliant  patients  or  patients  in  institutional  care  (proxy 
answers  by  a  member  of  stafo. 
Body-worn  gait  analysis  (Granat  et  al.  1995) 
This  was  used  to  measure  impairment  of  quality  of  gait.  The  patients  wear  their  normal 
footwear  with  a  pressure  sensitive  insole  fitted  inside.  Information  from  the  insole  is 
recorded  on  a  data  logger.  The  test  was  performed  in  the  fourth  week,  three  months  and 
six  months  after  randomisation.  The  patients  walked  8m  with  a  2m  acceleration  and 
deceleration  period  at  each  end.  They  were  assessed  on  the  same  carpeted  surface  on 
each  site.  Data  were  gathered  on  average  stride  length,  speed,  symmetry  of  gait,  degree 
of  excessive  inversion  or  eversion,  and  the  duration  of  heel  contact. 
Elderly  Mobility  Scale  (EMS)  (Smith  1994) 
This  is  a  7-item  measure  of  fimctional  mobility  disability,  scored  0-  20  (0  =  poor 
mobility,  20  =  independent  mobility).  It  is  increasingly  used,  both  clinically  and  iii 
research.  It  is  simple  to  administer,  the  majority  of  its  items  being  covered  by  the  other 
scales  we  used.  It  has  been  validated  for  elderly  patients  but  not  yet  specifically  for 
stroke  patients.  The  functional  reach  test  within  the  scale  has  been  sho'xn  to  be 
indicative  of  dynamic  balance  and  is  predictive  of  falls. 
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EuroQol  (Dorman  et  al.  1997) 
This  measure  of  health  related  quality  of  life  contains  6  items  and  a  ý,  ertical  N-isual 
44  analogue  scale  (scored  0-  100,0  =  "worst  imaginable"  health  state,  100  =  best 
imaginable"  health  state).  It  is  relatively  short  and  has  acceptable  validity  with 
patients  after  stroke.  It  was  completed  at  interview  in  order  to  assist  any  patients 
with  motor  or  visual  deficits  to  complete  the  form. 
Functional  Reach  Test  (Duncan  et  al.  1990) 
The  patients'  ability  to  reach  forward  whilst  standing  without  support,  was  measured  III 
centimetres,  then  categorised  (under  8cm  or  unable,  8-  16cm,  over  16cm).  This  is  a 
valid  test  of  the  patients'  balance  in  the  standing  position.  Balance  had  not  specifically 
been  addressed  in  the  other  measures  used.  The  test  is  included  within  the  Elderly 
Mobility  Scale  (see  above)  and  has  been  shown  to  be  indicative  of  dynamic  balance  and 
predictive  of  falls  in  elderly  patients  (Smith  1994). 
Mobility  Milestones  (Smith  &  Baer  1999)  (Baer  et  al.  2003) 
This  is  a  measure  of  functional  mobility  based  on  recognised  patterns  of  recovery. 
The  hierarchical  scale  gives  clearly  defined  criteria  for  the  assessment  of  each 
66milestone"  -  ability  to  sit  unsupported  for  a  minute;  ability  to  stand  unsupported 
for  10  seconds;  ability  to  take  10  steps  and  the  ability  to  walk  10  metres.  It  has  face 
validity  and  has  been  investigated  for  reliability.  It  is  used  in  a  number  of  clinical 
settings.  The  items  seem  to  forrn  an  obvious  hierarchy,  however  the  definitions  first 
published  prevented  subjects  using  a  walking  aid  in  their  attempts  at  10  paces 
though  an  aid  was  permitted  for  the  10  metre  walk.  This  resulted  in  some  patients 
being  scored  as  "able  to  walk  10  in  but  not  able  to  take  10  independent  steps".  We 
kept  the  original  definitions  throughout  our  study.  The  scale  is  reliable  and  Nralid 
but  has  a  ceiling  effect.  All  our  patients  were  required  to  have  sitting  balance  before 
being  considered  eligible  for  the  study. 
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Motricity  Index  (Demeurisse  et  al.  1980) 
This  index  combines  scores  from  3  tests  each  in  the  arm  and  leg  to  give  a  score  for  the 
left  and  right  side  of  the  body  (0  =  no  movement,  100  =  normal).  The  arm  score  is 
derived  from  scores  (0  -  33)  for  3  tasks,  +I=  score  out  of  maximum  100,  similarly,  the 
leg  has  3  scores  (0  -3  3),  +1  =  score  out  of  maximum  1  oo. 
Side  score  =  (arm  score  +  leg  score)  /  2.  The  patients  are  scored  for  both  their  sides. 
It  is  a  measure  of  impairment,  taking  into  account  general  upper  and  lower  11nib 
function.  It  is  quick  to  administer  and  has  been  tested  for  validity  and  rellabilitY  and 
is  sensitive  to  change  in  stroke  recovery  (Wade  1992). 
Nine  Hole  Peg  Test  (9HPT)  (Mathiowetz  et  al.  1985) 
This  measure  of  disability,  specifically  of  the  upper  limb,  requires  the  patient  to  place 
nine  wooden  pegs  in  holes  in  a  small  board  under  standard  conditions.  We  timed  the 
placing  of  the  pegs.  The  patients  were  allowed  a  maximum  of  50  seconds  to  complete 
the  task.  If  the  test  was  not  completed  in  50  seconds,  the  number  of  pegs  placed  was 
scored.  The  number  of  seconds  taken  to  place  each  peg  was  calculated.  Both  hands 
were  tested.  It  is  a  quick  and  easy  assessment,  frequently  used  in  clinical  practice  and 
research. 
Nottingham  Extended  Activities  of  Daily  Living  (NEADL)  Index  (Noun  & 
Lincoln  1987) 
This  is  a  22-item  measure  of  handicap  (participation  limitation)  in  4  sections 
(mobility,  in  the  kitchen,  domestic  tasks  and  leisure  activities)  scored  0-  66  (0  = 
inactive,  66  =  very  active).  The  sections  form  a  hierarchy  with  stroke  patients 
(Wade  1992)  and  the  scoring  dichotomises  responses  into  those  items  the  patient 
can  participate  in  alone  and  those  items  with  which  they  need  help  or  are  unable  to 
perfon-n. 
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Patient  Satisfaction  Questionnaire  (Pound  et  al.  1994) 
This  is  a  13  item  questionnaire  measuring  patient  satisfaction  with  "hospital  care 
and  treatment"  and  "discharge  and  after".  The  patients  were  sent  the  questionnaire 
by  post,  four  weeks  after  being  discharged  as  inpatients  from  the  rehabilitation 
hospital.  It  has  proven  reliability  and  validity  and  contains  specific  items  on  the 
type  and  amount  of  "therapy"  the  patient  received.  Relatives  or  carers  were  able  to 
help  the  patient  complete  the  questionnaire  but  the  views  expressed  should  havc 
been  those  of  the  patient.  Patients  that  were  discharged  Erom  rehabilitation  hospital 
to  institutional  care  were  not  sent  the  questionnaire. 
'Rankin'  Oxford  Handicap  Scale  (Rankin  1957) 
This  is  a  6-point  scale  (0  =  no  symptoms,  5=  severe  handicap)  that  measures 
"handicap".  We  used  the  cut  off  point  of  3  and  above  to  indicate  dependence  oil 
others.  Many  consider  it  to  be  more  of  a  measure  of  impairment  and  disability 
(especially  mobility  disability).  The  Rankin  score  is,  however,  quick  to  administer 
and  is  widely  used  in  stroke  research.  It  was  included  to  compare  pre-  and  post- 
stroke  handicap. 
Resource  Use 
Information  regarding  use  of  health  and  social  services  was  gathered  by  patient 
interview  at  the  3  and  6  month  assessments.  We  also  recorded  follow  up  that  ý,  V,  as 
planned  at  the  point  of  discharge  from  inpatient  rehabilitation  in  a  review  of  the 
patients'  hospital  records.  This  information  could  not  confirmed  with  the  patients' 
General  Practitioners  or  the  services  concerned  due  to  limited  resources. 
Rivermead  Mobility  Index  (RMI)  (Collen  et  al.  1991) 
This  is  a  15-itern  measure,  scored  0-  15  (0  =  poor  mobility,  15  =  good  mobility).  It 
includes  one  directly  observed  item.  It  measures  disability  (activity  impairment). 
specifically  mobility  disability.  It  is  frequently  used  in  research  and  clinical  practice.  It 
has  established  measurement  properties  and  is  simple  to  administer,  providing  a 
hierarchy  of  mobility  that  covers  a  broad  range  of  abilities  from  turning  in  bed  to 
running. 
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Rivermead  Visual  Gait  Analysis  (Lord  et  al.  1998) 
This  is  a  20  item  measure  of  gait  impairment  scored  from  0-  59  (0  =  normal  gait,  59  = 
grossly  abnormal  gait).  It  was  a  recently  developed  tool  and  has  not  been  widel",  used 
in  other  studies,  however  it  is  valid,  reliable  and  sensitive  to  change  in  mobilitý'.  We 
used  it  as  a  back-up  measure  for  the  high-tech  assessment  of  the  quality  of  gait  though 
in  practice  it  was  difficult  to  use  with  very  disabled  patients.  The  amount  of  data  Nve 
gathered  and  our  analyses  were  limited  and  results  are  not  presented  in  this  thesis. 
Trunk  Control  Test  (In  Wade  1992) 
This  is  a  4-item  measure  of  impainnent  of  (proximal)  trunk  stability,  scored  out  of 
100  (0  =  unable  to  move,  100  =  non-nal).  It  is  commonly  administered  in 
conjunction  with  the  Motricity  Index  (above)  and  is  simple  and  quick. 
Walking  speed  (Bradstater  et  al  1983) 
We  measured  the  patients'  walking  speed  several  different  ways.  They  are  quoted 
in  metres  per  second.  We  measured  the  patients  "preferred"  walking  speed  as 
opposed  to  their  maximum  walking  speed.  We  took  the  measurement  using  a 
stopwatch  and  also  by  electronic  timing  in  the  form  of  the  gait  analysis  equipment. 
We  used  standardised  instructions  for  the  patients  and  carried  out  the  assessment  on 
different  surfaces  both  "normal"  hospital  floor  (linoleum  or  wooden)  or  on  carpet. 
Measures  of  gait  speed  have  been  shown  to  be  valid  and  reliable  and  are  widely 
used  in  clinical  practice  and  research. 
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Glasgow  Augmented  Physiotherapy  After  Stroke  (GAPS)  study 
Collaborative  group  and  staff  members 
Steering  group 
Professor  Peter  Langhorne  (principal  grant  holder),  Academic  Section  of  Geriatric 
Medicine,  Royal  Infirmary,  Glasgow. 
Dr  Jon  Macdonald,  Consultant  in  geriatric  medicine,  Drunichapel  Hospital, 
Glasgow. 
Dr  Christine  McAlpine,  Consultant  in  geriatric  medicine,  Stobhill  Hospital, 
Glasgow. 
Dr  Malcolm  Granat,  Senior  lecturer,  Department  of  Bioengineering,  University  of 
Strathclyde. 
Mr  John  NoMe,  Deputy  director,  Robertson  Centre  for  Biostatistics,  University 
of  Glasgow. 
Mrs  Gisela  Creed,  Superintendent  physiotherapist,  Royal  Infirmary,  Glasgow. 
Miss  Margaret  Nutter,  Superintendent  physiotherapist,  Drunichapel  Hospital, 
Glasgow. 
Mrs  June  Lawrie,  Superintendent  physiotherapist,  Stobhill  Hospital,  Glasgow. 
Mr  Ian  Wellwood,  research  physiotherapist,  (study  co-ordinator). 
Ms  Thorlene  Egerton,  research  physiotherapist,  (principal  assessor). 
Staff  members 
Mrs  Fiona  Moffat,  research  physiotherapist,  Diumchapel  Hospital,  Glasgow. 
Miss  Patricia  Hagen,  research  physiotherapist,  Stobhill  Hospital,  Glasgow. 
Supportftom  Strathclyde  University 
Dr  Douglas  Maxwell 
SUPPortftom  Robertson  Centrefor  Biostatistics 
Miss  Heather  Bailley 
Dr  Janet  Love 
22  33 Appendix  IV 
APPENDIXIV 
Table  A4.1  Considerations  in  choosing  a  method  of  meta-analysis. 
(Deeks  et  al.  2001) 
Choice  of  summary  statistic  depends  upon: 
the  type  of  data  being  analysed  (binary,  continuous,  time-to-event) 
the  consistence  of  estimates  of  the  treatment  effect  across  trials  and  subgroups 
0  the  ease  of  interpretation  of  the  summary  statistic 
Choice  of  weighted  method  depend  upon: 
*  the  reliability  of  the  method  when  sample  sizes  are  small  (may  exclude  invci-sc 
variance  method). 
0  the  reliability  of  the  method  if  the  events  are  very  rare  (may  exclude  inverse 
variance  and  Mantel-Haenszel  methods). 
*  the  degree  of  imbalance  in  allocation  ratios  in  the  trials  (may  exclude  the  Peto 
method). 
*  the  reliability  of  the  method  when  treatment  effects  are  large  (may  exclude  the 
Peto  method). 
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Literature  search 
Main  search  strategy  (MEDLINE  database)  used  for  PINTAS  meta- 
analysis 
1.  cerebrovascular  disorders/  or  exp  basal  ganglia  cerebrovascular  disease/  or 
exp  brain  ischemia/  or  exp  carotid  artery  diseases/  or  cerebrovascular  accident' 
or  exp  brain  infarction/  or  exp  cerebrovascular  trauma/  or  exp  hypoxIa-Ischemia, 
brain/  or  exp  intracranial  arterial  diseases/  or  intracranial  arteriovenous 
malformations/  or  exp  "intracranial  embolism  and  thrombosis"/  or  exp 
intracranial  hemorrhages/  or  vasospasm,  intracranial/  or  vertebral  artery 
dissection/ 
2.  (stroke  or  poststroke  or  post-stroke  or  cerebrovasc$  or  cerebral  vascS  or  cvaS 
or  apoplexy).  tw. 
3.  ((brain$  or  cerebr$  or  cerebell$  or  intracran$  or  intracerebral)  adj  10 
(isch?  emi$  or  infarct$  or  thrombo$  or  emboli$  or  occlus$)).  tw. 
4.  ((brain$  or  cerebr$  or  cerebell$  or  intracerebral  or  intracran$  or  subarachnold) 
adj  10  (haemorrhage$  or  hemorrhage$  or  haematoma$  or  hematoma$  or 
bleed$)).  tw. 
5.  ((brain  or  intracranial)  adj  10  (vascular  adj  5  (disease$  or  disorder  or  accldcnt 
or  injur$  or  insult  or  event  or  attack))).  tw. 
6.  ((isch?  emic  or  apoplectic)  adJ5  (event  or  events  or  insult  or  attack$)).  tw. 
7.  hemiplegia/  or  exp  paresis/ 
8.  (hemipleg$  or  hemipar$  or  paresis  or  paretic  or  acquired  brain  injur$).  tw. 
9.  or/1-8 
10.  exp  Physical  Therapy  Techniques/ 
11.  "Physical  Therapy  (Specialty)"/ 
12.  Physical  Therapy  Department,  Hospital/ 
13.  exp  Exercise  Movement  Techniques/ 
14.  rehabilitation/  or  "activities  of  daily  living"/  or  early  ambulation/ 
15.  Motor  Activity/ 
16.  "Recovery  of  Function"/ 
17.  (physiotherap$  or  physical  therap$  or  exercise  or  rehabilitation  or  physical 
activity).  tw. 
18.  or/10-17 
19.9  and  18 
20.  cerebrovascular  disorders/rh  or  exp  basal  ganglia  cerebrovascular  disease/rh 
or  exp  brain  ischemia/rh  or  exp  carotid  artery  diseases/rh  or  cerebrovascular 
accident/rh  or  exp  brain  infarction/rh  or  exp  cerebrovascular  trauma/rh  or  exp 
hypoxia-ischemia,  brain/rh  or  exp  intracranial  arterial  diseases/rh  or  intracranial 
arteriovenous  malformations/rh  or  exp  "intracranial  embolism  and 
iU 
thrombosis"/rh  or  exp  intracranial  hemorrhages/rh  or  vasospasm,  intracrania  'Fh 
or  vertebral  artery  dissection/rh  or  (hemiplegia/rh  or  exp  paresis/rh) 
21.19  or  20 
22.  (intensive  or  intensity  or  augment$  or  accelerate$  or  additional  or  dosage  or 
dose-response  or  ftequency  or  amount  or  quantity)-tw. 
23.21  and  22 
24.  Randomized  Controlled  Trials/ 
25.  random  allocation/ 
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26.  Controlled  Clinical  Trials/ 
27.  control  groups/ 
28.  clinical  trials/  or  clinical  trials,  phase  i/  or  clinical  th  ii/  or  clinical  trials,  phase  iii/  or  clinical  trials,  phase  iv/ 
phase 
29.  Placebos/ 
30.  placebo  effect/ 
3  1.  Research  Design/ 
32.  Program  Evaluation/ 
33.  evaluation  studies/ 
34.  randomized  controlled  trial.  pt. 
35.  controlled  clinical  trial.  pt. 
36.  clinical  trial.  pt. 
37.  evaluation  studies.  pt. 
38.  meta  analysis.  pt. 
39.  meta-analysis/ 
40.  random$.  tw. 
41.  (controlled  adJ5  (trial$  or  stud$)).  tw. 
42.  (clinical$  adJ5  trial$).  tw. 
43.  ((control  or  treatment  or  experiment$  or  intervention)  adJ5  (group$  or 
subject$  or  patient$)).  tw. 
44.  (quasi-random$  or  quasi  randorn$  or  pseudo-random$  or  pseudo 
random$).  tw. 
45.  ((control  or  experiment$  or  conservative)  adJ5  (treatment  or  therapy  or 
procedure  or  manage$)).  tw. 
46.  (coin  adJ5  (flip  or  flipped  or  toss$)).  tw. 
47.  latin  square.  tw. 
48.  versus.  tw. 
49.  placebo$.  tw. 
50.  sham.  tw. 
5  1.  (assign$  or  alternate  or  allocat$  or  counterbalance$  or  multiple  baseline).  tw. 
52.  controls.  tw. 
53.  (meta-analy$  or  metaanaly$  or  meta  analy$  or  systematic  review  or 
systematic  overview).  tw. 
54.  or/24-53 
55.21  and  54 
56.55  not  23 
57.  limit  23  to  human 
58.  limit  56  to  human 
DOWNLOAD  SETS  57  AND  58 
We  searched  the  following  databases  up  until  the  end  of  2002: 
Medline  1966  onwards;  EMBASE  1980  onwards;  BIOSIS  1969  onwards;  Psych 
INFO  1967  onwards;  Derwent  Drug  File  1964  onwards-,  Scisearch  1974 
onwards;  AMED  1985  onwards;  CINAHL  1982  onwards  and  Cochrane  Strokc 
Group  Trials  Register  to  last  quarter  of  2002. 
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Table  A5.1  Trials  retrieved  for  detailed  evaluation 
Altschuler  et  al.  1999 
Carey  1990 
Duncan  et  al.  1998 
Feys  et  al.  1998 
GAPS  2000  (abstract) 
Green  et  al.  2002 
Kwakkel  et  al.  1999 
Kwakkel  and  Wagenar  2002 
Lincoln  et  al.  1999 
Lincoln  et  al.  1999 
Logigian  et  al.  1983 
Malouin  1993 
Miller  et  al.  2000  (abstract) 
Nugent  et  al.  1994 
Parry  et  al.  1999(a) 
Parry  et  al.  1999(b) 
Partridge  et  al.  2000 
Peacock  et  al.  1972 
Pollock  et  al.  2002 
Rodgers  et  al.  (in  press,  subsequently  published  2003) 
Rapoport  &  Judd-van  Eerd  1989 
Richards  et  al.  1993 
Ruff  et  al.  1999 
Sivenius  et  al.  1985 
Slade  et  al.  1999  (abstract) 
Slade  et  al.  2002 
Smith  et  al.  1981 
Stem  et  al.  1970 
Sunderland  et  al.  1992 
Sunderland  et  al.  1994 
Wade  et  al.  1992 
Walker  et  al.  2000 
Werner  and  Kessler  1996 
Ongoing 
Ng  &  Williams  (pilot) 
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Trials  excluded  from  the  PINTAS  meta-analysis 
We  excluded  a  number  of  trials  because  they  focused  only  on  outpatient 
interventions  (Smith  et  al.  1981)(Duncan  et  al.  1998)  and  (Wemer  and 
Kessler  1996)  or  were  examining  late  interventions  outwith  the  hospital 
setting  (Green  et  al.  2002)  (Wade  et  al.  1992).  Two  studies  were  excluded 
because  they  were  quasi-randomised  (Rappaport  &  Judd  van  Eerd 
1989)(Ruff  et  al.  1999). 
Some  studies  were  confounded  because  they  compared  stroke  unit  care  to 
some  other  form  of  care  (usually  general  medical  ward  care)(Peacock  et  al, 
1972)(Stern  et  al.  1970)(Sivenius  et  al.  1985).  Evidence  from  the  Stroke 
Unit  Trialists  Collaboration  Overview  (Stroke  Unit  Trialists  2003)  suggests 
that  any  treatment  effect  in  these  studies  might  reasonably  be  attributed  to 
the  effect  of  Stroke  Unit  care  rather  than  the  effect  of  increased  intensity  of 
physical  therapy. 
Some  studies  had  unusual  interventions  that  we  did  not  consider  to  reflect 
physiotherapy  practice  in  the  UK  healthcare  system:  using  a  rocking-chair 
and  a  splint  to  give  sensory-motor  stimulation  (Feys  et  al.  1998);  patients 
practising  arm  movement  on  their  own  with  the  use  of  a  mirror  (Altschuller 
et  al.  1999)  and  self-practise  of  rising  from  the  chair  (Pollock  et  al.  2000). 
The  others  identified  by  our  search  were  excluded  as  they  appeared  to  be 
more  focused  on  investigating  the  intervention  rather  than  the  intensity  of 
the  intervention  (Logigian  et  al.  1983)(Carey  1990)(Altschuller  et  al. 
1999)(Walker  et  al.  2000). 
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Table  A5.2  Reasons  for  excluding  studies  from  PINTAS  systematic  review 
Study  Reason  for  exclusion 
Altschuler  et  al.  (1999)  Late  intervention,  focus  Nvas  inten-entioii, 
not  intensity 
Carey  (1990)  Focus  was  intervention  not  intensitv 
Duncan  et  al.  (1998)  Home  based  intervention 
Feys  et  al.  (1998)  Novel  intervention 
Green  et  al.  2002  Late  intervention,  community  based 
Logigian  et  al.  (1983)  Focus  was  intervention,  not  intensity 
Ng  &  Williams  Ongoing  exploratory  pilot  study 
Nugent  et  al.  (1994)  Non  randomised 
Peacock  et  al.  (1972)  Confounded  -  different  settings  (no 
record  of  intensity) 
Pollock  et  al.  (2002)  Focus  was  novel  intervention  not 
intensity 
Rapoport  &  Judd-van  Eerd  (1989)  Quasi-randomised 
Ruff  et  al.  (1999)  Quasi-randomised 
Sivenius  et  al.  (1985)  Methodological  problems,  confounded  - 
different  settings 
Smith  et  al.  (19  8  1)  Part  of  intervention  was  outpatient  based 
and  data  were  not  available 
Stem  et  al.  (1970)  Confounded,  difficulties  witli 
randomisation,  incomparable  treatments 
Wade  et  al.  (1992)  Late  intervention,  community  based 
Walker  et  al.  (2000)  Focus  was  intervention  not  intensity. 
Werner  &Kessler  (1996)  Intervention  was  outpatient  based 
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Review  criteria  used  by  Scottish  Intercollegiate  Guidelines  Neftv,  ork  (SIGN  2004) 
Table  A6.1 
SIGN  Review  Criteria  -  Evaluation  of  internal  validity  of  selected  studies 
Evaluation  criterion 
Does  the  study  address  an  appropriate  and  clearly  focused  ýu--estion? 
Was  the  assignment  of  subjects  to  treatment  groups  randomised? 
Were  the  treatment  and  control  groups  similar  at  the  start  of  the 
trial? 
Was  an  adequate  concealment  method  used? 
Were  subjects  and  investigators  kept  blind  to  treatment  allocation? 
Are  all  relevant  outcomes  measured  in  a  standard,  valid  and  reliable 
way? 
Apart  from  the  treatment  under  investigation,  were  the  groups 
treated  equally? 
What  %  of  the  individuals  or  clusters  recruited  into  the  study  are 
included  in  the  analysis? 
Were  all  the  subjects  analysed  in  the  groups  to  which  they  were 
randomly  allocated? 
Are  the  results  homogeneous  between  sites? 
Table  A6.2  Overall  assessment  of  selected  studies 
Evaluation  criterion 
How  well  has  the  study  done  to  minimise  bias? 
Code  ++,  +,  or  - 
If  coded  +  or  -  what  is  the  likely  direction  in  which  bias  might 
affect  the  study  results? 
Taking  into  account  clinical  considerations,  your  evaluation  of  the 
methodology  used  and  the  statistical  power  of  the  study,  are  you 
certain  that  the  overall  effect  is  due  to  the  study  intervention? 
Gradings  for  overall  assessment  of  selected  studies  (meta-analyses) 
Well  covered 
Adequately  addressed 
Poorly  addressed 
Not  addressed  (i.  e.  not  mentioned,  or  indicates  that  this  aspect  of  study  design  was 
ignored) 
Not  reported  (i.  e.  mentioned  , 
but  insufficient  detail  to  allow  assessment  to  be  niade) 
Not  applicable 
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Internal  Validity 
Does  the  review  address  an  appropriate  and  clearly  focused  question? 
Does  the  review  include  a  description  of  the  methodology  used? 
Was  the  literature  search  sufficiently  rigourous  to  identify  all  relevant  studies? 
Was  study  quality  assessed  and  taken  into  account? 
Does  the  review  include  all  the  potential  benefits  and  harms  of  the  intervention? 
Was  it  reasonable  to  combine  the  studies? 
Do  the  conclusions  flow  from  the  evidence  reviewed? 
Overall  assessment  of  the  study 
How  well  has  the  study  done  to  minimise  bias? 
Code  ++,  +,  or  - 
If  coded  as  +,  or  -  what  is  the  likely  direction  in  which  bias  might  affect  the  study 
results? 
Are  the  results  of  the  study  directly  applicable  to  the  patient  group  targeted  by  this 
guideline? 
Selected  studies  are  described  and  tabulated  with  the  following  headings 
Study 
Intervention 
Outcome  measures  used 
Number  of  patients 
Scale  and  direction  of  measured  effect 
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Table  A6.3  Kev  to  the  Evidence  Statement.,.. 
Levels  of  Evidence  Inclusion  criteria  ::: 
1++  High  quality  meta-analyses,  systematic  rc\-iexvs  of 
ý 
,  randomised  controlled  trials  (RCTs),  or  RCTs  with  a  vei-%, 
low  risk  of  bias 
1+  Well-conducted  meta-analyses,  systematic  reviews  of 
RCTs,  or  RCTs  with  a  low  risk  of  bias 
1-  Meta-analyses,  systematic  reviews  of  RCTs,  or  RCTs  NN-ith 
a  high  risk  of  bias 
2++  High  quality  systematic  reviews  of  case  control  or  cohort 
studies. 
High  quality  case  control  or  cohort  studies  xvith  a  vci-y  lo\\- 
risk  of  confounding  or  bias  and  a  high  probability  that  the 
relationship  is  causal. 
2+  Well  conducted  case  control  or  cohort  studies  with  a  low 
risk  of  confounding  or  bias  and  a  moderate  probability  that 
the  relationship  is  causal. 
2-  Case  control  or  cohort  studies  with  a  high  risk  of 
confounding  or  bias  and  a  significant  risk  that  the 
relationship  is  not  causal. 
3  Non-analytic  studies,  case  reports,  case  series. 
4  Expert  opinion. 
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PINTAS  meta-analysis  -  Additional  data  and  statistical  comments 
This  appendix  contains  information  on  database  management  and  reports  oil 
additional  analyses  carried  out  on  the  Barthel  index  data  and  walking  speed  data  that 
are  not  covered  in  the  main  report. 
Forming  the  database  and  database  management 
Collaborators  provided  data  which  we  cleaned  to  form  a  workable  database  with 
information  on  field  structure,  labelling,  data  assumptions  and  handling  /  coding  of 
missing  values. 
We  incorporated  data  from  the  9  studies,  totalling  951  subjects.  The  data  were  read  ,,  to 
a  master  datafile  containing  data  on: 
Patient  identification  (ID)  number  (both  the  original  study  ID  and  an  assigned 
PINTAS  ID) 
"  Gender 
"  Age 
"  Randomised  treatment  group 
"  Treatment  target 
"  Date  of  onset  of  stroke 
"  Barthel  at  baseline,  1,3,6,  and  12  months 
"  ARAT  at  baseline,  1,3ý  6  and  12  months 
"  Motricity  Ann  Index  at  baseline,  1,3,6,  and  12  months 
Motricity  Leg  Index  at  baseline,  1,3,6,  and  12  months 
Motricity  Total  Index  at  baseline,  1,3,6,  and  12  months 
Standardisation  of  visits 
For  the  Barthel  index,  ARAT  and  Motricity  Index  measurements,  althouizh  most  studies 
measured  at  common  times,  we  chose  to  standardise  the  measurement  times  at  1,3'  6 
and  12  months  for  all  studies.  So  if,  for  example,  a  study  had  a  measurement  at  6  Ný'eeks, 
this  was  assigned  to  the  I  month  slot,  being  the  nearest  standard  time.  If  additional 
measurements  were  made  over  and  above  the  standard  times  e.  g.  at  20  ýeeks.  thell  these 
were  used  if  the  nearest  standard  time  was  missing  e.  g.  if  a6  month  i-cading  was 
missing,  the  20  week  (-  5  month)  reading  was  imputed  as  the  6  month  readim, 
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Measurement  scales 
The  scale  of  each  of  the  measurements  for  each  of  the  studies  NN-as  checked.  For 
example,  most  studies  reported  the  Barthel  index  on  a  scale  of  0-20,  but  some  reported 
on  a  scale  of  0-100,  with  each  point  of  the  0-20  scale  worth  5  points.  For  this  example 
re-scaling  the  0-100  to  the  0-20  scale  is  a  simple  division  by  5.  There  was  one  study  t1lat 
appeared  to  be  on  the  0-100  scale  -  it  had  values  of  88  and  99  -  but  on  closer  inspectioll 
the  distribution  was  entirely  within  the  range  0-20,  with  88  and  99  appearin-  to  be 
special  codes  (e.  g.  not  done,  or  lost).  The  Action  Research  Ann  Test  (ARAT)  values 
were  more  difficult:  the  usual  range  is  0-57,  with  4  subscales  -  two  each  with  a  total  of 
18  points,  one  at  12  and  one  at  9  (Lyle  1981). 
Missing  values 
Missing  values  are  an  important  issue.  As  in  the  example  given  above,  if  an  impossible 
value  has  been  reserved  for  the  missing  data,  there  is  usually  not  a  problem  -  it  call  be 
identified  quite  readily  and  changed  to  missing  in  the  analysis  database.  The  cxanlplc 
above  does  however  illustrate  that  when  combining  studies,  an  impossible  value  on  one 
scale  (88  and  99  on  a  scale  0-20)  can  become  a  legitimate  value  on  another  scale  for  tile 
same  measurement  (0-100).  The  most  difficult  situation  to  spot  is  when  a  legitimate 
value  is  used  as  a  missing  value,  most  commonly,  particularly  when  using  Excel  as  tllc 
datafile,  the  value  zero.  We  have  assumed  throughout  that  the  zeroes  on  the  file  are  all 
legitimate  values,  unless  the  context  clearly  indicates  otherwise.  It  should  be  noted  that 
the  appearance  of  zero  as  a  missing  value  can  happen  unexpectedly,  for  example,  if  data 
are  transferred  from  one  version  to  an  update,  or  to  another  platform  via  an  import  tool, 
or  a  database  translation  tool. 
Missing  data  -  analysis  issues 
There  is  a  further  issue  of  the  handling  of  missing  data  in  the  analysis.  The  analý'ses 
presented  here  are  on  the  basis  of  all  available  information.  That  is,  we  have  iiot 
attempted  to  fill  in  any  of  the  missing  data,  with  the  exception  of  the  'near  adjacclit 
values'  algorithm  stated  above. 
Take  for  example  the  Barthel  index  scores.  There  will  have  been  subjects  in  probably  all 
in 
of  the  studies  that  will  have  missing  Barthel  index  scores  for  a  defi  ite  reason  -  at  one 
extreme,  they  are  so  independent  that  they  have  stopped  participating  it,  the  study.  at  dic 
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other  extreme,  they  died  early  in  the  trial  e.  g.  after  2  weeks.  Somewhere  in-between  rnaý' 
be  the  subjects  who  suffered  a  setback  (e.  g.  a  further  stroke)  that  meant  theý,  NN  ere  not 
receiving  physiotherapy  or  fit  to  be  assessed.  All  of  these  subjects  have  missing  data  that 
may  be  informative  (in  a  statistical  sense)  i.  e.  it  is  not  missing  at  random,  or  missing 
completely  at  random.  If  there  were  any  difference  in  this  "missingn  wn  e  ,,  -  ess"  do  to  th 
randomised  treatment,  then  there  is  a  potential  problem  of  bias.  If  auggirierited 
physiotherapy  had  a  propensity  to  kill  people  (an  extreme  example),  and  further  to  kill 
people  who  were  more  severely  disabled,  or  to  hospitalise  people,  or  evell  to  cause 
people  to  withdraw  more  often  than  on  standard  treatment,  the  current  analý'sls  would 
potentially  be  biased  in  favour  of  augmented  physiotherapy  by  excluding  these  subjects. 
Barthel  index  scores  were  censured  at  death  to  avoid  zero  scores  being  recorded  in 
further  analyses. 
The  duration  of  in-patient  rehabilitation  time  was  measured  in  days.  There  were  a 
variety  of  possible  definitions  of  inpatient  rehabilitation.  Some  say  that  rehabilitation 
starts  on  first  entering  hospital  after  acute  stroke,  alternatively  we  could  take  the  date  of 
transfer  to  an  area  designated  as  a  rehabilitation  or  stroke  unit,  alternatively  wc  could 
look  just  at  the  date  of  randomisation  or  the  date  of  commencing  the  intervention.  Wc 
decided  to  compare  the  groups  from  the  date  the  patient  was  admitted  to  hospital  until 
they  were  either  discharged  home  or  to  another  institution  for  continuing  care.  This  was 
chosen  based  on  availability  and  clarity  of  definition. 
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Exploring  thresholds  of  improvement  in  Barthel  Index  scores 
One  feature  of  using  the  mean  change  in  Barthel  index  score  is  that  if  there  are  sublects 
who  do  worse  on  treatment,  they  tend  to  cancel  out  the  subjects  \vho  do  better  o1i 
treatment.  This  may  or  may  not  be  a  desirable  feature  for  an  outcome  measure.  If  for 
example,  those  who  did  worse  on  treatment  (either  augmented  or  standard)  WOUld  be 
taken  out  and  treated  differently  e.  g.  physiotherapy  was  suspended,  then  it  m1glit  bc 
better  to  use  an  outcome  that  focussed  on  treatment  successes. 
Tables  A8.1  and  A8.2  show  the  results  for  just  such  an  approach  based  on  3  month 
and  6  month  follow  up  data  respectively.  There  were  no  differences  at  any  threshold 
at  I  month  follow  up  (data  not  shown). 
We  defined  as  a  treatment  success  a  subject  who  either  (a)  has  a  change  ova  baselitie  is 
greater  than  or  equal  to  the  stated  threshold  change  over  baseline  Barthel  index  score  or 
(b),  or  a  subject  who  has  achieved  the  maximum  score  on  the  measure  (and  so  cannot 
improve  further).  Treatment  success  is  than  modelled  as  a  binary  outconie  in  a  logistic 
regression  using  study,  age,  gender,  and  treatment  group  as  covanates.  These  logistic 
regressions  were  fitted  separately  for  months  3  and  6  (See  Figure  A8.1).  The  data  for 
month  12  were  so  sparse  that  no  analysis  was  done  for  this  time. 
Table  A8.1  Defining  treatment  success  at  different  stated  thresholds  of  change  in 
Barthel  index  score  at  3  month  follow  uP 
Threshold 
Month  3 
N(ST)  N(AU)  OR(95%Cl)  p 
7  137(45%)  213(52%)  1.33(0.96,1.85)  0.086 
8  122(40%)  184(45%)  1.24(0.89,1.72)  0.20 
9  99(32%)  163(40%)  1.47(l.  04,2.06)  0.027 
10  86(28%)  143(35%) 
--.. 
1.47(1.03ý  2.08) 
--  ý1  -1  -  --  .*-  f-T  - 
0.033 
C-f-itipnre 
ST  =Standard  physiotherapy,  AU  =  AugmentecipIlYSIOUICIapy, 
interval 
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Table  A8.2  Defining  treatment  success  at  different  stated  thresholds  of  chanýCe 
Barthel  index  score  at  6  month  follow  up  I. 
Threshold  Month  6 
N(ST)  N(AU)  OR(95%Cl)  -P 
>7  144(54%)  223(63%)  1.40(0.99,  -2.00)0.06')- 
8  130(49%)  200(56%)  1.37(0.97,1.94)  0.0-7-9- 
9  117(44%)  185(52%) 
- 
1.41(0.99,1.99)  ý!  o.  ()-ý--4- 
10  101(38%)  16ý  (46%)  1.44(1.01-,  -2.05-)  --  To  o4ý, 
ST  =  Standard  physiotherapy,  AU  =  Augmented  physiotherapy,  OR  =  Odds  ratio,  Cl  =  Confidelice 
interval 
The  data  shown  are  the  number  of  subjects  (%)  in  each  randomised  treatment  aroup 0 
who  have  a  change  over  baseline  Barthel  index  score  at  least  as  great  as  the  stated 
threshold,  and  the  Odds  Ratio  (OR),  adjusted  for  study,  age  and  gender,  with  95% 
confidence  interval  and  associated  P-value  for  augmented  vs.  standard 
physiotherapy. 
Figure  A8.1  Exploration  of  threshold  of  change  in  Barthel  index  score  in  PINTAS 
database  in  order  to  define  "Treatment  success" 
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We  focussed  only  on  large  treatment  effects  of  a  change  over  baseline  of  -  units  of 
Barthel  index  or  greater.  At  the  earlier  time  of  3  months  there  appears  an  advantage  for 
augmented  over  standard  physiotherapy  at  very  large  treatment  effects  of  9  units  of 
Barthel  index  or  higher,  with  an  increase  in  odds  of  almost  50%  (Odds  Ratio  [OR]  1.47, 
95%  confidence  interval  1.04  to  2.06,  P=0.027  for  a  change  ýýt9,  P=0-033  for  a  change 
ý!!  10). 
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"Clinically  significant"  change  in  Barthel  index  score 
Following  the  Collaborators'  meeting  and  in  order  to  aid  interpretation  of  our  rcsLi  ts  t-)r  IL 
the  Barthel  index  analyses,  we  wanted  to  find  the  Collaborative  group  members'  opinion 
of  what  might  be  a  "clinically"  significant  change  in  BI  score. 
Before  they  were  aware  of  the  above  results  we  sent  a  short  questionnaire  to  all 
members  of  the  collaborative  group,  asking  their  opinion  on  the  folloNN'ing  questions: 
"at  do  you  consider  to  be  a  "clinically  significant  "  change  in  the  BI  score? 
e.  g.  a  change  in  score, 
percentage  improvement  over  baseline 
or  give  a  clinical  cut  offpoint  e.  g.  10120  or  16120for  categorizing  patients. 
We  also  asked  for  comments  and  for  the  group  to  identify  which  items  on  the  BI  wcre 
most  likely  to  be  influenced  by  physiotherapy  intervention,  which  might  reflect  overall 
impairment,  which  might  reflect  upper  limb  impairment  and  which  might  reflect  lowcr 
limb  impairment. 
All  but  one  collaborator  responded  and  there  were  a  wide  variety  of  comments  from  this 
small  group. 
Changes  in  score  varied  from  I  to  10  points  with  "significant  clinical  thresholds"  e.,, 
the  difference  between  dependent  and  independent  living,  varying  from  15  -  18  points 
Dn  the  Barthel  index. 
It  was  difficult  to  generalize  from  the  groups'  open  comments,  but  all  were  lookim-,  for 
far  greater  change  than  we  saw  in  results  from  our  analyses.  It  was  acknoxvIedged  that 
3mall  changes  may  still  be  clinically  significant  for  Indiv,  dual  patients  especially  where 
-hese  took  them  from  dependence  to  Independence  even  In  one  Itern  on  the  Bl. 
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ý'Clinically  significant"  change  in  Barthel  index  score 
Following  the  Collaborators'  meeting  and  in  order  to  aid  interpretation  Of  our  results  for 
Ie  Barthel  index  analyses,  we  wanted  to  find  the  Collaborative  group  members'  opinion 
: )f  what  might  be  a  "clinically"  significant  change  in  BI  score. 
Before  they  were  aware  of  the  above  results  we  sent  a  short  questionnaire  to  all 
members  of  the  collaborative  group,  asking  their  opinion  on  the  folloNý-ing  questions: 
"at  do  You  consi  . der  to  be  a  "clinically  significant  "  change  in  the  BI  score  " 
?.  g.  a  change  in  score, 
7ercentage  improvement  over  baseline 
)r  give  a  clinical  cut  offpoint  e.  g.  10120  or  16120for  categorizing  patients. 
We  also  asked  for  comments  and  for  the  group  to  identify  which  items  on  the  BI  were 
nost  likely  to  be  influenced  by  physiotherapy  intervention,  which  might  reflect  overall 
mpairment,  which  might  reflect  upper  limb  impairment  and  which  might  reflect  lo%\  cr 
imb  impairment. 
kll  but  one  collaborator  responded  and  there  were  a  wide  variety  of  comments  from  this 
mall  group. 
e.  'hanges  in  score  varied  from  I  to  10  points  with  "significant  clinical  thresholds' 
he  difference  between  dependent  and  independent  living,  varying  from  15  -  IS  points 
)n  the  Barthel  index. 
t  was  difficult  to  generalize  from  the  groups'  open  comments,  but  all  wcre  looking  for 
I  ar  greater  change  than  we  saw  in  results  from  our  analyses.  it  Nvas  acknowledged  that 
mall  changes  may  still  be  clinically  significant  for  individual  patients  especia]INI  wherc 
aese  took  them  from  dependence  to  independence  even  in  one  Itern  on  the  Bl. 
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Additional  data  summaries  for  "Change  in  outcome  score"  analyses  in  Chapter  5. 
Additional  data  are  given  from  the  available  trials  for  change  in  NRAT  score,  walking 
speed  and  change  in  Barthel  index  score. 
Table  A8.3  Mean  (SD)  Action  Research  Arm  Test  (ARAT)  scores  in  PINTAS  meta 
analysis 
Study  Time  Standard  Augmented  Total 
N  Mean(SD)  N  Mean(SD)  N  Mean(SD) 
o 
1  35  25.0(22-9)  34  27.7(20.5)  69  26.3(21.6) 
3  33  28.9(23.0)  32  31.5(21.0)  65  30.2(21.9) 
6  33  28.2(24.2)  28  30.3(20.6)  61  29.2(22.5) 
12  - 
-kw-akkel  0  37  1.3(3.1)  64  4.1(10.1)  101  3.0(8.3) 
1  35  7.3(15.4)  59  13.7(20.0)  94  11.3(18.6)  1 
3  35  8.7(17.7)  53  19.4(22.9)  88  15.1(21.6)---- 
6  37  10.2(19.5)  59  21.7(23.9)  96  ,  17.3(22.9) 
12  34  12.2(20.7)  57  20.6(23.2)  91  17.5(22.6) 
Lincoln  0  95  7.2(13.6)  187  5.9(12.3)  282  6.4(12.7) 
1  89  17.4(20.3)  166  17.6(21.0)  255  17.5(20.7) 
3  61  22.9(22.7)  128  22.7(23.0)  189  22.8(22.9) 
6 
12 
Rodgers  0  61  18.5(22.8)  62  19.1(22.0)  123  18.8(22.3) 
1 
3  51  36.5(25.3)  54  38.3(22.6)  105  37.4(23.8) 
6  48  40.8(22.9)  48  38.6(23.5)  96  39.7(23.1) 
12  - 
TOTAL  0  193  9.6(17.2)  313  8.2(15.4)  506  8.7(16.1) 
1  159  16.9(20.7)  259  18.0(21.0)  418  17.6(20-9) 
3  119  26.2(25.4)  139  29.5(23.7)  258  28.0(24.5) 
6  179  26.1(24.7)  263  26.2(23.8)  442  26.2(24.1) 
12  34  12.2(20.7)  57  20.6(23.3)  91  17.5(22.6) 
SD  =  Standard  deviation 
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Table  A8.4  Mean  walking  speed  in  PINTAS  meta-analysis 
Study  Time  Standard  Augme  ted  Difference  A-S 
n  Mean(SD)  n  Mean(SD) 
_  _Mean(9-5'lo 
Cl)  P-value 
GAPS  0  - 
1  35  0.36(0.37)  0.45(0.43) 
_ 
0.09  (-0.10,0.28) 
3  35  1  0.49(0.37)  32  0.54(0.34)  0.06  (412,0.23)  0.5 
6  34  0.48(0.36)  29  0.59(0.36)  J.  11  (408,0.29)  0.24 
-- 
12  -  -  -  -  -  akkel  Tw  0  37 
. 
05(0.22)  0  Z  4  0.04(0.14)  -- 
1  35  0.28(0.54)  57  0.42(0.63)  0.13  (-0.12,0.39) 
3  32  1  0.50(0.58)  56  0.64(0.66)  0.14  (-0.14 
ý  0.4  2) 
6  36  0.66(0.59)  59  0.73(0.65)  0.08  (-0.18ý  0.34)  1  0.54 
12  33  0.70(0.58)  53  0.81(0.67)  0.11  (-0.17,0.39)  0.43 
Partridge  0  60  0.01(0.06)  54  o(o)  -  -  1  56  0.15(0.22)  52  0.15(0.19) 
_0.00 
(-0.07,0,08)  -  0.92 
3 
6 
12 
Richards  0 
1  7  0.24(0.15)  15  0.28(0.17)  0.04  (412,0.19)  0.60 
3  7  0.34(0.22)  15  0.32(0.18)  -0.02  (-0.21, 
0.17) 
0.84 
6 
12 
Sunderland  0 
1  55  0.33(0.38)  57  0.33(0.37)  0.00  (-0.14,0.14)  0.96 
3  59  0.36(0.38)  54  0.39(0.41)  0.03  (-0.12,0.18)  0.68 
6  54  0.35(0.40)  55  0.45(0.44)  0.09  (-0.07,0.25)  0.25 
12  39  0.44(0.41)  36  0.50(0.48)  0.06  (-0.15,0.26)  0.58 
TOTAL  0  97  0.02(0.14)  118  0.02(0.11)  -  - 
1  188  0.27(0.38)  215  0.33(0.44)  0.05  (-0.03,0.13)  0.23 
3  133  0.42(0.43)  157  0.50(0.56)  0.07  (-0.04,0.17)  0.23 
6  124  0.48(0.47)  143  0.59(0.54)  0.09  (-0.03,0.21)  0.13 
12  72  0.56(0.51)  89  0.69(0.62)  0.09  (-0,09,0.26)  0.32 
SD  =  Standard  deviation,  CI  =  Confidence  interval 
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Table  A8.5.  PINTAS  meta-analysis:  Change  over  baseline  in  Barthel  index  score.  By  randomised  treatment  group,  and  difference  in  change  over  baseline  between 
randomised  treatment  groups 
Study  Time  Standard  Augme  ted  Augmented  -  Standard* 
n  Mean(SD)  n 
- 
Mean(SD)  - 
- 
-  Difference  (95Oo  P-value 
CI) 
GAPS  1  34  4.0(3.0)  3  3  2.9(2.6) 
3  33  5.7(4.0)  32  5.1(3.3)  -0.6(-2.4,1.2)  Ul 
6  34  5.9(4.1)  31  5.1(3.7)  -  -0.9(-2.8,  -1.1)  0.3", 
- -- 
12  -  - 
akkel  k  w  1  36  4.8(3.1)  60  6.0(4.4)  1.2(4428)  0.1  ý 
3  35  1  7.4(3.9)  56  9.5(3.8)  2.2(0.5,3.8)  0.009- 
6  37  9.7(4.1)  58  11.1(3.9)  1.4(-0.3,3.0)  0.1-0 
12  34  10.1(3.9)  54  10.7(4.0)  0.6(-1.2,2.1)  0.51 
Lincoln  1  89  5.1(4.4)  168  5.1(3.9)  0(-  1.1,1.0)  0.98 
3  83  6.6(4.0)  157  6.1(3.9)  -0.5(-1.5,0.6)  0.35 
6  79  7.3(4.6)  151  1  7.1(4.2)  -0.2(-1.4,  -1.0)  0.7, 
12  -  -I  - 
- 
-  - 
Richards  1  7  1  8.9(5.8)  15  7.5(4.9)  -1.4(-6.3,3.6)  U7 
3  7  10.5(5.0)  15  10.7(4.1)  0.2(-4.0,4.4)  0.  ()', 
6 
12 
Rodgers  1 
3  51  4.5(5.6)  51  4.0(5.5)  -0.5(-2.7,1.6)  0.62 
6  48  4.7(5.5)  45  5.5(4.8)  0.8(-1.3,2.9)  04, 
12  -  -  ---  Slade  1  39  1.7(2.0)  40  2.0(2.0)  0.3(-0.6,1.2)  0.40_ 
3  28  1.3(2.2)  37  2.6(3.1)  1.3(-0.1,2.6)  0,07-1 
6  7  0.3(0.7)  9  0.9(l.  6)  0.6(-0.8,2.0)  0.40 
12  2  1.9(l.  8)  0(-)  -1.9(-20,20)  U5 
Sunderland  1  65  3.4(3.9)  65  4.0(4.1)  0.6(-0.8,2.0)  0.3  8 
3  68  5.3(3.8)  63  6.2(4.9)  0.9(-0.6,2.4)  0.24 
6  61  6.5(3.6)  61  6.9(5.2)  0.4(-1.2,2.0)  0.63 
12  44  6.5(3.5)  34  8.1(4.9)  1.6(-0.3,3.5)  0.10 
TOTAL*  1  270  4.1(3.9)  381  4.6(4.0)  0.2(-0.4,0.8) 
-  - 
0.  ýs 
3  305  5.6(4.4)  411  6.1(4.6)  0.3(-0.3,6  .9 
)  0,40 
6  266  6.6(4.7)  55 
_ 
7.2(4.8)  0.3(-0.4,1.0)  0.47 
12  80  7.9(4.1)  q 
+ 
9  83  9.6(1ý6)  1.0(-0.3,2.2)  1  0.12 
SD  =  Standard  deviation,  Cl  =  Confidence  interval 
*  For  the  TOTAL,  from  a  separate  linear  model  for  each  time  point  that  adjusts  for 
study.  Otherwise,  for  each  individual  study,  from  a  separate  linear  model  for  each  time 
point. 
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Shortened  versions  of  the  Barthel  index 
There  is  a  suggestion  that  some  of  the  10  elements  of  the  Barthel  index  are  not  likely  to 
be  clinically  relevant  to  post  stroke  physiotherapy  inten,  ention.  Following 
. 
the 
investigations  of  Hobart  and  Thompson  (Hobart  and  Thompson  2001).  we  adopted  two 
shortened  versions  of  the  Barthel  index:  first,  a  score  using  just  3  categWrles  (tile 
transfer,  stairs  and  mobility  questions),  and  then  a  score  using  6  categories  (tile 
previously  listed  plus  dressing,  toilet  use,  and  bathing).  Results  for  these  versions  arc 
given  in  table  A8.6  and  table  A8.7  respectively. 
Table  A8.6  PINTAS  meta-analysis.  Using  a  3-item  shortened  Barthel  index 
(transfer,  stairs,  mobility)  -  number  of  subjects,  mean  and  standard  deviation  over 
time 
Time  Standard  Augmented 
N  Mean  SD  N  Mean  SD 
Baseline  226  2.02  1.84  345  1.86  1.77 
1  -month  198  4.00  2.70  301  3.83  2.72 
3-month  232  4.67  2.58  336  4.85 
_2.63  6-month  205  5.37  2.47  297  5.51  2.55 
SD  =  Standard  deviation 
There  was  no  statistical  evidence  of  a  development  of  the  change  over  baseline  in 
the  3-category  shortened  Barthel  index  between  augmented  and  standard 
physiotherapy  groups:  P=0.92  in  a  test  for  interaction  from  a  repeated  measures 
model  as  previously  specified  for  the  full  10  category  Barthel  index.  The  estimated 
treatment  effect  due  to  augmented  physiotherapy  compared  with  standard 
physiotherapy  was  0.16  (95%  confidence  interval  -0-23  to  0.56,  P=0.41). 
Table  A8.7  PINTAS  meta-analysis  -  Using  a  6-item  shortened  Barthel  index 
(transfer,  stairs,  mobility,  dressingg  toilet  use,  bathing)  -  number  of  subjects'  mean 
and  standard  deviation  over  time 
Time  Standard 
N  Mean  SD 
Baseline  226  3.11 
_2.86  1  -month  198  6.37 
- 
4.11 
3-month  232  7.87  4.12 
6-month  205  8.77  3.99 
Augmented 
N  Mean  SD 
345  2.80 
-  ----,  --1.84  -- 
301  6.06 
- 1ý 
4.06 
ý 
336  1  7.4  4.2  5  9 
--  20 
ýk879 
14.05 
SD  =  Standard  deviation 
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There  was  no  statistical  evidence  of  a  development  of  the  change  over  baseline  in 
the  6-category  shortened  Barthel  index  between  augmented  and  standard 
physiotherapy  groups:  P=0.87  in  a  test  for  interaction  from  a  repeated  rneastires 
model  as  previously  specified  for  the  full  10  category  Barthel  index.  The  estinlated 
treatment  effect  due  to  augmented  physiotherapy  compared  with  standard 
physiotherapy  was  0.23  (95%  confidence  interval  -0.40  to  0.85,  P=0.48). 
Additional  analysis  of  walking  speed,  excluding  subjects  who  were  not  obser%,  ed  to 
walk  at  any  time  during  the  study 
An  additional  analysis  of  the  walking  speed  data  was  undertaken,  in  which  subjects 
who  did  not  show  any  evidence  of  walking  at  any  point  in  the  study  werc  cxcluded. 
The  aim  here  was  to  take  out  any  effect  of  subjects  for  whom  no  amount  of 
physiotherapy,  augmented  or  standard,  was  having  an  effect,  and  so  allow  a  more 
precise  estimate  of  what  the  possible  advantage  of  intensive  physiotherapy  might 
have  in  the  subset  of  subjects  for  whom  an  improvement  through  the  use  of 
physiotherapy  might  be  anticipated.  This  analysis  therefore  attempts  to  mirror  what 
might  happen  in  practice  in  the  management  of  a  patient,  with  those  for  whom 
physiotherapy  is  inappropriate  or  impossible,  and/or  for  those  who  physiotherapy  is 
showing  consistently  no  progress  from  a  start  point  of  not  walking  not  considered 
for  further  physiotherapy  until  an  improvement  occurs. 
This  strategy  of  excluding  subjects  who  never  showed  any  evidence  of  a  non-zero 
walking  speed  resulted  in  the  omission  of  n=63  subjects  receiving  standard 
physiotherapy  and  n=58  subjects  receiving  augmented  physiotherapy.  That  similar 
numbers  were  excluded  from  each  group  is  encouraging  in  that  we  can  be  someývhat 
reassured  that  the  resulting  comparison  is  not  likely  to  be  seriously  blased  either  for 
or  against  augmented  physiotherapy.  If,  for  example,  augmented  physiotherapy 
worked  well  for  some  but  was  damaging  for  others,  one  might  expect  to  see  the 
latter  type  of  subjects  contributing  to  more  exclusions  from  the  augmented 
physiotherapy  group.  If  on  the  other  hand  augmented  physiotherapy  was  particularly 
beneficial  for  getting  the  non-walkers  started  again  at  NN'alkin,,  one  might  expcct  to 
see  fewer  patients  excluded  from  the  augmented  group  than  the  comparison  group. 
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Results  are  given  in  Table  A8.8  below. 
Table  A8.8  PINTAS  meta-analysis:  Walking  speed  (with  subjects  who  never 
walked  excluded)  by  month  and  treatment  group. 
Time  Standard  ugm  nted  Difference  A-S  I 
- 
N  Mean(SD)  N  Mean(SD)  Mean(95%  CI)  p 
0  54  0.04(0.19)  78_  0.03(0.13)  - 
1  131  0.39(0.40)  164  0.43(0.45)  0.05  (-0.05,0.15)  -0-35 
3  105  0.54(0.42)  132  0.60(0.49)  0.06  (-0.06,0.18)  0.33 
6  99  0.60(0.45)  114 
. 
0.7  5  (0.5  0)  0.12  (-0.01,0.25)  0.061 
12  59  0.68(0.48)  72  0.85(0.57)  0.13  (-0.06,0.32)  0.17 
SD  =  Standard  cleviation,  Ul  =  Uonlidence  mterval 
There  was  no  evidence  of  a  treatment  by  time  interaction  (P=0.41).  The  estimated  effect 
of  augmented  compared  with  standard  physiotherapy  on  walking  speed  amongst  the 
subjects  who  walked  at  some  point  in  the  study  was  0.07  rns-I  (95%  CI  -0.02  to  0.16, 
P=O.  12). 
For  the  pre-specified  subgroups  of  age,  disability  severity,  target  of  treatment,  and 
baseline  severity  of  arm  impairment  there  was  no  evidence  of  any  treatment  by  time 
interactions,  nor  of  any  formally  significant  differences  in  treatment  effect  between  the 
levels  of  the  subgroups.  Table  A8.9  below  surnmarises  these  results: 
Table  A8.9  PINTAS  meta-analysis:  Walking  speed  (with  subjects  who  never 
walked  excluded)  by  subgroup. 
Subgroup  Level  Augmented-Standard  (95% 
CI) 
- 
P-value 
Barthel  :! ý10  0.11  (0.03  to  0.24)  0.12 
>10  0.01  (-0.13  to  0.16)  0.86 
Target  Arm  Only  0.05  (-0.12  to  0.23)  0.23 
Leg  or  Mixed  0.08  (403  to  0.19)  0.16 
Age  <70  years  0.11  (0.03  to  0.25)  0.13 
>70  years  0.04  (407  to  0.15)  0.51 
Arm  impairment  Moderate  0.11  (-0.0  1  to  0.24)  0.079 
Severe  0.14(-0.03toO.  31) 
_ 
0.095 
CI  =  Confidence  interval 
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